Page last updated: 2024-11-06

epigallocatechin gallate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID65064
CHEMBL ID297453
CHEBI ID4806
SCHEMBL ID35258
MeSH IDM0132653

Synonyms (154)

Synonym
KBIO1_001317
DIVK1C_006373
SDCCGMLS-0066550.P001
(-)-egcg
teavigo
epigallocatechin-3-gallate
sunphenon
(-)-epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate)
ccris 3729
epigallo-catechin gallate
(-)-epigallocatechol gallate
egcg cpd
tea catechin
epigallocatechol, 3-gallate, (-)-
(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-chromen-3-yl 3,4,5-trihydroxybenzoate
(-)-epigallocatechin-3-o-gallate
(-)-epigallocatechin 3-gallate
CHEBI:4806 ,
[(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-chromen-3-yl] 3,4,5-trihydroxybenzoate
SPECTRUM_000316
BSPBIO_001628
ACON1_001054
MEGXP0_001166
SPECTRUM5_000102
(-)-epigallocatechin gallate ,
catechin deriv.
egcg ,
benzoic acid, 3,4,5-trihydroxy-, (2r,3r)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl ester
epigallocatechin gallate
[(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate
MLS001424000
C09731
989-51-5
epigallocatechin 3-gallate
smr000449288
MLS000758300
NCGC00164319-01
KBIO2_005932
KBIOSS_000796
KBIO3_001128
KBIO2_003364
KBIOGR_002002
KBIO2_000796
SPECPLUS_000277
SPECTRUM3_000244
SPECTRUM2_000168
SPBIO_000035
SPECTRUM4_001541
SPECTRUM210239
NCGC00164319-02
NCGC00164319-03
epigallocatechin-3-o-gallate
(-)-epigallocatechin gallate, >=80% (hplc), from green tea
(-)-epigallocatechin gallate, >=95%
LMPK12030005
HMS2051K21
E0694
(-)-cis-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2h)-benzopyran-3-yl gallate
CHEMBL297453 ,
epigalocatechin gallate
KDH ,
cid_65064
bdbm50070942
epigallocatechin monogallate, b
(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate
A845931
NCGC00164319-04
NCGC00164319-06
NCGC00257243-01
cas-989-51-5
dtxcid80567
dtxsid1029889 ,
tox21_303457
tox21_201468
NCGC00259019-01
AKOS015918182
CCG-38378
gallic acid, 3-ester with epigallocatechol, (-)-
nvp-xaa 723
unii-bqm438ctel
benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl ester, (2r-cis)-
epigallocatechin-3-monogallate
l-epigallocatechin gallate
bqm438ctel ,
pf-egcg 90
HY-13653
CS-1258
epigallocatechin-gallate
(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-chromen-3-yl-3,4,5-trihydroxybenzoate
egcg [mi]
epigallocatechin gallate [inci]
3-o-galloyl-(-)-epigallocatechin
(-)-epigallocatechin-3-o-gallate [usp-rs]
epigallocatechin 3-o-gallate
egcg [who-dd]
S2250
gtpl7002
(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
BP-30205
FR-109
[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate
NC00078
SCHEMBL35258
4AWM
3OOB
2KDH
3,4,5-trihydroxybenzoic acid (2r,3r)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl ester
AC-34075
Q-100914
3,4-dihydro-5,7-dihydroxy-2r-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3r-yl-3,4,5-trihydroxybenzoate
HMS3649E08
(-)-cis-3,3',4',5,5',7-hexahydroxy-flavane-3-gallate
(-)-cis-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1(2h)-benzopyran-3,5,7-triol 3-gallate
(-)-epigallocatechin gallate, analytical standard
epigallocatechol gallate
SR-01000759328-6
SR-01000759328-5
sr-01000759328
epigallocatechin gallate, primary pharmaceutical reference standard
(-)-epigallocatechin gallate, >=97.0% (hplc)
(-)-epigallocatechin-3-o-gallate, united states pharmacopeia (usp) reference standard
epigallocate
(-)-epigallocatechin gallat
(-)-epigallocatehin gallate
epigallocatcchin gallate
epigallocic acid
3-o-galloylepigallocatechin
teatannin ii
epigallocatechingallate
[(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2h-chromen-3-yl]3,4,5-trihydroxybenzoate
(-)-epigallocatechin 3-o-gallate
epigallocatechin gallate, pharmaceutical secondary standard; certified reference material
SW197458-3
DB12116
(-)-epigallocatechin-3-gallate; egcg
DS-9030
Q393339
galloyl-l-epigallocatechol
SR-01000946601-1
sr-01000946601
benzoic acid, 3,4,5-trihydroxy-,(2r,3r)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl ester
epigallocatechin-gallate-(-)
M01719
epigallocatechin-3-gallate 1000 microg/ml in acetonitrile
(-)-epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)-epicatechin gallate)
(2r,3r)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate
HY-13653R
CS-0694875
(-)-epigallocatechin gallate (standard)
((2r,3r)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate
(2r-cis)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2h-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate
(-)-epigallocatechin-3-o-gallate (usp-rs)
(-)-epigallocatechin-3-o-gallate (egcg) (constituent of powdered decaffeinated green tea extract)
(-)-epigallocatechin-3-gallate

Research Excerpts

Overview

Epigallocatechin gallate (EGCG) is a polyphenol present in green tea (Camellia sinensis) It has revealed anti-cancer effects toward a variety of cancer cells in vitro and protective potential against neurodegenerative diseases such as Alzheimer's and Parkinson's.

ExcerptReferenceRelevance
"Epigallocatechin gallate (EGCG) is a polyphenolic compound from green tea that exerts antiviral activity against diverse viruses."( EGCG Restricts PRRSV Proliferation by Disturbing Lipid Metabolism.
Chu, BB; Fu, PF; Li, HW; Li, XQ; Qi, YL; Wang, J; Wang, MD; Wang, Q; Yang, GY; Yu, PW; Zeng, L, 2022
)
1.44
"Epigallocatechin gallate (EGCG) is an active catechin in green tea and has multiple biological functions, such as anti-inflammation, anti-cancer, and immune regulation. "( Epigallocatechin gallate relieves asthmatic symptoms in mice by suppressing HIF-1α/VEGFA-mediated M2 skewing of macrophages.
Li, X; Yang, N, 2022
)
3.61
"Epigallocatechin gallate (EGCG) is a compound with very high therapeutic potential in the treatment of osteoporosis and cancer. "( Zeolites with Divalent Ions as Carriers in the Delivery of Epigallocatechin Gallate.
Chojnacka, M; Ratajczak, M; Sandomierski, M; Voelkel, A, 2023
)
2.6
"Epigallocatechin gallate (EGCG) is a polyphenol present in green tea (Camellia sinensis), which has revealed anti-cancer effects toward a variety of cancer cells in vitro and protective potential against neurodegenerative diseases such as Alzheimer's and Parkinson's. "( Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.
Bakun, P; Cerbin-Koczorowska, M; Goslinski, T; Jelińska, A; Koczorowski, T; Kolasiński, E; Kuźmińska, J; Mlynarczyk, DT; Piwowarczyk, L; Stawny, M, 2023
)
2.71
"(-)-Epigallocatechin gallate (EGCG) is a major, active component in green tea and may scavenge free radical oxygen and attenuate inflammation."( (-)-Epigallocatechin gallate-loaded polycaprolactone scaffolds fabricated using a 3D integrated moulding method alleviate immune stress and induce neurogenesis.
Cheng, Y; Fan, C; Fang, Z; Ouyang, Y; Qian, Y; Wang, X; Yao, Z; Yuan, WE, 2020
)
1.6
"Epigallocatechin gallate (EGCG) is an inhibitor of DYRK1A, a serine/threonine kinase considered to be a major contributor of cognitive dysfunctions in Down syndrome (DS). "( Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup
Cieuta-Walti, C; Dairou, J; de la Torre, R; Dierssen, M; Gu, Y; Janel, N; Moroy, G; Paul, JL; Rebillat, AS, 2020
)
2
"Epigallocatechin gallate (EGCG) is a natural polyphenol that exerts beneficial antioxidant and anti-inflammatory effects."( Epigallocatechin gallate alleviates neuronal cell damage against focal cerebral ischemia in rats.
Kang, JB; Koh, PO; Park, DJ, 2020
)
2.72
"Epigallocatechin gallate (EGCG) is a polyhydroxy phenolic compound extracted from tea and its antitumor effect has received widespread attention. "( Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats.
Chen, H; Fang, MZ; Huang, SL; Jin, HY; Kong, DS; Li, M; Sun, Y; Wang, SM; Wang, XF; Wang, Y; Zhang, X, 2020
)
3.44
"Epigallocatechin gallate (EGCg) is a polyphenol that is abundant in green tea."( Effect of epigallocatechin gallate on gene expression of Staphylococcus aureus.
Honjoh, KI; Katsuki, M; Kitichalermkiat, A; Masuda, Y; Miyamoto, T; Sato, J; Sonoda, T, 2020
)
1.68
"Epigallocatechin gallate (EGCG) is a naturally derived flavonoid with strong antioxidant property."( Identification of regulated proteins by epigallocatechin gallate treatment in an ischemic cerebral cortex animal model: a proteomics approach.
Kang, JB; Koh, PO; Park, DJ, 2021
)
1.61
"Epigallocatechin gallate (EGCG) is a potential therapeutic agent for treatment of atopic dermatitis (AD) due to its antioxidant and anti-inflammatory activities. "( Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.
Chen, MC; Chiu, YH; Hung, JI; Wu, YW, 2021
)
3.51
"Epigallocatechin gallate(EGCG) is a monomer separated from tea catechins, as an well-known antioxidant, which helps fight wrinkles and rejuvenate skin cells. "( Anti-skin-aging effect of epigallocatechin gallate by regulating epidermal growth factor receptor pathway on aging mouse model induced by d-Galactose.
Chen, J; Huang, Y; Li, T; Li, Y; Lu, H; Ma, X; Sheng, J; Shi, R; Wang, X; Wei, N; Zhu, Q, 2017
)
2.2
"Epigallocatechin gallate (EGCG) is a main constituent of green tea polyphenols that are widely used as food preservatives and are considered to be safe for consumption. "( Transcriptomic analysis of the response of Pseudomonas fluorescens to epigallocatechin gallate by RNA-seq.
Du, P; Li, J; Liu, X; Shen, B; Sun, A; Wang, J; Wang, N, 2017
)
2.13
"Epigallocatechin gallate (EGCG) is a potent activator of NRF2 and has shown beneficial effects on multiple diabetic complications."( NRF2 Plays a Critical Role in Both Self and EGCG Protection against Diabetic Testicular Damage.
Ha, L; Li, T; Liu, L; Liu, X; Pan, C; Song, Y; Tian, J; Wang, F; Wu, H; Wu, J; Zhou, S, 2017
)
1.18
"Epigallocatechin gallate is a polyphenol of tea plants. "( Epigallocatechin Gallate as an anti-obesity therapeutic compound: an in silico approach for structure-based drug designing.
Ashfaq, UA; Ijaz, B; Javaid, MS; Latief, N, 2018
)
3.37
"Epigallocatechin gallate (EGCG) is a catechin and an abundant polyphenol in green tea. "( Skin Protective Effect of Epigallocatechin Gallate.
Cho, JY; Han, SY; Hwang, K; Kim, E; Kim, EM; Lee, J; Park, J, 2018
)
2.22
"Epigallocatechin gallate (EGCG) is a natural phenolic compound found in many plants, especially in green tea, which is a popular and restorative beverage with many claimed health benefits such as antioxidant, anti-cancer, anti-microbial, anti-diabetic, and anti-obesity activities. "( Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
Cheng, LZ; Corke, H; Fang, YP; Gan, RY; Ge, YY; Wang, M; Wei, XL; Yang, QQ; Zhang, D, 2020
)
2.23
"Epigallocatechin gallate (EGCG) is a major polyphenol in green tea that has beneficial effects in diabetic."( Epigallocatechin-3-gallate stimulates autophagy and reduces apoptosis levels in retinal Müller cells under high-glucose conditions.
Du, J; Qin, X; Song, E; Sun, X; Wang, L; Xu, J; Xu, X; Zhu, M, 2019
)
1.24
"Epigallocatechin gallate (EGCG) is a polyphenol, which is the major biological component of green tea."( The Effects of Epigallocatechin Gallate (EGCG) on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-A Next-Generation Sequencing and Bioinformatic Approach.
Chang, KF; Chang, WA; Kuo, PL; Liao, SH; Sheu, CC; Tsai, MJ, 2019
)
1.59
"Epigallocatechin gallate (EGCG) is a polyphenol that is found in green tea that has been shown to ameliorate airway inflammation in an ovalbumin-sensitized asthmatic mouse model. "( Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model.
Shang, YX; Yang, N, 2019
)
3.4
"Epigallocatechin gallate (EGCG) is a major polyphenols of green tea may have the possibility to inhibit epidermal growth factor receptor (EGFR) activity and lead to reduce non-small cell lung cancer (NSCLC) progression. "( QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor.
Bommu, UD; Konidala, KK; Pabbaraju, N; Yeguvapalli, S, 2019
)
2.17
"Epigallocatechin gallate (EGCG) is a major polyphenol in green tea that has beneficial effects in the prevention of cardiovascular disease. "( Epigallocatechin gallate (EGCG) stimulates autophagy in vascular endothelial cells: a potential role for reducing lipid accumulation.
Jang, HJ; Kim, HS; Kim, JA; Montana, V; Parpura, V, 2013
)
3.28
"Epigallocatechin gallate (EGCG) is a green tea catechin found in a variety of green tea preparations."( Epigallocatechin gallate effectively ameliorates fluoride-induced oxidative stress and DNA damage in the liver of rats.
Miltonprabu, S; Thangapandiyan, S, 2013
)
2.55
"Epigallocatechin gallate (EGCG), which is a catechin derivative and exhibits potent antioxidant activity, has been reported to ameliorate autoimmune sialadenitis in a murine model, but the mechanism underlying its protective action remains to be investigated."( Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2.
Date, F; Mori, S; Ono, M; Saito, K, 2014
)
2.57
"Epigallocatechin gallate (EGCG) is a major polyphenol in green tea that has been shown to have anti-inflammatory, anti-cancer, anti-steatotic effects on the liver. "( Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance.
Bay, BH; Farah, BL; Singh, BK; Sinha, RA; Wu, Y; Yang, CS; Yen, PM; Zhou, J, 2014
)
1.85
"Epigallocatechin gallate (EGCG) is a powerful antioxidant and commonly used nutraceutical. "( Stability of catechins in green tea nutraceutical products: application of solid phase extraction-thin layer chromatography densitometry.
Abd-Elsalam, HA; Al-Ghobashy, MA; Ibrahim, MA; Zaazaa, HE, 2014
)
1.85
"Epigallocatechin gallate (EGCG) is an antioxidant found in green tea. "( The effect of epigallocatechin gallate on hepatocytes isolated from normal and partially hepatectomized rats.
Cervinkova, Z; Kucera, O; Mezera, V; Moravcova, A; Peterova, E, 2014
)
2.21
"(‑)‑Epigallocatechin gallate (EGCG) is a major component of green tea. "( (-)-Epigallocatechin gallate selectively inhibits adenosine diphosphate‑stimulated human platelet activation: suppression of heat shock protein 27 phosphorylation via p38 mitogen‑activated protein kinase.
Doi, T; Iida, H; Iida, Y; Kozawa, O; Matsushima-Nishiwaki, R; Ogura, S; Tokuda, H, 2014
)
1.52
"Epigallocatechin gallate (EGCG) is a major component of tea and its known interactions with caffeine make it worthwhile to further study them by investigating the influence of EGCG on the anticataleptic and locomotor-sensitizing effects of caffeine."( Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.
Acquas, E; Arote, S; Cotti, E; Gaikar, M; Kasture, SB; Kasture, V; Rosas, M; Salve, B, 2015
)
1.49
"Epigallocatechin gallate (EGCG) is a green tea catechin with potential health benefits, such as anti-oxidant, anti-carcinogenic and anti-inflammatory effects. "( Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate.
Calpena, AC; Egea, MA; Fangueiro, JF; Garcia, ML; Parra, A; Silva, AM; Souto, EB, 2014
)
2.07
"Epigallocatechin gallate (EGCG) is a major polyphenol in green tea with beneficial effects on the impairment in learning and memory. "( Epigallocatechin-3-gallate attenuates impairment of learning and memory in chronic unpredictable mild stress-treated rats by restoring hippocampal autophagic flux.
Gu, HF; Jing, KQ; Liao, DF; Nie, YX; Tang, YL; Tong, QZ; Zeng, Y; Zheng, XL, 2014
)
1.85
"Epigallocatechin gallate (EGCG) is an abundant tea byproduct and has more than 100-fold reducing power than vitamin C."( Promoting photosensitized reductive dechlorination of chlorothalonil using epigallocatechin gallate in water.
Cao, H; Hua, R; Huang, Q; Jin, L; Li, QX; Li, X; Shi, T; Tan, Y; Tang, J; Wu, X, 2014
)
1.35
"Epigallocatechin gallate (EGCG) is a major catechin compound found in green tea extracts and exhibits antioxidant and antimicrobial activities."( Inhibitory Effect of Epigallocatechin Gallate on the Virulence of Clostridium difficile PCR Ribotype 027.
Griffiths, MW; Hong, YS; Oh, S; Park, DJ; Park, S; Song, M; Yun, B, 2015
)
1.46
"Epigallocatechin gallate (EGCG) is a flavonoid belonging to the chemical class of falvan-3-ols (catechins) esterified with gallic acid. "( Epigallocatechin gallate and mitochondria-A story of life and death.
Daglia, M; Nabavi, SF; Nabavi, SM; Oliveira, MR; Rastrelli, L, 2016
)
3.32
"Epigallocatechin gallate (EGCG) is a green tea polyphenol that presents anticancer activities in multiple cancer cells, but no available report was addressed for the underling molecular mechanism of cytotoxic impacts on drug-resistant oral squamous cell carcinoma cells. "( Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.
Chen, FA; Chiang, JH; Chiang, NN; Horng, CT; Hsu, YM; Lee, CF; Lu, CC; Tsai, FJ; Yang, JS; Yuan, CH, 2017
)
3.34
"Epigallocatechin gallate (EGCG) is a major active compound in green tea polyphenols. "( Epigallocatechin Gallate Reduces Slow-Twitch Muscle Fiber Formation and Mitochondrial Biosynthesis in C2C12 Cells by Repressing AMPK Activity and PGC-1α Expression.
Gao, P; Jiang, Q; Shu, G; Wang, L; Wang, S; Wang, Z; Xi, Q; Yang, K; Zhang, Y; Zhu, X, 2016
)
3.32
"Epigallocatechin gallate (EGCG) is a major polyphenol in green tea. "( Activation of autophagic flux by epigallocatechin gallate mitigates TRAIL-induced tumor cell apoptosis via down-regulation of death receptors.
Kim, SW; Moon, JH; Park, SY, 2016
)
2.16
"Epigallocatechin gallate (EGCG) is a green tea antioxidant with adverse effects on rat liver mitochondria and hepatocytes at high doses. "( Effects of Epigallocatechin Gallate on Tert-Butyl Hydroperoxide-Induced Mitochondrial Dysfunction in Rat Liver Mitochondria and Hepatocytes.
Cervinkova, Z; Drahota, Z; Endlicher, R; Kucera, O; Mezera, V; Sobotka, O, 2016
)
2.27
"Epigallocatechin gallate (EGCG) is a major green tea polyphenol with pronounced antioxidative activity. "( Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stress resistance in Caenorhabditis elegans.
Abbas, S; Wink, M, 2009
)
3.24
"Epigallocatechin gallate (EGCG) is a major type of green tea polyphenols and is known to have cancer prevention effect. "( Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
Kwok, TT; Tsang, WP, 2010
)
3.25
"(-)-Epigallocatechin gallate (EGCG) is a major bioactive component in leaves of green tea, and has been widely investigated for its anti-tumor activity. "( Systematic characterization of the covalent interactions between (-)-epigallocatechin gallate and peptides under physiological conditions by mass spectrometry.
Cao, D; Qian, X; Zhang, H; Zhang, Y; Zhong, L, 2009
)
1.15
"Epigallocatechin gallate (EGCG) is a potent anti-inflammatory agent and an active ingredient of green tea and is suggested to have a role as a preventive agent in obesity, diabetes and CVD."( Effects of epigallocatechin gallate on regulatory T cell number and function in obese v. lean volunteers.
Devaraj, S; Jialal, I; Yun, JM, 2010
)
1.47
"(-)-Epigallocatechin gallate (EGCG) is a major polyphenol component of green tea that has antioxidant activities. "( (-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells.
Ho, W; Li, J; Liu, J; Wang, X; Wang, Y; Ye, L; Zhou, Y, 2012
)
1.5
"(-)-Epigallocatechin gallate (EGCg), which is a major component of tea polyphenols also inhibited the production of phenylacetic acid at 0.5 mg/mL in GAM broth."( Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis.
Okada, Y; Sakanaka, S, 2004
)
0.8
"Epigallocatechin gallate (EGCG) acts as an antioxidant, thus, EGCG may have a protective effect on the alteration of renal function resultant from oxygen free radicals."( Effect of epigallocatechin gallate on renal function in cyclosporine-induced nephrotoxicity.
Chang, EJ; Mun, KC, 2004
)
1.45
"(-)-Epigallocatechin gallate (EGCG) is a potent antioxidant that is neuroprotective against ischemia-induced brain damage. "( Neuroprotective effects of (-)-epigallocatechin gallate following hypoxia-ischemia-induced brain damage: novel mechanisms of action.
Appleton, I; Clarkson, AN; Jackson, DN; Sammut, IA; Shaw, OM; Sutherland, BA, 2005
)
1.17
"Epigallocatechin gallate (EGCG), which acts as a highly efficient free radical scavenger, may have a protective effect on CsA-induced hemolysis."( Effects of epigallocatechin gallate on the hemolysis induced by cyclosporine.
Chang, EJ; Kim, HC; Mun, KC, 2005
)
1.44
"Epigallocatechin gallate (EGCG) is a principle phenolic antioxidant found in a variety of plants, including green and black tea. "( Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis.
Chai, OH; Li, GZ; Song, CH, 2005
)
2.09
"Epigallocatechin gallate (EGCG) is a constituent of green tea, and increasing evidence suggests that EGCG has neuroprotective effects on oxidative stress-injured neuronal cells, especially motoneurons. "( The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.
Hwang, MS; Kim, HT; Kim, HY; Kim, J; Kim, MH; Kim, OH; Kim, SH; Koh, SH; Lee, KW; Lee, KY; Lee, SM; Lee, YJ; Song, C; Yang, KW, 2006
)
2.14
"Epigallocatechin gallate (EGCG) is a major compound of green tea polyphenol that has shown the protective activity against neuronal diseases."( Epigallocatechin gallate inhibits nitric oxide-induced apoptosis in rat PC12 cells.
Han, CR; Jeong, YJ; Jung, JY; Kim, HJ; Kim, SH; Kim, WJ; Lee, KH; Lim, HS; Oh, WM; Park, HO, 2007
)
2.5
"Epigallocatechin gallate (EGCG) is a major water-soluble component of green tea. "( Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice.
Fujita, K; Gondo, Y; Kamataki, T; Katsuki, M; Muto, S; Shioyama, Y; Yokoi, T, 1999
)
1.99
"Epigallocatechin gallate (EGCg) is a major form of tea catechin and has a variety of biological activities, including antitumor as well as antimicrobial activity against some pathogens. "( Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins.
Friedman, H; Klein, TW; Matsunaga, K; Yamamoto, Y, 2001
)
1.96
"Epigallocatechin gallate (EGCG) is a potent polyphenolic antioxidant extracted from green tea. "( Preformulation study of epigallocatechin gallate, a promising antioxidant for topical skin cancer prevention.
Blanchard, J; Liederer, BM; Proniuk, S, 2002
)
2.06

Effects

Epigallocatechin gallate (EGCG) has a variety of physiological activities, including anti-inflammatory, antioxidant, and anti-diabetes. It can reduce free radical-induced lipid peroxidation as a green tea polyphenol.

Epigallocatechin gallate (EGCG) has a variety of biological activities, but exhibits poor stability and low bioavailability. EGCG has multiple biological effects such as anti-tumor multiple drug resistance, antioxidation and anti-inflammatory properties.

ExcerptReferenceRelevance
"Epigallocatechin gallate (EGCG) has a variety of biological activities, but exhibits poor stability and low bioavailability. "( Bilosomes as effective delivery systems to improve the gastrointestinal stability and bioavailability of epigallocatechin gallate (EGCG).
Huang, X; Jing, H; Ma, C; Wang, H; Wang, L, 2021
)
2.28
"Epigallocatechin gallate (EGCG) has a wide consumption for its health advantages. "( Prenatal EGCG consumption causes obesity and perturbs glucose homeostasis in adult mice.
Fang, L; Huang, J; Ou, K; Song, J; Wang, C; Wang, Q; Xia, S; Zhang, S, 2023
)
2.35
"Epigallocatechin gallate (EGCG) has a variety of physiological activities, including anti-inflammatory, antioxidant, and anti-diabetes."( Epigallocatechin gallate improves the quality of diabetic oocytes.
Chao, S; Ge, ZJ; Huang, GA; Li, LJ; Lu, J; Shen, W; Sun, QY; Yin, S; Zhao, L; Zhao, MH; Zhao, SX; Zhao, Y, 2023
)
3.07
"(-)-Epigallocatechin gallate has a potent antioxidant property and can reduce free radical-induced lipid peroxidation as a green tea polyphenol. "( Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils.
Jung, JG; Kim, CY; Lee, JJ; Lee, SR; Lee, SY, 2003
)
1.14
"Epigallocatechin gallate (EGCG) has been reported to inhibit TMEM16F but this has been challenged."( Epigallocatechin gallate inhibits release of extracellular vesicles from platelets without inhibiting phosphatidylserine exposure.
Harper, MT; Millington-Burgess, SL, 2021
)
2.79
"Epigallocatechin gallate (EGCG) has a variety of biological activities, but exhibits poor stability and low bioavailability. "( Bilosomes as effective delivery systems to improve the gastrointestinal stability and bioavailability of epigallocatechin gallate (EGCG).
Huang, X; Jing, H; Ma, C; Wang, H; Wang, L, 2021
)
2.28
"Epigallocatechin gallate (EGCG) has attracted increasing attention due to its beneficial effect on cardiovascular health. "( EGCG protects against myocardial I/RI by regulating lncRNA Gm4419-mediated epigenetic silencing of the DUSP5/ERK1/2 axis.
Chen, JX; He, YL; Lin, WT; Wei, X; Xu, WX; Zeng, M, 2021
)
2.06
"Epigallocatechin gallate (EGCG) has a wide consumption for its health advantages. "( Prenatal EGCG consumption causes obesity and perturbs glucose homeostasis in adult mice.
Fang, L; Huang, J; Ou, K; Song, J; Wang, C; Wang, Q; Xia, S; Zhang, S, 2023
)
2.35
"Epigallocatechin gallate (EGCG) has been shown to have antihypertensive activity. "( Epigallocatechin gallate (EGCG) alleviates vascular dysfunction in angiotensin II-infused hypertensive mice by modulating oxidative stress and eNOS.
Lee, SK; Ling, WC; Mohd Sabri, NA; Murugan, DD, 2022
)
3.61
"Epigallocatechin gallate (EGCG) has a variety of physiological activities, including anti-inflammatory, antioxidant, and anti-diabetes."( Epigallocatechin gallate improves the quality of diabetic oocytes.
Chao, S; Ge, ZJ; Huang, GA; Li, LJ; Lu, J; Shen, W; Sun, QY; Yin, S; Zhao, L; Zhao, MH; Zhao, SX; Zhao, Y, 2023
)
3.07
"Epigallocatechin gallate (EGCG) has attracted the increasing attention of many researchers, especially in the field of tumor therapy. "( An EGCG-mediated self-assembled micellar complex acts as a bioactive drug carrier.
Chen, L; Cui, M; Duan, H; Gao, Z; Gong, L; Hou, Y; Huang, W; Jin, M; Liu, C; Liu, Y; Quan, X; Wan, H; Wang, Q; Wang, S; Wu, H; Zeng, B; Zhang, X; Zhao, H, 2023
)
2.35
"Epigallocatechin gallate (EGCG) has multiple biological effects such as anti-tumor multiple drug resistance, antioxidation and anti-inflammatory properties. "( EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis.
Chen, L; Gan, X; Jian, J; Liang, R; Wang, R; Yu, Q; Zhang, N, 2023
)
2.35
"Epigallocatechin gallate (EGCG) has established protective actions against myocardial ischemia/reperfusion (I/R) injury by regulating autophagy. "( MicroRNA-384-5p/Beclin-1 As Potential Indicators For Epigallocatechin Gallate Against Cardiomyocytes Ischemia Reperfusion Injury By Inhibiting Autophagy Via PI3K/Akt Pathway.
Chen, L; Gan, X; Jian, J; Liang, R; Yang, X; Zhang, C, 2019
)
2.21
"Epigallocatechin gallate (EGCG) has been reported to be an efficient inhibitor of amyloid formation by numerous proteins, among them α -synuclein."( The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of
Bolakhrif, N; Buell, AK; Haas, R; Peduzzo, A; Sternke-Hoffmann, R, 2020
)
1.28
"Neat epigallocatechin gallate (EGCG) has low bioavailability and tuna oil (TO) is prone to oxidation. "( Broccoli byproducts for protection and co-delivery of EGCG and tuna oil.
Augustin, MA; Sanguansri, L; Shi, M; Ye, JH; Ying, DY, 2020
)
1.07
"Epigallocatechin gallate (EGCG) has many biological functions; however, the use of EGCG in biomedical and food industries was limited due to its poor oral absorption and high susceptibility to degradation. "( Enhancement of the permeability and activities of epigallocatechin gallate by quaternary ammonium chitosan/fucoidan nanoparticles.
Ho, YC; Huang, TW; Lin, C; Mi, FL; Tsai, TN; Tseng, CL, 2020
)
2.25
"(-)-epigallocatechin gallate (EGCG) has emerged as a molecular modulator of αSN self-assembly, as it reduces the flexibility of the C-terminal region of αSN in the oligomer and inhibits the oligomer's ability to perturb phospholipid membranes and induce cell death."( How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein.
Andersen, CB; Mulder, FAA; Nielsen, J; Otzen, DE; Yoshimura, Y,
)
1.17
"Epigallocatechin gallate (EGCG) has been proved to be closely related with the regulation of inflammation and bone metabolism."( Epigallocatechin gallate regulates inflammatory responses and new bone formation through Wnt/β-Catenin/COX-2 pathway in spondyloarthritis.
Chen, ZH; Gao, F; Lin, DT; Lin, H; Yan, Q; Zhang, SL, 2021
)
2.79
"(-)-Epigallocatechin gallate (EGCG) has attracted significant research interest due to its health-promoting effects such as antioxidation, anti-inflammation and anti-cancer activities. "( Food-grade Encapsulation Systems for (-)-Epigallocatechin Gallate.
Cai, ZY; Li, QS; Li, XM; Liang, YR; Lu, JL; Ma, SC; Shi, M; Shi, YL; Yang, R; Ye, JH; Zheng, XQ, 2018
)
1.3
"Epigallocatechin gallate (EGCG) has well known anti-tumor effects; however, no data are available on the influence of EGCG on communication with cancer cells and TAM."( Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Jang, JY; Jeon, YK; Kim, CW; Lee, JK, 2013
)
1.43
"Epigallocatechin gallate (EGCG) has been ascribed to several health benefits, but its bitter taste influences the liking of products with high concentrations of this compound. "( Evaluation of the bitter-masking potential of food proteins for EGCG by a cell-based human bitter taste receptor assay and binding studies.
Bohin, MC; Dekker, P; Gouka, RJ; Gruppen, H; Roland, WS; Smit, G; van der Hijden, HT; Vincken, JP, 2013
)
1.83
"(-)-Epigallocatechin gallate (EGCG) has been shown to inhibit spontaneous metastasis of melanoma cell line into the lungs of mice, so we studied the effects of EGCG on cell motility, cell stiffness, and expression of vimentin and Slug, which are molecular phenotypes of epithelial-mesenchymal transition (EMT)."( Mechanism-based inhibition of cancer metastasis with (-)-epigallocatechin gallate.
Fujiki, H; Kurusu-Kanno, M; Li, Z; Mondal, A; Suganuma, M; Suzuki, K; Takahashi, A; Watanabe, T; Yamazaki, T, 2014
)
1.13
"(-)-Epigallocatechin gallate (EGCG) has recently been shown to exert neuroprotection in a variety of neurological diseases; however, its role and the underlying mechanisms in cerebral ischemic injury are not fully understood. "( (-)-Epigallocatechin gallate protects against cerebral ischemia-induced oxidative stress via Nrf2/ARE signaling.
Han, J; Jing, X; Lou, H; Ren, M; Shi, H; Wang, M, 2014
)
1.52
"(-)-Epigallocatechin gallate (EGCG) has become a popular disease-preventive supplement worldwide because it may aid in slowing down the onset of age-related diseases such as cancer, diabetes and tissue degeneration. "( Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems.
Ferguson, SJ; Krupkova, O; Wuertz-Kozak, K, 2016
)
1.33
"Epigallocatechin gallate (EGCG) has been studied for its beneficial effects. "( Nephro-toxic effects of intraperitoneally injected EGCG in diabetic mice: involvement of oxidative stress, inflammation and apoptosis.
Abdallah, DM; Ahmed, LA; El-Sayeh, BM; Rasheed, NO, 2017
)
1.9
"(-)-Epigallocatechin gallate [(-)-EGCG] has been implicated in cancer chemoprevention and has been shown as an inhibitor of tumor proteasomal chymotrypsin-like activity in vitro and in vivo. "( Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogs.
Chan, TH; Dou, QP; Huo, C; Kanwar, J; Mohammad, I; Yang, H, 2010
)
0.92
"Epigallocatechin gallate (EGCG) has been shown to be protective in various experimental models of liver injury, although opposite effects have also been reported. "( Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2.
Cermanova, J; Cervinkova, Z; Dolezelova, E; Hirsova, P; Hroch, M; Kadova, Z; Karlasova, G; Kucera, O; Lenicek, M; Micuda, S; Pavek, P; Sispera, L; Tomsik, P; Vitek, L; Zagorova, M, 2013
)
2.15
"Epigallocatechin gallate (EGCG) has exhibited antitumor properties against bladder cancer. "( Epigallocatechin gallate attenuates interstitial cystitis in human bladder urothelium cells by modulating purinergic receptors.
Che, JP; Feng, Y; Liu, M; Luo, J; Wang, GC; Xu, YF; Yang, FQ; Zhai, W; Zheng, JH, 2013
)
3.28
"(-)-Epigallocatechin gallate has a potent antioxidant property and can reduce free radical-induced lipid peroxidation as a green tea polyphenol. "( Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils.
Jung, JG; Kim, CY; Lee, JJ; Lee, SR; Lee, SY, 2003
)
1.14
"Epigallocatechin gallate has been shown to be an inhibitor of the protealytic activity of the proteasome; this inhibition has a significant implication for cell proliferation and the stability of transcription factors in the nucleus."( Regulation of gene transcription by botanicals: novel regulatory mechanisms.
Banz, WJ; Shay, NF, 2005
)
1.05
"Epigallocatechin gallate (EGCG) has been shown to have antioxidant effect and to protect hypoxia-induced damage."( Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells.
Bae, JH; Chung, JH; Chung, WJ; Hong, MS; Hwang, JS; Leem, K; Park, HJ; Shin, DH; Yoon, SH, 2006
)
2.5
"Epigallocatechin gallate has potential use as adjunctive therapy in HIV-1 infection."( Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
McCormick, TG; Nance, CL; Shearer, WT; Williamson, MP, 2006
)
3.22

Treatment

Epigallocatechin gallate treatment did not alter ER protein expression in MDA-MB-231 cells and thus was not a mechanism for the observed tumour suppression. Treatment with copper(II) chloride efficiently afforded an unstable quinone dimer, dehydrotheasinensin A.

ExcerptReferenceRelevance
"EPIGALLOCATECHIN GALLATE (EGCG) FOR TREATMENT OF UNEXPLAINED INFERTILITY ASSOCIATED WITH UTERINE FIBROIDS (PRE-FRIEND TRIAL): EARLY SAFETY ASSESSMENT."( Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.
Al-Hendy, A; Christman, GM; Flaminia, A; Flores, VA; González, F; Huang, H; Johnson, JJ; Segars, J; Siblini, H; Singh, B; Taylor, HS; Zhang, H, 2023
)
1.92
"Epigallocatechin gallate treatment did not affect embryonic development because embryos from nondiabetic dams treated with Epigallocatechin gallate did not exhibit any neural tube defects. "( The green tea polyphenol EGCG alleviates maternal diabetes-induced neural tube defects by inhibiting DNA hypermethylation.
Reece, EA; Xu, C; Yang, P; Zhong, J, 2016
)
1.88
"Epigallocatechin gallate treatment did not alter ER protein expression in MDA-MB-231 cells and thus was not a mechanism for the observed tumour suppression."( A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
Menzies, AR; Rosengren, RJ; Scandlyn, MJ; Somers-Edgar, TJ; Stuart, EC, 2008
)
1.29
"Treatment of epigallocatechin gallate with copper(II) chloride efficiently afforded an unstable quinone dimer, dehydrotheasinensin A, and subsequent treatment with ascorbic acid stereoselectively yielded theasinensin A."( Biomimetic one-pot preparation of a black tea polyphenol theasinensin A from epigallocatechin gallate by treatment with copper(II) chloride and ascorbic acid.
Kouno, I; Matsuo, Y; Miyamoto, M; Shii, T; Tanaka, T, 2011
)
0.95

Toxicity

ExcerptReferenceRelevance
" GTE was not toxic and no harmful effect was found during its clinical use."( Inhibitory effects and toxicity of green tea polyphenols for gastrointestinal carcinogenesis.
Iwata, Y; Kikuoka, N; Kitao, Y; Matsumoto, H; Nakatani, H; Oya, K; Takahashi, T; Yamane, T, 1996
)
0.29
"We conclude that it is safe for healthy individuals to take green tea polyphenol products in amounts equivalent to the EGCG content in 8-16 cups of green tea once a day or in divided doses twice a day for 4 weeks."( Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Alberts, DS; Brooks, CA; Cai, Y; Chow, HH; Crowell, JA; Dorr, RT; Hakim, IA; Hara, Y; Shahi, F, 2003
)
0.54
" The antiproliferative effects of tea polyphenolic extracts and EGCG were more pronounced towards immortalized, tumourigenic (CAL27, HSC-2, and HSG(1)) and non-tumourigenic (S-G) cells than towards normal (GN56 and HGF-1) fibroblasts and green tea was more toxic than black tea."( In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.
Babich, H; Sedaghat, T; Weisburg, JH; Weissman, DB, 2004
)
0.63
"Nephrotoxicity is a clinically important side effect of cyclosporine (CsA)."( Effect of epigallocatechin gallate on renal function in cyclosporine-induced nephrotoxicity.
Chang, EJ; Mun, KC, 2004
)
0.73
" The dietary administration of EGCG preparation to rats for 13 weeks was not toxic at doses up to 500 mg/kg/day."( Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies.
Bausch, J; Davidovich, A; Edwards, JA; Isbrucker, RA; Wolz, E, 2006
)
0.67
" A two-generation study in rats fed 1200, 3600 or 12,000 ppm EGCG preparation showed no adverse effects on reproduction or fertility."( Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats.
Bausch, J; Davidovich, A; Edwards, JA; Isbrucker, RA; Wolz, E, 2006
)
0.67
" Assays were performed in treated cells to evaluate the ability of EGCG to prevent the toxic effects of EtOH."( Epigallocatechin-3-gallate(-)protects Chang liver cells against ethanol-induced cytotoxicity and apoptosis.
Anuradha, CV; Gunasekaran, P; Kaviarasan, S; Ramamurthy, N; Varalakshmi, E, 2007
)
0.34
" For these agents, normal dietary intake, doses used in clinical trials, efficacious doses in rodents, and where available, toxic doses are compared."( Putative cancer chemopreventive agents of dietary origin-how safe are they?
Gescher, AJ; Steward, WP; Verschoyle, RD, 2007
)
0.34
" Amyloid fibrils formed from IAPP, intermediates generated in the assembly of IAPP amyloid, or both are toxic to β-cells, suggesting that islet amyloid formation may contribute to the pathology of type 2 diabetes."( The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.
Abedini, A; Meng, F; Plesner, A; Raleigh, DP; Verchere, CB, 2010
)
0.36
"Arsenic trioxide (ATO) treatment is a useful therapy against human acute promyelocytic leukemia (APL), however, it concomitantly brings potential adverse consequences including serious side effect, human carcinogenicity and possible development of resistance."( Cytotoxicity of arsenic trioxide is enhanced by (-)-epigallocatechin-3-gallate via suppression of ferritin in cancer cells.
Cheng, IC; Lee, TC; Shue, JJ; Wang, TC, 2011
)
0.37
" The aim of this study was to investigate the effect of green tea epigallocatechin-3-gallate on the nicotine-induced toxic and inflammatory responses in oral epithelial cells and gingival fibroblasts."( Neutralizing effect of green tea epigallocatechin-3-gallate on nicotine-induced toxicity and chemokine (C-C motif) ligand 5 secretion in human oral epithelial cells and fibroblasts.
Desjardins, J; Grenier, D, 2012
)
0.38
" Pretreatment of cells with epigallocatechin-3-gallate efficiently neutralized the nicotine-induced toxic effects in epithelial cells and fibroblasts."( Neutralizing effect of green tea epigallocatechin-3-gallate on nicotine-induced toxicity and chemokine (C-C motif) ligand 5 secretion in human oral epithelial cells and fibroblasts.
Desjardins, J; Grenier, D, 2012
)
0.38
"Excessive nitric oxide (NO) production is toxic to the cochlea and induces hearing loss."( (-)-Epigallocatechin-3-gallate protects against NO-induced ototoxicity through the regulation of caspase- 1, caspase-3, and NF-κB activation.
Hong, SH; Kim, BS; Kim, SJ; Lee, JH; Myung, NY; Park, R; So, HS; Um, JY, 2012
)
0.38
"Selenium, an essential trace element, can also be toxic at higher levels of exposure."( High-dose sodium selenite toxicity cannot be prevented by the co-administration of pharmacological levels of epigallocatechin-3-gallate which in turn aggravates the toxicity.
Sun, K; Thompson, HJ; Wan, X; Wang, Y; Wu, S; Zhang, J, 2013
)
0.39
"The article presents a method of conservative treatment of men with I-II stage prostatic adenoma using a combination of doxazosin and indigal, which has antioxidant, antiproliferative and anti-inflammatory properties, that allowed improving urodynamic parameters and reducing the progression prostate adenoma, minimizing the adverse effects of treatment."( [Results of open multicenter study of the safety of doxazosin in combination with indigal in men with stages I-II prostatic adenoma].
Abzalilov, RA; Bliumberg, BI; Boiarko, AV; Grigor'ev, MÉ; Izmaĭlov, AA; Kazikhinoruv, AA; Komiakov, BK; Pavlov, VN; Sivkov, AV,
)
0.13
" Our results demonstrate that TCDD is highly toxic for INS-1E cells, suggesting that pancreatic beta cells should be considered a relevant and sensitive target for dioxin acute toxicity."( The aryl receptor inhibitor epigallocatechin-3-gallate protects INS-1E beta-cell line against acute dioxin toxicity.
Beffy, P; De Tata, V; Giacopelli, D; Martino, L; Masiello, P; Masini, M; Novelli, M, 2013
)
0.39
" Consumption of EGCG during DOX therapy seems to be safe and beneficial, since EGCG does not decrease DOX anticancer efficacy and could ameliorate DOX hepatotoxicity."( Effect of selected catechins on doxorubicin antiproliferative efficacy and hepatotoxicity in vitro.
Bártíková, H; Boušová, I; Hanušová, V; Matoušková, P; Rudolfová, P; Skálová, L, 2014
)
0.4
" This results in protein aggregation and generation of toxic oligomers and fibrils."( Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.
Bonanomi, M; Colombo, G; Cornelli, G; Doglia, SM; Malabarba, MG; Natalello, A; Pastori, V; Penco, A; Regonesi, ME; Relini, A; Tortora, P; Visentin, C, 2014
)
0.4
"Cisplatin (CP) is a commonly used anticancer drug, but its notable side effect of nephrotoxicity limits its use in clinic."( Epigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse.
Chen, B; Hu, Z; Jiang, B; Liu, G; Pei, F; Song, J; Yang, X; Zou, P, 2014
)
0.4
"Consumer use of herbal and dietary supplements has recently grown in the United States and, with increased use, reports of rare adverse reactions have emerged."( Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice.
Ballard, S; Church, RJ; Churchill, GA; Eaddy, JS; Gatti, DM; Harrill, AH; Long, N; Mosedale, M; Navarro, V; Shi, Q; Threadgill, DW; Urban, TJ; Watkins, PB; Yang, X, 2015
)
0.69
" Overall, it appears that EGCG can modulate its own bioavailability and that dietary treatment may reduce the toxic potential of acute high oral bolus doses of EGCG."( Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
Forester, SC; James, KD; Lambert, JD, 2015
)
0.42
" EGCG in concentrations lower than 10 μmol/L was recognized as safe for hepatocytes in vitro."( In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes.
Cervinkova, Z; Drahota, Z; Endlicher, R; Kucera, O; Lotkova, H; Mezera, V; Moravcova, A, 2015
)
0.74
"Green tea is thought to provide health benefits, though adverse reactions to green tea extract (GTE) have been reported."( The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial.
Bedell, S; Dostal, AM; Kurzer, MS; Le, C; Samavat, H; Swenson, K; Torkelson, C; Ursin, G; Wang, R; Wu, AH; Yuan, JM, 2015
)
0.42
" A potential adverse effect of high-dose EGCG or green tea extracts is hepatotoxicity."( Melatonin attenuates (-)-epigallocatehin-3-gallate-triggered hepatotoxicity without compromising its downregulation of hepatic gluconeogenic and lipogenic genes in mice.
Reiter, RJ; Wan, X; Wang, D; Wang, T; Wei, Y; Yang, CS; Zhang, J, 2015
)
0.42
" Because of the probable link between hIAPP and the development of type II diabetes, there has been strong interest in developing reagents to study the aggregation of hIAPP and possible therapeutics to block its toxic effects."( Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives.
Brender, JR; Fierke, CA; Pithadia, A; Ramamoorthy, A, 2016
)
0.43
" However, the potential adverse health effects of Ni NPs are unclear."( Inhibition of Nickel Nanoparticles-Induced Toxicity by Epigallocatechin-3-Gallate in JB6 Cells May Be through Down-Regulation of the MAPK Signaling Pathways.
Bowman, L; Ding, M; Gu, Y; Liu, K; Liu, Y; Mao, G; Wang, Y; Xu, J; Zhao, J; Zhou, Q; Zou, B, 2016
)
0.43
" coli) as model organisms and was found to be more toxic towards gram-positive bacteria."( Selective toxicity of Catechin-a natural flavonoid towards bacteria.
Fathima, A; Rao, JR, 2016
)
0.43
" No differences were noted in adverse effects between the two treatment groups."( Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
Benejam, B; Blanco-Hinojo, L; Bléhaut, H; Catuara-Solarz, S; Cuenca-Royo, A; de la Torre, R; de Sola, S; Del Hoyo, L; Delabar, JM; Dierssen, M; Dueñas-Espín, I; Espadaler, JM; Farré, M; Fitó, M; Hernandez, G; Janel, N; Langohr, K; Principe, A; Pujol, J; Rodriguez, J; Sanchez-Benavides, G; Videla, S; Xicota, L, 2016
)
0.43
" Consumption of green tea is not associated with liver damage in humans, and green tea infusion and GTE-based beverages are considered safe in the range of historical uses."( Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements.
Dekant, W; Fujii, K; Morita, O; Shibata, E; Shimotoyodome, A, 2017
)
0.46
" Our findings demonstrate proof of concept for the feasibility of green tea catechin-based micellar nanocomplexes as a safe and effective cisplatin nanomedicine for ovarian cancer treatment."( Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
Ang, WX; Bae, KH; Chung, JE; Gao, SJ; Kurisawa, M; Tan, S; Wang, S; Yamashita, A, 2017
)
0.46
" The results suggest that exposure to DTC reduces toxic threshold of dietary polyphenols from green tea and possibly other plants, and vice versa."( Synergistic toxicity of epigallocatechin-3-gallate and diethyldithiocarbamate, a lethal encounter involving redox-active copper.
Dong, R; Sun, K; Wang, J; Wang, X; Yang, CS; Zhang, J; Zhang, K, 2017
)
0.46
" Although green tea beverage has a long history of safe use, a growing number of case-reports have linked GTE-based supplements to incidents of hepatotoxicity."( Potential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gallate in mice.
James, KD; Kennett, MJ; Lambert, JD, 2018
)
0.48
" By facilitating the fibril formation and thus eliminating the toxic AOs, EGCG was shown to suppress the membrane disrupting radiating amyloid fibril formation on the surface of liposomal membranes and thus protect the cells which could be readily affected by AOs."( EGCG-mediated Protection of the Membrane Disruption and Cytotoxicity Caused by the 'Active Oligomer' of α-Synuclein.
Bhak, G; Lee, JT; Lee, S; Paik, SR; Park, JH; Rhoo, KY; Yang, JE, 2017
)
0.46
" Therefore, habitat management is reported for the first time as a safe and effective approach to improving the yield and quality of tea leaves."( Habitat management as a safe and effective approach for improving yield and quality of tea (Camellia sinensis) leaves.
Chen, Y; Li, J; Qiao, X; Tang, H; Tang, J; Zhou, B; Zhou, Y, 2019
)
0.51
" The adverse health effects resulting from methylmercury (MeHg) exposure in humans are of worldwide concern."( (-)-Epigallocatechin-3-gallate attenuates the toxicity of methylmercury in Caenorhabditis elegans by activating SKN-1.
Cao, JJ; Chen, M; Chen, WH; Han, X; Ji, X; Liu, AL; Lu, WQ; Lu, WW; Wang, F, 2019
)
0.51
" These adverse effects of Pb were ameliorated by EGCG treatment, which increased testosterone, E2 serum level, and aromatase P450 gene expression, and improved testicular architecture and semen picture."( The protective effect of epigallocatechin-3-gallate on testicular oxidative stress in lead-induced toxicity mediated by Cyp19 gene / estradiol level.
Hassan, E; Hassan, M; Kahilo, K; Kamal, T; Saleh Elgawish, M, 2019
)
0.51
" The reductions in CYP-mediated acetaminophen bioactivation and uptake transporter, as well as enhanced antioxidant enzyme activity, may limit the accumulation of toxic products in the liver and thus lower hepatotoxicity."( Epigallocatechin-3-Gallate Reduces Hepatic Oxidative Stress and Lowers CYP-Mediated Bioactivation and Toxicity of Acetaminophen in Rats.
Chang, CH; Li, CC; Yao, HT, 2019
)
0.51
"To examine the role of the transcription factor nuclear factor-erythroid 2 (NF-E2)-related factor 2 (Nrf2) and the SAFE pathway (JAK/STAT) in the induction of germ cell apoptosis (GCA) and the protective role of epigallocatechin-3-gallate (EGCG) during testicular ischemia reperfusion injury (tIRI)."( Epigallocatechin-3-gallate modulates germ cell apoptosis through the SAFE/Nrf2 signaling pathway.
Al-Maghrebi, M; Alnajem, AS; Esmaeil, A, 2020
)
0.56
"The clinical studies proved the adverse effect of Propranolol on sexual function."( An Herbal Nanohybrid Formula of Epigallocatechin Gallate-Chitosan-Alginate Efficiently Restrict the Sexual Dysfunction Adverse Effect of
Abo El-Ela, FI; El-Banna, HA; El-Nesr, KA; El-Shahawy, AAG; Khaled, E; Zanaty, MI, 2020
)
0.84
" Animals received a single toxic dose of CP (7."( Epigallocatechin gallate and coenzyme Q10 attenuate cisplatin-induced hepatotoxicity in rats via targeting mitochondrial stress and apoptosis.
Aljaser, FS; Alrashed, M; Alsharidah, AS; AlSubki, RA; Banu, N; Fatima, S; Suhail, N; Wasi, S, 2021
)
2.06
" Of 72 treated participants, 62 (86%) had 229 treatment-emergent adverse events (AEs)."( Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study).
Aldea-Perona, A; Cés, SV; Cieuta-Walti, C; Cuenca-Royo, A; Dairou, J; Dierssen, M; Durand, S; Forcano, L; Fornell, RT; García, JG; Gomis-Gonzalez, M; González, TB; González-Lamuño Leguina, D; Janel, N; Lacaille, F; Langohr, K; Lévy, M; Lirio, J; López-Vílchez, MÁ; Mircher, C; Rakic, C; Ravel, A; Roure, MR; Sacco, S; Walti, H, 2022
)
0.94
"The use of EGCG is safe and well-tolerated in children with DS, but efficacy results do not support its use in this population."( Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study).
Aldea-Perona, A; Cés, SV; Cieuta-Walti, C; Cuenca-Royo, A; Dairou, J; Dierssen, M; Durand, S; Forcano, L; Fornell, RT; García, JG; Gomis-Gonzalez, M; González, TB; González-Lamuño Leguina, D; Janel, N; Lacaille, F; Langohr, K; Lévy, M; Lirio, J; López-Vílchez, MÁ; Mircher, C; Rakic, C; Ravel, A; Roure, MR; Sacco, S; Walti, H, 2022
)
0.94
" Specifically, our aim was to assess any adverse effects of EGCG alone or in combination with an ovarian stimulator on serum liver function tests (LFTs) and folate level."( Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women.
Al-Hendy, A; Christman, GM; Flaminia, A; Flores, VA; González, F; Huang, H; Johnson, JJ; Segars, J; Siblini, H; Singh, B; Taylor, HS; Zhang, H, 2023
)
1.19
" No adverse events were observed and reported associated with EGCG."( Efficacy and safety of epigallocatechin-3-gallate in treatment acute severe dermatitis in patients with cancer receiving radiotherapy: a phase I clinical trial.
Jia, L; Li, X; Meng, X; Wang, X; Xie, J; Xie, P; Xing, L; Yin, X; Zhao, H; Zhu, W, 2023
)
0.91
" These results underscore the potential of EGCG as a protective agent against the adverse effects of water-pipe smoking."( Assessing the Protective Role of Epigallocatechin Gallate (EGCG) against Water-Pipe Smoke-Induced Toxicity: A Comparative Study on Gene Expression and Histopathology.
Al Bawareed, O; Al Farraj, J; Al-Ameer, HJ; Al-Awaida, W; Goh, KW; Gushchina, YS; Hamad, I; Severin, AE; Srour, B; Torshin, VI, 2023
)
1.19

Pharmacokinetics

ExcerptReferenceRelevance
" The goal of this study was to determine the stability and pharmacokinetic parameters of pure EGCG administered topically to human and mouse skin."( Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin.
Alberts, DS; Dorr, RT; Dvorakova, K; Timmermann, B; Valcic, S, 1999
)
0.3
" To determine pharmacokinetic parameters of EGCG following topical application."( Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin.
Alberts, DS; Dorr, RT; Dvorakova, K; Timmermann, B; Valcic, S, 1999
)
0.3
" We performed a Phase I pharmacokinetic study to determine the systemic availability of green tea catechins after single oral dose administration of EGCG and Polyphenon E (decaffeinated green tea catechin mixture)."( Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Alberts, DS; Cai, Y; Chow, HH; Crowell, JA; Dorr, R; Hakim, I; Hara, Y; Shahi, F; Yang, CS, 2001
)
0.53
" In this report, the pharmacokinetic parameters of (-)-epigallocatechin-3-gallate (EGCG), (-)-epigallocatechin (EGC), and (-)-epicatechin (EC) were analyzed after administration of a single oral dose of green tea or decaffeinated green tea (20 mg tea solids/kg) or EGCG (2 mg/kg) to eight subjects."( Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
Bondoc, FY; Chen, L; Lambert, G; Lee, MJ; Maliakal, P; Meng, X; Mohr, S; Prabhu, S; Yang, CS, 2002
)
0.31
" The elimination half-life of EGCG was 62 +/- 11 and 48 +/- 13 min for intravenous (10 mg/kg) and oral (100 mg/kg) administration, respectively."( Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution.
Lin, LC; Sung, JS; Tsai, TH; Tseng, TY; Wang, MN, 2007
)
0.34
"Little is known regarding pharmacokinetic (PK) or pharmacodynamic interactions of flavonoids with each other: this is of significance since multiple flavonoids are present in the diet and in dietary supplements."( Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon, YJ; Morris, ME,
)
0.13
" The pharmacokinetic data indicate that the area under the plasma concentration-time curves (AUC) of CPT-11 and SN-38 were increased by 57."( Food-drug interaction of (-)-epigallocatechin-3-gallate on the pharmacokinetics of irinotecan and the metabolite SN-38.
Lin, LC; Tsai, TH; Wang, MN, 2008
)
0.35
" The pharmacokinetic experiment indicated that there was an approximately 151% increase in the maximum plasma concentration (C(max)) and an approximately 425% increase in the area under the plasma concentration curve (AUC) of 5-FU in the green tea-treated group compared with the control group."( Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.
Du, J; Gu, C; Han, M; Lu, W; Qiao, J; Shang, W; Wang, W; Yin, W; Zhu, M, 2011
)
0.37
" The integrated plasma concentration (C') of TP was calculated by means of self-defined weighing coefficient based on percent AUC of individual components, thereby assessing integrated pharmacokinetic (PK) parameters of TP via log C'-T curve."( [Integrated pharmacokinetic study of multiple effective components of tea polyphenols and its correlation with anti-free radical pharmacodynamics in rats].
Han, GZ; Li, N; Li, QS; Lü, L; Wang, CY; Xi, H; Zou, LL, 2012
)
0.38
" Further, cocrystallization resulted in marked effects on pharmacokinetic parameters including Cmax, Tmax, area under curve, relative bioavailability, and apparent terminal half-life."( Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats.
Arora, KK; Kavuru, P; Kesani, S; Shytle, RD; Smith, AJ; Tan, J; Zaworotko, MJ, 2013
)
0.39
" Pharmacokinetic parameters were estimated by a noncompartmental analysis."( Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Fukushima, T; Kimura, J; Misaka, S; Miyazaki, N; Yamada, S, 2013
)
0.39
" In vivo pharmacokinetic studies in rats by high-performance liquid chromatography confirmed a sustained and sequential release of both the drugs in plasma, indicating prolonged circulation of the nanomedicine and enhanced availability of the drugs when compared to the bare drugs."( Sequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics.
Manzoor, K; Menon, D; Mohan, CC; Narayanan, D; Narayanan, S; Pavithran, M; Viswanath, A, 2014
)
0.4
" Plasma and various ocular tissues were taken for pharmacokinetic analysis, oxidation marker testings and gene expression assays."( Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues.
Chan, KP; Chan, SO; Chu, KO; Li, WY; Pang, CP; Qin, YJ; Wang, CC; Yang, YP, 2015
)
0.42
" In pharmacokinetic studies, rats were divided into four groups."( Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu, X; Liu, Y; Wang, Y; Zhang, D; Zhang, W, 2018
)
0.7
" Blood samples for the pharmacokinetic assessments were collected up to 8 hours after each dose of rosuvastatin."( Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers.
Ha, N; Jeon, JY; Kim, H; Kim, MG; Kim, TE; Kim, Y; Lee, JW, 2017
)
0.46
"The aim of the present study is to investigate a possible role of a single dose of (-)-epigallocatechin gallate (EGCG), the major catechin in green tea, for the pharmacokinetic interaction between green tea and nadolol in humans."( Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
Abe, O; Fromm, MF; Kimura, J; Misaka, S; Miura, I; Müller, F; Ogata, H; Ono, T; Onoue, S; Sato, H; Shikama, Y; Yabe, H, 2018
)
1.08
" Plasma samples were collected for pharmacokinetic analysis."( Effect of tea polyphenols on the oral and intravenous pharmacokinetics of ticagrelor in rats and its in vitro metabolism.
Cai, WM; Liu, SB; Sun, H; Tang, ZJ; Wang, ZT; Xue, Y; Zhang, Z, 2020
)
0.56
" EGCG may be the main ingredient of green tea that affects the pharmacokinetic parameters of rosuvastatin."( Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin.
Bian, Y; Huang, C; Huang, S; Liu, L; Miao, L; Xu, Q; Zhang, S, 2020
)
0.85

Compound-Compound Interactions

A systematic investigation of the chemopreventive effect of sulindac (SL) in combination with either epigallocatechin gallate (EGCG) or kaempferol similar (KMP) has been carried out 1,2-dimethyl hydrazine-treated rats. The PME inhibition and mechanism by HHP (600 MPa/10 min) combined with epigAllocatechin Gallate (HHP-EG CG) treatment were investigated.

ExcerptReferenceRelevance
" In the present study, the stability of EGCG and product formation in Tris-HCl buffer was investigated using real- time mass spectrometry combined with tandem mass ion mapping."( Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping.
Buckley, B; Ho, CT; Sang, S; Yang, CS; Yang, I, 2007
)
0.34
" These results indicate that EGCG, which has anticandidal activity causing blockage of the hyphal formation, has the synergism combined with Amp B against disseminated candidiasis."( Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism.
Han, Y, 2007
)
0.34
" The results demonstrate that tamoxifen at realistic doses (75 mug kg(-1)) can suppress the growth of ER-negative breast cancer when combined with EGCG."( A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
Menzies, AR; Rosengren, RJ; Scandlyn, MJ; Somers-Edgar, TJ; Stuart, EC, 2008
)
0.56
" Finally, the effect of curcumin in combination with the green tea extract epigallocatechin-3 gallate (EGCG) was evaluated."( Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
Ghosh, AK; Kay, NE; Secreto, CR; Shanafelt, TD, 2009
)
0.35
" In this study, we determined if vorinostat alone or in combination with EGCG imparts anti-proliferative effects against human melanoma cells."( Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG).
Nihal, M; Roelke, CT; Wood, GS, 2010
)
0.36
" Antitumor activity of bortezomib in combination with EGCG or ascorbic acid was determined using several dosing regimens to evaluate different target plasma concentrations of EGCG and ascorbic acid."( Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
Bannerman, B; Berger, A; Bolen, J; Claiborne, C; Dick, L; Fleming, P; Hales, P; Jones, M; Kupperman, E; Manfredi, M; Monbaliu, J; Tsu, C; Xu, L; Yu, J, 2011
)
0.59
" However, when combined with EGCG such that the plasma concentrations of EGCG were >200 μM at the time of bortezomib dosing, all antitumor activity was abrogated (TGI = -17."( Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
Bannerman, B; Berger, A; Bolen, J; Claiborne, C; Dick, L; Fleming, P; Hales, P; Jones, M; Kupperman, E; Manfredi, M; Monbaliu, J; Tsu, C; Xu, L; Yu, J, 2011
)
0.59
" In the present study, we have tested the cytotoxicity of ascorbate to MMe cells in combination with drugs used in MMe therapy, such as cisplatin, etoposide, gemcitabine, imatinib, paclitaxel, and raltitrexed, as well as with promising antitumor compounds like taurolidine, α-tocopherol succinate, and epigallocatechin-3-gallate (EGCG)."( In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma.
Burlando, B; Martinotti, S; Ranzato, E, 2011
)
0.37
"Low-dose metronomic (LDM) chemotherapy represents a new strategy to treat solid tumors by stronger antiangiogenic activity and less side-effects, especially in combination with other antiangiogenic agents."( Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.
Wu, H; Xiao, Y; Xin, Y; Zhao, J, 2012
)
0.38
" The effect of EGCG combined with ALA is greater than the effect of EGCG alone in all anti-inflammation and anti-oxidant experiments."( Epigallocatechin-3-gallate combined with alpha lipoic acid attenuates high glucose-induced receptor for advanced glycation end products (RAGE) expression in human embryonic kidney cells.
Jian, JH; Leu, JG; Liang, YJ; Lin, CY; Shih, CY,
)
0.13
" Treatment of mice with EGCG in combination with tolcapone increased the bioavailability of EGCG and decreased the methylation of plasma norepinephrine: no apparent liver or behavioral toxicity was observed."( Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
Forester, SC; Lambert, JD, 2014
)
0.4
" (+)-Catechin activity was investigated when combined with different ratios of Cu(2+) ; 100°C heat treatment; autoclaving; and 14 day storage against Staphylococcus aureus."( Heat treatment enhances the antimicrobial activity of (+)-Catechin when combined with copper sulphate.
Fielder, MD; Gould, SW; Holloway, AC; Kelly, AF; Mueller-Harvey, I; Naughton, DP, 2015
)
0.42
" fruticosa leaves extracts (PFE) combined with green tea polyphenols (GTP) were studied to elucidate their use in combination and find specific combinations with least concentrations that enhance the antioxidant activity."( Synergistic Effects of Potentilla fruticosa L. Leaves Combined with Green Tea Polyphenols in a Variety of Oxidation Systems.
Jia, C; Li, D; Liu, Z; Luo, Z; Wang, D, 2016
)
0.43
" In this study we have examined the effects of four naturally occurring polyphenols in combination with β-cyclodextrin (β-CD) on the aggregation of α-synuclein in the presence of macromolecular crowding agents."( Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative.
Batra, R; Chowdhury, PK; Gautam, S; Karmakar, S; Kundu, B; Pradhan, P; Sharma, P; Singh, J, 2017
)
0.46
" Each group was orally treated with DSD alone (Group 1), DSD combined with EGCG (Group 2), SD alone (Group 3) and SD combined with EGCG (Group 4)."( Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu, X; Liu, Y; Wang, Y; Zhang, D; Zhang, W, 2018
)
0.7
" In this study, we evaluated metabolic properties of oral nutritional supplement epigallocatechin gallate (EGCG) in combination with GLP-1 agonist exendin-4 in a mouse model of dietary-induced diabetes and obesity."( Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice.
Flatt, PR; Gault, VA; Millar, PJB; Pathak, NM; Pathak, V, 2018
)
0.97
"EGCG alone and particularly in combination with exendin-4 exerts positive metabolic properties in HF mice."( Beneficial metabolic effects of dietary epigallocatechin gallate alone and in combination with exendin-4 in high fat diabetic mice.
Flatt, PR; Gault, VA; Millar, PJB; Pathak, NM; Pathak, V, 2018
)
0.75
"A systematic investigation of the chemopreventive effect of sulindac (SL) in combination with either epigallocatechin gallate (EGCG) or kaempferol similar (KMP) has been carried out 1,2-dimethyl hydrazine-treated rats (DMH)."( Chemopreventive effect of sulindac in combination with epigallocatechin gallate or kaempferol against 1,2-dimethyl hydrazine-induced preneoplastic lesions in rats: A Comparative Study.
Elahl, HMS; Hassan, ESG; Hassanein, NMA; Hegab, AM, 2018
)
0.94
" Induction of apoptosis was also higher after treatment with EGCG in combination with eugenol-amrogentin than individual compound treatments."( Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line.
Kumar Panda, C; Mandal, S; Pal, D; Roy, R; Sur, S, 2018
)
1.92
" salivarius WB21 on periodontitis and oral malodor may be synergistically enhanced by use in combination with EGCg."( Effects of Lactobacillus salivarius WB21 combined with green tea catechins on dental caries, periodontitis, and oral malodor.
Hanioka, T; Higuchi, T; Hirofuji, T; Nakaya, S; Omagari, S; Suzuki, N; Yoneda, M, 2019
)
0.51
" In this study, DBS-NP was fabricated using an eco-friendly method involving ultrasonication combined with recrystallization."( Green fabrication and characterization of debranched starch nanoparticles via ultrasonication combined with recrystallization.
Hu, Y; Jin, Z; Qin, Y; Qiu, C; Wang, J; Xu, X; Xue, L, 2020
)
0.56
" Various natural compounds, including epigallocatechin-3-gallate (EGCG) in combination with taxane, have the potential to be developed as anticancer therapeutics."( Multifunctional nanoparticles for targeting the tumor microenvironment to improve synergistic drug combinations and cancer treatment effects.
Chen, ML; Huang, CM; Lai, CJ; Lin, YH; Lin, YN, 2020
)
0.56
"To verify synergistic effects, we investigated the antimicrobial activity of seven phenolic phytochemicals (gallic acid; epicatechin; epigallocatechin gallate; daidzein; genistein; myricetin; 3-hydroxy-6-methoxyflavone) in combination with six antibiotics against multidrug-resistant isolates from the ESKAPE group."( Synergistic antimicrobial activities of epigallocatechin gallate, myricetin, daidzein, gallic acid, epicatechin, 3-hydroxy-6-methoxyflavone and genistein combined with antibiotics against ESKAPE pathogens.
Borchardt, J; Böttcher, I; Buchmann, D; Guenther, S; Schaufler, K; Schultze, N, 2022
)
1.19
"The aim of this study is to demonstrate the potential use of phenolic natural compounds in combination with conventional antibiotics against multidrug-resistant bacteria of the ESKAPE group."( Synergistic antimicrobial activities of epigallocatechin gallate, myricetin, daidzein, gallic acid, epicatechin, 3-hydroxy-6-methoxyflavone and genistein combined with antibiotics against ESKAPE pathogens.
Borchardt, J; Böttcher, I; Buchmann, D; Guenther, S; Schaufler, K; Schultze, N, 2022
)
0.99
" In this study, the PME inhibition and mechanism by HHP (600 MPa/10 min) combined with epigallocatechin gallate (HHP-EGCG) treatment were investigated."( Inhibition effect of high hydrostatic pressure combined with epigallocatechin gallate treatments on pectin methylesterase in orange juice and model system.
Liao, X; Liu, Y; Rao, L; Tian, X; Wang, Y; Zhao, L, 2022
)
1.19
"In this study, we investigated the protective effects and possible mechanism of epigallocatechin-3-o-gallate (EGCG) combined with organic selenium in transforming growth factor (TGF)-β1-activated LX-2 cells."( Protective effects of epigallocatechin-3-o-gallate combined with organic selenium against transforming growth factor-beta 1-induced fibrosis in LX-2 cells.
Li, YH; Qin, LQ; Xu, JY; Yin, XB; Yuan, L; Zhang, L, 2022
)
0.72
" In conclusion, CGA in combination with EGCG ameliorated the gut alterations induced by aging, in part, through antioxidant and anti-inflammatory effects, along with its gut microbiota modulatory capacity."( Chlorogenic acid combined with epigallocatechin-3-gallate mitigates D-galactose-induced gut aging in mice.
Mackenzie, GG; Su, Z; Wei, R, 2023
)
0.91
"We investigated the effects of celecoxib combined with (-)-epigallocatechin-3-gallate (EGCG) or polyphenon E in a cisplatin-induced lung tumorigenesis model."( Effect of a Cyclooxygenase-2 Inhibitor in Combination with (-)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice.
Hisamoto, A; Katayama, H; Kishino, D; Kiura, K; Kubo, T; Maeda, Y; Mimoto, J; Ochi, N; Okada, T; Sato, K; Takigawa, N; Tanimoto, M; Ueoka, H; Yoshino, T, 2023
)
1.15
" Difficulties in the treatment of infections caused by resistant microorganisms have led to the search and need for new antimicrobials or new molecules that interact synergistically with antimicrobials."( Antimicrobial synergistic effects of apigenin, (-)-epigallocatechin-3-gallate, myricetin and luteolin in combination with some antibiotics.
Hanci, H; Igan, H, 2023
)
0.91
" Treatment with EGCG combined with Dexa notably reduced tubular injury, MCP-1, HSP-70, NF-κB, and TLR-4 levels (p < 0."( Epigallocatechin-3-gallate in combination with corticosteroids mitigates heat stress-induced acute kidney injury through modulating heat shock protein 70 and toll-like receptor 4-dependent pathways.
Abu-Elsaad, N; El-Kashef, DH; Ibrahim, T; Shafeek, F, 2023
)
0.91

Bioavailability

Epigallocatechin gallate (EGCG) is a main anticancer component in green tea. It has a poor bioavailability in rats and humans due to oxidation, metabolism and its efflux. The purpose of the study is to develop the nanoformulation of EGCG to improve its bioavailability and penetration into the brain.

ExcerptReferenceRelevance
" The results indicated that tea catechin, EGCg, is absorbed from the digestive tract into the rat and human body and that the CL-HPLC method reported here should be a powerful tool for studying the metabolic fate and bioavailability of EGCg."( Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma.
Miyazawa, T; Nakagawa, K, 1997
)
0.3
" Our work has so far produced several important results with EGCG and green tea: a wide range of target organs in animal experiments for cancer prevention, wide bioavailability of 3H-EGCG in various organs of mice, delayed cancer onset of patients with a history of consuming over 10 cups of green tea per day, and absence of any severe adverse effects among volunteers who took 15 green tea tablets per day (2."( Mechanistic findings of green tea as cancer preventive for humans.
Fujiki, H; Imai, K; Kimura, S; Nakachi, K; Okabe, S; Sueoka, E; Suga, K; Suganuma, M, 1999
)
0.3
" The study on bioavailability of 3H-EGCG in mice revealed the wide distribution of radioactivity in multiple organs."( Green tea and cancer chemoprevention.
Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M, 1999
)
0.3
"The absorption characteristics and oral bioavailability of three tea catechins, namely (-)-epicatechin (EC), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin gallate (EGCG), were assessed in this study."( Oral absorption and bioavailability of tea catechins.
Chen, Y; Li, RC; Zhu, M, 2000
)
0.51
"Tea consumption has been associated with reduced risk of both cancer and cardiovascular disease in population studies, but clinical data demonstrating bioavailability of the individual catechins and other polyphenolic components of tea are limited."( Catechins are bioavailable in men and women drinking black tea throughout the day.
Balentine, DA; Beecher, GR; Clevidence, BA; Smith, LS; Warden, BA, 2001
)
0.31
" Thus, GTPs or EGCG might be potential agents for modulating the bioavailability of P-gp substrates at the intestine and the multidrug resistance phenotype associated with expression of this transporter in cancer cells."( Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols.
Beliveau, R; Demeule, M; Jodoin, J, 2002
)
0.31
"Phenolic compounds have recently attracted special attention due to their beneficial health effects; their intestinal absorption and bioavailability need, therefore, to be investigated and Caco-2 cell culture model appeared as a promising tool."( Hydrogen peroxide generation in caco-2 cell culture medium by addition of phenolic compounds: effect of ascorbic acid.
Besançon, P; Caporiccio, B; Landrault, N; Laurent, C; Roques, SC; Rouane, JM; Teissèdre, PL, 2002
)
0.31
" Inadequate knowledge regarding the bioavailability and biotransformation of EGCG in humans, however, has limited our understanding of its possible beneficial health effects."( Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats.
Ho, CT; Lee, MJ; Lu, H; Meng, X; Sang, S; Sheng, S; Yang, CS; Zhu, N, 2002
)
0.31
" The bioavailability and metabolic fate of tea polyphenols in humans, however, are not clearly understood."( Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
Bondoc, FY; Chen, L; Lambert, G; Lee, MJ; Maliakal, P; Meng, X; Mohr, S; Prabhu, S; Yang, CS, 2002
)
0.31
" The importance of some of these mechanisms in vivo remains in question due to an incomplete understanding of the bioavailability of the polyphenolic compounds in tea."( Cancer chemopreventive activity and bioavailability of tea and tea polyphenols.
Lambert, JD; Yang, CS,
)
0.13
" in comparison with topical application may be due to its less bioavailability in skin target cells."( Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin.
Elmets, CA; Katiyar, SK; Vayalil, PK, 2003
)
0.32
" MRP type efflux pumps may limit the bioavailability of EGCG."( Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites.
Hong, J; Lambert, JD; Lee, SH; Sinko, PJ; Yang, CS, 2003
)
0.32
" The bioavailability of EGCG in the most commonly used animal species, mice, is poorly understood."( Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice.
Hong, JJ; Lambert, JD; Lee, MJ; Lu, H; Meng, X; Seril, DN; Sturgill, MG; Yang, CS, 2003
)
0.32
" But studies suggest that EGCG and other catechins are poorly absorbed and undergo substantial biotransformation to species that include glucuronides, sulfates, and methylated compounds."( Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials.
Kumar, NB; Moyers, SB, 2004
)
0.32
" Previously, we reported the bioavailability of EGCG in rats (1."( Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.
Hong, J; Kim, DH; Lambert, JD; Mishin, VM; Yang, CS, 2004
)
0.32
" The relatively low bioavailability of catechins reported after oral exposure to green tea argues, however, against a causal role of these constituents in the reported liver disorders."( Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture.
Baumgart, A; Guédon, D; Kreuter, MH; Netsch, MI; Schmidlin, CB; Schmidt, M; Schmitz, HJ; Schrenk, D, 2005
)
0.33
" However, the understanding of the molecular mechanisms of EGCG's activity in vivo have been confounded by its low oral bioavailability and low plasma levels."( Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells.
Bensari, A; Chao, WR; Waleh, NS; Zaveri, NT,
)
0.13
" Critical areas of future investigation include: (1) identification of the direct molecular target(s) of EGCG and related polyphenolic compounds in cells; (2) the in vivo metabolism and bioavailability of these compounds; (3) the ancillary effects of these compounds on tumor-stromal interactions; (4) the development of synergistic combinations with other antitumor agents to enhance efficacy in cancer prevention and therapy, and also minimize potential toxicities."( Modulation of signal transduction by tea catechins and related phytochemicals.
Shimizu, M; Weinstein, IB, 2005
)
0.33
" A human intervention study was performed to evaluate the bioavailability and antioxidant capacity of (-)-epigallocatechin-3-gallate (EGCG) administered as a single large dose in the form of either purified EGCG or as green tea extract (Polyphenon E)."( Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.
Carpenter, CL; Hara, Y; Heber, D; Henning, SM; Lee, NH; Liu, Y; Minutti, RR; Niu, Y; Thames, GD; Wang, H, 2005
)
0.59
" Among the different activities of EGCG observed in cell culture systems, we need to select the physiologically relevant ones based on the biological importance of the target as well as the effective concentration and whether the reaction can take place in vivo because of the limited bioavailability of EGCG."( Possible mechanisms of the cancer-preventive activities of green tea.
Hou, Z; Ju, J; Lambert, JD; Lu, G; Sang, S; Yang, CS, 2006
)
0.33
" EGCG is poorly bioavailable in man and rodents."( Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Kim, DH; Lambert, JD; Yang, CS; Zheng, R, 2006
)
0.33
" The objective of this study was to determine the bioavailability and bioactivity of tea polyphenols (PP) and theaflavins in human serum and human and mouse tissues."( Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption.
Aronson, W; Barnard, RJ; Conde, F; Csathy, G; Go, VL; Harris, DM; Heber, D; Henning, SM; Hong, J; Lee, NH; Lee, RP; Lu, J; Moro, A; Niu, Y; Pak-Shan, L; Seeram, NP; Wang, H; Ziaee, HG, 2006
)
0.33
" Previously, we have reported the low bioavailability of EGCG in rats and mice."( Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate.
Ho, CT; Hong, J; Kwon, SJ; Lambert, JD; Lee, MJ; Sang, S; Yang, CS, 2006
)
0.33
" Because of the rather low bioavailability of most polyphenolic compounds, how much of an effect dietary polyphenols would have on DNA methylation in humans is not clear."( Dietary polyphenols may affect DNA methylation.
Chen, D; Fang, M; Yang, CS, 2007
)
0.34
" Polyphenon E was taken on an empty stomach to optimize the oral bioavailability of EGCG."( Modulation of human glutathione s-transferases by polyphenon e intervention.
Alberts, DS; Briehl, MM; Chow, HH; Cordova, CA; Crowell, JA; Hakim, IA; Mikhael, DM; Ranger-Moore, J; Tome, ME; Vining, DR, 2007
)
0.34
" However, some of these agents have poor bioavailability and many of the in-depth studies into their mechanisms of action have been carried out in vitro using doses which are unachievable in humans."( Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals.
Andreadi, CK; Foreman, BE; Howells, LM; Hudson, EA; Manson, MM; Moiseeva, EP; Neal, CP; Sun, YY, 2007
)
0.34
" In conclusion, various beverages, especially teas, inhibit the function of SULT1A3, and therefore may have the potential to increase the bioavailability of orally administered substrates of SULT1A3, such as beta(2) agonists."( Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3.
Hiratsuka, A; Nishimuta, H; Ogura, K; Ohtani, H; Sawada, Y; Tsujimoto, M, 2007
)
0.34
" The bioavailability and biotransformation of tea catechins play a key role in determining the importance of various mechanisms in vivo."( Biotransformation of green tea polyphenols and the biological activities of those metabolites.
Lambert, JD; Sang, S; Yang, CS,
)
0.13
" Our objective was to determine the effect of quercetin and (-)-epigallocatechin-3-gallate (EGCG), major flavonoids present in the diet, on the PK and bioavailability of biochanin A, a flavonoid with chemopreventive properties."( Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon, YJ; Morris, ME,
)
0.13
"Despite presenting bioavailability problems, tea catechins have emerged as promising chemopreventive agents because of their observed efficacy in various animal models."( Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
Cabezas-Herrera, J; Chazarra, S; Otón, F; Rodríguez-López, JN; Sánchez-del-Campo, L; Tárraga, A, 2008
)
0.35
" The extent and rate of absorption of EGCG by the small intestine depends on various factors such as molecular size, lipophilicity, solubility, pKa, gastric and intestinal transit time, lumen pH, membrane permeability and first pass metabolism."( Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered (-)epigallocatechin-3-gallate from green tea extract: a human study.
Gawande, S; Kale, A; Kotwal, S, 2008
)
0.35
" The advantage of EGCG-P is that it may act as a prodrug, leading to higher bioavailability than EGCG itself."( Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Chan, TH; Chan, WK; Lam, WH; Lee, SC; Lee, TW; Wang, X; Wong, YC, 2008
)
0.35
" Induction of Cytochrome P450 (Cyp)1b1 in maternal liver may reduce bioavailability of DBP to the fetus as a mechanism of chemoprevention."( Chemoprevention of dibenzo[a,l]pyrene transplacental carcinogenesis in mice born to mothers administered green tea: primary role of caffeine.
Castro, DJ; Dashwood, RH; Fischer, KA; Giovanini, JN; Löhr, CV; Orner, GA; Pereira, CB; Williams, DE; Yu, Z, 2008
)
0.35
" Previously, we have reported the bioavailability of EGCG in rats and mice."( Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.
Bose, M; Hao, X; Hong, J; Ju, J; Kwon, SJ; Lambert, JD; Lee, MJ; Yang, CS, 2008
)
0.35
" On the other hand, there are a number of issues, such as stability, bioavailability and metabolic transformations under physiological conditions, facing the development of green tea polyphenols into therapeutic agents."( The challenge of developing green tea polyphenols as therapeutic agents.
Chan, TH; Chen, D; Dou, QP; Huo, C; Lam, WH; Landis-Piwowar, KR; Li, L; Wan, SB; Wang, Z, 2008
)
0.35
" Despite promising results in preclinical settings, its applicability to humans has met with limited success largely due to inefficient systemic delivery and bioavailability of promising chemopreventive agents."( Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
Adhami, VM; Ahmad, N; Asim, M; Bharali, DJ; Cui, H; Hafeez, BB; Khwaja, SI; Mousa, SA; Mukhtar, H; Siddiqui, IA, 2009
)
0.35
" However, compared with the controls, both the AUC and the relative bioavailability of verapamil were significantly (p<0."( Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Choi, DH; Choi, JS; Chung, JH, 2009
)
0.7
"The effects of epigallocatechin gallate (EGCG) on the oral bioavailability and pharmacokinetics of tamoxifen and its metabolite, 4-hydroxytamoxifen, were investigated in rats."( Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
Choi, JS; Shin, SC, 2009
)
1.1
"Epigallocatechin gallate (EGCG), a main anticancer component in green tea, has a poor bioavailability in rats and humans due to oxidation, metabolism and its efflux."( Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract.
Gawande, S; Ivanov, V; Kale, A; Kotwal, S; Netke, S; Niedzwiecki, A; Rath, M; Roomi, W, 2010
)
2.01
"As intestinal metabolism strongly influences the bioavailability of flavonoids, this study investigated the microbial deconjugation and degradation of the most common flavan-3-ols using the pig cecum in vitro model system developed in the authors' group."( Degradation and metabolism of catechin, epigallocatechin-3-gallate (EGCG), and related compounds by the intestinal microbiota in the pig cecum model.
Humpf, HU; van't Slot, G, 2009
)
0.35
" These findings (modulation of plasma EGCG level by CAF) provide ideas for modulating the bioavailability of tea catechins, which can be applied to tea-related drinks and foods."( Effects of co-administration of tea epigallocatechin-3-gallate (EGCG) and caffeine on absorption and metabolism of EGCG in humans.
Kimura, F; Miyazawa, T; Nakagawa, K; Nakamura, M; Nakayama, K; Niino, H; Sookwong, P; Tsuduki, T, 2009
)
0.35
"The bioavailability values observed are in agreement with previous reports, although the dosage of polyphenols ingested in this study is remarkably lower."( Bioavailability of catechins from ready-to-drink tea.
Brighenti, F; Calani, L; Cordero, C; Del Rio, D; Jechiu, L; Scazzina, F, 2010
)
0.36
" These results demonstrate the feasibility of developing a diet-based combinatorial approach for CaP prevention and treatment and raise the possibility that serum added to culture medium might affect uptake, bioavailability and biological efficacy of dietary phytochemicals."( Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.
Hsieh, TC; Wu, JM, 2009
)
0.35
" Reduction in endothelin-1 (ET-1) synthesis may also increase bioavailability of nitric oxide."( Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1.
Kim, JA; Quon, MJ; Reiter, CE, 2010
)
0.68
" While some studies suggest that methylations can increase the bioavailability of polyphenols, other studies indicate a decrease in the anticancer benefits of methylated polyphenols."( Polyphenols: biological activities, molecular targets, and the effect of methylation.
Dou, QP; Landis-Piwowar, KR, 2008
)
0.35
" However, the stability and bioavailability of EGCG are restricted."( A pro-drug of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine.
Chan, TH; Chang, RC; Chao, J; Ho, YS; Huie, MJ; Lai, CS; Lam, WH; Lau, WK; Wang, M; Yu, MS; Yuen, WH, 2010
)
0.36
"The aim of this study was to investigate green tea flavan-3-ol catabolism and plasma pharmacokinetic and urinary excretion by high-performance liquid chromatography with tandem mass spectrometry to evaluate their absolute bioavailability by taking into account all known and some unknown catabolites deriving from their interaction with the gastrointestinal tract and its host microflora."( Bioavailability and catabolism of green tea flavan-3-ols in humans.
Brighenti, F; Calani, L; Cordero, C; Del Rio, D; Pellegrini, N; Salvatore, S,
)
0.13
" The calculated bioavailability was equal to 39% and it is interesting to notice the great variability in urinary excretion of colonic metabolites among participants, probably related to differences in their own colonic microflora."( Bioavailability and catabolism of green tea flavan-3-ols in humans.
Brighenti, F; Calani, L; Cordero, C; Del Rio, D; Pellegrini, N; Salvatore, S,
)
0.13
" We have recently shown promising preclinical results with the use of green tea polyphenol, (-)-epigallocatechin-3-gallate (EGCG) in mouse models of both diseases, however the translation into clinical use has been problematic primarily as a result of poor bioavailability and inefficient delivery to the central nervous system (CNS)."( Nanolipidic particles improve the bioavailability and alpha-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease.
Bickford, PC; Fountain, M; Giunta, B; Shytle, RD; Smith, A; Tan, J, 2010
)
0.36
" Fish oil enhanced bioavailability of EGCG versus EGCG treatment alone (P<0."( Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice.
Giunta, B; Hou, H; Ruscin, A; Salemi, J; Shytle, RD; Tan, J; Zhu, Y, 2010
)
0.36
" Compared to controls (without EGCG), the AUCs of oral nicardipine and the extent of absolute oral bioavailability (F) were also greater with oral EGCG."( Effects of oral epigallocatechin gallate on the pharmacokinetics of nicardipine in rats.
Burm, JP; Choi, JS, 2009
)
0.7
" Amongst many reasons, inefficient systemic delivery and bioavailability of promising chemopreventive agents are considered to significantly contribute to such a disconnect."( Nanochemoprevention by bioactive food components: a perspective.
Mukhtar, H; Siddiqui, IA, 2010
)
0.36
" The review also addresses the limitations of the dose, pharmacokinetics, and bioavailability of EGCG in experimental animals and findings related to the EGCG-drug interaction."( Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise.
Ahmed, S, 2010
)
0.36
" Plasma free catechins were detectable in both beverage and extract groups versus controls at screen and at 8 weeks, indicating compliance and bioavailability of green tea catechins."( Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.
Aston, CE; Basu, A; Betts, NM; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M, 2010
)
0.36
" Studies have shown that concomitant use of a COMT inhibitor is highly beneficial in controlling the wearing-off phenomenon by improving L-DOPA bioavailability as well as brain entry."( Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies.
Bishop, SC; Fukui, M; Kang, KS; Wen, Y; Yamabe, N; Zhu, BT, 2010
)
0.36
" Despite accomplished outcomes in preclinical settings, its applicability to humans has met with limited success for many reasons including inefficient systemic delivery and bioavailability of promising chemopreventive agents."( Nanochemoprevention: sustained release of bioactive food components for cancer prevention.
Adhami, VM; Ahmad, N; Mukhtar, H; Siddiqui, IA, 2010
)
0.36
"Bioactive constituents of pecan nuts such as γ-tocopherol and flavan-3-ol monomers show antioxidant properties in vitro, but bioavailability in humans is not known."( Pecans acutely increase plasma postprandial antioxidant capacity and catechins and decrease LDL oxidation in humans.
Haddad, EH; Hudthagosol, C; McCarthy, K; Oda, K; Sabaté, J; Wang, P, 2011
)
0.37
" Our study firstly showed that EGCG interacted with sunitinib and reduced the bioavailability of sunitinib."( Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability.
Chen, Y; Cheng, K; Dong, H; Gao, F; Ge, J; He, JP; Hou, JM; Li, HZ; Li, LH; Lin, HJ; Liu, JY; Peng, XC; Qiu, M; Su, JM; Tan, BX; Wei, M; Wu, Y; Yang, L; Zhao, Y; Zhao, YL, 2011
)
0.37
" Future studies should be designed to account for a disease process in which the pathogenic factors may take place for years before disease manifestations take place, the possibly limited bioavailability of polyphenols, and the potential need to provide combinations or modifications of polyphenols."( Polyphenols: planting the seeds of treatment for the metabolic syndrome.
Cherniack, EP, 2011
)
0.37
"The bioactivities and bioavailability of plant polyphenols including proanthocyanidins and other catechin derivatives may be affected by covalent reaction between polyphenol and proteins."( Capillary electrophoresis methods for the determination of covalent polyphenol-protein complexes.
Danielson, ND; Hagerman, AE; Loegel, TN; Trombley, JD, 2011
)
0.37
" However, the major concerns with GTPs are their bioavailability and stability under physiologic conditions."( A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells.
Chan, TH; Meeran, SM; Patel, SN; Tollefsbol, TO, 2011
)
0.37
" However, the effects of concurrent consumption of tea on the bioavailability and the net therapeutic potential of co-administered chemical drugs are not clear."( Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro.
Du, J; Gu, C; Han, M; Lu, W; Qiao, J; Shang, W; Wang, W; Yin, W; Zhu, M, 2011
)
0.37
" Current knowledge on how to enhance bioavailability could be the answer to some of these issues."( Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?
Hunstein, W; Mereles, D, 2011
)
0.37
"Nanochemoprevention by oral consumption was developed by the encapsulation of (-)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG."( Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability.
Hu, B; Huang, Q; Tang, W; Ting, Y; Yang, X; Zeng, X, 2012
)
0.38
"9 mg/kg body weight) or the combination of the both - piperine was used in this combination to enhance the bioavailability of EGCG."( Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis.
Brückner, M; Domschke, W; Kucharzik, T; Lügering, A; Westphal, S, 2012
)
0.38
"Compared to control, consumption of GT with milk, caseinate, or soy protein significantly reduced the bioavailability (mean area under the plasma concentration-time curve) of total catechins (means ± SEM; GT + M, 87 ± 5%; GT + CS, 79 ± 5%; GT + S, 88 ± 4%), epigallocatechin gallate (GT + M, 68 ± 4%; GT + CS, 63 ± 5%; GT + S, 76 ± 5%), and epicatechin gallate (GT + M, 68 ± 5%; GT + CS, 66 ± 6%; GT + S, 77 ± 6%), while the bioavailability of non-galloylated catechins such as epigallocatechin (GT + M, 134 ± 9%; GT + CS, 118 ± 9 %; GT + S, 123 ± 8%) and epicatechin (GT + M, 125 ± 10%; GT + CS, 114 ± 11%; GT + S, 110 ± 8%) significantly increased."( Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from green tea in humans.
Egert, S; Frank, J; Müller, MJ; Rimbach, G; Tereszczuk, J; Wein, S; Wolffram, S, 2013
)
0.57
"Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from GT in humans."( Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylated catechins from green tea in humans.
Egert, S; Frank, J; Müller, MJ; Rimbach, G; Tereszczuk, J; Wein, S; Wolffram, S, 2013
)
0.39
" The effect of quercetin on bioavailability and metabolism of GTPs was confirmed in vivo."( Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo.
Heber, D; Henning, SM; Wang, P, 2012
)
0.38
" Indeed, natural products have been the most productive source of leads for the development of anti-cancer drugs but perceived disadvantages, such as low bioavailability and week potency, have limited their development and use in the clinic."( Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells.
Chan, TH; Chen, D; Cui, Q; Dou, QP; Pamu, S, 2012
)
0.86
" The bioavailability of catechin may be improved by co-administration of functional foods."( Influence of gallate and pyrogallol moieties on the intestinal absorption of (-)-epicatechin and (-)-epicatechin gallate.
Choshi, T; Hibino, S; Kamishikiryou, J; Sugihara, N; Tagashira, T, 2012
)
0.38
" The bioavailability of these natural compounds is an important factor that determines their efficacy."( Tea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs.
Alotaibi, A; Anderson, D; Bhatnagar, P; Gupta, KC; Najafzadeh, M, 2013
)
0.39
" A prodrug of EGCG (pro-EGCG, EGCG octaacetate) is utilized to enhance the stability and bioavailability of EGCG in vivo."( Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Chan, TH; Cheng, JT; Chu, CY; Chu, KO; He, YX; Kwong, J; Lau, TS; Li, G; Man, GC; Qin, L; Wang, CC; Xu, H; Zhang, T, 2013
)
0.39
"This study was carried out to elucidate the structural advantage of a gallated form of tea catechin on modulating bioavailability of dietary starch in rats."( Gallated form of tea catechin, not nongallated form, increases fecal starch excretion in rats.
Matsumoto, Y; Unno, T; Yamamoto, Y, 2012
)
0.38
" Since the anticancer activity of polyphenols largely depends on their susceptibility to biotransformation reactions, numerous EGCG derivatives, analogs and prodrugs have been designed to improve the stability, bioavailability and anticancer potency of the native compound."( Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - present).
Chan, TH; Chen, D; Dou, QP; Foldes, R; Landis-Piwowar, K, 2013
)
0.87
" Finally, we highlight the role of synergy, bioavailability and pharmacokinetics of tea polyphenols, current status of clinical trials, discuss future directions, and comment on the future challenges involved in the effective use of tea polyphenols for the prevention and management of liver cancer."( Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer.
Bishayee, A; Darvesh, AS, 2013
)
0.39
" It emerged that the poor bioavailability of these nutraceuticals poses an obstacle to their exerting adequate anti-cancer potential."( Nutraceuticals as new treatment approaches for oral cancer: II. Green tea extracts and resveratrol.
Chaushu, G; Dayan, A; Dayan, D; Salo, T; Vered, M; Zlotogorski, A, 2013
)
0.39
" Results provide a potential strategy to enhance the delivery and bioavailability of catechins in humans by modulating green tea formulation with vitamin C and xylitol."( Green tea formulations with vitamin C and xylitol on enhanced intestinal transport of green tea catechins.
Chung, JH; Chung, JO; Kim, S; Lee, SJ; Oh, YJ; Shim, SM, 2013
)
0.39
" However, metabolism and bioavailability of C are not fully understood."( Dose-response plasma appearance of green tea catechins in adults.
Beaumont, M; Dionisi, F; Guy, PA; Lepage, M; Marmet, C; Renouf, M; Williamson, G, 2013
)
0.39
"This study investigates the human bioavailability (plasma appearance) of C after drinking three doses of infused green tea in a randomized cross-over design."( Dose-response plasma appearance of green tea catechins in adults.
Beaumont, M; Dionisi, F; Guy, PA; Lepage, M; Marmet, C; Renouf, M; Williamson, G, 2013
)
0.39
" However, the low level of stability and bioavailability in the body makes administering EGCG at chemopreventive doses unrealistic."( Anticancer activities of (-)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells.
Cai, Q; de Pace, RC; Fan, Z; Gao, W; Liu, X; Nie, S; Pan, X; Sun, M; Wang, S; Zhang, J, 2013
)
0.39
" The bioavailability and efficacy of antioxidants in human corneal limbal epithelial (HCLE) cells were measured to determine whether antioxidants might be beneficial constituents of lubricant eye drops."( Bioavailability of antioxidants applied to stratified human corneal epithelial cells.
Koetje, LR; Mitchell, AK; Schotanus, MP; Stoddard, AR; Ubels, JL, 2013
)
0.39
" Many reasons are attributed to this limited success, including inefficient systemic delivery and bioavailability under in vivo conditions."( Synthesis of PLGA nanoparticles of tea polyphenols and their strong in vivo protective effect against chemically induced DNA damage.
Bhatnagar, P; Gupta, KC; Kumar, P; Mishra, S; Shukla, Y; Singh, M; Srivastava, AK, 2013
)
0.39
" Conventional preformulation methods have been employed to improve the bioavailability of EGCg."( Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats.
Arora, KK; Kavuru, P; Kesani, S; Shytle, RD; Smith, AJ; Tan, J; Zaworotko, MJ, 2013
)
0.39
" This research provided a practical approach that may enhance the bioavailability and bioactivity of procyanidins in cranberries."( Depolymerization of cranberry procyanidins using (+)-catechin, (-)-epicatechin, and (-)-epigallocatechin gallate as chain breakers.
Gao, JM; Gu, L; Liu, H; Zou, T, 2013
)
0.61
" Poor absorption results in low systemic bioavailability of EGCG after oral administration but high colonic mucosal exposure."( A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis.
Beatty, K; Dryden, GW; Lam, A; McClain, CJ; Qazzaz, HH, 2013
)
0.39
" Finally, the challenges of developing flavonoid delivery systems that improve flavonoid bioavailability and their anticancer therapy potentials were summarized."( Delivering flavonoids into solid tumors using nanotechnologies.
Chen, M; Wang, S; Wang, Y; Zhang, J, 2013
)
0.39
" This drawback could be overcome by designing green tea catechins with better bioavailability and/or by cotreatment combining breast cancer endocrine treatment with green tea catechins."( Effect of green tea catechins on breast carcinogenesis: a systematic review of in-vitro and in-vivo experimental studies.
Yiannakopoulou, ECh, 2014
)
0.4
" In order to improve pharmacological activity and bioavailability of natural tea catechins, two major strategies have been adopted to date which include synthesizing catechin analogs/prodrugs and the development of novel drug delivery systems."( Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties.
Bansal, S; Bhattacharya, S; Sharma, M; Vyas, S, 2013
)
0.39
" However, the limited bioavailability of active agents could be one reason for their restricted usefulness for human consumption."( Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
Adhami, VM; Bharali, DJ; Cui, H; Khan, N; Mousa, SA; Mukhtar, H; Shabana, SM; Siddiqui, IA, 2014
)
0.4
" In this study, we compared the bioavailability of EGCG and O-methyl EGCGs in rats, and clarified the pharmacokinetics of O-methyl EGCGs."( Comparison of (-)-epigallocatechin-3-O-gallate (EGCG) and O-methyl EGCG bioavailability in rats.
Ichiyanagi, T; Ito, R; Ito, T; Maruki-Uchida, H; Oritani, Y; Setoguchi, Y, 2013
)
0.39
" Treatment of mice with EGCG in combination with tolcapone increased the bioavailability of EGCG and decreased the methylation of plasma norepinephrine: no apparent liver or behavioral toxicity was observed."( Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
Forester, SC; Lambert, JD, 2014
)
0.4
" Epigallocatechin gallate-casein complexes were able to decrease the proliferation of HT-29 cancer cells, demonstrating that bioavailability may not be reduced by the nanoencapsulation."( Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells.
Corredig, M; Haratifar, S; Meckling, KA, 2014
)
1.31
" However, the generally low solubility, stability, bioavailability and target specificity, together with the side effects seen when used at high levels, have limited their application."( Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.
Moustaid-Moussa, N; Nie, S; Su, R; Sun, M; Wang, S; Wu, D; Zhang, J, 2014
)
0.4
"Nanoparticles have the potential to increase bioavailability of nutraceutical compounds such as (-)-epigallocatechin gallate (EGCG)."( Fabrication of self-assembled (-)-epigallocatechin gallate (EGCG) ovalbumin-dextran conjugate nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells.
Gu, L; Li, Z, 2014
)
0.9
"The consumption of cacao-derived products, particularly in the form of dark chocolate is known to provide beneficial cardiovascular effects in normal individuals and in those with vascular dysfunction (reduced nitric oxide [NO] bioavailability and/or synthesis)."( Cell membrane mediated (-)-epicatechin effects on upstream endothelial cell signaling: evidence for a surface receptor.
Ceballos, G; Moreno-Ulloa, A; Ramirez-Sanchez, I; Romero-Perez, D; Villarreal, F, 2014
)
0.4
" Their efficacy has been tested in tumor xenografted mice and considerable experimental findings have stimulated researchers to further improve the bioavailability of these nutraceuticals."( Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets.
Aras, A; Farooqi, AA; Hechenleitner, AA; Khokhar, AR; Pineda, EA; Qureshi, MZ; Silva, MF; Sobczak-Kupiec, A, 2014
)
0.4
" Furthermore, EGCG treatment was also effective in vivo, demonstrating oral bioavailability and reduced parasitic loads without altering serological toxicity markers."( The effect of (-)-epigallocatechin 3-O--gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action.
Almeida-Amaral, EE; Canto-Cavalheiro, MM; Gervazoni, L; Inacio, JD, 2014
)
0.4
"5% of native polyphenols, suggesting potential bioavailability of significant amounts of antioxidants through the oral mucosal epithelium that might be gastric sensitive and/or poorly absorbed in the intestine."( Simulated gastrointestinal digestion, intestinal permeation and plasma protein interaction of white, green, and black tea polyphenols.
Campiglia, P; Giannetti, D; Novellino, E; Tenore, GC, 2015
)
0.42
"The encapsulation of epigallocatechin gallate (EGCG) in lipid nanoparticles (LNs) could be a suitable approach to avoid drug oxidation and epimerization, which are common processes that lead to low bioavailability of the drug limiting its therapeutic efficacy."( Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
Andreani, T; Egea, MA; Fangueiro, JF; Fernandes, L; Garcia, ML; Silva, AM; Souto, EB, 2014
)
1
"Interactions between polyphenols and macromolecules may impact polyphenol stability and bioavailability from foods."( Thermal degradation of green tea flavan-3-ols and formation of hetero- and homocatechin dimers in model dairy beverages.
Ferruzzi, MG; Manganais, C; Song, BJ, 2015
)
0.42
" We examined the effect of pretreatment with dietary EGCG on the hepatotoxicity and bioavailability of acute oral bolus dosing with EGCG in CF-1 mice."( Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
Forester, SC; James, KD; Lambert, JD, 2015
)
0.42
" Epigallocatechin gallate (EGCG) is often described as the most potently chemopreventive green tea catechin; however, the low bioavailability of EGCG is a limiting factor for its biological effect."( Chemopreventive potential of the tannase-mediated biotransformation of green tea.
Camara, LE; Ferreira, LR; Gambero, A; Macedo, GA; Macedo, JA; Ribeiro, ML; Santos, JC, 2012
)
1.29
" Although their bioavailability is discussed, various studies suggest that EGCG modulates cellular and molecular mechanisms of various symptoms leading to metabolic syndrome."( Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome.
Clere, N; Faure, S; Fillon, L; Legeay, S; Rodier, M, 2015
)
1.86
" The poor bioavailability of EGCG limits HCV antiviral activity in vitro."( Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.
Burton, DR; Douglas, D; Egli, A; Forester, S; Houghton, M; Humar, A; Kneteman, N; Lambert, J; Law, J; Law, M; Lund, G; O'Shea, D; Tyrrell, DL, 2016
)
0.65
" As a result of this, a significant decrease in the intestinal uptake and peroral bioavailability of the P-glycoprotein substrates (verapamil and atorvastatin) was observed along with the progression of diabetes as compared to normal animals."( Increased intestinal P-glycoprotein expression and activity with progression of diabetes and its modulation by epigallocatechin-3-gallate: Evidence from pharmacokinetic studies.
Agarwal, M; Dash, RP; Ellendula, B; Nivsarkar, M, 2015
)
0.42
" This interaction may modulate their bioavailability and effectiveness."( N- and S-homocysteinylation reduce the binding of human serum albumin to catechins.
Arru, D; Carru, C; Cossu, A; Giordo, R; Mangoni, AA; Pintus, G; Posadino, AM; Scanu, B; Sotgia, S; Zinellu, A, 2017
)
0.46
" Among many reasons, inefficient systemic delivery and bioavailability of promising chemopreventive agents are considered to significantly contribute to such a disconnection."( Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.
Sanna, V; Siddiqui, IA, 2016
)
0.43
" We developed a prodrug of EGCG (Pro-EGCG or 1) which shows increased stability, bioavailability and biological activity in vivo as compared to EGCG."( Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
Ahmed, RS; Chan, TH; Dou, QP; El-Banna, HA; El-Ghoneimy, AA; Farshi, P; Foldes, R; Liu, G; Renzetti, A; Saed, G; Soave, C; Yang, H, 2016
)
0.66
" However, limitations in terms of stability and bioavailability have hampered its application in clinical settings."( Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
Granja, A; Pinheiro, M; Reis, S, 2016
)
1.88
" However, the use of EGCG in modern therapeutics is limited due to its poor bioavailability and limited stability at physiological pH."( Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
Bhargava, S; Gudem, S; Kulhari, H; Pooja, D; Radhakrishnan, R; Shukla, R; Sistla, R, 2016
)
0.43
"The instability and low bioavailability of polyphenols limit their applications in food industries."( Epigallocatechin Gallate (EGCG) Decorating Soybean Seed Ferritin as a Rutin Nanocarrier with Prolonged Release Property in the Gastrointestinal Tract.
Blanchard, C; Li, Q; Strappe, P; Sun, G; Yang, R; Zhang, M; Zhou, Z, 2016
)
1.88
"Under the current scenario, the role of EGCG as a therapeutic agent is being utilised and new approaches are being formulated to overcome the problem of stability and bioavailability of EGCG."( Therapeutic effects of EGCG: a patent review.
Agrawal, R; Chakrawarti, L; Dang, S; Gabrani, R; Gupta, S, 2016
)
0.43
" The major problem that limits the clinical application of this polyphenol is its low bioavailability and stability."( Potent effects of peracetylated (-)-epigallocatechin-3-gallate against hydrogen peroxide-induced damage in human epidermal melanocytes via attenuation of oxidative stress and apoptosis.
Fu, L; Jin, R; Liu, D; Ning, W; Wang, S; Xu, A, 2016
)
0.43
" However, the bioavailability of a substance is a prerequisite for any post absorptive effect in vivo."( Systemic Absorption of Catechins after Intraruminal or Intraduodenal Application of a Green Tea Extract in Cows.
Beyer, B; Blank, R; Gohlke, A; Metges, CC; Wein, S; Wolffram, S, 2016
)
0.43
" Owing to a difference in the affinity of T3 and Toc for the α-tocopherol transfer protein, the bioavailability of orally ingested T3 is lower than that of Toc."( Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.
Eitsuka, T; Miyazawa, T; Nakagawa, K; Nishida, H; Tatewaki, N, 2016
)
0.43
" The inconsistency between the biological activity of EGCG in cell cultures and in vivo can be attributed to its low stability, which not only decreases its bioavailability but also leads to the formation of degradation products and prooxidant molecules with possible side-effects."( Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems.
Ferguson, SJ; Krupkova, O; Wuertz-Kozak, K, 2016
)
0.77
"The relatively low oral bioavailability of flavan-3-ols from acute doses is commonly highlighted as a limitation when considering the biological significance of these compounds."( Differentiated Caco-2 cell monolayers exhibit adaptation in the transport and metabolism of flavan-3-ols with chronic exposure to both isolated flavan-3-ols and enriched extracts.
Chegeni, M; Ferruzzi, MG; Redan, BW, 2017
)
0.46
" This review, starting from the structure, source, bioavailability and pharmacokinetics of relevant polyphenols, highlights recent studies on the effect and potential molecular mechanism(s) of action of the phenolic compounds epigallocatechin-3-gallate, resveratrol and hydroxytyrosol in restoring mitochondrial energy deficit and in reversing phenotypical alteration in DS."( Plant polyphenols as natural drugs for the management of Down syndrome and related disorders.
Braidy, N; Caccamese, S; Daglia, M; Nabavi, SM; Vacca, RA; Valenti, D, 2016
)
0.43
" Thus, we can infer that niosomal encapsulation might be a promising approach to improve the oral bioavailability of EGCG in the body."( Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions.
Chen, L; Liang, R; Williams, PA; Yokoyama, W; Zhong, F, 2016
)
0.65
" However, the success of EGCG in preclinical studies is difficult to translate into clinical trials due to issues of low solubility, bioavailability and an uncertain therapeutic window."( Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles.
Begun, J; De, R; Popat, A; Tyagi, N, 2017
)
0.46
"plantarum; (ii) to develop and evaluate a microstructured synbox (microencapsulating both probiotic and EGCG together) in rat model of alcohol liver disease (ALD); and, (iii) to confirm whether the combination can address issues of EGCG bioavailability and probiotic survivability in adverse gut conditions."( Better Management of Alcohol Liver Disease Using a 'Microstructured Synbox' System Comprising L. plantarum and EGCG.
Arora, S; Chopra, K; Kaur, IP; Kaur, UJ; Rishi, P, 2017
)
0.46
" The obtained data supported our hypothesis of target-specific enhanced bioavailability and limited unwanted toxicity, thus leading to a significant potential for probable clinical outcome."( Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
Adhami, VM; Chamcheu, JC; Jashari, R; Mukhtar, H; Rady, I; Sanna, V; Sechi, M; Siddiqui, IA; Singh, CK, 2017
)
0.46
" Different types of formulations have been designed for the improvement of bioavailability of these compounds, nanonization being one of the most notable approaches among them."( Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.
Abdollahi, M; Bahramsoltani, R; Davatgaran-Taghipour, Y; Farzaei, MH; Karimi-Soureh, Z; Masoomzadeh, S; Rahimi, R, 2017
)
0.46
" For these encouraging results, this catechin is currently used in clinical trials for treatment of various type of cancer and other diseases, although its poor bioavailability and poor stability represent severe limitations."( An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer
Bimonte, S; Caliendo, D; Cascella, M; Cuomo, A; Izzo, F; Leongito, M; Palaia, R, 2017
)
0.46
" However, a key problem is their short half-life and low bioavailability under in vivo conditions."( Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
Benlloch, M; Castellano, G; Dellinger, RW; Estrela, JM; Mena, S; Obrador, E; Salvador, R, 2017
)
0.46
" In this work, EGCG-loaded nanostructured lipid carriers (NLC) functionalized with folic acid were optimized through a Box-Behnken design intended to provide an enhanced oral absorption and increased bioavailability of EGCG."( Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Chaves, LL; Granja, A; Neves, AR; Nunes, C; Pinheiro, M; Reis, S; Vieira, AC, 2017
)
0.46
" The human gastrointestinal digestion tract is the first place where the food grade macromolecule nanoparticles exert their effects on improving the bioavailability of diet polyphenols, via enhancing their solubility, preventing their degradation in the intestinal environment, elevating the permeation in small intestine, and even increasing their contents in the bloodstream."( Food macromolecule based nanodelivery systems for enhancing the bioavailability of polyphenols.
Hu, B; Liu, X; Zeng, X; Zhang, C, 2017
)
0.46
" The present work intends to bring molecular and thermodynamic insights on the ability of green tea epigalhocatechin-3-gallate (EGCG) to interact and modulate the bioavailability of a major CD immunodominant peptide (32-mer)."( Molecular insights on the interaction and preventive potential of epigallocatechin-3-gallate in Celiac Disease.
Brás, NF; Dias, R; Fernandes, I; Freitas, V; Mateus, N; Pérez-Gregorio, M, 2018
)
0.48
" However, its instability and poor bioavailability have largely limited its efficacy and application."( Food-grade Encapsulation Systems for (-)-Epigallocatechin Gallate.
Cai, ZY; Li, QS; Li, XM; Liang, YR; Lu, JL; Ma, SC; Shi, M; Shi, YL; Yang, R; Ye, JH; Zheng, XQ, 2018
)
0.75
" The use of Pro- epigallocatechin gallate (Pro-EGCG) as a prodrug appears to offer improved in vitro stability as well as better in vivo bioavailability and efficacies in a number of animal studies, suggesting its potential as a therapeutic agent for further study and development."( Perspectives on the recent developments with green tea polyphenols in drug discovery.
Chan, TH; Chen, Y; Dou, QP; Fardous, R; Lewandowski, A; Li, D; Li, F; Liu, J; Qiao, X; Wang, Y, 2018
)
0.82
"Inhibiting component of therapy with (-)-epigallocatechin-3-gallate (EGCG) is low bioavailability of fresh tea polyphenols that outcome from insecurity under stomach related circumstances, insufficient transcellular transport."( Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach.
Feng, A; He, Y; Li, X; Yuan, X; Zheng, W; Zhou, G, 2018
)
0.48
"Numerous clinical and bioavailability studies addressed epigallocatechin gallate (EGCG) beneficial effects; however, our previous work revealed EGCG-induced nephrotoxicity in the presence of diabetes."( Paradoxical cardiotoxicity of intraperitoneally-injected epigallocatechin gallate preparation in diabetic mice.
Abdallah, DM; Ahmed, LA; El-Sayeh, BM; Rasheed, NOA, 2018
)
0.97
" However, its therapeutic potential is limited in-vivo due to its poor bioavailability and stability."( Inhibition of Al(III)-Induced A
Khan, ZA; Mandal, AKA; Singh, NA, 2018
)
0.48
"The glycosylation of plant polyphenols may modulate their solubility and bioavailability and protect these molecules from oxygen, light degradation, and during gastrointestinal transit."( Efficient α-Glucosylation of Epigallocatechin Gallate Catalyzed by Cyclodextrin Glucanotransferase from Thermoanaerobacter Species.
Ballesteros, AO; Gonzalez-Alfonso, JL; Jimenez-Barbero, J; Leemans, L; Plou, FJ; Poveda, A, 2018
)
0.77
" However, bioavailability issues have restricted the development of EGCG for the treatment of psoriasis."( Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Adame, S; Adhami, VM; Babatunde, AS; Bharali, DJ; Chamcheu, JC; Esnault, S; Longley, BJ; Massey, RJ; Mousa, SA; Mukhtar, H; Siddiqui, IA; Wood, GS, 2018
)
0.48
"The purpose of the study is to develop the nanoformulation of Epigallocatechin gallate (EGCG) in order to improve its bioavailability and penetration into the brain."( A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies.
Aggarwal, R; Chakrabarti, A; Kaur, H; Kumar, B; Medhi, B; Modi, M; Radotra, BD; Sinha, VR, 2019
)
1.01
" The results suggest that coconsumption GTE or EnzGTE with GTE-derived flavonols could improve the bioavailability of epicatechins."( Impact of Bioconversion of Gallated Catechins and Flavonol Glycosides on Bioaccessibility and Intestinal Cellular Uptake of Catechins.
Balusamy, SR; Choi, EH; Kim, DO; Rha, CS; Shim, SM, 2019
)
0.51
" Despite its great curative potential, the poor bioavailability of EGCG restricts its clinical applcation."( Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
Cheng, LZ; Corke, H; Fang, YP; Gan, RY; Ge, YY; Wang, M; Wei, XL; Yang, QQ; Zhang, D, 2020
)
0.79
" However, its molecular structure is susceptible to modifications due to cellular enzymes affecting its stability, bioavailability and hence, overall efficiency."( Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.
Bhargava, S; Gudem, S; Kulhari, H; Pooja, D; Radhakrishnan, R; Ramakrishna, S; Ravuri, HG, 2019
)
0.75
" Therefore, an attempt was made to enhance permeability and bioavailability of EGCG using curcumin to treat hyperlipidemia."( Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
Dalal, PS; Joshi, SR; Pandit, AP; Patole, VC, 2019
)
0.51
" However, its pharmaceutical activity is limited due to low bioavailability and chemical instability."( Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
Mandal, AKA; Ramesh, N, 2019
)
0.51
" (-)-epigallocatechin-3-gallate (EGCG) is a promising nutraceutical in this regard; however, it suffers chemical instability and low bioavailability resulting in inefficient delivery."( Colloidal (-)-epigallocatechin-3-gallate vesicular systems for prevention and treatment of skin cancer: A comprehensive experimental study with preclinical investigation.
El-Kayal, M; Elkheshen, S; Mortada, N; Nasr, M, 2019
)
0.51
"The low solubility, instability, and low bioavailability of food bioactive compounds such as polyphenols and flavonoids, restrict their applications in the fields of food science and nutrition."( Fabrication, structure, and function evaluation of the ferritin based nano-carrier for food bioactive compounds.
Blanchard, C; Liu, J; Liu, Y; Meng, D; Yang, R; Zhang, Y; Zhou, Z, 2019
)
0.51
" Numerous nanoformulations, including solid lipid nanoparticles, polymeric nanoparticles, micelles, and liposomes, have been formulated to enhance the bioavailability and stability, as well as the therapeutic efficacy of polyphenols."( Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma.
Ashby, CR; Chauhan, H; Heenatigala Palliyage, G; Singh, S; Tiwari, AK, 2019
)
0.51
"Many studies have shown that epigallocatechin gallate (EGCg) contribute to the health benefits of green tea, although its bioavailability is usually low."( Identification of the Catechin Uptake Transporter Responsible for Intestinal Absorption of Epigallocatechin Gallate in Mice.
Ishii, S; Kirino, A; Kitazawa, H; Mori, T; Nakamura, S; Osaki, N; Shimotoyodome, A; Tamai, I, 2019
)
1.03
" WGA-EF-NP exhibited superior anti-tumor activity and pro-apoptotic efficacy compared to the drugs and nanoparticles without WGA decoration owing to better bioavailability and longer circulation time in vivo."( Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles.
Chen, J; Chen, Z; Di, L; Hu, L; Huang, J; Li, J; Qiao, H; Wang, H; Wang, R; Yang, M, 2019
)
0.51
" There has been a continually increasing interest to formulate nanoformulations of phytochemicals by using various nanocarriers, such as liposomes, micelles, nanoemulsions, and nanoparticles, to improve their bioavailability and target specificity, thereby maximizing the therapeutic potential."( Phytochemicals based chemopreventive and chemotherapeutic strategies and modern technologies to overcome limitations for better clinical applications.
Ansari, MI; Arora, D; Sharma, PK; Singh, VK, 2019
)
0.51
" But translation of in vitro anti-ACR activity into in vivo is mainly mediated by bioavailability and biotransformation of individual polyphenols."( Translating In Vitro Acrolein-Trapping Capacities of Tea Polyphenol and Soy Genistein to In Vivo Situation is Mediated by the Bioavailability and Biotransformation of Individual Polyphenols.
Huang, Q; Lv, L; Sang, S; Zhu, Y, 2020
)
0.56
" The bioavailability and biotransformation of individual polyphenols, and especially the gut microbiome, contribute to in vivo anti-ACR ability of dietary polyphenols."( Translating In Vitro Acrolein-Trapping Capacities of Tea Polyphenol and Soy Genistein to In Vivo Situation is Mediated by the Bioavailability and Biotransformation of Individual Polyphenols.
Huang, Q; Lv, L; Sang, S; Zhu, Y, 2020
)
0.56
" EGCG enhances the bioavailability of normal NO by reducing levels of the endogenous NO inhibitor asymmetric dimethylarginine."( Protective Effect of Epigallocatechin Gallate on Endothelial Disorders in Atherosclerosis.
Yamagata, K, 2020
)
0.88
" These molecules have poor bioavailability that may remain as the limiting factor in their clinical effects."( Natural polyphenols in preclinical models of epilepsy.
Dhir, A, 2020
)
0.56
" A prodrug of EGCG (pro-EGCG) enhances the bioavailability of EGCG."( A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells.
Du, J; Guo, Y; Liu, X; Qin, X; Song, E; Sun, X; Tu, Y; Wang, L; Wang, Y; Xu, X; Zhu, M, 2020
)
0.56
"Neat epigallocatechin gallate (EGCG) has low bioavailability and tuna oil (TO) is prone to oxidation."( Broccoli byproducts for protection and co-delivery of EGCG and tuna oil.
Augustin, MA; Sanguansri, L; Shi, M; Ye, JH; Ying, DY, 2020
)
1.07
" A major challenge with EGCG is its low bioavailability which is being targeted for improvement by encapsulating EGCG in nano-sized vehicles for further delivery."( Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.
Aggarwal, D; Aggarwal, V; Barwal, TS; Bishayee, A; Jain, A; Kaur, G; Pandey, A; Ritzer, EE; Sak, K; Srivastava, S; Tania, M; Tuli, HS; Varol, M, 2022
)
1
" Despite pharmacotherapy strategies, the current topical administration of eye drops remains a great challenge owing to their low bioavailability and short residence time."( Long-acting mucoadhesive thermogels for improving topical treatments of dry eye disease.
Lai, JY; Luo, LJ; Nguyen, DD, 2020
)
0.56
"Currently, the clinical benefits of tea polyphenols have contributed to the development of efficient systemic delivery systems with adequate bioavailability and stability."( Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
Chen, W; Chen, X; Lu, Y; Tu, G; Wu, L; Zhang, L; Zheng, D, 2020
)
0.8
" Several studies have shown the ability to overcome poor bioavailability through nanotechnology-based strategies such as encapsulation, liposome, micelles, nanoparticles and various other formulation."( Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.
Alhumaydhi, FA; Almatroodi, SA; Almatroudi, A; Alsahli, MA; Khan, AA; Rahmani, AH, 2020
)
0.84
" Besides, the safety, blood-brain barrier (BBB) penetration and bioavailability issues in conducting clinical trials were also discussed."( The pharmacological activity of epigallocatechin-3-gallate (EGCG) on Alzheimer's disease animal model: A systematic review.
Chen, JY; Lu, JH; OuYang, D; Zhang, S; Zhu, Q, 2020
)
0.56
" However, its poor bioavailability and requirement of a high dosage to manifest activity have restricted its clinical application."( Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.
Chan, TH; Kwong, J; Lau, TS; Leung, KT; Man, GCW; Ng, TB; Song, Y; Wang, CC; Wang, H; Wang, J; Wong, JH; Zhao, Y, 2020
)
0.56
" These results suggest that the extent of intestinal absorption of lisinopril was significantly impaired in the presence of GTE, whereas it had no major effect on the absorption rate and renal excretion of lisinopril."( Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers.
Abe, O; Misaka, S; Ogata, H; Ono, T; Ono, Y; Onoue, S; Sato, H; Shikama, Y; Shimomura, K; Suzuki, M; Uchida, A, 2021
)
0.62
" However, poor stability, low bioavailability and antitumor efficacy limit the application of EGCG."( Codelivery of epigallocatechin-3-gallate and diallyl trisulfide by near-infrared light-responsive mesoporous polydopamine nanoparticles for enhanced antitumor efficacy.
Gu, H; Huang, D; Liang, J; Liu, Q; Xu, J; Xue, W; Zhou, X, 2021
)
0.62
" However, its bioavailability is poor due to the low absorption and P-gp efflux."( Natural P-gp inhibitor EGCG improves the acteoside absorption in Caco-2 cell monolayers and increases the oral bioavailability of acteoside in rats.
Chen, Q; Huang, W; Liu, X; Lu, B; Peng, J; Wu, L; Xu, T; Zhou, F, 2020
)
0.56
" Therefore, in this paper, EGCG-loaded chitosan nanoparticles (ECN) were fabricated and entrapped into chitosan/alginate (CS/Alg) scaffolds to form CS/Alg-ECN scaffolds for improving the bioavailability of EGCG."( Sustained release of epigallocatechin-3-gallate from chitosan-based scaffolds to promote osteogenesis of mesenchymal stem cell.
Cai, H; Hao, M; Sun, Q; Tan, WS; Wang, J; Wei, Y, 2021
)
0.62
" However, the poor stability and low bioavailability of EGCG limit its potential application."( Fabrication of oral nanovesicle in-situ gel based on Epigallocatechin gallate phospholipid complex: Application in dental anti-caries.
Dai, Z; Guo, H; Kou, X; Liu, M; Sun, H; Xu, X; You, X; Zhang, Z; Zhu, H, 2021
)
0.87
"Epigallocatechin-3-gallate (EGCG) has been considered an anticancer agent despite conflicting and discrepant bioavailability views."( CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression.
Banerjee, S; Banerjee, SK; Chatterjee, I; Das, A; De, A; Dutta, D; Ghosh, A; Gunewardena, S; Haque, I; Quadir, M; Ray, P; Weir, S, 2021
)
0.62
" Future studies will assess the potential for nanocarriers to increase the oral bioavailability of EGCG."( Epigallocatechin-3-Gallate Protects Pro-Acinar Epithelia Against Salivary Gland Radiation Injury.
Brimson, JM; Chaisuparat, R; Chansaenroj, A; Ferreira, JN; Oonsiri, S; Sariya, L; Sulistiyani, E; Tencomnao, T; Urkasemsin, G; Vacharaksa, A, 2021
)
0.62
" We developed an EGCG liposomal formulation to improve its bioavailability and evaluated the neuroprotective activity in in vitro and in vivo neuroinflammation models."( Epigallocatechin-3-Gallate-Loaded Liposomes Favor Anti-Inflammation of Microglia Cells and Promote Neuroprotection.
Barro, L; Chao, CW; Cheng, CY; Chin, TY; Feng, TW; Hsieh, MF; Tsai, ST; Wu, XY; Yu, RS, 2021
)
0.62
" Unexpected interactions may lead to changes in bioaccessibility, bioactivity, and bioavailability of phytochemicals."( Identify the interactions between phytochemicals and proteins in the complicated food matrix.
Liu, PF; Mengesha, NM; Tsai, YH, 2021
)
0.62
" Additionally, we identified supporting evidence for the nephroprotective function of gallic acid using molecular docking and bioavailability investigations."( Identification of gallic acid as a active ingredient of Syzygium aromaticum against tacrolimus-induced damage in renal epithelial LLC-PK1 cells and rat kidney.
Hong, G; Jung, K; Kang, KS; Kim, CE; Kim, DW; Lee, HL; Lee, JH; Park, M, 2021
)
0.62
"Despite widespread interest in chemoprevention and therapy due to the high margin of safety of dietary natural compounds, clinical intervention with single agents has failed to yield the expected outcomes, mostly due to poor bioavailability and low potency."( Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth
Amin, ARMR; Chen, ZG; Lamichhane, R; Nannapaneni, S; Shin, DM; Wang, D, 2021
)
0.89
" However, inherent instability of EGCG greatly limits its bioavailability and clinical efficacy."( Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.
Chen, MC; Chiu, YH; Hung, JI; Wu, YW, 2021
)
2.06
" It has been reported that EGCG reduces plasma nadolol bioavailability in normotensive models."( Oral epigallocatechin gallate reduces intestinal nadolol absorption via modulation of Oatp1a5 and Oct1 transcriptional levels in spontaneously hypertensive rats.
Chua, AL; Lee, SK; Ling, WC; Tan, HJ, 2021
)
1.14
"These data concluded that exposure to EGCG could lead to reduced nadolol bioavailability and therefore, uncontrolled raised blood pressure and higher risks of cardiovascular events."( Oral epigallocatechin gallate reduces intestinal nadolol absorption via modulation of Oatp1a5 and Oct1 transcriptional levels in spontaneously hypertensive rats.
Chua, AL; Lee, SK; Ling, WC; Tan, HJ, 2021
)
1.14
" The bioavailability of EGCG was higher in the hydrogel beads than those in the double emulsions, while the quercetin bioavailability was not significantly different expect for the ratio of 3:7."( Co-encapsulation of (-)-epigallocatechin-3-gallate and quercetin in double emulsion hydrogel beads: Microstructures, functional properties, and digestion behaviors.
Du, X; Hu, M; Li, Y; Liu, G; Qi, B; Zhang, W, 2022
)
0.72
"The use of glyceryl monooleate (GMO)-based nanoparticles has not yet been explored in overcoming the low bioavailability of Epigallocatechin-3-gallate (EGCG), a green tea polyphenol with a known anticancer activity."( Tuning curvature and phase behavior of monoolein bilayers by epigallocatechin-3-gallate: Structural insight and cytotoxicity.
Armeni, T; Galeazzi, R; Gerelli, Y; Laudadio, E; Mariani, P; Minnelli, C; Mobbili, G; Moretti, P; Pigozzo, A, 2022
)
0.72
" Pharmacokinetic study showed that the oral bioavailability presented nearly 12-fold increment."( Study on the stability and oral bioavailability of curcumin loaded (-)-epigallocatechin-3-gallate/poly(N-vinylpyrrolidone) nanoparticles based on hydrogen bonding-driven self-assembly.
Chen, Y; Hu, J; Lei, X; Ming, J; Rao, Z; Sun, Y; Wang, J; Wang, Q; Xu, Z; Zeng, K; Zhao, J, 2022
)
0.72
" It is susceptible to lower stability, lesser bioavailability, and lower absorption rate due to various environmental, processing, formulations, and gastrointestinal conditions of the human body."( Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies.
Gul, S; Khan, MI; Mahtab, N; Maqsood, M; Mehmood, S; Sahar, A; Zaib, S, 2022
)
2.16
" These findings contribute to improving the bioavailability of EGCG and help mine highly active metabolites, which can be used as raw materials for the development of pharmaceutical intermediates or functional foods."( The interplays between epigallocatechin-3-gallate (EGCG) and Aspergillus niger RAF106 based on metabolism.
Du, MR; Fang, X; Liu, T; Peng, H; Shi, QS; Wang, J; Wang, YS; Xie, XB; Zhou, G,
)
0.13
" The nanoscale vehicle may improve the EGCG solubility and bioavailability while overcoming constraints and cellular barriers."( The applications of epigallocatechin gallate (EGCG)-nanogold conjugate in cancer therapy.
Alalikhan, A; Hashemian, P; Hashemzadeh, A; Javid, H; Karimi-Shahri, M, 2023
)
1.23
"The application of Epigallocatechin-3-gallate (EGCG) in food industry was limited by its low stability in aqueous solutions and poor bioavailability in vivo."( Stability of glycosylated complexes loaded with Epigallocatechin 3-gallate (EGCG).
Cui, H; Qiu, J; Wang, X; Xiong, C; Yao, C; Yao, L; Zhang, J; Zheng, Q; Zhong, Y, 2023
)
0.91
" However, the low bioavailability and off-target effects of EGCG and its reactivity with some chemotherapeutic agents limit its clinical application."( EGCG adjuvant chemotherapy: Current status and future perspectives.
Feng, K; Li, P; Wang, L, 2023
)
0.91
"The synergistic effect of epigallocatechin-3-gallate (E) and quercetin (Q) enhances the therapeutic efficacy on related diseases; however, the instability and lower bioavailability of E and Q limited their application."( The synergistic effect of epigallocatechin-3-gallate and quercetin co-loaded hydrogel beads on inflammatory bowel disease.
Du, X; Hu, M; Huang, Y; Li, Y; Liu, G; Qi, B, 2023
)
0.91
" However, the limited bioavailability restricts their application."( Co-assembled nanocomplexes comprising epigallocatechin gallate and berberine for enhanced antibacterial activity against multidrug resistant Staphylococcus aureus.
Chen, H; Chen, R; Cui, M; Dong, Z; Feng, Y; Li, Y; Liu, W; Sun, S; Wang, J; Ye, H; Zhang, Q; Zhang, Y; Zheng, T, 2023
)
1.18
" This review focuses on the effects of EGCG on the functional capabilities acquired by breast tumor cells during its multistep development, the molecular and signal pathways involved, the synergistic effects in combination with current drugs, and how nanomaterials can improve its bioavailability on breast cancer treatment."( The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment.
Burgos, V; Maria, DA; Marín, V; Pardi, P; Paz, C; Pérez, R, 2023
)
0.91
" Unfortunately, EGCG presents disappointing bioavailability after oral administration, primarily due to its chemical instability and poor absorption."( Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.
Bakun, P; Cerbin-Koczorowska, M; Goslinski, T; Jelińska, A; Koczorowski, T; Kolasiński, E; Kuźmińska, J; Mlynarczyk, DT; Piwowarczyk, L; Stawny, M, 2023
)
1.26
"Acetylation could improve the bioavailability of (-)-Epigallocatechin-3-Gallate (EGCG), but the relationship of substitution degree and antioxidant capacity of acetylated EGCG was unclear."( Separation and antioxidant activities of new acetylated EGCG compounds.
Cui, H; Engelhardt, UH; Wang, Y; Yin, J; Yu, J; Zhang, J; Zhao, Y, 2023
)
0.91

Dosage Studied

Green tea extract (Epigallocatechin gallate, EGCG) at a daily dosage of 856. PMA-treated RD cells showed dose-response inhibition of MMP-9 by doxycycline and epig allocatechin Gallate.

ExcerptRelevanceReference
" After determining the maximally tolerated dosage of the tea products, their effect in a colon cancer model was investigated."( Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer.
Aliaga, C; Balentine, DA; Boone, CW; Kelloff, GJ; Pittman, B; Reinhardt, J; Rivenson, A; Steele, VE; Weisburger, JH; Zang, E, 1998
)
0.57
" Human subjects were UVB irradiated on sun-protected skin to four times their minimal erythema dosage (MED) and skin biopsies or keratomes were obtained either 24 h or 48 h later."( Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin.
Elmets, CA; Katiyar, SK; Matsui, MS; Mukhtar, H, 1999
)
0.3
" Results indicated that maximum plasma concentrations for the catechins (15-112 micrograms/ml) were achieved at 2 h post-oral dosing and the apparent volume of distribution (Vd/F) ranged from 30 to 63 l/kg."( Oral absorption and bioavailability of tea catechins.
Chen, Y; Li, RC; Zhu, M, 2000
)
0.31
" However, dosing the GSNO-treated cells with 9, 14, or 18 microg/ml of EGCG resulted in only 74 +/- 8%, 66 +/- 1%, and 43 +/- 3% of the cells, respectively, in the G(1)-phase."( Epigallocatechin gallate protects U937 cells against nitric oxide-induced cell cycle arrest and apoptosis.
Geigerman, CM; Kelly, MR; Loo, G, 2001
)
1.75
" In each dosage group, the kinetic profile revealed rapid absorption with a one-peak plasma concentration versus time course, followed by a multiphasic decrease consisting of a distribution phase and an elimination phase."( A single ascending dose study of epigallocatechin gallate in healthy volunteers.
Decourt, JP; Girault, J; Girault, N; Haller, J; Pineau, B; Richard-Caudron, AS; Ullmann, U; Weber, P,
)
0.41
" There was a >60% increase in the area under the plasma EGCG concentration-time curve after 4 weeks of green tea polyphenol treatment at a dosing schedule of 800 mg once daily."( Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Alberts, DS; Brooks, CA; Cai, Y; Chow, HH; Crowell, JA; Dorr, RT; Hakim, IA; Hara, Y; Shahi, F, 2003
)
0.54
"We investigated the effect of different doses of L-EGCG on GMCs proliferation at 24 h, 48 h and 72 h respectively, and screened the best dosage and time point."( [Effect of L-EGCG on lipopolysaccharide-induced glomerular mesangial cell proliferation in rats].
He, XJ; Lu, XY; Yi, ZW, 2003
)
0.32
" The distribution and elimination half-lives were 6 and 72 min respectively, after the dosage of 30 mg/kg."( Determination of (-)-epigallocatechin gallate in rat blood by microdialysis coupled with liquid chromatography.
Hung, LC; Lin, LC; Tsai, TH, 2004
)
0.64
"This randomized, double-blind, placebo-controlled study assessed the safety, tolerability, and plasma-kinetic behavior of 94% pure crystalline epigallocatechin gallate (EGCG) after ten days' repeated dosing in 36 healthy male volunteers."( Plasma-kinetic characteristics of purified and isolated green tea catechin epigallocatechin gallate (EGCG) after 10 days repeated dosing in healthy volunteers.
Decourt, JD; Girault, J; Haller, J; Spitzer, V; Ullmann, U; Weber, P, 2004
)
0.75
" Consequently, the picture is becoming ever more complicated, not least because results often appear to be cell-type specific, dose-response relationships are critical, and any one agent appears to have multiple mechanisms of action."( Inhibition of survival signalling by dietary polyphenols and indole-3-carbinol.
Manson, MM, 2005
)
0.33
" Furthermore, EGCG is the most potent inducer of HO-1 expression of the different green tea constituents that we analyzed, but had no detectable cytotoxic effects over the 25-100 microM dosage range."( Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways.
Hsieh, CW; Hsu, MC; Lai, PH; Lin, JB; Wu, CC; Wung, BS, 2006
)
0.33
" To determine if oral administration of green tea would prevent development of diabetes, young Zucker diabetic rats were dosed with green tea extract containing 50-125 mg/kg of Epigallocatechin gallate (EGCG) starting at 7 weeks of age, before the appearance of excessive weight gain and glucose elevation."( Effect of long-term oral administration of green tea extract on weight gain and glucose tolerance in Zucker diabetic (ZDF) rats.
Janle, EM; Portocarrero, C; Zhou, Q; Zhu, Y, 2005
)
0.52
" These data indicate that transdermal EGCG is useful for delivering prolonged levels of EGCG to plasma and tissues, and may provide an alternative to tea consumption as a dosage form of EGCG."( Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
Kim, DH; Lambert, JD; Yang, CS; Zheng, R, 2006
)
0.33
" To distinguish between blocking and suppressing effects, and thus provide mechanistic insights into prevention during the initiation versus post-initiation phases of carcinogenesis, white tea, and green tea were administered at 2% (w/v) as the sole source of drinking fluid either 2 wk before and 2 wk during PhIP dosing (100 mg/kg, every other day by oral gavage), or starting 1 wk after the carcinogen and continued until the study was terminated at 16 wk."( Comparison of white tea, green tea, epigallocatechin-3-gallate, and caffeine as inhibitors of PhIP-induced colonic aberrant crypts.
Bailey, GS; Carter, O; Dashwood, RH; Dashwood, WM; Fischer, KA; Löhr, CV; Orner, GA; Pereira, CB; Wang, R; Williams, DE, 2007
)
0.34
" Dose-response relationships observed in several epidemiological studies have indicated that pronounced cardiovascular and metabolic health benefits can be obtained by regular consumption of 5-6 or more cups of green tea per day."( Effects of green tea and EGCG on cardiovascular and metabolic health.
Wolfram, S, 2007
)
0.34
"01, respectively) in mice belonging to all EGCG dosing groups."( Protective effects of epigallocatechin gallate on colon preneoplastic lesions induced by 2-amino-3-methylimidazo[4,5-f ] quinoline in mice.
Li, YQ; Yang, XY; Yuan, JH,
)
0.45
" Gene dosage correction induces a rescue of the brain volume alterations."( Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A.
Arbones, M; Bizot, JC; Delabar, JM; Gillet, B; Guedj, F; Ledru, A; Paly, E; Rivals, I; Rubin, E; Sébrié, C; Smith, D, 2009
)
0.35
"The bioavailability values observed are in agreement with previous reports, although the dosage of polyphenols ingested in this study is remarkably lower."( Bioavailability of catechins from ready-to-drink tea.
Brighenti, F; Calani, L; Cordero, C; Del Rio, D; Jechiu, L; Scazzina, F, 2010
)
0.36
" Once-daily dosing with EGCG increased hepatotoxic response."( Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.
Ju, J; Kennett, MJ; Lambert, JD; Reuhl, KR; Sang, S; Yang, CS, 2010
)
0.36
" Nevertheless, the dose-response relationship of the inhibitory activity in vivo has not been systematically characterized."( Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro.
Chen, YK; Guan, F; Hou, Z; Jin, H; Lee, MJ; Li, GX; Liu, B; Lu, G; Xiao, H; Yang, CS; Yang, Z; Yu, A, 2010
)
0.36
" The tea and extract groups had similar dosing of epiogallocatechin-3-gallate (EGCG), the active compound in green tea."( Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.
Aston, CE; Basu, A; Betts, NM; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M, 2010
)
0.36
" Both the beverage and extract groups had similar dosing of epigallocatechin-3-gallate, the active green tea polyphenol."( Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.
Aston, CE; Basu, A; Betts, NM; Blevins, S; Du, M; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M, 2011
)
0.37
" Although there is a considerable amount of data available, questions remain in terms of the primary mechanism(s) of action, the dose-response relationships involved, and the best way to translate the results to human intervention studies."( Weight control and prevention of metabolic syndrome by green tea.
Grove, KA; Lambert, JD; Sae-tan, S, 2011
)
0.37
" Antitumor activity of bortezomib in combination with EGCG or ascorbic acid was determined using several dosing regimens to evaluate different target plasma concentrations of EGCG and ascorbic acid."( Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea.
Bannerman, B; Berger, A; Bolen, J; Claiborne, C; Dick, L; Fleming, P; Hales, P; Jones, M; Kupperman, E; Manfredi, M; Monbaliu, J; Tsu, C; Xu, L; Yu, J, 2011
)
0.59
"Responses were evaluated from dose-response curves of the metabolites and metabolic inhibitors in which growth of HeLa cells, apoptosis based on DAPI fluorescence and cytosolic NADH levels were correlated with sphingomyelinase and spingosine kinase activities and levels of ceramide and sphingosine1-phosphate."( Metabolite modulation of HeLa cell response to ENOX2 inhibitors EGCG and phenoxodiol.
De Luca, T; Morré, DJ; Morré, DM; Watanabe, T; Wu, LY, 2011
)
0.37
" Dose-response curves obtained for each compound by applying the neutral red uptake (NRU) assay to MMe cells growing in vitro, allowed to obtain IC50 values for each compound used singularly."( In vitro screening of synergistic ascorbate-drug combinations for the treatment of malignant mesothelioma.
Burlando, B; Martinotti, S; Ranzato, E, 2011
)
0.37
" An open-loop 3-zone SMB approach was used, a gradient of solvent strength in zones I and II was formed by different methanol dosage in purge and desorbent solutions and pre-equilibration was reached by the elution at the end of zone III."( Separation of epigallocatechin gallate from tea polyphenol by simulated moving bed chromatography.
Liang, Y; Wang, S; Zheng, S, 2012
)
0.74
" EGCG prevented DON-induced cytotoxicity to HT-29 cells in a dose-response manner."( Cytoprotective effect of epigallocatechin-3-gallate against deoxynivalenol-induced toxicity through anti-oxidative and anti-inflammatory mechanisms in HT-29 cells.
Bharathi Priya, L; Kalaiselvi, P; Padma, VV; Rajashree, K, 2013
)
0.39
" Adenomyosis was induced in 28 female ICR mice neonatally dosed with tamoxifen, while another 12 (group C) were dosed with solvent only, which served as a blank control."( Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.
Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B, 2013
)
0.39
" These cocrystals were subsequently dosed at 100 mg EGCg per kg body weight in rats, and the plasma levels were monitored over the course of eight hours following the single oral dose."( Crystal engineering of green tea epigallocatechin-3-gallate (EGCg) cocrystals and pharmacokinetic modulation in rats.
Arora, KK; Kavuru, P; Kesani, S; Shytle, RD; Smith, AJ; Tan, J; Zaworotko, MJ, 2013
)
0.39
" The effect of green tea catechins on breast cell carcinogenesis has been investigated in different experimental models and under different experimental conditions, that is, carcinogen investigated, green tea catechin dosage regimen, treatment with green tea extract versus pure synthetic EGCG, and time point of treatment with green tea catechins in relation to the exposure to the carcinogen."( Effect of green tea catechins on breast carcinogenesis: a systematic review of in-vitro and in-vivo experimental studies.
Yiannakopoulou, ECh, 2014
)
0.4
" PMA-treated RD cells showed dose-response inhibition of MMP-9 by doxycycline and epigallocatechin gallate and both MMPs by NM."( In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW, 2014
)
0.63
" There were no dose-limiting toxicities reported in all EGCG dosing tiers."( A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer.
Li, H; Sun, X; Xie, P; Xing, L; Yu, J; Zhang, X; Zhao, H; Zhu, W, 2014
)
0.4
" Studies have demonstrated the hepatotoxicity of high-dose oral bolus dosing with the tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) in mice and dogs."( Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
Forester, SC; James, KD; Lambert, JD, 2015
)
0.42
" First, we performed a dose-response study to evaluate nociceptive sensation after administration of EGCG and its derivatives 23 and 30, using the Hargreaves test at 7 and 21 days after injury (dpi)."( Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in mice.
Alberch, J; Boadas-Vaello, P; Puig, T; Turrado, C; Verdú, E; Vidal-Sancho, L; Xifró, X, 2015
)
0.42
"To examine the effect and safety of high-dose green tea extract (Epigallocatechin gallate, EGCG) at a daily dosage of 856."( Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial.
Chen, IJ; Chiu, JP; Hsu, CH; Liu, CY, 2016
)
0.67
" Using the live fiber model system, we also determine the dose-response curve for both IGF-1 and insulin on Foxo1 nucleo-cytoplasmic distribution."( Green tea component EGCG, insulin and IGF-1 promote nuclear efflux of atrophy-associated transcription factor Foxo1 in skeletal muscle fibers.
Russell, SJ; Schneider, MF; Wimmer, RJ, 2015
)
0.42
" Conversely, the MG132 dose-response curve was unaffected by co-administration of EGCG."( EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
Bettuzzi, S; Bonacini, M; Giovanna Troglio, M; Modernelli, A; Naponelli, V; Ramazzina, I; Rizzi, F, 2015
)
0.42
" The current study investigated if an EGCG dosage similar to that study would yield similar improvements in either cognitive or skeletal deficits."( Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
Abeysekera, I; Dria, KJ; Goodlett, CR; LaCombe, J; Roper, RJ; Stancombe, K; Stewart, RJ; Stringer, M; Thomas, J; Wallace, JM, 2017
)
0.46
" Our findings suggest that GN carrier is responsible for enhanced pharmacological efficacy of topically instilled EGCG, thereby demonstrating the benefits of using biodegradable in situ gelling delivery system to overcome the drawbacks of limited dry eye relief associated with eye drop dosage form."( Epigallocatechin Gallate-Loaded Gelatin-g-Poly(N-Isopropylacrylamide) as a New Ophthalmic Pharmaceutical Formulation for Topical Use in the Treatment of Dry Eye Syndrome.
Lai, JY; Luo, LJ, 2017
)
1.9
" This novel hypothesis is important to human health, and the dose-response relationship of this synergistic toxicity needs to be further characterized."( Synergistic toxicity of epigallocatechin-3-gallate and diethyldithiocarbamate, a lethal encounter involving redox-active copper.
Dong, R; Sun, K; Wang, J; Wang, X; Yang, CS; Zhang, J; Zhang, K, 2017
)
0.46
" Specifically, EGCG extended lifespan in an inverted U-shaped dose-response manner."( Epigallocatechin-3-gallate promotes healthy lifespan through mitohormesis during early-to-mid adulthood in Caenorhabditis elegans.
Chen, YJ; Gong, YS; Huang, JA; Liu, ZH; Tong, JW; Xiong, LG, 2018
)
0.48
" Intragastric dosing with EGCG (500 - 750 mg/kg) once daily for 3 d caused hepatic inflammation, necrosis, and hemorrhage."( Potential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gallate in mice.
James, KD; Kennett, MJ; Lambert, JD, 2018
)
0.48
" The effects of doses and dosage forms on catechin toxicity, the mechanisms involved, and factors that may affect toxicity are discussed."( Studies on the Prevention of Cancer and Cardiometabolic Diseases by Tea: Issues on Mechanisms, Effective Doses, and Toxicities.
Yang, CS; Zhang, J, 2019
)
0.51
" Furthermore, the effect of oral single dosage of EGC-M5 on glucose tolerance test with ICR mice was examined and significant suppression of hyperglycemia was observed."( Effects of Microbial Metabolites of (-)-Epigallocatechin Gallate on Glucose Uptake in L6 Skeletal Muscle Cell and Glucose Tolerance in ICR Mice.
Ashida, H; Hara-Terawaki, A; Ikeda, M; Nagano, T; Seto, R; Takagaki, A; Yamashita, Y; Yoshioka, Y, 2019
)
0.78
" Overall, we propose that dosage imbalance of the Hsa21 gene DYRK1A affects downstream Wnt target genes."( Downregulated Wnt/β-catenin signalling in the Down syndrome hippocampus.
Almudimeegh, S; Berwick, DC; Cleverley, K; Fisher, EMC; Granno, S; Harvey, K; Heaton, G; Nagda, Z; Nixon-Abell, J; Plagnol, V; Rain, JC; Tosh, J; Tybulewicz, VLJ; Wiseman, FK; Zanda, M, 2019
)
0.51
" Additionally, the thermal dosage in the treatment of cancer cells could also probably harm the healthy cells."( Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells.
Chao, CY; Chen, WT; Hsieh, CH; Kuo, YY; Lu, CH, 2019
)
0.75
" Further study is needed to determine whether higher dosage of EGCG might aggravate cerebral IRI post-CA/CPR."( Cerebral protection of epigallocatechin gallate (EGCG) via preservation of mitochondrial function and ERK inhibition in a rat resuscitation model.
Chen, MH; Fang, W; Li, N; Qin, S; Qin, T; Tan, XF; Xie, L; Yang, YG, 2019
)
0.82
" EGCG mouthwash was administered at the assigned dosage level (starting at 440 μmol/L, three times a day) in a standard 3 + 3 dose escalation design."( Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial.
Jia, L; Li, X; Mei, H; Meng, X; Xing, L; Yu, J; Zhao, H; Zhao, X; Zhu, W, 2020
)
0.56
" Clinically achievable dosing of EGCG was well-tolerated in diethylnitrosamine-injured rats and was associated with improved serum liver markers including alanine transaminase, aspartate transaminase, and total bilirubin, and reduced HCC tumor formation."( Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma.
Erstad, DJ; Fuchs, BC; Fujii, T; Hirschfield, H; Hoshida, Y; Kim, RS; Lanuti, M; Lauwers, GY; Sojoodi, M; Tanabe, KK; Wei, L; Yamada, S, 2020
)
2
" Considering dosage is a crucial factor in the prooxidant effects of EGCG; further studies are required to find the appropriate dose at which EGCG could bring more health benefits with lower toxicity."( Prooxidant Effects of Epigallocatechin-3-Gallate in Health Benefits and Potential Adverse Effect.
Huang, J; Liu, Z; Ouyang, J; Zhu, K, 2020
)
0.56
" However, its poor bioavailability and requirement of a high dosage to manifest activity have restricted its clinical application."( Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.
Chan, TH; Kwong, J; Lau, TS; Leung, KT; Man, GCW; Ng, TB; Song, Y; Wang, CC; Wang, H; Wang, J; Wong, JH; Zhao, Y, 2020
)
0.56
" This may be related to factors such as the population and the dosage and time of taking natural products involved in different studies."( Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis.
Chen, W; Feng, X; Li, L; Xu, S; Zhang, L; Zhang, S, 2021
)
0.62
" However, higher GTE-EGCG dosing disrupted normal development and increased facial dysmorphology in both trisomic and euploid mice."( Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome.
Albaigès, J; De La Torre, R; Dierssen, M; González, A; Gonzàlez, R; Llambrich, S; Martínez-Abadías, N; Sarlé, A; Sevillano, X; Sharpe, J; Starbuck, JM; Vande Velde, G; Wouters, J, 2021
)
0.62
" The treatment was safe at a daily dosage up to 800 mg EGCG."( Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial.
Aktas, O; Bellmann-Strobl, J; Brandt, A; Dörr, J; Faiss, J; Groppa, S; Heesen, C; Heidrich, E; Hoffmann, F; Infante-Duarte, C; Körtgen, B; Lorenz, M; Paul, F; Pfüller, C; Radbruch, H; Rust, R; Siffrin, V; Wernecke, KD; Wuerfel, J; Zimmermann, B; Zipp, F, 2021
)
2.06
" actinomycetemcomitans-mediated cytotoxicity, but a multiple dosing strategy had improved effects."( Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Brown, AC; Chang, EH, 2021
)
2.06
"Together, these results demonstrate that EGCg has important, but complicated, effects on toxin secretion and activity; new dosing strategies and comprehensive model systems may be required to properly develop these anti-virulence activities."( Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
Brown, AC; Chang, EH, 2021
)
2.06
" Once-weekly MN dosing regimen may provide patients with a more convenient, therapeutically equivalent option to daily topical dosing, and may increase compliance and long-term persistence with AD therapy."( Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.
Chen, MC; Chiu, YH; Hung, JI; Wu, YW, 2021
)
2.06
" Because EGCG treatment improved mostly trabecular skeletal deficits, we hypothesized that increasing EGCG treatment dosage and length of administration would positively affect both trabecular and cortical bone in Ts65Dn mice."( Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models.
Blackwell, M; Jamal, R; LaCombe, J; Patel, R; Roper, RJ; Sloan, K; Thomas, JR; Wallace, JM, 2022
)
0.72
"The OTM distance and root resorption of rats in the dosed group decreased, and the number of TRAP positive cells in their periodontium decreased significantly."( Effects of green tea extract epigallocatechin-3-gallate (EGCG) on orthodontic tooth movement and root resorption in rats.
Chen, F; Chen, H; Du, SM; Li, YL; Sun, TK; Zhang, J; Zou, JH, 2023
)
0.91
" Here, we show nanostructured EGCG/ascorbic acid nanoparticles (EGCG/AA NPs) dose-dependently reduced METH self-administration (SA) under fixed-ratio 1 (FR1) and progressive ratio (PR) reinforcement schedules in mice and shifted METH dose-response curves downward."( EGCG attenuates METH self-administration and reinstatement of METH seeking in mice.
Gong, X; Huang, J; Li, L; Lin, S; Liu, Y; Qian, L; Ruan, Y; Si, Z; Wang, X; Yu, Z, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (7)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
Hsp90 inhibitorAn EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor that blocks the action of heat shock protein 90.
neuroprotective agentAny compound that can be used for the treatment of neurodegenerative disorders.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
apoptosis inducerAny substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
gallate esterA benzoate ester that is any ester resulting from the formal condensation of the carboxy group of gallic acid (3,4,5-trihydroxybenzoic acid) with an alcoholic or phenolic hydroxy group.
polyphenolMembers of the class of phenols that contain 2 or more benzene rings each of which is substituted by at least one hydroxy group.
flavansAny flavonoid with a 3,4-dihydro-2-aryl-2H-1-benzopyran skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
galloylated catechin biosynthesis013
Flavan-3-ol metabolic pathway070

Protein Targets (124)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.89130.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency0.31620.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency14.09190.140911.194039.8107AID2451
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency8.91250.177814.390939.8107AID2147
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency3.16230.125919.1169125.8920AID2549
LuciferasePhotinus pyralis (common eastern firefly)Potency28.36150.007215.758889.3584AID1224835; AID588342
acetylcholinesteraseHomo sapiens (human)Potency79.90070.002541.796015,848.9004AID1347397
phosphopantetheinyl transferaseBacillus subtilisPotency11.22020.141337.9142100.0000AID1490
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency44.80623.189029.884159.4836AID1224846; AID1224894
GLI family zinc finger 3Homo sapiens (human)Potency27.49400.000714.592883.7951AID1259369; AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency18.85410.180013.557439.8107AID1460; AID1468
AR proteinHomo sapiens (human)Potency53.10010.000221.22318,912.5098AID1259243; AID743035; AID743040; AID743042; AID743063
thioredoxin glutathione reductaseSchistosoma mansoniPotency11.22020.100022.9075100.0000AID485364
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency27.54310.001022.650876.6163AID1224838; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency55.32900.001530.607315,848.9004AID1224841; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency39.63410.000229.305416,493.5996AID743069; AID743075; AID743078; AID743080
bromodomain adjacent to zinc finger domain 2BHomo sapiens (human)Potency8.91250.707936.904389.1251AID504333
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency41.34580.001019.414170.9645AID588537; AID743140
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency1.77830.035520.977089.1251AID504332
thyroid stimulating hormone receptorHomo sapiens (human)Potency36.08820.001628.015177.1139AID1224843; AID1224895; AID1259385
activating transcription factor 6Homo sapiens (human)Potency43.29920.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency52.970719.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency14.33610.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency48.54200.039147.5451146.8240AID1224845; AID1224896
lysosomal alpha-glucosidase preproproteinHomo sapiens (human)Potency3.98110.036619.637650.1187AID2100
galactokinaseHomo sapiens (human)Potency10.00000.943115.289453.0367AID1868
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency28.18380.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency25.91030.000323.4451159.6830AID743065; AID743066; AID743067
heat shock protein beta-1Homo sapiens (human)Potency54.00680.042027.378961.6448AID743210; AID743228
pyruvate kinase PKM isoform aHomo sapiens (human)Potency3.98110.04017.459031.6228AID1631; AID1634
DNA polymerase betaHomo sapiens (human)Potency0.44670.022421.010289.1251AID485314
nuclear factor NF-kappa-B p105 subunit isoform 1Homo sapiens (human)Potency12.58934.466824.832944.6684AID651749
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency22.24070.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
Cellular tumor antigen p53Homo sapiens (human)Potency45.23620.002319.595674.0614AID651631
Adenosine receptor A1Rattus norvegicus (Norway rat)Potency10.00000.06314.137115.8489AID1868
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, POLYMERASE PAInfluenza A virusIC50 (µMol)1.90001.90001.90001.9000AID977608
Chain A, Polymerase PaInfluenza A virus (A/California/04/2009(H1N1))IC50 (µMol)1.90001.90001.90001.9000AID977608
Chain A, Polymerase PaInfluenza A virus (A/California/04/2009(H1N1))IC50 (µMol)1.90001.90001.90001.9000AID977608
Chain A, Polymerase PaInfluenza A virus (A/California/04/2009(H1N1))IC50 (µMol)1.90001.90001.90001.9000AID977608
Chain A, Polymerase PaInfluenza A virus (A/California/04/2009(H1N1))IC50 (µMol)1.90001.90001.90001.9000AID977608
Genome polyprotein Zika virusIC50 (µMol)87.00001.10001.94004.1000AID1558317
Replicase polyprotein 1abBetacoronavirus England 1IC50 (µMol)10.00000.00403.43889.5100AID1640022
Prostaglandin E synthaseHomo sapiens (human)IC50 (µMol)1.80000.00102.030810.0000AID1357408
Telomerase reverse transcriptaseHomo sapiens (human)IC50 (µMol)1.08670.00062.69489.4000AID704071; AID704076; AID704077
Bile salt export pumpHomo sapiens (human)IC50 (µMol)214.00000.11007.190310.0000AID681155
NAD kinaseHomo sapiens (human)IC50 (µMol)0.96000.96000.96000.9600AID1865601
NAD kinaseHomo sapiens (human)Ki3.28003.28003.28003.2800AID1865600
Urokinase-type plasminogen activatorHomo sapiens (human)IC50 (µMol)0.09100.03703.385910.0000AID1799783
Tissue-type plasminogen activatorHomo sapiens (human)IC50 (µMol)0.09100.03402.54256.6000AID1799783
Polymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))IC50 (µMol)5.86001.88004.68805.8600AID1888156
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1Oryctolagus cuniculus (rabbit)IC50 (µMol)12.00000.00022.81679.0000AID1605036
Amyloid-beta precursor proteinHomo sapiens (human)IC50 (µMol)27.02500.00053.889510.0000AID1224170; AID1224173; AID1228876; AID748709
Plasminogen activator inhibitor 1Homo sapiens (human)IC50 (µMol)0.09100.09104.892810.0000AID1799783
Heme oxygenase 1 Rattus norvegicus (Norway rat)IC50 (µMol)18.00001.10004.320010.0000AID1633147
Urokinase-type plasminogen activatorMus musculus (house mouse)IC50 (µMol)0.09100.09102.92026.6000AID1799783
ATP-dependent translocase ABCB1Homo sapiens (human)IC50 (µMol)0.12330.00022.318510.0000AID1228905; AID1228930
Heat shock protein HSP 90-betaHomo sapiens (human)IC50 (µMol)155.00000.00100.683610.0000AID1140778
Neutrophil elastaseHomo sapiens (human)IC50 (µMol)12.80000.00632.073422.3780AID453985
72 kDa type IV collagenaseHomo sapiens (human)IC50 (µMol)7.61430.00001.284810.0000AID1799773; AID428322
Hepatocyte growth factor receptorHomo sapiens (human)IC50 (µMol)10.00000.00040.372210.0000AID437510
Hepatocyte growth factor receptorHomo sapiens (human)Ki3.30000.00050.73579.4000AID437511
MatrilysinHomo sapiens (human)IC50 (µMol)9.31430.00142.085910.0000AID1799773; AID428321
Enoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12IC50 (µMol)10.00000.00501.576510.0000AID1682375; AID277584
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2IC50 (µMol)1.15000.00022.45859.9600AID1640021
Alpha-amylase 1A Homo sapiens (human)IC50 (µMol)1,400.00000.50004.02039.6400AID1248402
Apoptosis regulator Bcl-2Homo sapiens (human)IC50 (µMol)0.45000.00100.57634.3000AID1858782
Apoptosis regulator Bcl-2Homo sapiens (human)Ki0.36220.00000.19012.9000AID1858755; AID330776
Microtubule-associated protein tauHomo sapiens (human)IC50 (µMol)1.80000.06901.97693.5000AID748713
60 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)2.30000.17004.559010.0000AID1594139
Glucose-6-phosphate 1-dehydrogenaseSaccharomyces cerevisiae S288CIC50 (µMol)0.25000.18000.22500.2500AID319369
Fatty acid synthaseGallus gallus (chicken)IC50 (µMol)68.00006.15007.63008.3700AID1609174; AID697060; AID697061
CPG DNA methylaseSpiroplasma monobiaeKi0.02800.02800.12900.2300AID675175
Lethal factorBacillus anthracisIC50 (µMol)0.09700.09702.85976.0000AID1895851
Phosphoglycerate mutase 1Homo sapiens (human)IC50 (µMol)0.49000.49002.14677.2000AID1390564; AID1708710
Cannabinoid receptor 1Homo sapiens (human)Ki33.60000.00010.50779.6000AID1371464; AID1625177
Heme oxygenase 2Rattus norvegicus (Norway rat)IC50 (µMol)18.00001.10004.483310.0000AID1633147
DNA (cytosine-5)-methyltransferase 1Homo sapiens (human)IC50 (µMol)0.50000.01861.64886.0000AID1199269
Dipeptidyl peptidase 4Homo sapiens (human)IC50 (µMol)10.21000.00010.444410.0000AID1395903
Proteasome subunit beta type-5Homo sapiens (human)IC50 (µMol)6.36200.00050.939410.0000AID1633145; AID1633146; AID1633147
Cannabinoid receptor 2 Homo sapiens (human)Ki42.80000.00000.415610.0000AID1625178
DNA repair protein RAD52 homologHomo sapiens (human)IC50 (µMol)2.51080.25502.63016.7000AID1639797; AID1639798; AID1639799; AID1639800; AID1743766
Fatty acid synthaseHomo sapiens (human)IC50 (µMol)51.97000.00772.46245.8000AID517164
Matrix metalloproteinase-14Homo sapiens (human)IC50 (µMol)6.80000.00030.718210.0000AID428320
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)IC50 (µMol)7.28330.06003.89568.3000AID1799773
Squalene monooxygenase Rattus norvegicus (Norway rat)IC50 (µMol)0.69000.06102.344610.0000AID204664; AID357310
6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)IC50 (µMol)0.72000.21000.91501.4500AID319370
BH3-interacting domain death agonistHomo sapiens (human)IC50 (µMol)1.07330.02501.08673.0300AID1858758; AID1858782; AID1858783; AID1858784; AID1858785; AID1858786
Beta-secretase 1Homo sapiens (human)IC50 (µMol)1.17850.00061.619410.0000AID646974; AID647157
10 kDa heat shock protein, mitochondrialHomo sapiens (human)IC50 (µMol)2.30000.17004.559010.0000AID1594139
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)IC50 (µMol)21.00000.00021.014010.0000AID1799774
Bcl-2-like protein 1Homo sapiens (human)IC50 (µMol)0.59000.00031.04829.5400AID1858758
Induced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)IC50 (µMol)0.92000.00442.923510.0000AID1858786
Histone acetyltransferase p300Homo sapiens (human)IC50 (µMol)30.00000.26004.00008.5000AID1282375; AID1607715
Alpha-(1,3)-fucosyltransferase 7Homo sapiens (human)IC50 (µMol)7.28330.06003.89568.3000AID1799773
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)IC50 (µMol)7.28330.06003.89568.3000AID1799773
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)IC50 (µMol)20.00000.82003.90675.9000AID761659
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)IC50 (µMol)2.93240.00310.71409.0120AID1062363; AID1420022; AID1851170; AID1890678; AID637860
Mitogen-activated protein kinase 14Homo sapiens (human)IC50 (µMol)2.21000.00010.72667.8000AID566611
Bcl-2-related protein A1Homo sapiens (human)IC50 (µMol)1.79000.00441.65144.3000AID1858785
Thiosulfate sulfurtransferaseHomo sapiens (human)IC50 (µMol)7.30000.06003.96319.7000AID1594135
60 kDa chaperonin Escherichia coliIC50 (µMol)0.47000.03903.55529.8000AID1594140; AID1594141
Sigma non-opioid intracellular receptor 1Cavia porcellus (domestic guinea pig)IC50 (µMol)10.00000.00202.123310.0000AID437510
Dual specificity tyrosine-phosphorylation-regulated kinase 1ARattus norvegicus (Norway rat)IC50 (µMol)0.33000.01000.57412.8000AID1237106
Reverse transcriptase/RNaseH Human immunodeficiency virus 1IC50 (µMol)0.73000.00011.076810.0000AID83435
10 kDa chaperonin Escherichia coliIC50 (µMol)0.47000.03903.55529.8000AID1594140; AID1594141
3-oxoacyl-[acyl-carrier-protein] reductase Plasmodium falciparum 3D7IC50 (µMol)0.32000.32000.32000.3200AID771681
MAP kinase-activated protein kinase 5Homo sapiens (human)IC50 (µMol)1.00000.00501.15753.0100AID1420023
CREB-binding proteinHomo sapiens (human)IC50 (µMol)50.00001.30006.689210.0000AID1282376; AID1607749
Histone acetyltransferase KAT2BHomo sapiens (human)IC50 (µMol)60.00005.00006.01678.5000AID1282377; AID1607716
Bcl-2-like protein 2Homo sapiens (human)IC50 (µMol)2.33000.00100.32512.3300AID1858783
Bcl2-associated agonist of cell death Homo sapiens (human)Ki0.49000.00050.15890.4900AID1858755
Histone acetyltransferase KAT5Homo sapiens (human)IC50 (µMol)70.00002.00003.75009.0000AID1282378; AID1607750
Enoyl-acyl-carrier protein reductase Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)0.22500.06601.549910.0000AID265759; AID277583
Enoyl-acyl-carrier protein reductase Plasmodium falciparum (malaria parasite P. falciparum)Ki0.09100.00000.57785.5000AID277585; AID277586; AID277587
3-oxoacyl-acyl-carrier protein reductase Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)0.30000.30003.772710.0000AID265760
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)Plasmodium falciparum (malaria parasite P. falciparum)IC50 (µMol)0.21500.03002.94428.0000AID265758; AID771680
Bcl-2-like protein 10Homo sapiens (human)IC50 (µMol)0.36000.36000.36000.3600AID1858784
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Troponin C, slow skeletal and cardiac musclesHomo sapiens (human)Kd1,100.00001,100.00001,100.00001,100.0000AID977611
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Kd21.600021.600021.600021.6000AID977611
POsterior SegregationCaenorhabditis elegansEC50 (µMol)5.89202.201047.1808186.6810AID1964
Polycomb protein EEDHomo sapiens (human)Kd15.10002.80002.81332.8200AID1872389
NAD kinaseHomo sapiens (human)Kd1.78001.78001.78001.7800AID1865599
TransthyretinHomo sapiens (human)Kd0.40000.00301.348210.0000AID1475194; AID1705466
Sodium-dependent noradrenaline transporter Homo sapiens (human)EC50 (µMol)0.72700.082031.0243168.9080AID1960
Signal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)Kd0.70000.70000.70000.7000AID1070486
Zinc finger protein mex-5Caenorhabditis elegansEC50 (µMol)0.72700.082033.5679168.9080AID1960
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dihydrofolate reductaseHomo sapiens (human)Activity0.92000.92001.35001.7800AID318326
LactoperoxidaseBos taurus (cattle)Km0.32000.30001.57788.4100AID1490876
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (1023)

Processvia Protein(s)Taxonomy
prostaglandin biosynthetic processProstaglandin E synthaseHomo sapiens (human)
prostaglandin metabolic processProstaglandin E synthaseHomo sapiens (human)
signal transductionProstaglandin E synthaseHomo sapiens (human)
cell population proliferationProstaglandin E synthaseHomo sapiens (human)
negative regulation of cell population proliferationProstaglandin E synthaseHomo sapiens (human)
sensory perception of painProstaglandin E synthaseHomo sapiens (human)
regulation of fever generationProstaglandin E synthaseHomo sapiens (human)
positive regulation of prostaglandin secretionProstaglandin E synthaseHomo sapiens (human)
regulation of inflammatory responseProstaglandin E synthaseHomo sapiens (human)
cellular oxidant detoxificationProstaglandin E synthaseHomo sapiens (human)
telomere maintenanceTelomerase reverse transcriptaseHomo sapiens (human)
RNA-templated transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
RNA-templated DNA biosynthetic processTelomerase reverse transcriptaseHomo sapiens (human)
telomere maintenance via telomeraseTelomerase reverse transcriptaseHomo sapiens (human)
mitochondrion organizationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of gene expressionTelomerase reverse transcriptaseHomo sapiens (human)
DNA strand elongationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of Wnt signaling pathwayTelomerase reverse transcriptaseHomo sapiens (human)
siRNA processingTelomerase reverse transcriptaseHomo sapiens (human)
regulation of protein stabilityTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of hair cycleTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of neuron apoptotic processTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of angiogenesisTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of glucose importTelomerase reverse transcriptaseHomo sapiens (human)
response to cadmium ionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityTelomerase reverse transcriptaseHomo sapiens (human)
establishment of protein localization to telomereTelomerase reverse transcriptaseHomo sapiens (human)
cellular response to hypoxiaTelomerase reverse transcriptaseHomo sapiens (human)
DNA biosynthetic processTelomerase reverse transcriptaseHomo sapiens (human)
replicative senescenceTelomerase reverse transcriptaseHomo sapiens (human)
siRNA transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of miRNA transcriptionTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of transdifferentiationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of protein localization to nucleolusTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell migrationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of endothelial cell apoptotic processTelomerase reverse transcriptaseHomo sapiens (human)
positive regulation of stem cell proliferationTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of cellular senescenceTelomerase reverse transcriptaseHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandTelomerase reverse transcriptaseHomo sapiens (human)
spinal cord developmentPolycomb protein EEDHomo sapiens (human)
negative regulation of DNA-templated transcriptionPolycomb protein EEDHomo sapiens (human)
heterochromatin formationPolycomb protein EEDHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPolycomb protein EEDHomo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
phosphorylationNAD kinaseHomo sapiens (human)
NAD metabolic processNAD kinaseHomo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusNAD kinaseHomo sapiens (human)
ATP metabolic processNAD kinaseHomo sapiens (human)
NADP biosynthetic processNAD kinaseHomo sapiens (human)
tetrahydrobiopterin biosynthetic processDihydrofolate reductaseHomo sapiens (human)
one-carbon metabolic processDihydrofolate reductaseHomo sapiens (human)
negative regulation of translationDihydrofolate reductaseHomo sapiens (human)
axon regenerationDihydrofolate reductaseHomo sapiens (human)
response to methotrexateDihydrofolate reductaseHomo sapiens (human)
dihydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate metabolic processDihydrofolate reductaseHomo sapiens (human)
tetrahydrofolate biosynthetic processDihydrofolate reductaseHomo sapiens (human)
folic acid metabolic processDihydrofolate reductaseHomo sapiens (human)
positive regulation of nitric-oxide synthase activityDihydrofolate reductaseHomo sapiens (human)
regulation of removal of superoxide radicalsDihydrofolate reductaseHomo sapiens (human)
positive regulation of cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
response to hypoxiaUrokinase-type plasminogen activatorHomo sapiens (human)
proteolysisUrokinase-type plasminogen activatorHomo sapiens (human)
chemotaxisUrokinase-type plasminogen activatorHomo sapiens (human)
signal transductionUrokinase-type plasminogen activatorHomo sapiens (human)
blood coagulationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of signaling receptor activityUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell migrationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
plasminogen activationUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell adhesion mediated by integrinUrokinase-type plasminogen activatorHomo sapiens (human)
urokinase plasminogen activator signaling pathwayUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of cell population proliferationUrokinase-type plasminogen activatorHomo sapiens (human)
fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
negative regulation of fibrinolysisUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of wound healingUrokinase-type plasminogen activatorHomo sapiens (human)
regulation of smooth muscle cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
response to hypoxiaTissue-type plasminogen activatorHomo sapiens (human)
proteolysisTissue-type plasminogen activatorHomo sapiens (human)
blood coagulationTissue-type plasminogen activatorHomo sapiens (human)
negative regulation of plasminogen activationTissue-type plasminogen activatorHomo sapiens (human)
plasminogen activationTissue-type plasminogen activatorHomo sapiens (human)
protein modification processTissue-type plasminogen activatorHomo sapiens (human)
fibrinolysisTissue-type plasminogen activatorHomo sapiens (human)
negative regulation of proteolysisTissue-type plasminogen activatorHomo sapiens (human)
negative regulation of fibrinolysisTissue-type plasminogen activatorHomo sapiens (human)
prevention of polyspermyTissue-type plasminogen activatorHomo sapiens (human)
trans-synaptic signaling by BDNF, modulating synaptic transmissionTissue-type plasminogen activatorHomo sapiens (human)
platelet-derived growth factor receptor signaling pathwayTissue-type plasminogen activatorHomo sapiens (human)
smooth muscle cell migrationTissue-type plasminogen activatorHomo sapiens (human)
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
cognitionAmyloid-beta precursor proteinHomo sapiens (human)
G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglial cell activationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
suckling behaviorAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activation involved in immune responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of translationAmyloid-beta precursor proteinHomo sapiens (human)
protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
intracellular copper ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
endocytosisAmyloid-beta precursor proteinHomo sapiens (human)
response to oxidative stressAmyloid-beta precursor proteinHomo sapiens (human)
cell adhesionAmyloid-beta precursor proteinHomo sapiens (human)
regulation of epidermal growth factor-activated receptor activityAmyloid-beta precursor proteinHomo sapiens (human)
Notch signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
axonogenesisAmyloid-beta precursor proteinHomo sapiens (human)
learning or memoryAmyloid-beta precursor proteinHomo sapiens (human)
learningAmyloid-beta precursor proteinHomo sapiens (human)
mating behaviorAmyloid-beta precursor proteinHomo sapiens (human)
locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
axo-dendritic transportAmyloid-beta precursor proteinHomo sapiens (human)
cholesterol metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of cell population proliferationAmyloid-beta precursor proteinHomo sapiens (human)
adult locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
visual learningAmyloid-beta precursor proteinHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglia developmentAmyloid-beta precursor proteinHomo sapiens (human)
axon midline choice point recognitionAmyloid-beta precursor proteinHomo sapiens (human)
neuron remodelingAmyloid-beta precursor proteinHomo sapiens (human)
dendrite developmentAmyloid-beta precursor proteinHomo sapiens (human)
regulation of Wnt signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
extracellular matrix organizationAmyloid-beta precursor proteinHomo sapiens (human)
forebrain developmentAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection developmentAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of chemokine productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-1 beta productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-6 productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of tumor necrosis factor productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of multicellular organism growthAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of neuron differentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of glycolytic processAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of JNK cascadeAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAmyloid-beta precursor proteinHomo sapiens (human)
collateral sprouting in absence of injuryAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of inflammatory responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of synapse structure or activityAmyloid-beta precursor proteinHomo sapiens (human)
synapse organizationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of calcium-mediated signalingAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular process controlling balanceAmyloid-beta precursor proteinHomo sapiens (human)
synaptic assembly at neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
neuron apoptotic processAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulum calcium ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
neuron cellular homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAmyloid-beta precursor proteinHomo sapiens (human)
response to interleukin-1Amyloid-beta precursor proteinHomo sapiens (human)
modulation of excitatory postsynaptic potentialAmyloid-beta precursor proteinHomo sapiens (human)
NMDA selective glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of spontaneous synaptic transmissionAmyloid-beta precursor proteinHomo sapiens (human)
cytosolic mRNA polyadenylationAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionAmyloid-beta precursor proteinHomo sapiens (human)
cellular response to amyloid-betaAmyloid-beta precursor proteinHomo sapiens (human)
regulation of presynapse assemblyAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection maintenanceAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of T cell migrationAmyloid-beta precursor proteinHomo sapiens (human)
central nervous system developmentAmyloid-beta precursor proteinHomo sapiens (human)
angiogenesisPlasminogen activator inhibitor 1Homo sapiens (human)
regulation of signaling receptor activityPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of plasminogen activationPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of endopeptidase activityPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of smooth muscle cell migrationPlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of blood coagulationPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of blood coagulationPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of cell migrationPlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of interleukin-8 productionPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of cell adhesion mediated by integrinPlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of leukotriene production involved in inflammatory responsePlasminogen activator inhibitor 1Homo sapiens (human)
fibrinolysisPlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of angiogenesisPlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of receptor-mediated endocytosisPlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of inflammatory responsePlasminogen activator inhibitor 1Homo sapiens (human)
defense response to Gram-negative bacteriumPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of fibrinolysisPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of vascular wound healingPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of wound healingPlasminogen activator inhibitor 1Homo sapiens (human)
cellular response to lipopolysaccharidePlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of monocyte chemotaxisPlasminogen activator inhibitor 1Homo sapiens (human)
replicative senescencePlasminogen activator inhibitor 1Homo sapiens (human)
dentinogenesisPlasminogen activator inhibitor 1Homo sapiens (human)
positive regulation of odontoblast differentiationPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of smooth muscle cell-matrix adhesionPlasminogen activator inhibitor 1Homo sapiens (human)
negative regulation of endothelial cell apoptotic processPlasminogen activator inhibitor 1Homo sapiens (human)
G2/M transition of mitotic cell cycleATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic metabolic processATP-dependent translocase ABCB1Homo sapiens (human)
response to xenobiotic stimulusATP-dependent translocase ABCB1Homo sapiens (human)
phospholipid translocationATP-dependent translocase ABCB1Homo sapiens (human)
terpenoid transportATP-dependent translocase ABCB1Homo sapiens (human)
regulation of response to osmotic stressATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
transepithelial transportATP-dependent translocase ABCB1Homo sapiens (human)
stem cell proliferationATP-dependent translocase ABCB1Homo sapiens (human)
ceramide translocationATP-dependent translocase ABCB1Homo sapiens (human)
export across plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
positive regulation of anion channel activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transportATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic detoxification by transmembrane export across the plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transport across blood-brain barrierATP-dependent translocase ABCB1Homo sapiens (human)
regulation of chloride transportATP-dependent translocase ABCB1Homo sapiens (human)
telomere maintenance via telomeraseHeat shock protein HSP 90-betaHomo sapiens (human)
placenta developmentHeat shock protein HSP 90-betaHomo sapiens (human)
response to unfolded proteinHeat shock protein HSP 90-betaHomo sapiens (human)
virion attachment to host cellHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathwayHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of protein ubiquitinationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of proteasomal ubiquitin-dependent protein catabolic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of phosphoprotein phosphatase activityHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of protein localizationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of apoptotic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of cell differentiationHeat shock protein HSP 90-betaHomo sapiens (human)
chaperone-mediated protein complex assemblyHeat shock protein HSP 90-betaHomo sapiens (human)
regulation of cell cycleHeat shock protein HSP 90-betaHomo sapiens (human)
chaperone-mediated protein foldingHeat shock protein HSP 90-betaHomo sapiens (human)
cellular response to interleukin-4Heat shock protein HSP 90-betaHomo sapiens (human)
supramolecular fiber organizationHeat shock protein HSP 90-betaHomo sapiens (human)
negative regulation of proteasomal protein catabolic processHeat shock protein HSP 90-betaHomo sapiens (human)
telomerase holoenzyme complex assemblyHeat shock protein HSP 90-betaHomo sapiens (human)
positive regulation of protein localization to cell surfaceHeat shock protein HSP 90-betaHomo sapiens (human)
cellular response to heatHeat shock protein HSP 90-betaHomo sapiens (human)
protein foldingHeat shock protein HSP 90-betaHomo sapiens (human)
protein stabilizationHeat shock protein HSP 90-betaHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINeutrophil elastaseHomo sapiens (human)
response to yeastNeutrophil elastaseHomo sapiens (human)
leukocyte migration involved in inflammatory responseNeutrophil elastaseHomo sapiens (human)
biosynthetic process of antibacterial peptides active against Gram-negative bacteriaNeutrophil elastaseHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
intracellular calcium ion homeostasisNeutrophil elastaseHomo sapiens (human)
response to UVNeutrophil elastaseHomo sapiens (human)
extracellular matrix disassemblyNeutrophil elastaseHomo sapiens (human)
protein catabolic processNeutrophil elastaseHomo sapiens (human)
response to lipopolysaccharideNeutrophil elastaseHomo sapiens (human)
negative regulation of chemokine productionNeutrophil elastaseHomo sapiens (human)
negative regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
positive regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
defense response to bacteriumNeutrophil elastaseHomo sapiens (human)
positive regulation of MAP kinase activityNeutrophil elastaseHomo sapiens (human)
positive regulation of smooth muscle cell proliferationNeutrophil elastaseHomo sapiens (human)
negative regulation of inflammatory responseNeutrophil elastaseHomo sapiens (human)
positive regulation of immune responseNeutrophil elastaseHomo sapiens (human)
negative regulation of chemotaxisNeutrophil elastaseHomo sapiens (human)
pyroptosisNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of fungusNeutrophil elastaseHomo sapiens (human)
positive regulation of leukocyte tethering or rollingNeutrophil elastaseHomo sapiens (human)
phagocytosisNeutrophil elastaseHomo sapiens (human)
acute inflammatory response to antigenic stimulusNeutrophil elastaseHomo sapiens (human)
angiogenesis72 kDa type IV collagenaseHomo sapiens (human)
ovarian follicle development72 kDa type IV collagenaseHomo sapiens (human)
ovulation from ovarian follicle72 kDa type IV collagenaseHomo sapiens (human)
luteinization72 kDa type IV collagenaseHomo sapiens (human)
blood vessel maturation72 kDa type IV collagenaseHomo sapiens (human)
intramembranous ossification72 kDa type IV collagenaseHomo sapiens (human)
proteolysis72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of cell adhesion72 kDa type IV collagenaseHomo sapiens (human)
heart development72 kDa type IV collagenaseHomo sapiens (human)
embryo implantation72 kDa type IV collagenaseHomo sapiens (human)
parturition72 kDa type IV collagenaseHomo sapiens (human)
response to xenobiotic stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to mechanical stimulus72 kDa type IV collagenaseHomo sapiens (human)
peripheral nervous system axon regeneration72 kDa type IV collagenaseHomo sapiens (human)
response to activity72 kDa type IV collagenaseHomo sapiens (human)
protein metabolic process72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix disassembly72 kDa type IV collagenaseHomo sapiens (human)
protein catabolic process72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of cell migration72 kDa type IV collagenaseHomo sapiens (human)
collagen catabolic process72 kDa type IV collagenaseHomo sapiens (human)
response to retinoic acid72 kDa type IV collagenaseHomo sapiens (human)
cellular response to reactive oxygen species72 kDa type IV collagenaseHomo sapiens (human)
response to nicotine72 kDa type IV collagenaseHomo sapiens (human)
endodermal cell differentiation72 kDa type IV collagenaseHomo sapiens (human)
response to hydrogen peroxide72 kDa type IV collagenaseHomo sapiens (human)
response to estrogen72 kDa type IV collagenaseHomo sapiens (human)
negative regulation of vasoconstriction72 kDa type IV collagenaseHomo sapiens (human)
ephrin receptor signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
macrophage chemotaxis72 kDa type IV collagenaseHomo sapiens (human)
response to electrical stimulus72 kDa type IV collagenaseHomo sapiens (human)
response to hyperoxia72 kDa type IV collagenaseHomo sapiens (human)
face morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
bone trabecula formation72 kDa type IV collagenaseHomo sapiens (human)
prostate gland epithelium morphogenesis72 kDa type IV collagenaseHomo sapiens (human)
cellular response to amino acid stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to interleukin-172 kDa type IV collagenaseHomo sapiens (human)
cellular response to estradiol stimulus72 kDa type IV collagenaseHomo sapiens (human)
cellular response to UV-A72 kDa type IV collagenaseHomo sapiens (human)
cellular response to fluid shear stress72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway72 kDa type IV collagenaseHomo sapiens (human)
response to amyloid-beta72 kDa type IV collagenaseHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferation72 kDa type IV collagenaseHomo sapiens (human)
extracellular matrix organization72 kDa type IV collagenaseHomo sapiens (human)
response to hypoxia72 kDa type IV collagenaseHomo sapiens (human)
tissue remodeling72 kDa type IV collagenaseHomo sapiens (human)
endothelial cell morphogenesisHepatocyte growth factor receptorHomo sapiens (human)
signal transductionHepatocyte growth factor receptorHomo sapiens (human)
cell surface receptor signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of autophagyHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of microtubule polymerizationHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of Rho protein signal transductionHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHepatocyte growth factor receptorHomo sapiens (human)
hepatocyte growth factor receptor signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
branching morphogenesis of an epithelial tubeHepatocyte growth factor receptorHomo sapiens (human)
positive chemotaxisHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of stress fiber assemblyHepatocyte growth factor receptorHomo sapiens (human)
excitatory postsynaptic potentialHepatocyte growth factor receptorHomo sapiens (human)
establishment of skin barrierHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of thrombin-activated receptor signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
semaphorin-plexin signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of hydrogen peroxide-mediated programmed cell deathHepatocyte growth factor receptorHomo sapiens (human)
negative regulation of guanyl-nucleotide exchange factor activityHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of endothelial cell chemotaxisHepatocyte growth factor receptorHomo sapiens (human)
liver developmentHepatocyte growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayHepatocyte growth factor receptorHomo sapiens (human)
phagocytosisHepatocyte growth factor receptorHomo sapiens (human)
multicellular organism developmentHepatocyte growth factor receptorHomo sapiens (human)
neuron differentiationHepatocyte growth factor receptorHomo sapiens (human)
positive regulation of kinase activityHepatocyte growth factor receptorHomo sapiens (human)
cell migrationHepatocyte growth factor receptorHomo sapiens (human)
pancreas developmentHepatocyte growth factor receptorHomo sapiens (human)
nervous system developmentHepatocyte growth factor receptorHomo sapiens (human)
membrane protein ectodomain proteolysisMatrilysinHomo sapiens (human)
membrane protein intracellular domain proteolysisMatrilysinHomo sapiens (human)
antibacterial peptide secretionMatrilysinHomo sapiens (human)
antibacterial peptide biosynthetic processMatrilysinHomo sapiens (human)
proteolysisMatrilysinHomo sapiens (human)
response to xenobiotic stimulusMatrilysinHomo sapiens (human)
extracellular matrix disassemblyMatrilysinHomo sapiens (human)
positive regulation of cell migrationMatrilysinHomo sapiens (human)
collagen catabolic processMatrilysinHomo sapiens (human)
regulation of cell population proliferationMatrilysinHomo sapiens (human)
defense response to Gram-negative bacteriumMatrilysinHomo sapiens (human)
defense response to Gram-positive bacteriumMatrilysinHomo sapiens (human)
extracellular matrix organizationMatrilysinHomo sapiens (human)
protein folding60 kDa chaperoninEscherichia coli K-12
response to radiation60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
virion assembly60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
protein refolding60 kDa chaperoninEscherichia coli K-12
chaperone cofactor-dependent protein refolding60 kDa chaperoninEscherichia coli K-12
response to heat60 kDa chaperoninEscherichia coli K-12
lipid biosynthetic processEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
fatty acid elongationEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
protein homotetramerizationEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
fatty acid biosynthetic processEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
biotin biosynthetic processEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
fatty acid elongationEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
response to antibioticEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
oligosaccharide metabolic processAlpha-amylase 1A Homo sapiens (human)
carbohydrate metabolic processAlpha-amylase 1A Homo sapiens (human)
protein polyubiquitinationApoptosis regulator Bcl-2Homo sapiens (human)
apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsApoptosis regulator Bcl-2Homo sapiens (human)
response to xenobiotic stimulusApoptosis regulator Bcl-2Homo sapiens (human)
response to toxic substanceApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of cell growthApoptosis regulator Bcl-2Homo sapiens (human)
response to cytokineApoptosis regulator Bcl-2Homo sapiens (human)
B cell proliferationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
regulation of calcium ion transportApoptosis regulator Bcl-2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandApoptosis regulator Bcl-2Homo sapiens (human)
G1/S transition of mitotic cell cycleApoptosis regulator Bcl-2Homo sapiens (human)
ossificationApoptosis regulator Bcl-2Homo sapiens (human)
ovarian follicle developmentApoptosis regulator Bcl-2Homo sapiens (human)
metanephros developmentApoptosis regulator Bcl-2Homo sapiens (human)
branching involved in ureteric bud morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
behavioral fear responseApoptosis regulator Bcl-2Homo sapiens (human)
B cell homeostasisApoptosis regulator Bcl-2Homo sapiens (human)
B cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
release of cytochrome c from mitochondriaApoptosis regulator Bcl-2Homo sapiens (human)
regulation of cell-matrix adhesionApoptosis regulator Bcl-2Homo sapiens (human)
lymphoid progenitor cell differentiationApoptosis regulator Bcl-2Homo sapiens (human)
B cell lineage commitmentApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of B cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
response to ischemiaApoptosis regulator Bcl-2Homo sapiens (human)
renal system processApoptosis regulator Bcl-2Homo sapiens (human)
melanin metabolic processApoptosis regulator Bcl-2Homo sapiens (human)
regulation of nitrogen utilizationApoptosis regulator Bcl-2Homo sapiens (human)
autophagyApoptosis regulator Bcl-2Homo sapiens (human)
humoral immune responseApoptosis regulator Bcl-2Homo sapiens (human)
DNA damage responseApoptosis regulator Bcl-2Homo sapiens (human)
actin filament organizationApoptosis regulator Bcl-2Homo sapiens (human)
axonogenesisApoptosis regulator Bcl-2Homo sapiens (human)
female pregnancyApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of cell population proliferationApoptosis regulator Bcl-2Homo sapiens (human)
male gonad developmentApoptosis regulator Bcl-2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to oxidative stressApoptosis regulator Bcl-2Homo sapiens (human)
response to radiationApoptosis regulator Bcl-2Homo sapiens (human)
response to xenobiotic stimulusApoptosis regulator Bcl-2Homo sapiens (human)
response to toxic substanceApoptosis regulator Bcl-2Homo sapiens (human)
post-embryonic developmentApoptosis regulator Bcl-2Homo sapiens (human)
response to iron ionApoptosis regulator Bcl-2Homo sapiens (human)
response to UV-BApoptosis regulator Bcl-2Homo sapiens (human)
response to gamma radiationApoptosis regulator Bcl-2Homo sapiens (human)
regulation of gene expressionApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of autophagyApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of calcium ion transport into cytosolApoptosis regulator Bcl-2Homo sapiens (human)
regulation of glycoprotein biosynthetic processApoptosis regulator Bcl-2Homo sapiens (human)
mesenchymal cell developmentApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of neuron maturationApoptosis regulator Bcl-2Homo sapiens (human)
smooth muscle cell migrationApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of smooth muscle cell migrationApoptosis regulator Bcl-2Homo sapiens (human)
cochlear nucleus developmentApoptosis regulator Bcl-2Homo sapiens (human)
gland morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
regulation of transmembrane transporter activityApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of ossificationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of cell growthApoptosis regulator Bcl-2Homo sapiens (human)
melanocyte differentiationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of cell migrationApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of B cell proliferationApoptosis regulator Bcl-2Homo sapiens (human)
hair follicle morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
axon regenerationApoptosis regulator Bcl-2Homo sapiens (human)
regulation of protein stabilityApoptosis regulator Bcl-2Homo sapiens (human)
endoplasmic reticulum calcium ion homeostasisApoptosis regulator Bcl-2Homo sapiens (human)
glomerulus developmentApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of cellular pH reductionApoptosis regulator Bcl-2Homo sapiens (human)
regulation of protein localizationApoptosis regulator Bcl-2Homo sapiens (human)
myeloid cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of myeloid cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
T cell differentiation in thymusApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationApoptosis regulator Bcl-2Homo sapiens (human)
osteoblast proliferationApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of osteoblast proliferationApoptosis regulator Bcl-2Homo sapiens (human)
response to nicotineApoptosis regulator Bcl-2Homo sapiens (human)
organ growthApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of multicellular organism growthApoptosis regulator Bcl-2Homo sapiens (human)
cellular response to glucose starvationApoptosis regulator Bcl-2Homo sapiens (human)
response to hydrogen peroxideApoptosis regulator Bcl-2Homo sapiens (human)
neuron maturationApoptosis regulator Bcl-2Homo sapiens (human)
T cell homeostasisApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
CD8-positive, alpha-beta T cell lineage commitmentApoptosis regulator Bcl-2Homo sapiens (human)
ear developmentApoptosis regulator Bcl-2Homo sapiens (human)
regulation of viral genome replicationApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of melanocyte differentiationApoptosis regulator Bcl-2Homo sapiens (human)
retinal cell programmed cell deathApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of retinal cell programmed cell deathApoptosis regulator Bcl-2Homo sapiens (human)
regulation of mitochondrial membrane permeabilityApoptosis regulator Bcl-2Homo sapiens (human)
focal adhesion assemblyApoptosis regulator Bcl-2Homo sapiens (human)
spleen developmentApoptosis regulator Bcl-2Homo sapiens (human)
thymus developmentApoptosis regulator Bcl-2Homo sapiens (human)
digestive tract morphogenesisApoptosis regulator Bcl-2Homo sapiens (human)
oocyte developmentApoptosis regulator Bcl-2Homo sapiens (human)
skeletal muscle fiber developmentApoptosis regulator Bcl-2Homo sapiens (human)
positive regulation of skeletal muscle fiber developmentApoptosis regulator Bcl-2Homo sapiens (human)
pigment granule organizationApoptosis regulator Bcl-2Homo sapiens (human)
stem cell developmentApoptosis regulator Bcl-2Homo sapiens (human)
homeostasis of number of cells within a tissueApoptosis regulator Bcl-2Homo sapiens (human)
B cell receptor signaling pathwayApoptosis regulator Bcl-2Homo sapiens (human)
response to glucocorticoidApoptosis regulator Bcl-2Homo sapiens (human)
neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
defense response to virusApoptosis regulator Bcl-2Homo sapiens (human)
establishment of localization in cellApoptosis regulator Bcl-2Homo sapiens (human)
regulation of mitochondrial membrane potentialApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of mitochondrial depolarizationApoptosis regulator Bcl-2Homo sapiens (human)
hematopoietic stem cell differentiationApoptosis regulator Bcl-2Homo sapiens (human)
calcium ion transport into cytosolApoptosis regulator Bcl-2Homo sapiens (human)
T cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of T cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
cellular response to organic substanceApoptosis regulator Bcl-2Homo sapiens (human)
cellular response to hypoxiaApoptosis regulator Bcl-2Homo sapiens (human)
reactive oxygen species metabolic processApoptosis regulator Bcl-2Homo sapiens (human)
dendritic cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
motor neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
cell-cell adhesionApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorApoptosis regulator Bcl-2Homo sapiens (human)
epithelial cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of epithelial cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of G1/S transition of mitotic cell cycleApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of dendritic cell apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of motor neuron apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of anoikisApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of apoptotic signaling pathwayApoptosis regulator Bcl-2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayApoptosis regulator Bcl-2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageApoptosis regulator Bcl-2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandApoptosis regulator Bcl-2Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processApoptosis regulator Bcl-2Homo sapiens (human)
regulation of autophagyMicrotubule-associated protein tauHomo sapiens (human)
microtubule cytoskeleton organizationMicrotubule-associated protein tauHomo sapiens (human)
microglial cell activationMicrotubule-associated protein tauHomo sapiens (human)
internal protein amino acid acetylationMicrotubule-associated protein tauHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processMicrotubule-associated protein tauHomo sapiens (human)
DNA damage responseMicrotubule-associated protein tauHomo sapiens (human)
cell-cell signalingMicrotubule-associated protein tauHomo sapiens (human)
memoryMicrotubule-associated protein tauHomo sapiens (human)
response to lead ionMicrotubule-associated protein tauHomo sapiens (human)
negative regulation of gene expressionMicrotubule-associated protein tauHomo sapiens (human)
negative regulation of mitochondrial membrane potentialMicrotubule-associated protein tauHomo sapiens (human)
rRNA metabolic processMicrotubule-associated protein tauHomo sapiens (human)
axonal transport of mitochondrionMicrotubule-associated protein tauHomo sapiens (human)
central nervous system neuron developmentMicrotubule-associated protein tauHomo sapiens (human)
regulation of microtubule polymerization or depolymerizationMicrotubule-associated protein tauHomo sapiens (human)
regulation of microtubule polymerizationMicrotubule-associated protein tauHomo sapiens (human)
positive regulation of microtubule polymerizationMicrotubule-associated protein tauHomo sapiens (human)
cytoplasmic microtubule organizationMicrotubule-associated protein tauHomo sapiens (human)
neuron projection developmentMicrotubule-associated protein tauHomo sapiens (human)
positive regulation of superoxide anion generationMicrotubule-associated protein tauHomo sapiens (human)
regulation of chromosome organizationMicrotubule-associated protein tauHomo sapiens (human)
negative regulation of kinase activityMicrotubule-associated protein tauHomo sapiens (human)
stress granule assemblyMicrotubule-associated protein tauHomo sapiens (human)
cellular response to heatMicrotubule-associated protein tauHomo sapiens (human)
cellular response to reactive oxygen speciesMicrotubule-associated protein tauHomo sapiens (human)
positive regulation of axon extensionMicrotubule-associated protein tauHomo sapiens (human)
microtubule polymerizationMicrotubule-associated protein tauHomo sapiens (human)
astrocyte activationMicrotubule-associated protein tauHomo sapiens (human)
regulation of synaptic plasticityMicrotubule-associated protein tauHomo sapiens (human)
intracellular distribution of mitochondriaMicrotubule-associated protein tauHomo sapiens (human)
generation of neuronsMicrotubule-associated protein tauHomo sapiens (human)
synapse organizationMicrotubule-associated protein tauHomo sapiens (human)
regulation of calcium-mediated signalingMicrotubule-associated protein tauHomo sapiens (human)
protein polymerizationMicrotubule-associated protein tauHomo sapiens (human)
axon developmentMicrotubule-associated protein tauHomo sapiens (human)
regulation of microtubule cytoskeleton organizationMicrotubule-associated protein tauHomo sapiens (human)
plus-end-directed organelle transport along microtubuleMicrotubule-associated protein tauHomo sapiens (human)
regulation of mitochondrial fissionMicrotubule-associated protein tauHomo sapiens (human)
negative regulation of mitochondrial fissionMicrotubule-associated protein tauHomo sapiens (human)
supramolecular fiber organizationMicrotubule-associated protein tauHomo sapiens (human)
axonal transportMicrotubule-associated protein tauHomo sapiens (human)
regulation of cellular response to heatMicrotubule-associated protein tauHomo sapiens (human)
regulation of long-term synaptic depressionMicrotubule-associated protein tauHomo sapiens (human)
positive regulation of protein localization to synapseMicrotubule-associated protein tauHomo sapiens (human)
neurofibrillary tangle assemblyMicrotubule-associated protein tauHomo sapiens (human)
negative regulation of establishment of protein localization to mitochondrionMicrotubule-associated protein tauHomo sapiens (human)
positive regulation of protein localizationMicrotubule-associated protein tauHomo sapiens (human)
negative regulation of tubulin deacetylationMicrotubule-associated protein tauHomo sapiens (human)
positive regulation of diacylglycerol kinase activityMicrotubule-associated protein tauHomo sapiens (human)
amyloid fibril formationMicrotubule-associated protein tauHomo sapiens (human)
cellular response to nerve growth factor stimulusMicrotubule-associated protein tauHomo sapiens (human)
cellular response to brain-derived neurotrophic factor stimulusMicrotubule-associated protein tauHomo sapiens (human)
adhesion of symbiont to host60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
MyD88-dependent toll-like receptor signaling pathway60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell mediated immune response to tumor cell60 kDa heat shock protein, mitochondrialHomo sapiens (human)
'de novo' protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein60 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to cold60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interferon-alpha production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of type II interferon production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-10 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-12 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of interleukin-6 production60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein refolding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell proliferation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
B cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of macrophage activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
negative regulation of apoptotic process60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isotype switching to IgG isotypes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein stabilization60 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone-mediated protein complex assembly60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein maturation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
biological process involved in interaction with symbiont60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cellular response to interleukin-760 kDa heat shock protein, mitochondrialHomo sapiens (human)
T cell activation60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein import into mitochondrial intermembrane space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial unfolded protein response60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apoptotic mitochondrial changes60 kDa heat shock protein, mitochondrialHomo sapiens (human)
lactate metabolic processFatty acid synthaseGallus gallus (chicken)
fatty acid biosynthetic processFatty acid synthaseGallus gallus (chicken)
positive regulation of appetiteFatty acid synthaseGallus gallus (chicken)
gluconeogenesisPhosphoglycerate mutase 1Homo sapiens (human)
canonical glycolysisPhosphoglycerate mutase 1Homo sapiens (human)
positive regulation of acute inflammatory response to antigenic stimulusCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-modulating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
spermatogenesisCannabinoid receptor 1Homo sapiens (human)
axonal fasciculationCannabinoid receptor 1Homo sapiens (human)
response to nutrientCannabinoid receptor 1Homo sapiens (human)
memoryCannabinoid receptor 1Homo sapiens (human)
positive regulation of neuron projection developmentCannabinoid receptor 1Homo sapiens (human)
negative regulation of serotonin secretionCannabinoid receptor 1Homo sapiens (human)
positive regulation of fever generationCannabinoid receptor 1Homo sapiens (human)
negative regulation of fatty acid beta-oxidationCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, GABAergicCannabinoid receptor 1Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 1Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 1Homo sapiens (human)
negative regulation of dopamine secretionCannabinoid receptor 1Homo sapiens (human)
response to nicotineCannabinoid receptor 1Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 1Homo sapiens (human)
response to cocaineCannabinoid receptor 1Homo sapiens (human)
glucose homeostasisCannabinoid receptor 1Homo sapiens (human)
positive regulation of apoptotic processCannabinoid receptor 1Homo sapiens (human)
response to ethanolCannabinoid receptor 1Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 1Homo sapiens (human)
negative regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
positive regulation of blood pressureCannabinoid receptor 1Homo sapiens (human)
regulation of insulin secretionCannabinoid receptor 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicCannabinoid receptor 1Homo sapiens (human)
maternal process involved in female pregnancyCannabinoid receptor 1Homo sapiens (human)
regulation of feeding behaviorCannabinoid receptor 1Homo sapiens (human)
regulation of penile erectionCannabinoid receptor 1Homo sapiens (human)
retrograde trans-synaptic signaling by endocannabinoidCannabinoid receptor 1Homo sapiens (human)
regulation of presynaptic cytosolic calcium ion concentrationCannabinoid receptor 1Homo sapiens (human)
trans-synaptic signaling by endocannabinoid, modulating synaptic transmissionCannabinoid receptor 1Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 1Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 1Homo sapiens (human)
monoamine transportSodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter transportSodium-dependent noradrenaline transporter Homo sapiens (human)
chemical synaptic transmissionSodium-dependent noradrenaline transporter Homo sapiens (human)
response to xenobiotic stimulusSodium-dependent noradrenaline transporter Homo sapiens (human)
response to painSodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine uptakeSodium-dependent noradrenaline transporter Homo sapiens (human)
neuron cellular homeostasisSodium-dependent noradrenaline transporter Homo sapiens (human)
amino acid transportSodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine transportSodium-dependent noradrenaline transporter Homo sapiens (human)
dopamine uptake involved in synaptic transmissionSodium-dependent noradrenaline transporter Homo sapiens (human)
sodium ion transmembrane transportSodium-dependent noradrenaline transporter Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA methylation-dependent heterochromatin formationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA-templated transcriptionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
positive regulation of gene expressionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of gene expressionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
methylationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
epigenetic programming of gene expressionDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of gene expression via chromosomal CpG island methylationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
cellular response to amino acid stimulusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
chromosomal DNA methylation maintenance following DNA replicationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
cellular response to bisphenol ADNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell apoptotic processDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switchingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
behavioral fear responseDipeptidyl peptidase 4Homo sapiens (human)
response to hypoxiaDipeptidyl peptidase 4Homo sapiens (human)
proteolysisDipeptidyl peptidase 4Homo sapiens (human)
cell adhesionDipeptidyl peptidase 4Homo sapiens (human)
positive regulation of cell population proliferationDipeptidyl peptidase 4Homo sapiens (human)
negative regulation of extracellular matrix disassemblyDipeptidyl peptidase 4Homo sapiens (human)
peptide hormone processingDipeptidyl peptidase 4Homo sapiens (human)
receptor-mediated endocytosis of virus by host cellDipeptidyl peptidase 4Homo sapiens (human)
T cell costimulationDipeptidyl peptidase 4Homo sapiens (human)
regulation of cell-cell adhesion mediated by integrinDipeptidyl peptidase 4Homo sapiens (human)
locomotory exploration behaviorDipeptidyl peptidase 4Homo sapiens (human)
psychomotor behaviorDipeptidyl peptidase 4Homo sapiens (human)
T cell activationDipeptidyl peptidase 4Homo sapiens (human)
endothelial cell migrationDipeptidyl peptidase 4Homo sapiens (human)
symbiont entry into host cellDipeptidyl peptidase 4Homo sapiens (human)
receptor-mediated virion attachment to host cellDipeptidyl peptidase 4Homo sapiens (human)
negative chemotaxisDipeptidyl peptidase 4Homo sapiens (human)
membrane fusionDipeptidyl peptidase 4Homo sapiens (human)
negative regulation of neutrophil chemotaxisDipeptidyl peptidase 4Homo sapiens (human)
glucagon processingDipeptidyl peptidase 4Homo sapiens (human)
proteolysisProteasome subunit beta type-5Homo sapiens (human)
response to oxidative stressProteasome subunit beta type-5Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processProteasome subunit beta type-5Homo sapiens (human)
response to amphetamineCannabinoid receptor 2 Homo sapiens (human)
inflammatory responseCannabinoid receptor 2 Homo sapiens (human)
immune responseCannabinoid receptor 2 Homo sapiens (human)
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messengerCannabinoid receptor 2 Homo sapiens (human)
leukocyte chemotaxisCannabinoid receptor 2 Homo sapiens (human)
negative regulation of synaptic transmission, GABAergicCannabinoid receptor 2 Homo sapiens (human)
response to lipopolysaccharideCannabinoid receptor 2 Homo sapiens (human)
negative regulation of mast cell activationCannabinoid receptor 2 Homo sapiens (human)
cannabinoid signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
negative regulation of action potentialCannabinoid receptor 2 Homo sapiens (human)
regulation of metabolic processCannabinoid receptor 2 Homo sapiens (human)
adenylate cyclase-activating G protein-coupled receptor signaling pathwayCannabinoid receptor 2 Homo sapiens (human)
endothelial cell migrationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IISignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
negative regulation of endothelial cell proliferationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of mesenchymal cell proliferationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of defense response to virus by hostSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesisSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
regulation of transcription by RNA polymerase IISignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to nutrientSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
blood circulationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to xenobiotic stimulusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to mechanical stimulusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
macrophage derived foam cell differentiationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
negative regulation of angiogenesisSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of interferon-alpha productionSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cellular response to insulin stimulusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
tumor necrosis factor-mediated signaling pathwaySignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to cytokineSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to type II interferonSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to interferon-betaSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cellular response to interferon-betaSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
interleukin-9-mediated signaling pathwaySignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to hydrogen peroxideSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
regulation of apoptotic processSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
negative regulation of canonical NF-kappaB signal transductionSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to peptide hormoneSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of erythrocyte differentiationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IISignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
negative regulation by virus of viral protein levels in host cellSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of smooth muscle cell proliferationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
response to cAMPSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
defense response to virusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
positive regulation of nitric-oxide synthase biosynthetic processSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
type II interferon-mediated signaling pathwaySignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
type I interferon-mediated signaling pathwaySignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
renal tubule developmentSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
interleukin-27-mediated signaling pathwaySignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cellular response to type II interferonSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cellular response to organic cyclic compoundSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
metanephric mesenchymal cell proliferation involved in metanephros developmentSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
metanephric mesenchymal cell differentiationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
negative regulation of metanephric nephron tubule epithelial cell differentiationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
regulation of cell population proliferationSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
defense responseSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
DNA double-strand break processing involved in repair via single-strand annealingDNA repair protein RAD52 homologHomo sapiens (human)
cellular response to oxidative stressDNA repair protein RAD52 homologHomo sapiens (human)
regulation of nucleotide-excision repairDNA repair protein RAD52 homologHomo sapiens (human)
DNA recombinase assemblyDNA repair protein RAD52 homologHomo sapiens (human)
double-strand break repairDNA repair protein RAD52 homologHomo sapiens (human)
DNA recombinationDNA repair protein RAD52 homologHomo sapiens (human)
double-strand break repair via homologous recombinationDNA repair protein RAD52 homologHomo sapiens (human)
mitotic recombinationDNA repair protein RAD52 homologHomo sapiens (human)
double-strand break repair via single-strand annealingDNA repair protein RAD52 homologHomo sapiens (human)
osteoblast differentiationFatty acid synthaseHomo sapiens (human)
glandular epithelial cell developmentFatty acid synthaseHomo sapiens (human)
fatty acid metabolic processFatty acid synthaseHomo sapiens (human)
fatty acid biosynthetic processFatty acid synthaseHomo sapiens (human)
inflammatory responseFatty acid synthaseHomo sapiens (human)
ether lipid biosynthetic processFatty acid synthaseHomo sapiens (human)
neutrophil differentiationFatty acid synthaseHomo sapiens (human)
monocyte differentiationFatty acid synthaseHomo sapiens (human)
mammary gland developmentFatty acid synthaseHomo sapiens (human)
modulation by host of viral processFatty acid synthaseHomo sapiens (human)
cellular response to interleukin-4Fatty acid synthaseHomo sapiens (human)
establishment of endothelial intestinal barrierFatty acid synthaseHomo sapiens (human)
fatty-acyl-CoA biosynthetic processFatty acid synthaseHomo sapiens (human)
angiogenesisMatrix metalloproteinase-14Homo sapiens (human)
ovarian follicle developmentMatrix metalloproteinase-14Homo sapiens (human)
response to hypoxiaMatrix metalloproteinase-14Homo sapiens (human)
endothelial cell proliferationMatrix metalloproteinase-14Homo sapiens (human)
endochondral ossificationMatrix metalloproteinase-14Homo sapiens (human)
proteolysisMatrix metalloproteinase-14Homo sapiens (human)
response to oxidative stressMatrix metalloproteinase-14Homo sapiens (human)
male gonad developmentMatrix metalloproteinase-14Homo sapiens (human)
response to mechanical stimulusMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of myotube differentiationMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of protein processingMatrix metalloproteinase-14Homo sapiens (human)
response to organic cyclic compoundMatrix metalloproteinase-14Homo sapiens (human)
protein processingMatrix metalloproteinase-14Homo sapiens (human)
extracellular matrix disassemblyMatrix metalloproteinase-14Homo sapiens (human)
protein catabolic processMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of cell growthMatrix metalloproteinase-14Homo sapiens (human)
lung developmentMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of cell migrationMatrix metalloproteinase-14Homo sapiens (human)
collagen catabolic processMatrix metalloproteinase-14Homo sapiens (human)
zymogen activationMatrix metalloproteinase-14Homo sapiens (human)
endodermal cell differentiationMatrix metalloproteinase-14Homo sapiens (human)
chondrocyte proliferationMatrix metalloproteinase-14Homo sapiens (human)
astrocyte cell migrationMatrix metalloproteinase-14Homo sapiens (human)
response to estrogenMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of B cell differentiationMatrix metalloproteinase-14Homo sapiens (human)
negative regulation of Notch signaling pathwayMatrix metalloproteinase-14Homo sapiens (human)
embryonic cranial skeleton morphogenesisMatrix metalloproteinase-14Homo sapiens (human)
branching morphogenesis of an epithelial tubeMatrix metalloproteinase-14Homo sapiens (human)
tissue remodelingMatrix metalloproteinase-14Homo sapiens (human)
cell motilityMatrix metalloproteinase-14Homo sapiens (human)
negative regulation of focal adhesion assemblyMatrix metalloproteinase-14Homo sapiens (human)
head developmentMatrix metalloproteinase-14Homo sapiens (human)
craniofacial suture morphogenesisMatrix metalloproteinase-14Homo sapiens (human)
negative regulation of GDF15-GFRAL signaling pathwayMatrix metalloproteinase-14Homo sapiens (human)
regulation of protein localization to plasma membraneMatrix metalloproteinase-14Homo sapiens (human)
positive regulation of macrophage migrationMatrix metalloproteinase-14Homo sapiens (human)
response to odorantMatrix metalloproteinase-14Homo sapiens (human)
extracellular matrix organizationMatrix metalloproteinase-14Homo sapiens (human)
skeletal system developmentMatrix metalloproteinase-14Homo sapiens (human)
protein glycosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
protein N-linked glycosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
protein O-linked glycosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
ceramide metabolic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
glycosphingolipid biosynthetic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
oligosaccharide biosynthetic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
N-glycan fucosylation4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
L-fucose catabolic process4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
oocyte axis specification4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
pentose-phosphate shunt6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
pentose-phosphate shunt, oxidative branch6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
pentose biosynthetic process6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
D-gluconate catabolic process6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
release of cytochrome c from mitochondriaBH3-interacting domain death agonistHomo sapiens (human)
protein targeting to mitochondrionBH3-interacting domain death agonistHomo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of mitochondrial membrane potentialBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of protein-containing complex assemblyBH3-interacting domain death agonistHomo sapiens (human)
regulation of T cell proliferationBH3-interacting domain death agonistHomo sapiens (human)
signal transduction in response to DNA damageBH3-interacting domain death agonistHomo sapiens (human)
mitochondrial ATP synthesis coupled electron transportBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
regulation of epithelial cell proliferationBH3-interacting domain death agonistHomo sapiens (human)
neuron apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
protein-containing complex assemblyBH3-interacting domain death agonistHomo sapiens (human)
establishment of protein localization to membraneBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaBH3-interacting domain death agonistHomo sapiens (human)
hepatocyte apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
mitochondrial outer membrane permeabilizationBH3-interacting domain death agonistHomo sapiens (human)
supramolecular fiber organizationBH3-interacting domain death agonistHomo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damageBH3-interacting domain death agonistHomo sapiens (human)
regulation of G1/S transition of mitotic cell cycleBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of fibroblast apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathwayBH3-interacting domain death agonistHomo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayBH3-interacting domain death agonistHomo sapiens (human)
apoptotic mitochondrial changesBH3-interacting domain death agonistHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBH3-interacting domain death agonistHomo sapiens (human)
proteolysisBeta-secretase 1Homo sapiens (human)
membrane protein ectodomain proteolysisBeta-secretase 1Homo sapiens (human)
response to lead ionBeta-secretase 1Homo sapiens (human)
protein processingBeta-secretase 1Homo sapiens (human)
amyloid-beta formationBeta-secretase 1Homo sapiens (human)
amyloid precursor protein catabolic processBeta-secretase 1Homo sapiens (human)
positive regulation of neuron apoptotic processBeta-secretase 1Homo sapiens (human)
amyloid-beta metabolic processBeta-secretase 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painBeta-secretase 1Homo sapiens (human)
prepulse inhibitionBeta-secretase 1Homo sapiens (human)
cellular response to copper ionBeta-secretase 1Homo sapiens (human)
cellular response to manganese ionBeta-secretase 1Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionBeta-secretase 1Homo sapiens (human)
signaling receptor ligand precursor processingBeta-secretase 1Homo sapiens (human)
cellular response to amyloid-betaBeta-secretase 1Homo sapiens (human)
amyloid fibril formationBeta-secretase 1Homo sapiens (human)
osteoblast differentiation10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic process10 kDa heat shock protein, mitochondrialHomo sapiens (human)
response to unfolded protein10 kDa heat shock protein, mitochondrialHomo sapiens (human)
chaperone cofactor-dependent protein refolding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to hypoxiaDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
neutrophil mediated immunityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
germinal center formationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of leukocyte chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch receptor processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to xenobiotic stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
signal releaseDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
B cell differentiationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to lipopolysaccharideDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of chemokine productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
regulation of mast cell apoptotic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
T cell differentiation in thymusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesion mediated by integrinDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
wound healing, spreading of epidermal cellsDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor-activated receptor activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
spleen developmentDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell motilityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
defense response to Gram-positive bacteriumDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cellular response to high density lipoprotein particle stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
commissural neuron axon guidanceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of cold-induced thermogenesisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to oxidative stressLactoperoxidaseBos taurus (cattle)
thiocyanate metabolic processLactoperoxidaseBos taurus (cattle)
antibacterial humoral responseLactoperoxidaseBos taurus (cattle)
hydrogen peroxide catabolic processLactoperoxidaseBos taurus (cattle)
cellular oxidant detoxificationLactoperoxidaseBos taurus (cattle)
response to cytokineBcl-2-like protein 1Homo sapiens (human)
negative regulation of apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway via death domain receptorsBcl-2-like protein 1Homo sapiens (human)
ovarian follicle developmentBcl-2-like protein 1Homo sapiens (human)
in utero embryonic developmentBcl-2-like protein 1Homo sapiens (human)
release of cytochrome c from mitochondriaBcl-2-like protein 1Homo sapiens (human)
endocytosisBcl-2-like protein 1Homo sapiens (human)
germ cell developmentBcl-2-like protein 1Homo sapiens (human)
spermatogenesisBcl-2-like protein 1Homo sapiens (human)
male gonad developmentBcl-2-like protein 1Homo sapiens (human)
apoptotic mitochondrial changesBcl-2-like protein 1Homo sapiens (human)
fertilizationBcl-2-like protein 1Homo sapiens (human)
regulation of cytokinesisBcl-2-like protein 1Homo sapiens (human)
positive regulation of mononuclear cell proliferationBcl-2-like protein 1Homo sapiens (human)
ectopic germ cell programmed cell deathBcl-2-like protein 1Homo sapiens (human)
regulation of growthBcl-2-like protein 1Homo sapiens (human)
negative regulation of apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of neuron apoptotic processBcl-2-like protein 1Homo sapiens (human)
dendritic cell proliferationBcl-2-like protein 1Homo sapiens (human)
response to cycloheximideBcl-2-like protein 1Homo sapiens (human)
regulation of mitochondrial membrane permeabilityBcl-2-like protein 1Homo sapiens (human)
epithelial cell proliferationBcl-2-like protein 1Homo sapiens (human)
negative regulation of developmental processBcl-2-like protein 1Homo sapiens (human)
neuron apoptotic processBcl-2-like protein 1Homo sapiens (human)
defense response to virusBcl-2-like protein 1Homo sapiens (human)
regulation of mitochondrial membrane potentialBcl-2-like protein 1Homo sapiens (human)
cellular response to amino acid stimulusBcl-2-like protein 1Homo sapiens (human)
cellular response to alkaloidBcl-2-like protein 1Homo sapiens (human)
cellular response to gamma radiationBcl-2-like protein 1Homo sapiens (human)
apoptotic process in bone marrow cellBcl-2-like protein 1Homo sapiens (human)
negative regulation of release of cytochrome c from mitochondriaBcl-2-like protein 1Homo sapiens (human)
dendritic cell apoptotic processBcl-2-like protein 1Homo sapiens (human)
hepatocyte apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of execution phase of apoptosisBcl-2-like protein 1Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-like protein 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayBcl-2-like protein 1Homo sapiens (human)
negative regulation of protein localization to plasma membraneBcl-2-like protein 1Homo sapiens (human)
negative regulation of reproductive processBcl-2-like protein 1Homo sapiens (human)
negative regulation of dendritic cell apoptotic processBcl-2-like protein 1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandBcl-2-like protein 1Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathwayBcl-2-like protein 1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-like protein 1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl-2-like protein 1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl-2-like protein 1Homo sapiens (human)
DNA damage responseInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
response to cytokineInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cell fate determinationInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of autophagyInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cellular homeostasisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transportInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of anoikisInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial fusionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
release of cytochrome c from mitochondriaInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase p300Homo sapiens (human)
response to hypoxiaHistone acetyltransferase p300Homo sapiens (human)
somitogenesisHistone acetyltransferase p300Homo sapiens (human)
thigmotaxisHistone acetyltransferase p300Homo sapiens (human)
behavioral defense responseHistone acetyltransferase p300Homo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
regulation of glycolytic processHistone acetyltransferase p300Homo sapiens (human)
protein acetylationHistone acetyltransferase p300Homo sapiens (human)
internal protein amino acid acetylationHistone acetyltransferase p300Homo sapiens (human)
apoptotic processHistone acetyltransferase p300Homo sapiens (human)
canonical NF-kappaB signal transductionHistone acetyltransferase p300Homo sapiens (human)
nervous system developmentHistone acetyltransferase p300Homo sapiens (human)
heart developmentHistone acetyltransferase p300Homo sapiens (human)
skeletal muscle tissue developmentHistone acetyltransferase p300Homo sapiens (human)
learning or memoryHistone acetyltransferase p300Homo sapiens (human)
circadian rhythmHistone acetyltransferase p300Homo sapiens (human)
animal organ morphogenesisHistone acetyltransferase p300Homo sapiens (human)
regulation of autophagyHistone acetyltransferase p300Homo sapiens (human)
negative regulation of autophagyHistone acetyltransferase p300Homo sapiens (human)
macrophage derived foam cell differentiationHistone acetyltransferase p300Homo sapiens (human)
regulation of mitochondrion organizationHistone acetyltransferase p300Homo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase p300Homo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase p300Homo sapiens (human)
B cell differentiationHistone acetyltransferase p300Homo sapiens (human)
platelet formationHistone acetyltransferase p300Homo sapiens (human)
lung developmentHistone acetyltransferase p300Homo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
negative regulation of protein-containing complex assemblyHistone acetyltransferase p300Homo sapiens (human)
protein destabilizationHistone acetyltransferase p300Homo sapiens (human)
cellular response to nutrient levelsHistone acetyltransferase p300Homo sapiens (human)
cellular response to UVHistone acetyltransferase p300Homo sapiens (human)
multicellular organism growthHistone acetyltransferase p300Homo sapiens (human)
megakaryocyte developmentHistone acetyltransferase p300Homo sapiens (human)
swimmingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of protein import into nucleusHistone acetyltransferase p300Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorHistone acetyltransferase p300Homo sapiens (human)
response to estrogenHistone acetyltransferase p300Homo sapiens (human)
positive regulation by host of viral transcriptionHistone acetyltransferase p300Homo sapiens (human)
fat cell differentiationHistone acetyltransferase p300Homo sapiens (human)
negative regulation of gluconeogenesisHistone acetyltransferase p300Homo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase p300Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase p300Homo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATHistone acetyltransferase p300Homo sapiens (human)
protein stabilizationHistone acetyltransferase p300Homo sapiens (human)
positive regulation of DNA-binding transcription factor activityHistone acetyltransferase p300Homo sapiens (human)
face morphogenesisHistone acetyltransferase p300Homo sapiens (human)
regulation of androgen receptor signaling pathwayHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine propionylationHistone acetyltransferase p300Homo sapiens (human)
cellular response to L-leucineHistone acetyltransferase p300Homo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine crotonylationHistone acetyltransferase p300Homo sapiens (human)
peptidyl-lysine butyrylationHistone acetyltransferase p300Homo sapiens (human)
regulation of cellular response to heatHistone acetyltransferase p300Homo sapiens (human)
regulation of signal transduction by p53 class mediatorHistone acetyltransferase p300Homo sapiens (human)
positive regulation of TORC1 signalingHistone acetyltransferase p300Homo sapiens (human)
positive regulation of T-helper 17 cell lineage commitmentHistone acetyltransferase p300Homo sapiens (human)
regulation of type IV hypersensitivityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
leukocyte migration involved in immune responseAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
leukocyte migration involved in inflammatory responseAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
protein glycosylationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
ceramide metabolic processAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
inflammatory responseAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
embryo implantationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
oligosaccharide biosynthetic processAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of cell-cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of cell-cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
L-fucose catabolic processAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of insulin receptor signaling pathwayAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of cell adhesion molecule productionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
T cell migrationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
lymphocyte migration into lymph nodeAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of neutrophil migrationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of leukocyte cell-cell adhesionAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of leukocyte tethering or rollingAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of leukocyte tethering or rollingAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
regulation of neutrophil extravasationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
fucosylationAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
memory B cell differentiationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
N-acetylneuraminate metabolic processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein N-linked glycosylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
ganglioside biosynthetic process via lactosylceramideCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
O-glycan processingCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
keratan sulfate biosynthetic processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
viral protein processingCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein modification processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
sialylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic processCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein sialylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
protein glycosylationCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
microtubule polymerizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein phosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of cytokinesisPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein peptidyl-prolyl isomerizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
response to hypoxiaPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein phosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of mitotic nuclear divisionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of gene expressionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
neuron differentiationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein stabilityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of protein dephosphorylationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of protein catabolic processPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of GTPase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
synapse organizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein stabilizationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of SMAD protein signal transductionPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadePeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
positive regulation of canonical Wnt signaling pathwayPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
regulation of protein localization to nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of amyloid-beta formationPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
negative regulation of cell motilityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
peptidyl-tyrosine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
chromatin remodelingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
regulation of transcription by RNA polymerase IIDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nervous system developmentDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
circadian rhythmDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-serine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-threonine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-tyrosine phosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of microtubule polymerizationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
positive regulation of RNA splicingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
amyloid-beta formationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-serine autophosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
peptidyl-tyrosine autophosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of DNA damage response, signal transduction by p53 class mediatorDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein autophosphorylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of mRNA splicing, via spliceosomeDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
negative regulation of DNA methylation-dependent heterochromatin formationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
positive regulation of protein deacetylationDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
positive regulation of DNA-templated transcriptionDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
positive regulation of blood vessel endothelial cell migrationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipopolysaccharideMitogen-activated protein kinase 14Homo sapiens (human)
DNA damage checkpoint signalingMitogen-activated protein kinase 14Homo sapiens (human)
cell morphogenesisMitogen-activated protein kinase 14Homo sapiens (human)
cartilage condensationMitogen-activated protein kinase 14Homo sapiens (human)
angiogenesisMitogen-activated protein kinase 14Homo sapiens (human)
osteoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
placenta developmentMitogen-activated protein kinase 14Homo sapiens (human)
response to dietary excessMitogen-activated protein kinase 14Homo sapiens (human)
chondrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of inflammatory response to antigenic stimulusMitogen-activated protein kinase 14Homo sapiens (human)
glucose metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
apoptotic processMitogen-activated protein kinase 14Homo sapiens (human)
chemotaxisMitogen-activated protein kinase 14Homo sapiens (human)
signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
cell surface receptor protein serine/threonine kinase signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
skeletal muscle tissue developmentMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myotube differentiationMitogen-activated protein kinase 14Homo sapiens (human)
peptidyl-serine phosphorylationMitogen-activated protein kinase 14Homo sapiens (human)
fatty acid oxidationMitogen-activated protein kinase 14Homo sapiens (human)
platelet activationMitogen-activated protein kinase 14Homo sapiens (human)
regulation of ossificationMitogen-activated protein kinase 14Homo sapiens (human)
osteoclast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated protein kinase signaling cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cyclase activityMitogen-activated protein kinase 14Homo sapiens (human)
lipopolysaccharide-mediated signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
response to muramyl dipeptideMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of interleukin-12 productionMitogen-activated protein kinase 14Homo sapiens (human)
response to insulinMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of hippo signalingMitogen-activated protein kinase 14Homo sapiens (human)
intracellular signal transductionMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to vascular endothelial growth factor stimulusMitogen-activated protein kinase 14Homo sapiens (human)
response to muscle stretchMitogen-activated protein kinase 14Homo sapiens (human)
p38MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of protein import into nucleusMitogen-activated protein kinase 14Homo sapiens (human)
signal transduction in response to DNA damageMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of erythrocyte differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIMitogen-activated protein kinase 14Homo sapiens (human)
glucose importMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of glucose importMitogen-activated protein kinase 14Homo sapiens (human)
vascular endothelial growth factor receptor signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
stem cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
striated muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of muscle cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of cardiac muscle cell proliferationMitogen-activated protein kinase 14Homo sapiens (human)
bone developmentMitogen-activated protein kinase 14Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to lipoteichoic acidMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to tumor necrosis factorMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to ionizing radiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to UV-BMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of canonical Wnt signaling pathwayMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of brown fat cell differentiationMitogen-activated protein kinase 14Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 14Homo sapiens (human)
stress-induced premature senescenceMitogen-activated protein kinase 14Homo sapiens (human)
cellular response to virusMitogen-activated protein kinase 14Homo sapiens (human)
regulation of synaptic membrane adhesionMitogen-activated protein kinase 14Homo sapiens (human)
regulation of cytokine production involved in inflammatory responseMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of myoblast fusionMitogen-activated protein kinase 14Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processMitogen-activated protein kinase 14Homo sapiens (human)
negative regulation of apoptotic processBcl-2-related protein A1Homo sapiens (human)
transmembrane transportBcl-2-related protein A1Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-related protein A1Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl-2-related protein A1Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl-2-related protein A1Homo sapiens (human)
release of cytochrome c from mitochondriaBcl-2-related protein A1Homo sapiens (human)
mitochondrial fusionBcl-2-related protein A1Homo sapiens (human)
sulfur amino acid catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
cyanate catabolic processThiosulfate sulfurtransferaseHomo sapiens (human)
epithelial cell differentiationThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA import into mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
rRNA transportThiosulfate sulfurtransferaseHomo sapiens (human)
MAPK cascadeMAP kinase-activated protein kinase 5Homo sapiens (human)
regulation of translationMAP kinase-activated protein kinase 5Homo sapiens (human)
signal transductionMAP kinase-activated protein kinase 5Homo sapiens (human)
Ras protein signal transductionMAP kinase-activated protein kinase 5Homo sapiens (human)
negative regulation of TOR signalingMAP kinase-activated protein kinase 5Homo sapiens (human)
positive regulation of telomere maintenance via telomeraseMAP kinase-activated protein kinase 5Homo sapiens (human)
protein autophosphorylationMAP kinase-activated protein kinase 5Homo sapiens (human)
positive regulation of telomerase activityMAP kinase-activated protein kinase 5Homo sapiens (human)
positive regulation of dendritic spine developmentMAP kinase-activated protein kinase 5Homo sapiens (human)
cellular senescenceMAP kinase-activated protein kinase 5Homo sapiens (human)
stress-induced premature senescenceMAP kinase-activated protein kinase 5Homo sapiens (human)
regulation of signal transduction by p53 class mediatorMAP kinase-activated protein kinase 5Homo sapiens (human)
positive regulation of telomere cappingMAP kinase-activated protein kinase 5Homo sapiens (human)
peptidyl-serine phosphorylationMAP kinase-activated protein kinase 5Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICREB-binding proteinHomo sapiens (human)
response to hypoxiaCREB-binding proteinHomo sapiens (human)
stimulatory C-type lectin receptor signaling pathwayCREB-binding proteinHomo sapiens (human)
chromatin remodelingCREB-binding proteinHomo sapiens (human)
regulation of DNA-templated transcriptionCREB-binding proteinHomo sapiens (human)
protein acetylationCREB-binding proteinHomo sapiens (human)
signal transductionCREB-binding proteinHomo sapiens (human)
canonical NF-kappaB signal transductionCREB-binding proteinHomo sapiens (human)
regulation of smoothened signaling pathwayCREB-binding proteinHomo sapiens (human)
negative regulation of transcription by RNA polymerase ICREB-binding proteinHomo sapiens (human)
N-terminal peptidyl-lysine acetylationCREB-binding proteinHomo sapiens (human)
positive regulation of transforming growth factor beta receptor signaling pathwayCREB-binding proteinHomo sapiens (human)
protein destabilizationCREB-binding proteinHomo sapiens (human)
cellular response to nutrient levelsCREB-binding proteinHomo sapiens (human)
cellular response to UVCREB-binding proteinHomo sapiens (human)
homeostatic processCREB-binding proteinHomo sapiens (human)
embryonic digit morphogenesisCREB-binding proteinHomo sapiens (human)
positive regulation of DNA-templated transcriptionCREB-binding proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IICREB-binding proteinHomo sapiens (human)
rhythmic processCREB-binding proteinHomo sapiens (human)
protein-containing complex assemblyCREB-binding proteinHomo sapiens (human)
regulation of cellular response to heatCREB-binding proteinHomo sapiens (human)
positive regulation of protein localization to nucleusCREB-binding proteinHomo sapiens (human)
positive regulation of double-strand break repair via homologous recombinationCREB-binding proteinHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription from RNA polymerase II promoter by glucoseHistone acetyltransferase KAT2BHomo sapiens (human)
gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA repairHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
protein acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
heart developmentHistone acetyltransferase KAT2BHomo sapiens (human)
memoryHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of cell population proliferationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of protein ADP-ribosylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase KAT2BHomo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to insulin stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to oxidative stressHistone acetyltransferase KAT2BHomo sapiens (human)
vasodilationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of RNA splicingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of fatty acid biosynthetic processHistone acetyltransferase KAT2BHomo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of glycolytic processHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of embryonic developmentHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of centriole replicationHistone acetyltransferase KAT2BHomo sapiens (human)
rhythmic processHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell divisionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell cycleHistone acetyltransferase KAT2BHomo sapiens (human)
limb developmentHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to parathyroid hormone stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of rRNA processingHistone acetyltransferase KAT2BHomo sapiens (human)
response to ischemiaBcl-2-like protein 2Homo sapiens (human)
spermatogenesisBcl-2-like protein 2Homo sapiens (human)
negative regulation of mitochondrial membrane permeabilityBcl-2-like protein 2Homo sapiens (human)
regulation of apoptotic processBcl-2-like protein 2Homo sapiens (human)
negative regulation of apoptotic processBcl-2-like protein 2Homo sapiens (human)
Sertoli cell proliferationBcl-2-like protein 2Homo sapiens (human)
cellular response to estradiol stimulusBcl-2-like protein 2Homo sapiens (human)
negative regulation of release of cytochrome c from mitochondriaBcl-2-like protein 2Homo sapiens (human)
cellular response to amyloid-betaBcl-2-like protein 2Homo sapiens (human)
cellular response to glycineBcl-2-like protein 2Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl-2-like protein 2Homo sapiens (human)
release of cytochrome c from mitochondriaBcl-2-like protein 2Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-like protein 2Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl-2-like protein 2Homo sapiens (human)
glucose catabolic processBcl2-associated agonist of cell death Homo sapiens (human)
apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsBcl2-associated agonist of cell death Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of autophagyBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of mitochondrial membrane potentialBcl2-associated agonist of cell death Homo sapiens (human)
cytokine-mediated signaling pathwayBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of insulin secretionBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of glucokinase activityBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusBcl2-associated agonist of cell death Homo sapiens (human)
glucose homeostasisBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
type B pancreatic cell proliferationBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of B cell differentiationBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of T cell differentiationBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of proteolysisBcl2-associated agonist of cell death Homo sapiens (human)
ADP metabolic processBcl2-associated agonist of cell death Homo sapiens (human)
ATP metabolic processBcl2-associated agonist of cell death Homo sapiens (human)
regulation of mitochondrial membrane permeabilityBcl2-associated agonist of cell death Homo sapiens (human)
pore complex assemblyBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of epithelial cell proliferationBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to mechanical stimulusBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to nicotineBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to lipidBcl2-associated agonist of cell death Homo sapiens (human)
cellular response to hypoxiaBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaBcl2-associated agonist of cell death Homo sapiens (human)
extrinsic apoptotic signaling pathwayBcl2-associated agonist of cell death Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl2-associated agonist of cell death Homo sapiens (human)
intrinsic apoptotic signaling pathwayBcl2-associated agonist of cell death Homo sapiens (human)
activation of cysteine-type endopeptidase activityBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stressBcl2-associated agonist of cell death Homo sapiens (human)
positive regulation of type B pancreatic cell developmentBcl2-associated agonist of cell death Homo sapiens (human)
release of cytochrome c from mitochondriaBcl2-associated agonist of cell death Homo sapiens (human)
lipid droplet disassemblyHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT5Homo sapiens (human)
establishment of mitotic spindle orientationHistone acetyltransferase KAT5Homo sapiens (human)
double-strand break repair via homologous recombinationHistone acetyltransferase KAT5Homo sapiens (human)
nucleotide-excision repairHistone acetyltransferase KAT5Homo sapiens (human)
double-strand break repairHistone acetyltransferase KAT5Homo sapiens (human)
apoptotic processHistone acetyltransferase KAT5Homo sapiens (human)
DNA damage responseHistone acetyltransferase KAT5Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorHistone acetyltransferase KAT5Homo sapiens (human)
spermatid developmentHistone acetyltransferase KAT5Homo sapiens (human)
response to ionizing radiationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of autophagyHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of triglyceride biosynthetic processHistone acetyltransferase KAT5Homo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase KAT5Homo sapiens (human)
neural tube developmentHistone acetyltransferase KAT5Homo sapiens (human)
neurogenesisHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of interleukin-2 productionHistone acetyltransferase KAT5Homo sapiens (human)
sperm DNA condensationHistone acetyltransferase KAT5Homo sapiens (human)
cellular response to glucose starvationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of circadian rhythmHistone acetyltransferase KAT5Homo sapiens (human)
regulation of apoptotic processHistone acetyltransferase KAT5Homo sapiens (human)
proteasome-mediated ubiquitin-dependent protein catabolic processHistone acetyltransferase KAT5Homo sapiens (human)
innate immune responseHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of regulatory T cell differentiationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of myoblast differentiationHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of DNA-templated transcriptionHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT5Homo sapiens (human)
regulation of cell cycleHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of mitotic sister chromatid segregationHistone acetyltransferase KAT5Homo sapiens (human)
cellular response to glucose stimulusHistone acetyltransferase KAT5Homo sapiens (human)
cellular response to estradiol stimulusHistone acetyltransferase KAT5Homo sapiens (human)
cellular senescenceHistone acetyltransferase KAT5Homo sapiens (human)
DNA repair-dependent chromatin remodelingHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of protein acetylationHistone acetyltransferase KAT5Homo sapiens (human)
regulation of hematopoietic stem cell differentiationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of double-strand break repair via homologous recombinationHistone acetyltransferase KAT5Homo sapiens (human)
positive regulation of aggrephagyHistone acetyltransferase KAT5Homo sapiens (human)
negative regulation of double-strand break repair via homologous recombinationHistone acetyltransferase KAT5Homo sapiens (human)
regulation of double-strand break repairHistone acetyltransferase KAT5Homo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT5Homo sapiens (human)
apoptotic processBcl-2-like protein 10Homo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processBcl-2-like protein 10Homo sapiens (human)
spermatogenesisBcl-2-like protein 10Homo sapiens (human)
female gamete generationBcl-2-like protein 10Homo sapiens (human)
microtubule organizing center organizationBcl-2-like protein 10Homo sapiens (human)
negative regulation of apoptotic processBcl-2-like protein 10Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageBcl-2-like protein 10Homo sapiens (human)
extrinsic apoptotic signaling pathway in absence of ligandBcl-2-like protein 10Homo sapiens (human)
release of cytochrome c from mitochondriaBcl-2-like protein 10Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (300)

Processvia Protein(s)Taxonomy
glutathione transferase activityProstaglandin E synthaseHomo sapiens (human)
glutathione peroxidase activityProstaglandin E synthaseHomo sapiens (human)
prostaglandin-D synthase activityProstaglandin E synthaseHomo sapiens (human)
protein bindingProstaglandin E synthaseHomo sapiens (human)
glutathione bindingProstaglandin E synthaseHomo sapiens (human)
prostaglandin-E synthase activityProstaglandin E synthaseHomo sapiens (human)
tRNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
transcription coactivator bindingTelomerase reverse transcriptaseHomo sapiens (human)
DNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
telomerase activityTelomerase reverse transcriptaseHomo sapiens (human)
telomerase RNA reverse transcriptase activityTelomerase reverse transcriptaseHomo sapiens (human)
RNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
RNA-directed DNA polymerase activityTelomerase reverse transcriptaseHomo sapiens (human)
RNA-dependent RNA polymerase activityTelomerase reverse transcriptaseHomo sapiens (human)
protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
identical protein bindingTelomerase reverse transcriptaseHomo sapiens (human)
protein homodimerization activityTelomerase reverse transcriptaseHomo sapiens (human)
metal ion bindingTelomerase reverse transcriptaseHomo sapiens (human)
protein-folding chaperone bindingTelomerase reverse transcriptaseHomo sapiens (human)
telomerase RNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
template-free RNA nucleotidyltransferaseTelomerase reverse transcriptaseHomo sapiens (human)
telomeric DNA bindingTelomerase reverse transcriptaseHomo sapiens (human)
transcription corepressor bindingPolycomb protein EEDHomo sapiens (human)
protein bindingPolycomb protein EEDHomo sapiens (human)
enzyme activator activityPolycomb protein EEDHomo sapiens (human)
histone methyltransferase activityPolycomb protein EEDHomo sapiens (human)
identical protein bindingPolycomb protein EEDHomo sapiens (human)
nucleosome bindingPolycomb protein EEDHomo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
NAD+ kinase activityNAD kinaseHomo sapiens (human)
protein bindingNAD kinaseHomo sapiens (human)
ATP bindingNAD kinaseHomo sapiens (human)
metal ion bindingNAD kinaseHomo sapiens (human)
mRNA regulatory element binding translation repressor activityDihydrofolate reductaseHomo sapiens (human)
mRNA bindingDihydrofolate reductaseHomo sapiens (human)
dihydrofolate reductase activityDihydrofolate reductaseHomo sapiens (human)
folic acid bindingDihydrofolate reductaseHomo sapiens (human)
NADPH bindingDihydrofolate reductaseHomo sapiens (human)
sequence-specific mRNA bindingDihydrofolate reductaseHomo sapiens (human)
NADP bindingDihydrofolate reductaseHomo sapiens (human)
serine-type endopeptidase activityUrokinase-type plasminogen activatorHomo sapiens (human)
protein bindingUrokinase-type plasminogen activatorHomo sapiens (human)
serine-type endopeptidase activityTissue-type plasminogen activatorHomo sapiens (human)
signaling receptor bindingTissue-type plasminogen activatorHomo sapiens (human)
protein bindingTissue-type plasminogen activatorHomo sapiens (human)
phosphoprotein bindingTissue-type plasminogen activatorHomo sapiens (human)
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
serine-type endopeptidase inhibitor activityAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
heparin bindingAmyloid-beta precursor proteinHomo sapiens (human)
enzyme bindingAmyloid-beta precursor proteinHomo sapiens (human)
identical protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
transition metal ion bindingAmyloid-beta precursor proteinHomo sapiens (human)
receptor ligand activityAmyloid-beta precursor proteinHomo sapiens (human)
PTB domain bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein serine/threonine kinase bindingAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor activator activityAmyloid-beta precursor proteinHomo sapiens (human)
protease bindingPlasminogen activator inhibitor 1Homo sapiens (human)
serine-type endopeptidase inhibitor activityPlasminogen activator inhibitor 1Homo sapiens (human)
signaling receptor bindingPlasminogen activator inhibitor 1Homo sapiens (human)
protein bindingPlasminogen activator inhibitor 1Homo sapiens (human)
protein bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATP bindingATP-dependent translocase ABCB1Homo sapiens (human)
ABC-type xenobiotic transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
efflux transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ATP hydrolysis activityATP-dependent translocase ABCB1Homo sapiens (human)
transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
ubiquitin protein ligase bindingATP-dependent translocase ABCB1Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
xenobiotic transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
carboxylic acid transmembrane transporter activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylcholine floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
phosphatidylethanolamine flippase activityATP-dependent translocase ABCB1Homo sapiens (human)
ceramide floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
floppase activityATP-dependent translocase ABCB1Homo sapiens (human)
RNA bindingHeat shock protein HSP 90-betaHomo sapiens (human)
double-stranded RNA bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP hydrolysis activityHeat shock protein HSP 90-betaHomo sapiens (human)
protein kinase regulator activityHeat shock protein HSP 90-betaHomo sapiens (human)
kinase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein kinase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
MHC class II protein complex bindingHeat shock protein HSP 90-betaHomo sapiens (human)
nitric-oxide synthase regulator activityHeat shock protein HSP 90-betaHomo sapiens (human)
TPR domain bindingHeat shock protein HSP 90-betaHomo sapiens (human)
heat shock protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ubiquitin protein ligase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
peptide bindingHeat shock protein HSP 90-betaHomo sapiens (human)
identical protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein homodimerization activityHeat shock protein HSP 90-betaHomo sapiens (human)
histone deacetylase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP-dependent protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein folding chaperoneHeat shock protein HSP 90-betaHomo sapiens (human)
cadherin bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protein dimerization activityHeat shock protein HSP 90-betaHomo sapiens (human)
tau protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
DNA polymerase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
disordered domain specific bindingHeat shock protein HSP 90-betaHomo sapiens (human)
ATP-dependent protein folding chaperoneHeat shock protein HSP 90-betaHomo sapiens (human)
receptor ligand inhibitor activityHeat shock protein HSP 90-betaHomo sapiens (human)
histone methyltransferase bindingHeat shock protein HSP 90-betaHomo sapiens (human)
unfolded protein bindingHeat shock protein HSP 90-betaHomo sapiens (human)
protease bindingNeutrophil elastaseHomo sapiens (human)
transcription corepressor activityNeutrophil elastaseHomo sapiens (human)
endopeptidase activityNeutrophil elastaseHomo sapiens (human)
serine-type endopeptidase activityNeutrophil elastaseHomo sapiens (human)
protein bindingNeutrophil elastaseHomo sapiens (human)
heparin bindingNeutrophil elastaseHomo sapiens (human)
peptidase activityNeutrophil elastaseHomo sapiens (human)
cytokine bindingNeutrophil elastaseHomo sapiens (human)
fibronectin binding72 kDa type IV collagenaseHomo sapiens (human)
endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
metalloendopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
serine-type endopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
protein binding72 kDa type IV collagenaseHomo sapiens (human)
metallopeptidase activity72 kDa type IV collagenaseHomo sapiens (human)
zinc ion binding72 kDa type IV collagenaseHomo sapiens (human)
protein tyrosine kinase activityHepatocyte growth factor receptorHomo sapiens (human)
protein bindingHepatocyte growth factor receptorHomo sapiens (human)
ATP bindingHepatocyte growth factor receptorHomo sapiens (human)
semaphorin receptor activityHepatocyte growth factor receptorHomo sapiens (human)
protein phosphatase bindingHepatocyte growth factor receptorHomo sapiens (human)
identical protein bindingHepatocyte growth factor receptorHomo sapiens (human)
molecular function activator activityHepatocyte growth factor receptorHomo sapiens (human)
hepatocyte growth factor receptor activityHepatocyte growth factor receptorHomo sapiens (human)
endopeptidase activityMatrilysinHomo sapiens (human)
metalloendopeptidase activityMatrilysinHomo sapiens (human)
serine-type endopeptidase activityMatrilysinHomo sapiens (human)
protein bindingMatrilysinHomo sapiens (human)
metallopeptidase activityMatrilysinHomo sapiens (human)
zinc ion bindingMatrilysinHomo sapiens (human)
magnesium ion binding60 kDa chaperoninEscherichia coli K-12
protein binding60 kDa chaperoninEscherichia coli K-12
ATP binding60 kDa chaperoninEscherichia coli K-12
isomerase activity60 kDa chaperoninEscherichia coli K-12
ATP hydrolysis activity60 kDa chaperoninEscherichia coli K-12
identical protein binding60 kDa chaperoninEscherichia coli K-12
unfolded protein binding60 kDa chaperoninEscherichia coli K-12
ATP-dependent protein folding chaperone60 kDa chaperoninEscherichia coli K-12
enoyl-[acyl-carrier-protein] reductase (NADH) activityEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
protein bindingEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
oxidoreductase activityEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
identical protein bindingEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
NADH bindingEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
mRNA guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
RNA endonuclease activity, producing 3'-phosphomonoestersReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
ISG15-specific peptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
protein guanylyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
alpha-amylase activityAlpha-amylase 1A Homo sapiens (human)
calcium ion bindingAlpha-amylase 1A Homo sapiens (human)
chloride ion bindingAlpha-amylase 1A Homo sapiens (human)
protease bindingApoptosis regulator Bcl-2Homo sapiens (human)
protein bindingApoptosis regulator Bcl-2Homo sapiens (human)
channel activityApoptosis regulator Bcl-2Homo sapiens (human)
channel inhibitor activityApoptosis regulator Bcl-2Homo sapiens (human)
ubiquitin protein ligase bindingApoptosis regulator Bcl-2Homo sapiens (human)
identical protein bindingApoptosis regulator Bcl-2Homo sapiens (human)
sequence-specific DNA bindingApoptosis regulator Bcl-2Homo sapiens (human)
protein heterodimerization activityApoptosis regulator Bcl-2Homo sapiens (human)
BH3 domain bindingApoptosis regulator Bcl-2Homo sapiens (human)
protein phosphatase 2A bindingApoptosis regulator Bcl-2Homo sapiens (human)
molecular adaptor activityApoptosis regulator Bcl-2Homo sapiens (human)
DNA-binding transcription factor bindingApoptosis regulator Bcl-2Homo sapiens (human)
BH domain bindingApoptosis regulator Bcl-2Homo sapiens (human)
DNA bindingMicrotubule-associated protein tauHomo sapiens (human)
minor groove of adenine-thymine-rich DNA bindingMicrotubule-associated protein tauHomo sapiens (human)
double-stranded DNA bindingMicrotubule-associated protein tauHomo sapiens (human)
single-stranded DNA bindingMicrotubule-associated protein tauHomo sapiens (human)
RNA bindingMicrotubule-associated protein tauHomo sapiens (human)
actin bindingMicrotubule-associated protein tauHomo sapiens (human)
protein bindingMicrotubule-associated protein tauHomo sapiens (human)
microtubule bindingMicrotubule-associated protein tauHomo sapiens (human)
SH3 domain bindingMicrotubule-associated protein tauHomo sapiens (human)
enzyme bindingMicrotubule-associated protein tauHomo sapiens (human)
protein kinase bindingMicrotubule-associated protein tauHomo sapiens (human)
protein-macromolecule adaptor activityMicrotubule-associated protein tauHomo sapiens (human)
apolipoprotein bindingMicrotubule-associated protein tauHomo sapiens (human)
dynactin bindingMicrotubule-associated protein tauHomo sapiens (human)
phosphatidylinositol bindingMicrotubule-associated protein tauHomo sapiens (human)
identical protein bindingMicrotubule-associated protein tauHomo sapiens (human)
sequence-specific DNA bindingMicrotubule-associated protein tauHomo sapiens (human)
protein-folding chaperone bindingMicrotubule-associated protein tauHomo sapiens (human)
protein phosphatase 2A bindingMicrotubule-associated protein tauHomo sapiens (human)
Hsp90 protein bindingMicrotubule-associated protein tauHomo sapiens (human)
lipoprotein particle bindingMicrotubule-associated protein tauHomo sapiens (human)
histone-dependent DNA bindingMicrotubule-associated protein tauHomo sapiens (human)
microtubule lateral bindingMicrotubule-associated protein tauHomo sapiens (human)
phosphatidylinositol bisphosphate bindingMicrotubule-associated protein tauHomo sapiens (human)
lipopolysaccharide binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
p53 binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
DNA replication origin binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
single-stranded DNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
double-stranded RNA binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
high-density lipoprotein particle binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
isomerase activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP hydrolysis activity60 kDa heat shock protein, mitochondrialHomo sapiens (human)
enzyme binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ubiquitin protein ligase binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
apolipoprotein A-I binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding60 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP-dependent protein folding chaperone60 kDa heat shock protein, mitochondrialHomo sapiens (human)
single-stranded DNA bindingFatty acid synthaseGallus gallus (chicken)
fatty acid synthase activityFatty acid synthaseGallus gallus (chicken)
[acyl-carrier-protein] S-acetyltransferase activityFatty acid synthaseGallus gallus (chicken)
[acyl-carrier-protein] S-malonyltransferase activityFatty acid synthaseGallus gallus (chicken)
3-oxoacyl-[acyl-carrier-protein] synthase activityFatty acid synthaseGallus gallus (chicken)
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
fatty acyl-[ACP] hydrolase activityFatty acid synthaseGallus gallus (chicken)
phosphopantetheine bindingFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxybutanoyl-[acyl-carrier-protein] hydratase activityFatty acid synthaseGallus gallus (chicken)
(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseGallus gallus (chicken)
enoyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseGallus gallus (chicken)
bisphosphoglycerate mutase activityPhosphoglycerate mutase 1Homo sapiens (human)
phosphoglycerate mutase activityPhosphoglycerate mutase 1Homo sapiens (human)
protein bindingPhosphoglycerate mutase 1Homo sapiens (human)
hydrolase activityPhosphoglycerate mutase 1Homo sapiens (human)
protein kinase bindingPhosphoglycerate mutase 1Homo sapiens (human)
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activityPhosphoglycerate mutase 1Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 1Homo sapiens (human)
protein bindingCannabinoid receptor 1Homo sapiens (human)
identical protein bindingCannabinoid receptor 1Homo sapiens (human)
G protein-coupled receptor activityCannabinoid receptor 1Homo sapiens (human)
actin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter transmembrane transporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
neurotransmitter:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
dopamine:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
norepinephrine:sodium symporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
protein bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
monoamine transmembrane transporter activitySodium-dependent noradrenaline transporter Homo sapiens (human)
alpha-tubulin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
metal ion bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
beta-tubulin bindingSodium-dependent noradrenaline transporter Homo sapiens (human)
DNA bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
RNA bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA (cytosine-5-)-methyltransferase activityDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
protein bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
zinc ion bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
methyl-CpG bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
DNA-methyltransferase activityDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
promoter-specific chromatin bindingDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
virus receptor activityDipeptidyl peptidase 4Homo sapiens (human)
protease bindingDipeptidyl peptidase 4Homo sapiens (human)
aminopeptidase activityDipeptidyl peptidase 4Homo sapiens (human)
serine-type endopeptidase activityDipeptidyl peptidase 4Homo sapiens (human)
signaling receptor bindingDipeptidyl peptidase 4Homo sapiens (human)
protein bindingDipeptidyl peptidase 4Homo sapiens (human)
serine-type peptidase activityDipeptidyl peptidase 4Homo sapiens (human)
dipeptidyl-peptidase activityDipeptidyl peptidase 4Homo sapiens (human)
identical protein bindingDipeptidyl peptidase 4Homo sapiens (human)
protein homodimerization activityDipeptidyl peptidase 4Homo sapiens (human)
chemorepellent activityDipeptidyl peptidase 4Homo sapiens (human)
threonine-type endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
protein bindingProteasome subunit beta type-5Homo sapiens (human)
peptidase activityProteasome subunit beta type-5Homo sapiens (human)
endopeptidase activityProteasome subunit beta type-5Homo sapiens (human)
protein bindingCannabinoid receptor 2 Homo sapiens (human)
cannabinoid receptor activityCannabinoid receptor 2 Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
RNA polymerase II core promoter sequence-specific DNA bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
transcription corepressor bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
transcription coactivator bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
double-stranded DNA bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
DNA-binding transcription factor activitySignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
tumor necrosis factor receptor bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
protein bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
nuclear receptor bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
enzyme bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
CCR5 chemokine receptor bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
histone acetyltransferase bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
histone bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
identical protein bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
protein homodimerization activitySignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
ubiquitin-like protein ligase bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cadherin bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
protein phosphatase 2A bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
promoter-specific chromatin bindingSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
DNA bindingDNA repair protein RAD52 homologHomo sapiens (human)
single-stranded DNA bindingDNA repair protein RAD52 homologHomo sapiens (human)
protein bindingDNA repair protein RAD52 homologHomo sapiens (human)
identical protein bindingDNA repair protein RAD52 homologHomo sapiens (human)
RNA bindingFatty acid synthaseHomo sapiens (human)
[acyl-carrier-protein] S-acetyltransferase activityFatty acid synthaseHomo sapiens (human)
[acyl-carrier-protein] S-malonyltransferase activityFatty acid synthaseHomo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] synthase activityFatty acid synthaseHomo sapiens (human)
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
protein bindingFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxymyristoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
fatty acyl-[ACP] hydrolase activityFatty acid synthaseHomo sapiens (human)
phosphopantetheine bindingFatty acid synthaseHomo sapiens (human)
cadherin bindingFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxybutanoyl-[acyl-carrier-protein] hydratase activityFatty acid synthaseHomo sapiens (human)
(3R)-3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activityFatty acid synthaseHomo sapiens (human)
enoyl-[acyl-carrier-protein] reductase (NADPH) activityFatty acid synthaseHomo sapiens (human)
fatty acid synthase activityFatty acid synthaseHomo sapiens (human)
endopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
metalloendopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
serine-type endopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
integrin bindingMatrix metalloproteinase-14Homo sapiens (human)
protein bindingMatrix metalloproteinase-14Homo sapiens (human)
zinc ion bindingMatrix metalloproteinase-14Homo sapiens (human)
metalloaminopeptidase activityMatrix metalloproteinase-14Homo sapiens (human)
fucosyltransferase activity4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
alpha-(1->3)-fucosyltransferase activity4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
phosphogluconate dehydrogenase (decarboxylating) activity6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
NADP binding6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
death receptor bindingBH3-interacting domain death agonistHomo sapiens (human)
protein bindingBH3-interacting domain death agonistHomo sapiens (human)
ubiquitin protein ligase bindingBH3-interacting domain death agonistHomo sapiens (human)
amyloid-beta bindingBeta-secretase 1Homo sapiens (human)
endopeptidase activityBeta-secretase 1Homo sapiens (human)
aspartic-type endopeptidase activityBeta-secretase 1Homo sapiens (human)
protein bindingBeta-secretase 1Homo sapiens (human)
peptidase activityBeta-secretase 1Homo sapiens (human)
beta-aspartyl-peptidase activityBeta-secretase 1Homo sapiens (human)
enzyme bindingBeta-secretase 1Homo sapiens (human)
protein serine/threonine kinase bindingBeta-secretase 1Homo sapiens (human)
RNA binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
ATP binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein folding chaperone10 kDa heat shock protein, mitochondrialHomo sapiens (human)
unfolded protein binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-folding chaperone binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
metal ion binding10 kDa heat shock protein, mitochondrialHomo sapiens (human)
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
interleukin-6 receptor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytokine bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
PDZ domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
tumor necrosis factor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peroxidase activityLactoperoxidaseBos taurus (cattle)
calcium ion bindingLactoperoxidaseBos taurus (cattle)
heme bindingLactoperoxidaseBos taurus (cattle)
thiocyanate peroxidase activityLactoperoxidaseBos taurus (cattle)
lactoperoxidase activityLactoperoxidaseBos taurus (cattle)
protein bindingBcl-2-like protein 1Homo sapiens (human)
protein kinase bindingBcl-2-like protein 1Homo sapiens (human)
identical protein bindingBcl-2-like protein 1Homo sapiens (human)
BH3 domain bindingBcl-2-like protein 1Homo sapiens (human)
BH domain bindingBcl-2-like protein 1Homo sapiens (human)
protein bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein transmembrane transporter activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
protein heterodimerization activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH3 domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
channel activityInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
BH domain bindingInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
transcription coregulator bindingHistone acetyltransferase p300Homo sapiens (human)
transcription coactivator bindingHistone acetyltransferase p300Homo sapiens (human)
p53 bindingHistone acetyltransferase p300Homo sapiens (human)
DNA bindingHistone acetyltransferase p300Homo sapiens (human)
chromatin bindingHistone acetyltransferase p300Homo sapiens (human)
damaged DNA bindingHistone acetyltransferase p300Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase p300Homo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase p300Homo sapiens (human)
protein bindingHistone acetyltransferase p300Homo sapiens (human)
beta-catenin bindingHistone acetyltransferase p300Homo sapiens (human)
zinc ion bindingHistone acetyltransferase p300Homo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
nuclear receptor bindingHistone acetyltransferase p300Homo sapiens (human)
peptide N-acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H3K18 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H2B acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone H3K27 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
tau protein bindingHistone acetyltransferase p300Homo sapiens (human)
nuclear androgen receptor bindingHistone acetyltransferase p300Homo sapiens (human)
NF-kappaB bindingHistone acetyltransferase p300Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingHistone acetyltransferase p300Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
protein propionyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
pre-mRNA intronic bindingHistone acetyltransferase p300Homo sapiens (human)
STAT family protein bindingHistone acetyltransferase p300Homo sapiens (human)
peptide 2-hydroxyisobutyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone lactyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
acetylation-dependent protein bindingHistone acetyltransferase p300Homo sapiens (human)
peptide butyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone crotonyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
histone butyryltransferase activityHistone acetyltransferase p300Homo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase p300Homo sapiens (human)
histone H3K122 acetyltransferase activityHistone acetyltransferase p300Homo sapiens (human)
chromatin DNA bindingHistone acetyltransferase p300Homo sapiens (human)
protein bindingAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
fucosyltransferase activityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
alpha-(1->3)-fucosyltransferase activityAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
beta-galactoside (CMP) alpha-2,3-sialyltransferase activityCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
sialyltransferase activityCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferaseCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
peptidyl-prolyl cis-trans isomerase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytoskeletal motor activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
beta-catenin bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cis-trans isomerase activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
mitogen-activated protein kinase kinase bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
GTPase activating protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
tau protein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphoserine residue bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphothreonine residue bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
phosphoprotein bindingPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
ubiquitin ligase activator activityPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
protein kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein serine/threonine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein serine/threonine/tyrosine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein tyrosine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
non-membrane spanning protein tyrosine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
ATP bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
identical protein bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
tau protein bindingDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
tau-protein kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein serine kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
histone H3T45 kinase activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
transcription coactivator activityDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
MAP kinase kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 14Homo sapiens (human)
enzyme bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein phosphatase bindingMitogen-activated protein kinase 14Homo sapiens (human)
mitogen-activated protein kinase p38 bindingMitogen-activated protein kinase 14Homo sapiens (human)
NFAT protein bindingMitogen-activated protein kinase 14Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 14Homo sapiens (human)
protein bindingBcl-2-related protein A1Homo sapiens (human)
channel activityBcl-2-related protein A1Homo sapiens (human)
BH domain bindingBcl-2-related protein A1Homo sapiens (human)
thiosulfate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
5S rRNA bindingThiosulfate sulfurtransferaseHomo sapiens (human)
3-mercaptopyruvate sulfurtransferase activityThiosulfate sulfurtransferaseHomo sapiens (human)
p53 bindingMAP kinase-activated protein kinase 5Homo sapiens (human)
protein serine/threonine kinase activityMAP kinase-activated protein kinase 5Homo sapiens (human)
MAP kinase kinase activityMAP kinase-activated protein kinase 5Homo sapiens (human)
protein bindingMAP kinase-activated protein kinase 5Homo sapiens (human)
ATP bindingMAP kinase-activated protein kinase 5Homo sapiens (human)
protein serine kinase activityMAP kinase-activated protein kinase 5Homo sapiens (human)
calmodulin-dependent protein kinase activityMAP kinase-activated protein kinase 5Homo sapiens (human)
mitogen-activated protein kinase bindingMAP kinase-activated protein kinase 5Homo sapiens (human)
calcium-dependent protein serine/threonine kinase activityMAP kinase-activated protein kinase 5Homo sapiens (human)
calmodulin bindingMAP kinase-activated protein kinase 5Homo sapiens (human)
transcription coactivator bindingCREB-binding proteinHomo sapiens (human)
p53 bindingCREB-binding proteinHomo sapiens (human)
chromatin bindingCREB-binding proteinHomo sapiens (human)
damaged DNA bindingCREB-binding proteinHomo sapiens (human)
transcription coactivator activityCREB-binding proteinHomo sapiens (human)
transcription corepressor activityCREB-binding proteinHomo sapiens (human)
histone acetyltransferase activityCREB-binding proteinHomo sapiens (human)
protein bindingCREB-binding proteinHomo sapiens (human)
zinc ion bindingCREB-binding proteinHomo sapiens (human)
acetyltransferase activityCREB-binding proteinHomo sapiens (human)
peptide N-acetyltransferase activityCREB-binding proteinHomo sapiens (human)
MRF bindingCREB-binding proteinHomo sapiens (human)
histone H3K18 acetyltransferase activityCREB-binding proteinHomo sapiens (human)
histone H3K27 acetyltransferase activityCREB-binding proteinHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCREB-binding proteinHomo sapiens (human)
peptide-lysine-N-acetyltransferase activityCREB-binding proteinHomo sapiens (human)
peptide lactyltransferase activityCREB-binding proteinHomo sapiens (human)
DNA-binding transcription factor bindingCREB-binding proteinHomo sapiens (human)
chromatin DNA bindingCREB-binding proteinHomo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin bindingHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT2BHomo sapiens (human)
diamine N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase KAT2BHomo sapiens (human)
cyclin-dependent protein serine/threonine kinase inhibitor activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein bindingHistone acetyltransferase KAT2BHomo sapiens (human)
acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein kinase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone deacetylase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3K9 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein bindingBcl-2-like protein 2Homo sapiens (human)
identical protein bindingBcl-2-like protein 2Homo sapiens (human)
protein-containing complex bindingBcl-2-like protein 2Homo sapiens (human)
disordered domain specific bindingBcl-2-like protein 2Homo sapiens (human)
BH domain bindingBcl-2-like protein 2Homo sapiens (human)
protein bindingBcl2-associated agonist of cell death Homo sapiens (human)
phospholipid bindingBcl2-associated agonist of cell death Homo sapiens (human)
lipid bindingBcl2-associated agonist of cell death Homo sapiens (human)
cysteine-type endopeptidase activator activity involved in apoptotic processBcl2-associated agonist of cell death Homo sapiens (human)
protein kinase bindingBcl2-associated agonist of cell death Homo sapiens (human)
protein phosphatase bindingBcl2-associated agonist of cell death Homo sapiens (human)
chromatin bindingHistone acetyltransferase KAT5Homo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT5Homo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
protein bindingHistone acetyltransferase KAT5Homo sapiens (human)
histone H4 acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
histone H2A acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
histone H2AK5 acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
metal ion bindingHistone acetyltransferase KAT5Homo sapiens (human)
histone H4K16 acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide 2-hydroxyisobutyryltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide crotonyltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
peptide butyryltransferase activityHistone acetyltransferase KAT5Homo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase KAT5Homo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT5Homo sapiens (human)
calcium ion bindingBcl-2-like protein 10Homo sapiens (human)
protein bindingBcl-2-like protein 10Homo sapiens (human)
caspase bindingBcl-2-like protein 10Homo sapiens (human)
BH domain bindingBcl-2-like protein 10Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (189)

Processvia Protein(s)Taxonomy
nuclear envelope lumenProstaglandin E synthaseHomo sapiens (human)
endoplasmic reticulum membraneProstaglandin E synthaseHomo sapiens (human)
membraneProstaglandin E synthaseHomo sapiens (human)
perinuclear region of cytoplasmProstaglandin E synthaseHomo sapiens (human)
membraneProstaglandin E synthaseHomo sapiens (human)
PML bodyTelomerase reverse transcriptaseHomo sapiens (human)
chromosome, telomeric regionTelomerase reverse transcriptaseHomo sapiens (human)
nucleusTelomerase reverse transcriptaseHomo sapiens (human)
nucleoplasmTelomerase reverse transcriptaseHomo sapiens (human)
telomerase holoenzyme complexTelomerase reverse transcriptaseHomo sapiens (human)
nucleolusTelomerase reverse transcriptaseHomo sapiens (human)
cytosolTelomerase reverse transcriptaseHomo sapiens (human)
plasma membraneTelomerase reverse transcriptaseHomo sapiens (human)
nuclear speckTelomerase reverse transcriptaseHomo sapiens (human)
mitochondrial nucleoidTelomerase reverse transcriptaseHomo sapiens (human)
TERT-RMRP complexTelomerase reverse transcriptaseHomo sapiens (human)
telomerase catalytic core complexTelomerase reverse transcriptaseHomo sapiens (human)
nuclear telomere cap complexTelomerase reverse transcriptaseHomo sapiens (human)
RNA-directed RNA polymerase complexTelomerase reverse transcriptaseHomo sapiens (human)
nucleusPolycomb protein EEDHomo sapiens (human)
nucleoplasmPolycomb protein EEDHomo sapiens (human)
chromosomePolycomb protein EEDHomo sapiens (human)
cytosolPolycomb protein EEDHomo sapiens (human)
ESC/E(Z) complexPolycomb protein EEDHomo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
cytosolNAD kinaseHomo sapiens (human)
mitochondrionDihydrofolate reductaseHomo sapiens (human)
cytosolDihydrofolate reductaseHomo sapiens (human)
mitochondrionDihydrofolate reductaseHomo sapiens (human)
extracellular regionUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
focal adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
external side of plasma membraneUrokinase-type plasminogen activatorHomo sapiens (human)
cell surfaceUrokinase-type plasminogen activatorHomo sapiens (human)
specific granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular exosomeUrokinase-type plasminogen activatorHomo sapiens (human)
tertiary granule membraneUrokinase-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexUrokinase-type plasminogen activatorHomo sapiens (human)
protein complex involved in cell-matrix adhesionUrokinase-type plasminogen activatorHomo sapiens (human)
serine-type endopeptidase complexUrokinase-type plasminogen activatorHomo sapiens (human)
extracellular spaceUrokinase-type plasminogen activatorHomo sapiens (human)
collagen-containing extracellular matrixTissue-type plasminogen activatorHomo sapiens (human)
extracellular regionTissue-type plasminogen activatorHomo sapiens (human)
cytoplasmTissue-type plasminogen activatorHomo sapiens (human)
cell surfaceTissue-type plasminogen activatorHomo sapiens (human)
secretory granuleTissue-type plasminogen activatorHomo sapiens (human)
apical part of cellTissue-type plasminogen activatorHomo sapiens (human)
extracellular exosomeTissue-type plasminogen activatorHomo sapiens (human)
serine protease inhibitor complexTissue-type plasminogen activatorHomo sapiens (human)
Schaffer collateral - CA1 synapseTissue-type plasminogen activatorHomo sapiens (human)
glutamatergic synapseTissue-type plasminogen activatorHomo sapiens (human)
extracellular spaceTissue-type plasminogen activatorHomo sapiens (human)
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
extracellular regionPolymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
dendriteAmyloid-beta precursor proteinHomo sapiens (human)
extracellular regionAmyloid-beta precursor proteinHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
nuclear envelope lumenAmyloid-beta precursor proteinHomo sapiens (human)
cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
mitochondrial inner membraneAmyloid-beta precursor proteinHomo sapiens (human)
endosomeAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulum lumenAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
Golgi lumenAmyloid-beta precursor proteinHomo sapiens (human)
Golgi-associated vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cytosolAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
clathrin-coated pitAmyloid-beta precursor proteinHomo sapiens (human)
cell-cell junctionAmyloid-beta precursor proteinHomo sapiens (human)
synaptic vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
membraneAmyloid-beta precursor proteinHomo sapiens (human)
COPII-coated ER to Golgi transport vesicleAmyloid-beta precursor proteinHomo sapiens (human)
axonAmyloid-beta precursor proteinHomo sapiens (human)
growth coneAmyloid-beta precursor proteinHomo sapiens (human)
platelet alpha granule lumenAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
endosome lumenAmyloid-beta precursor proteinHomo sapiens (human)
trans-Golgi network membraneAmyloid-beta precursor proteinHomo sapiens (human)
ciliary rootletAmyloid-beta precursor proteinHomo sapiens (human)
dendritic spineAmyloid-beta precursor proteinHomo sapiens (human)
dendritic shaftAmyloid-beta precursor proteinHomo sapiens (human)
perikaryonAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
apical part of cellAmyloid-beta precursor proteinHomo sapiens (human)
synapseAmyloid-beta precursor proteinHomo sapiens (human)
perinuclear region of cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
presynaptic active zoneAmyloid-beta precursor proteinHomo sapiens (human)
spindle midzoneAmyloid-beta precursor proteinHomo sapiens (human)
recycling endosomeAmyloid-beta precursor proteinHomo sapiens (human)
extracellular exosomeAmyloid-beta precursor proteinHomo sapiens (human)
receptor complexAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
collagen-containing extracellular matrixPlasminogen activator inhibitor 1Homo sapiens (human)
extracellular regionPlasminogen activator inhibitor 1Homo sapiens (human)
extracellular spacePlasminogen activator inhibitor 1Homo sapiens (human)
plasma membranePlasminogen activator inhibitor 1Homo sapiens (human)
platelet alpha granule lumenPlasminogen activator inhibitor 1Homo sapiens (human)
collagen-containing extracellular matrixPlasminogen activator inhibitor 1Homo sapiens (human)
extracellular exosomePlasminogen activator inhibitor 1Homo sapiens (human)
serine protease inhibitor complexPlasminogen activator inhibitor 1Homo sapiens (human)
peptidase inhibitor complexPlasminogen activator inhibitor 1Homo sapiens (human)
extracellular spacePlasminogen activator inhibitor 1Homo sapiens (human)
cytoplasmATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
cell surfaceATP-dependent translocase ABCB1Homo sapiens (human)
membraneATP-dependent translocase ABCB1Homo sapiens (human)
apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
extracellular exosomeATP-dependent translocase ABCB1Homo sapiens (human)
external side of apical plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
plasma membraneATP-dependent translocase ABCB1Homo sapiens (human)
COP9 signalosomeHeat shock protein HSP 90-betaHomo sapiens (human)
protein folding chaperone complexHeat shock protein HSP 90-betaHomo sapiens (human)
extracellular regionHeat shock protein HSP 90-betaHomo sapiens (human)
nucleusHeat shock protein HSP 90-betaHomo sapiens (human)
nucleoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
mitochondrionHeat shock protein HSP 90-betaHomo sapiens (human)
cytosolHeat shock protein HSP 90-betaHomo sapiens (human)
cell surfaceHeat shock protein HSP 90-betaHomo sapiens (human)
membraneHeat shock protein HSP 90-betaHomo sapiens (human)
secretory granule lumenHeat shock protein HSP 90-betaHomo sapiens (human)
melanosomeHeat shock protein HSP 90-betaHomo sapiens (human)
neuronal cell bodyHeat shock protein HSP 90-betaHomo sapiens (human)
dendritic growth coneHeat shock protein HSP 90-betaHomo sapiens (human)
axonal growth coneHeat shock protein HSP 90-betaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
extracellular exosomeHeat shock protein HSP 90-betaHomo sapiens (human)
dynein axonemal particleHeat shock protein HSP 90-betaHomo sapiens (human)
ficolin-1-rich granule lumenHeat shock protein HSP 90-betaHomo sapiens (human)
protein-containing complexHeat shock protein HSP 90-betaHomo sapiens (human)
aryl hydrocarbon receptor complexHeat shock protein HSP 90-betaHomo sapiens (human)
HSP90-CDC37 chaperone complexHeat shock protein HSP 90-betaHomo sapiens (human)
perinuclear region of cytoplasmHeat shock protein HSP 90-betaHomo sapiens (human)
plasma membraneHeat shock protein HSP 90-betaHomo sapiens (human)
cytosolHeat shock protein HSP 90-betaHomo sapiens (human)
extracellular regionNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
cytoplasmNeutrophil elastaseHomo sapiens (human)
cytosolNeutrophil elastaseHomo sapiens (human)
cell surfaceNeutrophil elastaseHomo sapiens (human)
secretory granuleNeutrophil elastaseHomo sapiens (human)
azurophil granule lumenNeutrophil elastaseHomo sapiens (human)
specific granule lumenNeutrophil elastaseHomo sapiens (human)
phagocytic vesicleNeutrophil elastaseHomo sapiens (human)
collagen-containing extracellular matrixNeutrophil elastaseHomo sapiens (human)
extracellular exosomeNeutrophil elastaseHomo sapiens (human)
transcription repressor complexNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular region72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
nucleus72 kDa type IV collagenaseHomo sapiens (human)
mitochondrion72 kDa type IV collagenaseHomo sapiens (human)
plasma membrane72 kDa type IV collagenaseHomo sapiens (human)
sarcomere72 kDa type IV collagenaseHomo sapiens (human)
collagen-containing extracellular matrix72 kDa type IV collagenaseHomo sapiens (human)
extracellular space72 kDa type IV collagenaseHomo sapiens (human)
extracellular regionHepatocyte growth factor receptorHomo sapiens (human)
plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
basal plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
cell surfaceHepatocyte growth factor receptorHomo sapiens (human)
membraneHepatocyte growth factor receptorHomo sapiens (human)
postsynapseHepatocyte growth factor receptorHomo sapiens (human)
basal plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
plasma membraneHepatocyte growth factor receptorHomo sapiens (human)
receptor complexHepatocyte growth factor receptorHomo sapiens (human)
extracellular regionMatrilysinHomo sapiens (human)
extracellular matrixMatrilysinHomo sapiens (human)
extracellular exosomeMatrilysinHomo sapiens (human)
extracellular spaceMatrilysinHomo sapiens (human)
cytoplasm60 kDa chaperoninEscherichia coli K-12
cytosol60 kDa chaperoninEscherichia coli K-12
membrane60 kDa chaperoninEscherichia coli K-12
GroEL-GroES complex60 kDa chaperoninEscherichia coli K-12
cytosolEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
membraneEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
protein-containing complexEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
catalytic complexEnoyl-[acyl-carrier-protein] reductase [NADH] FabIEscherichia coli K-12
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome coronavirus 2
extracellular spaceAlpha-amylase 1A Homo sapiens (human)
extracellular exosomeAlpha-amylase 1A Homo sapiens (human)
extracellular spaceAlpha-amylase 1A Homo sapiens (human)
mitochondrial outer membraneApoptosis regulator Bcl-2Homo sapiens (human)
endoplasmic reticulum membraneApoptosis regulator Bcl-2Homo sapiens (human)
nucleusApoptosis regulator Bcl-2Homo sapiens (human)
cytoplasmApoptosis regulator Bcl-2Homo sapiens (human)
mitochondrionApoptosis regulator Bcl-2Homo sapiens (human)
mitochondrial outer membraneApoptosis regulator Bcl-2Homo sapiens (human)
endoplasmic reticulumApoptosis regulator Bcl-2Homo sapiens (human)
cytosolApoptosis regulator Bcl-2Homo sapiens (human)
membraneApoptosis regulator Bcl-2Homo sapiens (human)
nuclear membraneApoptosis regulator Bcl-2Homo sapiens (human)
myelin sheathApoptosis regulator Bcl-2Homo sapiens (human)
BAD-BCL-2 complexApoptosis regulator Bcl-2Homo sapiens (human)
protein-containing complexApoptosis regulator Bcl-2Homo sapiens (human)
pore complexApoptosis regulator Bcl-2Homo sapiens (human)
microtubuleMicrotubule-associated protein tauHomo sapiens (human)
membraneMicrotubule-associated protein tauHomo sapiens (human)
extracellular regionMicrotubule-associated protein tauHomo sapiens (human)
nucleusMicrotubule-associated protein tauHomo sapiens (human)
cytoplasmMicrotubule-associated protein tauHomo sapiens (human)
mitochondrionMicrotubule-associated protein tauHomo sapiens (human)
cytosolMicrotubule-associated protein tauHomo sapiens (human)
plasma membraneMicrotubule-associated protein tauHomo sapiens (human)
microtubule cytoskeletonMicrotubule-associated protein tauHomo sapiens (human)
nuclear speckMicrotubule-associated protein tauHomo sapiens (human)
axonMicrotubule-associated protein tauHomo sapiens (human)
dendriteMicrotubule-associated protein tauHomo sapiens (human)
growth coneMicrotubule-associated protein tauHomo sapiens (human)
axolemmaMicrotubule-associated protein tauHomo sapiens (human)
nuclear peripheryMicrotubule-associated protein tauHomo sapiens (human)
cytoplasmic ribonucleoprotein granuleMicrotubule-associated protein tauHomo sapiens (human)
somatodendritic compartmentMicrotubule-associated protein tauHomo sapiens (human)
neuronal cell bodyMicrotubule-associated protein tauHomo sapiens (human)
dendritic spineMicrotubule-associated protein tauHomo sapiens (human)
cell bodyMicrotubule-associated protein tauHomo sapiens (human)
main axonMicrotubule-associated protein tauHomo sapiens (human)
membrane raftMicrotubule-associated protein tauHomo sapiens (human)
glial cell projectionMicrotubule-associated protein tauHomo sapiens (human)
neurofibrillary tangleMicrotubule-associated protein tauHomo sapiens (human)
axon cytoplasmMicrotubule-associated protein tauHomo sapiens (human)
tubulin complexMicrotubule-associated protein tauHomo sapiens (human)
neuron projectionMicrotubule-associated protein tauHomo sapiens (human)
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular space60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytoplasm60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrion60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix60 kDa heat shock protein, mitochondrialHomo sapiens (human)
early endosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytosol60 kDa heat shock protein, mitochondrialHomo sapiens (human)
plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
clathrin-coated pit60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cell surface60 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
coated vesicle60 kDa heat shock protein, mitochondrialHomo sapiens (human)
secretory granule60 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm midpiece60 kDa heat shock protein, mitochondrialHomo sapiens (human)
sperm plasma membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
migrasome60 kDa heat shock protein, mitochondrialHomo sapiens (human)
protein-containing complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
lipopolysaccharide receptor complex60 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial inner membrane60 kDa heat shock protein, mitochondrialHomo sapiens (human)
cytoplasmFatty acid synthaseGallus gallus (chicken)
extracellular regionPhosphoglycerate mutase 1Homo sapiens (human)
cytoplasmPhosphoglycerate mutase 1Homo sapiens (human)
cytosolPhosphoglycerate mutase 1Homo sapiens (human)
membranePhosphoglycerate mutase 1Homo sapiens (human)
secretory granule lumenPhosphoglycerate mutase 1Homo sapiens (human)
extracellular exosomePhosphoglycerate mutase 1Homo sapiens (human)
ficolin-1-rich granule lumenPhosphoglycerate mutase 1Homo sapiens (human)
mitochondrial outer membraneCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
actin cytoskeletonCannabinoid receptor 1Homo sapiens (human)
growth coneCannabinoid receptor 1Homo sapiens (human)
presynaptic membraneCannabinoid receptor 1Homo sapiens (human)
membrane raftCannabinoid receptor 1Homo sapiens (human)
glutamatergic synapseCannabinoid receptor 1Homo sapiens (human)
GABA-ergic synapseCannabinoid receptor 1Homo sapiens (human)
plasma membraneCannabinoid receptor 1Homo sapiens (human)
cytoplasmCannabinoid receptor 1Homo sapiens (human)
plasma membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
cell surfaceSodium-dependent noradrenaline transporter Homo sapiens (human)
membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
neuronal cell body membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
presynaptic membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
plasma membraneSodium-dependent noradrenaline transporter Homo sapiens (human)
axonSodium-dependent noradrenaline transporter Homo sapiens (human)
female germ cell nucleusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nucleoplasmDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
replication forkDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
pericentric heterochromatinDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
nucleusDNA (cytosine-5)-methyltransferase 1Homo sapiens (human)
extracellular regionDipeptidyl peptidase 4Homo sapiens (human)
lysosomal membraneDipeptidyl peptidase 4Homo sapiens (human)
plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
focal adhesionDipeptidyl peptidase 4Homo sapiens (human)
cell surfaceDipeptidyl peptidase 4Homo sapiens (human)
membraneDipeptidyl peptidase 4Homo sapiens (human)
apical plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
lamellipodiumDipeptidyl peptidase 4Homo sapiens (human)
endocytic vesicleDipeptidyl peptidase 4Homo sapiens (human)
lamellipodium membraneDipeptidyl peptidase 4Homo sapiens (human)
membrane raftDipeptidyl peptidase 4Homo sapiens (human)
intercellular canaliculusDipeptidyl peptidase 4Homo sapiens (human)
extracellular exosomeDipeptidyl peptidase 4Homo sapiens (human)
plasma membraneDipeptidyl peptidase 4Homo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
cytoplasmProteasome subunit beta type-5Homo sapiens (human)
proteasome complexProteasome subunit beta type-5Homo sapiens (human)
nucleusProteasome subunit beta type-5Homo sapiens (human)
nucleoplasmProteasome subunit beta type-5Homo sapiens (human)
centrosomeProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
extracellular exosomeProteasome subunit beta type-5Homo sapiens (human)
proteasome core complexProteasome subunit beta type-5Homo sapiens (human)
proteasome core complex, beta-subunit complexProteasome subunit beta type-5Homo sapiens (human)
cytosolProteasome subunit beta type-5Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
dendriteCannabinoid receptor 2 Homo sapiens (human)
extrinsic component of cytoplasmic side of plasma membraneCannabinoid receptor 2 Homo sapiens (human)
perikaryonCannabinoid receptor 2 Homo sapiens (human)
endoplasmic reticulumCannabinoid receptor 2 Homo sapiens (human)
plasma membraneCannabinoid receptor 2 Homo sapiens (human)
cytoplasmCannabinoid receptor 2 Homo sapiens (human)
nucleusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
nucleusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
nucleusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
nucleoplasmSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
nucleolusSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cytoplasmSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cytosolSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
axonSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
dendriteSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
perinuclear region of cytoplasmSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
ISGF3 complexSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
RNA polymerase II transcription regulator complexSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
chromatinSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
protein-containing complexSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
cytoplasmSignal transducer and activator of transcription 1-alpha/betaHomo sapiens (human)
nucleusDNA repair protein RAD52 homologHomo sapiens (human)
nucleoplasmDNA repair protein RAD52 homologHomo sapiens (human)
protein-containing complexDNA repair protein RAD52 homologHomo sapiens (human)
protein-DNA complexDNA repair protein RAD52 homologHomo sapiens (human)
nucleusDNA repair protein RAD52 homologHomo sapiens (human)
Golgi apparatusFatty acid synthaseHomo sapiens (human)
cytosolFatty acid synthaseHomo sapiens (human)
plasma membraneFatty acid synthaseHomo sapiens (human)
membraneFatty acid synthaseHomo sapiens (human)
melanosomeFatty acid synthaseHomo sapiens (human)
glycogen granuleFatty acid synthaseHomo sapiens (human)
extracellular exosomeFatty acid synthaseHomo sapiens (human)
cytoplasmFatty acid synthaseHomo sapiens (human)
cytoplasmMatrix metalloproteinase-14Homo sapiens (human)
plasma membraneMatrix metalloproteinase-14Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-14Homo sapiens (human)
nucleusMatrix metalloproteinase-14Homo sapiens (human)
Golgi lumenMatrix metalloproteinase-14Homo sapiens (human)
cytosolMatrix metalloproteinase-14Homo sapiens (human)
plasma membraneMatrix metalloproteinase-14Homo sapiens (human)
focal adhesionMatrix metalloproteinase-14Homo sapiens (human)
extracellular matrixMatrix metalloproteinase-14Homo sapiens (human)
cytoplasmic vesicleMatrix metalloproteinase-14Homo sapiens (human)
melanosomeMatrix metalloproteinase-14Homo sapiens (human)
macropinosomeMatrix metalloproteinase-14Homo sapiens (human)
intermediate filament cytoskeletonMatrix metalloproteinase-14Homo sapiens (human)
extracellular spaceMatrix metalloproteinase-14Homo sapiens (human)
Golgi membrane4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
extracellular region4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
Golgi apparatus4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
Golgi cisterna membrane4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
extracellular exosome4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
methylosome4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6Homo sapiens (human)
nucleus6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
cytosol6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
extracellular exosome6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
cytosol6-phosphogluconate dehydrogenase, decarboxylatingHomo sapiens (human)
mitochondrial outer membraneBH3-interacting domain death agonistHomo sapiens (human)
cytosolBH3-interacting domain death agonistHomo sapiens (human)
membraneBH3-interacting domain death agonistHomo sapiens (human)
mitochondrionBH3-interacting domain death agonistHomo sapiens (human)
cytosolBH3-interacting domain death agonistHomo sapiens (human)
lysosomeBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
early endosomeBeta-secretase 1Homo sapiens (human)
late endosomeBeta-secretase 1Homo sapiens (human)
multivesicular bodyBeta-secretase 1Homo sapiens (human)
endoplasmic reticulum lumenBeta-secretase 1Homo sapiens (human)
Golgi apparatusBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
synaptic vesicleBeta-secretase 1Homo sapiens (human)
cell surfaceBeta-secretase 1Homo sapiens (human)
endosome membraneBeta-secretase 1Homo sapiens (human)
membraneBeta-secretase 1Homo sapiens (human)
axonBeta-secretase 1Homo sapiens (human)
dendriteBeta-secretase 1Homo sapiens (human)
neuronal cell bodyBeta-secretase 1Homo sapiens (human)
membrane raftBeta-secretase 1Homo sapiens (human)
recycling endosomeBeta-secretase 1Homo sapiens (human)
Golgi-associated vesicle lumenBeta-secretase 1Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseBeta-secretase 1Homo sapiens (human)
endosomeBeta-secretase 1Homo sapiens (human)
plasma membraneBeta-secretase 1Homo sapiens (human)
trans-Golgi networkBeta-secretase 1Homo sapiens (human)
mitochondrion10 kDa heat shock protein, mitochondrialHomo sapiens (human)
membrane10 kDa heat shock protein, mitochondrialHomo sapiens (human)
extracellular exosome10 kDa heat shock protein, mitochondrialHomo sapiens (human)
mitochondrial matrix10 kDa heat shock protein, mitochondrialHomo sapiens (human)
cell-cell junctionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
ruffle membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytosolDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
actin cytoskeletonDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
apical plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane raftDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
extracellular spaceLactoperoxidaseBos taurus (cattle)
cytoplasmLactoperoxidaseBos taurus (cattle)
cytoplasmBcl-2-like protein 1Homo sapiens (human)
mitochondrionBcl-2-like protein 1Homo sapiens (human)
mitochondrial outer membraneBcl-2-like protein 1Homo sapiens (human)
mitochondrial inner membraneBcl-2-like protein 1Homo sapiens (human)
mitochondrial matrixBcl-2-like protein 1Homo sapiens (human)
endoplasmic reticulumBcl-2-like protein 1Homo sapiens (human)
centrosomeBcl-2-like protein 1Homo sapiens (human)
cytosolBcl-2-like protein 1Homo sapiens (human)
synaptic vesicle membraneBcl-2-like protein 1Homo sapiens (human)
nuclear membraneBcl-2-like protein 1Homo sapiens (human)
Bcl-2 family protein complexBcl-2-like protein 1Homo sapiens (human)
mitochondrial outer membraneBcl-2-like protein 1Homo sapiens (human)
nucleusInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
nucleoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytoplasmInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrionInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytosolInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
Bcl-2 family protein complexInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
mitochondrial outer membraneInduced myeloid leukemia cell differentiation protein Mcl-1Homo sapiens (human)
cytoplasmHistone acetyltransferase p300Homo sapiens (human)
cytosolHistone acetyltransferase p300Homo sapiens (human)
nucleusHistone acetyltransferase p300Homo sapiens (human)
nucleoplasmHistone acetyltransferase p300Homo sapiens (human)
cytosolHistone acetyltransferase p300Homo sapiens (human)
chromatinHistone acetyltransferase p300Homo sapiens (human)
protein-DNA complexHistone acetyltransferase p300Homo sapiens (human)
transcription regulator complexHistone acetyltransferase p300Homo sapiens (human)
histone acetyltransferase complexHistone acetyltransferase p300Homo sapiens (human)
Golgi membraneAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
Golgi apparatusAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
trans-Golgi networkAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
membraneAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
Golgi cisterna membraneAlpha-(1,3)-fucosyltransferase 7Homo sapiens (human)
Golgi membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
trans-Golgi network membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
extracellular exosomeCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
Golgi medial cisterna membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
Golgi trans cisterna membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
membraneCMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1Homo sapiens (human)
glutamatergic synapsePeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
postsynaptic cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleoplasmPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytoplasmPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nuclear speckPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
midbodyPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
ciliary basal bodyPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
nucleusPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytosolPeptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)
cytoskeletonDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nucleusDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nucleusDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nucleoplasmDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
cytoplasmDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
nuclear speckDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
axonDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
dendriteDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
ribonucleoprotein complexDual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
spindle poleMitogen-activated protein kinase 14Homo sapiens (human)
extracellular regionMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
mitochondrionMitogen-activated protein kinase 14Homo sapiens (human)
cytosolMitogen-activated protein kinase 14Homo sapiens (human)
nuclear speckMitogen-activated protein kinase 14Homo sapiens (human)
secretory granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
glutamatergic synapseMitogen-activated protein kinase 14Homo sapiens (human)
ficolin-1-rich granule lumenMitogen-activated protein kinase 14Homo sapiens (human)
nucleusMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 14Homo sapiens (human)
cytoplasmBcl-2-related protein A1Homo sapiens (human)
cytosolBcl-2-related protein A1Homo sapiens (human)
mitochondrial outer membraneBcl-2-related protein A1Homo sapiens (human)
extracellular spaceThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrial matrixThiosulfate sulfurtransferaseHomo sapiens (human)
mitochondrionThiosulfate sulfurtransferaseHomo sapiens (human)
nucleoplasmMAP kinase-activated protein kinase 5Homo sapiens (human)
cytosolMAP kinase-activated protein kinase 5Homo sapiens (human)
septin cytoskeletonMAP kinase-activated protein kinase 5Homo sapiens (human)
protein-containing complexMAP kinase-activated protein kinase 5Homo sapiens (human)
cytoplasmMAP kinase-activated protein kinase 5Homo sapiens (human)
nucleusMAP kinase-activated protein kinase 5Homo sapiens (human)
cytoplasmCREB-binding proteinHomo sapiens (human)
nucleusCREB-binding proteinHomo sapiens (human)
nucleoplasmCREB-binding proteinHomo sapiens (human)
cytoplasmCREB-binding proteinHomo sapiens (human)
cytosolCREB-binding proteinHomo sapiens (human)
nuclear bodyCREB-binding proteinHomo sapiens (human)
chromatinCREB-binding proteinHomo sapiens (human)
histone acetyltransferase complexCREB-binding proteinHomo sapiens (human)
transcription regulator complexCREB-binding proteinHomo sapiens (human)
SAGA complexHistone acetyltransferase KAT2BHomo sapiens (human)
kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
nucleusHistone acetyltransferase KAT2BHomo sapiens (human)
nucleoplasmHistone acetyltransferase KAT2BHomo sapiens (human)
centrosomeHistone acetyltransferase KAT2BHomo sapiens (human)
cytosolHistone acetyltransferase KAT2BHomo sapiens (human)
A bandHistone acetyltransferase KAT2BHomo sapiens (human)
I bandHistone acetyltransferase KAT2BHomo sapiens (human)
actomyosinHistone acetyltransferase KAT2BHomo sapiens (human)
mitotic spindleHistone acetyltransferase KAT2BHomo sapiens (human)
ATAC complexHistone acetyltransferase KAT2BHomo sapiens (human)
protein-containing complexHistone acetyltransferase KAT2BHomo sapiens (human)
cytosolBcl-2-like protein 2Homo sapiens (human)
Bcl-2 family protein complexBcl-2-like protein 2Homo sapiens (human)
mitochondrial outer membraneBcl-2-like protein 2Homo sapiens (human)
mitochondrionBcl2-associated agonist of cell death Homo sapiens (human)
mitochondrial outer membraneBcl2-associated agonist of cell death Homo sapiens (human)
cytosolBcl2-associated agonist of cell death Homo sapiens (human)
BAD-BCL-2 complexBcl2-associated agonist of cell death Homo sapiens (human)
cytosolBcl2-associated agonist of cell death Homo sapiens (human)
mitochondrionBcl2-associated agonist of cell death Homo sapiens (human)
site of double-strand breakHistone acetyltransferase KAT5Homo sapiens (human)
kinetochoreHistone acetyltransferase KAT5Homo sapiens (human)
nucleosomeHistone acetyltransferase KAT5Homo sapiens (human)
nucleusHistone acetyltransferase KAT5Homo sapiens (human)
nucleoplasmHistone acetyltransferase KAT5Homo sapiens (human)
nucleolusHistone acetyltransferase KAT5Homo sapiens (human)
cytoplasmHistone acetyltransferase KAT5Homo sapiens (human)
cytosolHistone acetyltransferase KAT5Homo sapiens (human)
piccolo histone acetyltransferase complexHistone acetyltransferase KAT5Homo sapiens (human)
NuA4 histone acetyltransferase complexHistone acetyltransferase KAT5Homo sapiens (human)
intracellular membrane-bounded organelleHistone acetyltransferase KAT5Homo sapiens (human)
perinuclear region of cytoplasmHistone acetyltransferase KAT5Homo sapiens (human)
mitotic spindle poleHistone acetyltransferase KAT5Homo sapiens (human)
chromatinHistone acetyltransferase KAT5Homo sapiens (human)
Swr1 complexHistone acetyltransferase KAT5Homo sapiens (human)
transcription regulator complexHistone acetyltransferase KAT5Homo sapiens (human)
nucleusHistone acetyltransferase KAT5Homo sapiens (human)
mitochondrionBcl-2-like protein 10Homo sapiens (human)
endoplasmic reticulumBcl-2-like protein 10Homo sapiens (human)
spindleBcl-2-like protein 10Homo sapiens (human)
cytosolBcl-2-like protein 10Homo sapiens (human)
membraneBcl-2-like protein 10Homo sapiens (human)
nuclear membraneBcl-2-like protein 10Homo sapiens (human)
mitochondria-associated endoplasmic reticulum membrane contact siteBcl-2-like protein 10Homo sapiens (human)
mitochondrial outer membraneBcl-2-like protein 10Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (828)

Assay IDTitleYearJournalArticle
AID1371376Cytotoxicity against human MML1 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID675175Competitive inhibition of Spiroplasma sp. MQ1 SssI methyltransferase using pUC18 as substrate measured for 10 mins by Dixon plot analysis2012European journal of medicinal chemistry, Sep, Volume: 55New cytosine derivatives as inhibitors of DNA methylation.
AID363882Antiproliferative activity against human HL60 cells assessed as cell viability at 10 uM after 3 days2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate.
AID1513556Antiproliferative activity against human MCF7 cells2019Journal of medicinal chemistry, 01-10, Volume: 62, Issue:1
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design.
AID1245401Effect on H2O2 scavenging activity of the compound after 1.5 hrs by Amplex red/horseradish peroxidase detection method2015Bioorganic & medicinal chemistry, Oct-01, Volume: 23, Issue:19
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.
AID1239586Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 0.28 mM after 24 hrs by time kill assay in presence of 0.42 mM of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID650645Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Tea catechins and flavonoids from the leaves of Camellia sinensis inhibit yeast alcohol dehydrogenase.
AID1465943Effect on SopE2-CPG2-HA fusion protein expression expressed in Salmonella typhimurium using Glu-CyFur as substrate at 0.39 to 100 uM after 4 hrs by fluorescence assay2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID774359Selectivity index, ratio of IC50 for Swiss mouse peritoneal macrophages to IC50 for intracellular amastigotes of Leishmania amazonensis MHOM/BR/75/LTB00162013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID165900In vitro assay for EBV activation in Raji cells induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) at the concentration of 10 (mol ratio / 32 pmol TPA)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID396440Toxicity against human dermal fibroblasts assessed as cell viability at 10 uM relative to control2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID542193Antiviral activity against Human herpesvirus 1 isolate P56 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1780097Cardioprotective activity in rat H9c2 cells assessed as reduction in hypoxia/reoxygenation-induced intracellular Zn2+ level depletion by measuring improvement in intracellular TSQ fluorescence intensity at 10 uM treated at the onset of 1 hr reoxygenation 2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID542180Antiviral activity against Human herpesvirus 2 isolate P12 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID310894Displacement of ethidium bromide from Escherichia coli DNA gyrase B2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
AID704069Inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate at 1 uM incubated for 15 mins prior to extension reaction by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID1609138Inhibition of FASN in human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as disruption of AKT/FASN positive feedback loop by measuring decrease in FASN expression at 100 uM after 48 hrs by Western immunoblot based densitometri2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID542208Antiviral activity against Human herpesvirus 1 isolate P32 infected in African green monkey vero cells assessed as reduction in viral titer2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1233379Neuroprotective activity against 0.1 uM amyloid beta 42-induced toxicity in rat PC12 cells assessed as cell viability at 10 uM after 24 hrs by MTT assay2015Bioorganic & medicinal chemistry letters, Jul-15, Volume: 25, Issue:14
Inhibitory activities of biflavonoids against amyloid-β peptide 42 cytotoxicity in PC-12 cells.
AID541911Antiviral activity against Human herpesvirus 1 isolate P15 infected in African green monkey vero cells assessed as reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1066532Inhibition of 67LR co-localization in lipid rafts containing cholera toxin labeled GM1 gangliosides in human A431 cells after 30 mins by immunofluorescence-based confocal microscopic analysis (Rvb = 75%)2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1890678Inhibition of DYRK1A (unknown origin) using HT-497 as substrate preincubated with compound followed by substrate addition and measured after 30 mins in the presence of ATP by ELISA analysis2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
AID764702Antiproliferative activity against human PC3 cells at 10 to 100 uM after 48 hrs by hemocytometric cell counting method2013Bioorganic & medicinal chemistry letters, Sep-01, Volume: 23, Issue:17
Syntheses of procyanidin B2 and B3 gallate derivatives using equimolar condensation mediated by Yb(OTf)3 and their antitumor activities.
AID456194Inhibition of beta amyloid (1 to 40) fibril formation2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID318322Growth inhibition of human Caco-2 cells at 25 uM after 6 days2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
AID1780107Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as viable cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period by AnnexinV-FITC/propidium iodide staining based flow cytometry ana2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID596589Growth inhibition against human Raji cells assessed as cell viability at 10 uM after 48 hrs by trypan blue based microscopic analysis in presence of superoxide dismutase and catalase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID596476Cell cycle arrest in human HL60 cells by assessed as accumulation at subG1 phase at 10 uM using propidium iodide staining by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1890688Anti-inflammatory activity in MOG (35 to 55 residues)-induced experimental autoimmune encephalomyelitis mouse model assessed as reduction in spinal cord axonal neurodegeneration severity score by Bielschowsky silver staining based light microscopic analys2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
AID300029Inhibition of chymotrypsin like activity of 20S proteasome2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer.
AID704070Binding affinity to Stenotrophomonas sp. TSG4 5'-(GGGATT)3GGGTT-3' DNA assessed as G-quadruplex stabilization at 2 uM by thermal melt analysis2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID646986Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 10 uM preincubated for 30 mins prior substrate addition measured after 7 hrs by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1187049Antiviral activity against HCV genotype 1a assessed as inhibition of viral entry into Huh7 cells treated for 2 hr followed by 28 hrs incubation period in compound-free medium by immunofluorescence assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
AID1865600Non-competitive inhibition of N-terminal full length NADK (unknown origin) expressed in Escherichia coli BL21(DE3) cells by HDX-MS analysis2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID343517Selectivity, ratio of CC50 for dog MDCK cells to EC50 for Influenza (A/PR8/34(H1N1))2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
AID541969Antiviral activity against Human herpesvirus 1 isolate P32 infected in African green monkey vero cells assessed as log reduction in viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID165902In vitro assay for EBV activation in Raji cells induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) at the concentration of 1000 (mol ratio / 32 pmol TPA)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID541956Antiviral activity against Human herpesvirus 2 isolate P22 infected in African green monkey CV1 cells2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1604455Antiproliferative activity against human MCF7 cells2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions.
AID541954Antiviral activity against Human herpesvirus 2 isolate P11 infected in African green monkey CV1 cells2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID542175Antiviral activity against Human herpesvirus 2 isolate P22 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID355162Inhibition of Streptococcus sobrinus glucosyltransferase assessed as blockade of adherent water insoluble glucan synthesis at 10 ug/mL1996Journal of natural products, Sep, Volume: 59, Issue:9
Macrocarpals H, I, and J from the Leaves of Eucalyptus globulus.
AID1239525Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239570Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 at 0.56 mM after 4 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1609127Induction of apoptosis in human NCI-H1703 cells expressing FASN assessed as increase in late apoptotic cells at 100 uM after 72 hrs by Annexin-V FITC staining/PI-based flow cytometry2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1865606Cytotoxicity against human A549 cells harboring KRAS G12C mutant assessed as inhibition of cell growth at 30 uM2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID729674Cytotoxicity against CHO cells expressing OATP1B1*1b after 48 hrs by fluorescence based CellTiter-Glo assay relative to wild type CHO cells2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID318325Prooxidant activity assessed as enhancement of NADPH oxidation at 50 uM2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
AID1633147Inhibition of chymotrypsin-like activity of human 26S proteasome in human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Arg-AMC as substrate preincubated for 12 hrs followed by addition of substrate and measured after 2 hrs by fluoro2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID704076Inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate incubated for 15 mins prior to extension reaction by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID468521Drug uptake assessed as incorporation into egg phosphatidylcholine liposome by HPLC2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID270215Hydroxyl radical scavenging activity2006Bioorganic & medicinal chemistry letters, Oct-01, Volume: 16, Issue:19
Stereospecificity in hydroxyl radical scavenging activities of four ginsenosides produced by heat processing.
AID751801Inhibition of Clostridium histolyticum collagenase using N-[3-(2-Furyl)acryloyl]-Leu-Gly-Pro-Ala as substrate at 100 ug/ml after 15 mins by spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
(+)-Usnic acid enamines with remarkable cicatrizing properties.
AID1187054Inhibition of Plasmodium falciparum FabZ2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.
AID597201Antifibrotic activity against rat HSC-T6 cells assessed as inhibition of proliferation after 48 hrs by BrdU incorporation assay2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
Antifibrotic constituents of Alnus firma on hepatic stellate cells.
AID542195Antiviral activity against Human herpesvirus 1 isolate P56 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID542206Antiviral activity against Human herpesvirus 1 isolate P15 infected in African green monkey vero cells assessed as reduction in viral titer2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1743766Inhibition of 6His-tagged human RD52 assessed as reduction in RD52 binding to Cy3-dT30-Cy5 ssDNA incubated for 30 mins by FRET assay2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Synthetic Lethality through the Lens of Medicinal Chemistry.
AID646995Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 100 uM preincubated for 30 mins prior substrate addition measured after 6 hrs by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID541950Antiviral activity against Human herpesvirus 2 isolate P27 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 12.5 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1557207Antibiofilm activity against Streptococcus mutans assessed as inhibition of biofilm formation2019MedChemComm, Jul-01, Volume: 10, Issue:7
Targeting
AID596475Growth inhibition against human Raji cells assessed as cell viability at 10 uM after 48 hrs by trypan blue based microscopic analysis in presence of catalase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID748709Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
AID1465949Inhibition of SPI-1 T3SS in Salmonella typhimurium assessed as reduction in SPI-1 T3SS substrates by measuring FliC protein level at 5 to 100 uM after 4 hrs by Coomassie staining based SDS-PAGE method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID596483Induction of apoptosis in human Raji cells assessed as early apoptotic cells at 10 uM after 6 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 3.7 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1682375Inhibition of Escherichia coli FabI using trans-2-octanoyl-N-acetylcysteamine as substrate by spectrophotometry2020Bioorganic & medicinal chemistry letters, 12-15, Volume: 30, Issue:24
The food-grade antimicrobial xanthorrhizol targets the enoyl-ACP reductase (FabI) in Escherichia coli.
AID376603Neuroprotective effect against 6-OHDA-induced neurotoxicity in human SH-SY5Y cells at 1 uM treated 1 hr before 6-OHDA injury after 24 hrs by MTT assay relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Neuroprotective bibenzyl glycosides of Stemona tuberosa roots.
AID1520361Inhibition of erastin-induced ferroptosis in HEK293 cells preincubated for 4 hrs followed by erastin stimulation and measured at next day by MTS assay
AID1239548Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1689109Cytotoxicity against dog MDCK cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay
AID277586Inhibition of Plasmodium falciparum ENR using crotonyl-CoA substrate2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID596388Induction of 67 kDa laminin receptor expression in human K562 cells after 24 hrs by flow cytometry analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID541958Antiviral activity against Human herpesvirus 2 isolate P47 infected in African green monkey CV1 cells2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID690143Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1609117Antiproliferative activity against human NCI-H1299 cells expressing FASN assessed as reduction in cell viability after 72 hrs by MTS assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1858755Binding affinity to Bcl-2/Bad (unknown origin) assessed as inhibition constant by fluorescence polarisation assay2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID1490878Induction of H2O2-inactivated bovine milk lactoperoxidase pseudo-halogenating activity assessed as increase in hypothiocyanate formation by measuring ratio of Kcat to Km for substrate using thiocyanate as substrate by Lineweaver-Burk plot2017Journal of natural products, 05-26, Volume: 80, Issue:5
Tannins and Tannin-Related Derivatives Enhance the (Pseudo-)Halogenating Activity of Lactoperoxidase.
AID68460Inhibitory activity against lipid peroxidation of egg-phosphatidylcholine (PC) liposome caused by lipid-soluble radical initiator [2,2'-azobis(2,4- dimethylvaleronitrile] (AMVN)1998Bioorganic & medicinal chemistry letters, Jul-21, Volume: 8, Issue:14
Synthesis and antioxidant activity of novel amphipathic derivatives of tea polyphenol.
AID595312Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at G2/M phase at 25 uM after 24 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID1780104Zinc ionophore activity assessed as uptake of zinc ions into liposomes by measuring increase in liposome-encapsulated FluoZin3-fluorescence at 10 uM measured after 1 hr in presence of ZnCl2 and TPEN by fluorescence analysis2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID277584Inhibition of Escherichia coli ENR2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID1357408Inhibition of mPGES1 in human A549 cell microsomal membrane using pGH2 as substrate pretreated for 15 mins followed by substrate addition and measured after 1 min by RP-HPLC method2018European journal of medicinal chemistry, Jun-10, Volume: 153Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation.
AID637864Inhibition of DYRK1A in human 293T cells assessed as reduction of GLI1 transcription activity after 12 hrs by dual-luciferase reporter gene assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay.
AID355161Inhibition of Streptococcus sobrinus glucosyltransferase assessed as blockade of adherent water insoluble glucan synthesis at 100 ug/mL1996Journal of natural products, Sep, Volume: 59, Issue:9
Macrocarpals H, I, and J from the Leaves of Eucalyptus globulus.
AID1890676Oral bioavailability in Sprague-Dawley rat at 100 mg/kg2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
AID1239559Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID165921Tested for % viability of Rajii cells, in an in vitro assay for TPA-induced EBV activation at concentration of 1000 (mol ratio / 32 pmol TPA)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID1371369Cytotoxicity against human T47D cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1607750Inhibition of Tip60 (unknown origin)2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID596477Cell cycle arrest in human HL60 cells by assessed as accumulation at subG1 phase at 10 uM using propidium iodide staining by flow cytometry in presence of superoxide dismutase and catalase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1744554Octanol-water distribution coefficient, log D of the compound at pH 7.4 after 1 hr by UV-VIS spectroscopic analysis2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1780106Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as necrotic cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period in presence of ZnCl2 by AnnexinV-FITC/propidium iodide staining b2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID392677Neuroprotection against beta-amyloid peptide 1-42-induced toxicity in human SH-SY5Y cells assessed as lactate dehydrogenase release2009Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
Neuroprotective activity and evaluation of Hsp90 inhibitors in an immortalized neuronal cell line.
AID646997Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 100 uM incubated with substrate for 6 hrs prior compound addition by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID596395Induction of intracellular reactive oxygen species production in human K562 cells at 10 uM after 1 to 3 hrs by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID596384Cytotoxicity against human HL60 cells assessed as cell growth inhibition after 7 days by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID541955Antiviral activity against Human herpesvirus 2 isolate P12 infected in African green monkey CV1 cells2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1371410Cytotoxicity against human BxPC3 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1070486Binding affinity to STAT1 (unknown origin) by surface plasmon resonance assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Direct interaction of garcinol and related polyisoprenylated benzophenones of Garcinia cambogia fruits with the transcription factor STAT-1 as a likely mechanism of their inhibitory effect on cytokine signaling pathways.
AID1609174Inhibition of chicken liver FASN using acetyl-CoA, malonyl-CoA and NADPH as substrate by spectrophotometer analysis2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1578840Inhibition of MexAB/OprM in Pseudomonas aeruginosa PAO1 assessed as potentiation of tetracycline-induced antibacterial activity by measuring tetracycline MIC at 128 ug/ml incubated for 18 hrs (Rvb = 8 ug/ml)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID541913Antiviral activity against Human herpesvirus 1 isolate P32 infected in African green monkey vero cells assessed as reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID704077Inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate incubated for 15 mins prior to extension reaction followed by compound washout by spin-telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID646958Induction of H2O2 production in human HT-29 cells at 100 ug/ml after 72 hrs by ferrous oxidation xylenol orange assay in presence of catalase2012Journal of natural products, Jan-27, Volume: 75, Issue:1
Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells.
AID1187055Inhibition of Plasmodium falciparum FabG2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
2-Octadecynoic acid as a dual life stage inhibitor of Plasmodium infections and plasmodial FAS-II enzymes.
AID312043Antiproliferative activity against rat HSC-T6 cells after 48 hrs by MTT assay2007Journal of natural products, Dec, Volume: 70, Issue:12
Antifibrotic phenanthrenes of Dendrobium nobile stems.
AID647157Inhibition of BACE1 using Rh-EVNLDAEFK-Quencher as substrate2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1780099Cardioprotective activity against hypoxia/reoxygenation-induced injury in rat H9c2 cells assessed as cell viability at 10 uM treated after 8 hrs of hypoxia and before 16 hrs of reoxygenation period in presence of ZnCl2 by MTT assay2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID400265Cytotoxicity against human Raji cells assessed as cell viability at 10 molar ratio2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID596394Induction of intracellular reactive oxygen species production in human Raji cells at 10 uM after 1 to 3 hrs by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID595308Antiproliferative activity against rat HSC-T6 cells at 50 uM after 48 hrs by MTT assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID1578837Inhibition of MexAB/OprM in Pseudomonas aeruginosa PAO1 assessed as potentiation of chloramphenicol-induced antibacterial activity by measuring chloramphenicol MIC at 128 ug/ml incubated for 18 hrs (Rvb = 64 ug/ml)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID647160Antialzheimer's disease activity in mouse cortex assessed as inhibition of beta-secretase mediated amyloid beta1-42 production at 1.5 mg/kg2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1851170Inhibition of DYRK1A (unknown origin)2022Bioorganic & medicinal chemistry, 09-15, Volume: 70A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.
AID461137Inhibition of chymotrypsin like activity of rabbit 20S proteasome assessed as cleavage of Suc-LLVY-AMC substrate after 2 hrs by fluorogenic assay2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs.
AID453984Inhibition of human neutrophil elastase at 100 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa.
AID1371465Induction of DOPC/n-decane bilayer property changes assessed as concentration required to double gramicidin-induced quencher influx rate by single-channel electrophysiology method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID596489Induction of apoptosis in human Raji cells assessed as early apoptotic cells at 10 uM after 24 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 3.7 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1858786Inhibition of Mcl-1/Bid (unknown origin)2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID474218Inhibition of FCepsilonRI alpha subunit mRNA expression in human HMC1 cells at 50 uM after 36 hrs by RT-PCR analysis2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
New inhibitors for expression of IgE receptor on human mast cell.
AID1440623Antiviral activity against influenza A virus (A/Chile/1/83) infected in MDCK cells after 2 to 3 days by crystal violet staining based plaque reduction assay2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
AID1264958Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1228059Induction of intracellular ROS generation in Leishmania amazonensis MHOM/BR/75/LTB0016 promastigotes at 500 uM incubated for 72 hrs by H2DCFDA dye based assay2015Journal of natural products, Apr-24, Volume: 78, Issue:4
Effect of Apigenin on Leishmania amazonensis Is Associated with Reactive Oxygen Species Production Followed by Mitochondrial Dysfunction.
AID646974Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID595307Antiproliferative activity against rat HSC-T6 cells at 10 uM after 48 hrs by MTT assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID319371Inhibition of IDH2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID1239555Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1813148Reversal of Pgp-mediated paclitaxel resistance in human LCC6MDR cells assessed as relative fold by measuring paclitaxel IC50 at 10 uM after 5 days by Cell Titer-Glo luminescence assay relative to control2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers.
AID542197Antiviral activity against Human herpesvirus 1 isolate P56 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1169597Antiproliferative activity against rat HSC-T6 cells assessed as reduction in cell viability2014Journal of natural products, Nov-26, Volume: 77, Issue:11
Antiproliferative prenylated xanthones and benzophenones from the roots of Cudrania tricuspidata in HSC-T6 cells.
AID1744551Inhibition of cytochrome c (unknown origin) assessed as half-time reaction2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID319369Inhibition of yeast G6PD2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID1239531Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1066549Antiproliferative activity against anti-67LR treated human A431 cells overexpressing ErbB assessed as cell viability at 100 to 200 uM after 24 hrs by WST-1 staining-based spectrophotometric analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1858782Inhibition of Bcl-2/Bid (unknown origin)2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID1390550Inhibition of enolase (unknown origin) at 0.625 uM using 2-PG relative to control2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
AID649121Neuroprotective activity against Abeta25-35-induced human PC12 cells assessed as cell viability at 10 uM preincubated for 2 hrs prior Abeta25-35 challenge measured after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and biological evaluation of 21-arylidenepregnenolone derivatives as neuroprotective agents.
AID704066Selectivity ratio of IC50 for telomerase in human HeLa cells to IC50 for tetrahymena telomerase by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID91437Inhibition against HIV-1 integrase at 25 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID647154Cytotoxicity against CHO cells transfected with human BACE1 and human APP with Swedish mutation at 1 nM to 10 uM by MTT assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID456317Antioxidant activity assessed as trolox equivalent by TEAC assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID541910Antiviral activity against Human herpesvirus 1 isolate P56 infected in African green monkey vero cells assessed as log reduction in viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID165919Tested for % viability of Rajii cells, in an in vitro assay for TPA-induced EBV activation at concentration of 10 (mol ratio / 32 pmol TPA)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID1395903Inhibition of DPP4 (unknown origin) using Gly-Pro-AMC as substrate preincubated for 4 secs followed by substrate addition and measured after 30 mins by luminescence assay2018European journal of medicinal chemistry, May-10, Volume: 151Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
AID1683895Inhibition of human alpha-synuclein aggregation expressed in Escherichia coli BL21 (DE3) cells at 400 uM at 5:1 molar ratio after 72 hrs by ThT fluorescence assay relative to control2020Journal of natural products, 12-24, Volume: 83, Issue:12
Anti-prion and α-Synuclein Aggregation Inhibitory Sterols from the Sponge
AID310893Displacement of picogreen from Escherichia coli DNA gyrase B2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
AID1239564Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1881926Inhibition of recombinant PKM2 (unknown origin) Asp178, Asp177, Ser362, Lys367, Hie78, Ser205, Gly128, Thr129, Tyr83, Asn75, Ile51 residues at 40 uM relative to control2022Journal of medicinal chemistry, 01-27, Volume: 65, Issue:2
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
AID1594141Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID403353Inhibition of COX1 at 30 ug/mL2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID1315355Neuroprotection against amyloid beta (25 to 35)-induced cell toxicity in human SH-SY5Y cells assessed as cell viability at 10 uM incubated for 2 hrs followed by amyloid beta (25 to 35) treatment for 24 hrs by MTT assay (Rvb = 62.4 +/- 3.5%)2016Journal of natural products, 05-27, Volume: 79, Issue:5
Biginkgosides A-I, Unexpected Minor Dimeric Flavonol Diglycosidic Truxinate and Truxillate Esters from Ginkgo biloba Leaves and Their Antineuroinflammatory and Neuroprotective Activities.
AID363881Antiproliferative activity against human HL60 cells after 3 days2008Bioorganic & medicinal chemistry, Sep-01, Volume: 16, Issue:17
Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate.
AID1176108Neuroprotective activity against amyloid beta(25 to 35)-induced cell damage in human SH-SY5Y cells assessed as increase in cell viability preincubated at 10 uM 2 hrs prior to challenge by MTT assay relative to control2015Bioorganic & medicinal chemistry, Jan-01, Volume: 23, Issue:1
Bioactive constituents from the green alga Caulerpa racemosa.
AID1441294Inhibition of CaCl2 activated hyaluronidase (unknown origin) up to 3000 uM using hyaluronic acid as substrate preincubated for 20 mins followed by substrate addition measured after 10 mins in presence of up to 21% DMSO by colorimetric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID1689110Selectivity index, ratio of CC50 for dog MDCK cells to EC50 for Influenza A virus (A/WSN/1933(H1N1)) infected in dog MDCK cells
AID542210Antiviral activity against Human herpesvirus 1 isolate P42 infected in African green monkey vero cells assessed as reduction in viral titer2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID461141Inhibition of chymotrypsin like activity of 20S proteasome in human MDA-MB-231 cells lysates with high catechol-O-methyltransferase activity assessed as cleavage of Suc-LLVY-AMC substrate at 10 uM after 2 hrs by fluorogenic assay2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs.
AID1490876Induction of H2O2-inactivated bovine milk lactoperoxidase pseudo-halogenating activity assessed as increase in hypothiocyanate formation by measuring substrate Km using thiocyanate as substrate by Lineweaver-Burk plot2017Journal of natural products, 05-26, Volume: 80, Issue:5
Tannins and Tannin-Related Derivatives Enhance the (Pseudo-)Halogenating Activity of Lactoperoxidase.
AID1239584Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 0.56 mM after 24 hrs by time kill assay in presence of 0.85 mM of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID542198Antiviral activity against Human herpesvirus 2 strain 333 infected in African green monkey CV-1 cells assessed as log reduction in viral titer at 100 uM after 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID453985Inhibition of human neutrophil elastase2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa.
AID596393Induction of intracellular reactive oxygen species production in human HL60 cells at 10 uM after 1 to 3 hrs by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID456192Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 40) fibril formation2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1780105Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as late apoptotic cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period in presence of ZnCl2 by AnnexinV-FITC/propidium iodide stai2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID736867Induction of apoptosis in CHO cells expressing OATP1B3 haplotype 1 at 1 uM after 48 hrs using propidium iodide and FITC Annexin V staining by flow cytometry2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID647152Inhibition of recombinant human BACE1 expressed in CHO cells co-transfected with human APP with Swedish mutation assessed as amyloid beta1-40 secretion at 0.1 uM by alphaLISA technique2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID541949Antiviral activity against Human herpesvirus 2 isolate P22 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 12.5 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID736869Plasma concentration in human at 1600 mg2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID1390564Inhibition of recombinant human His-tagged PGAM1 expressed in Escherichia coli BL21 competent cells by kinase-glo assay2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
AID482770Inhibition of osteoclastogenesis in RANKL-stimulated mouse osteoclast at 20 uM2010Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11
Emerging targets in osteoporosis disease modification.
AID1609171Selectivity index, ratio of IC50 for human SAE cells lacking FASN expression to IC50 for human A549 cells expressing FASN2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID333764Chemical stability in DMEM/F12 medium in presence of fetal calf serum2004Journal of natural products, Dec, Volume: 67, Issue:12
Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts.
AID1594139Inhibition of human N-terminal octa-His-tagged HSP60 expressed in Escherichia coli Rosetta(DE3) pLysS/human HSP10 expressed in Escherichia coli Rosetta(DE3) assessed as reduction in HSP60/HSP10-mediated denatured MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID358554Antioxidant activity assessed as DPPH radical scavenging activity2001Journal of natural products, Jan, Volume: 64, Issue:1
Antioxidant benzoylated flavan-3-ol glycoside from Celastrus orbiculatus.
AID1239571Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 after 24 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID690144Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID541966Antiviral activity against Human herpesvirus 2 isolate P2 infected in African green monkey CV1 cells assessed as log reduction viral titer at 12.5 ug/ml2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1172986Antiproliferative activity against human MDA-MB-231 cells after 4 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Inhibitory effects of ginseng sapogenins on the proliferation of triple negative breast cancer MDA-MB-231 cells.
AID646975Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 10 uM incubated with substrate for 6 hrs prior compound addition by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID774352Toxicity in stationary-phase promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected BALB/c mouse assessed as serum alanine aminotransferase level at 30 mg/kg, po administered 5 times per week2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID310895Antibacterial activity against Escherichia coli2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
AID682910Cytotoxicity against human SKBR3 cells after 48 hrs by MTT assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
New synthetic inhibitors of fatty acid synthase with anticancer activity.
AID1243511Neuroprotective activity in human SH-SY5Y cells assessed as production against amyloid beta (25 to 35)-induced cell death by measuring cell viability at 1 uM after 24 hrs by MTT assay2015Journal of natural products, Sep-25, Volume: 78, Issue:9
Natural β-Dihydroagarofuran-Type Sesquiterpenoids as Cognition-Enhancing and Neuroprotective Agents from Medicinal Plants of the Genus Celastrus.
AID596588Growth inhibition against human HL60 cells assessed as cell viability at 10 uM after 48 hrs by trypan blue based microscopic analysis in presence of superoxide dismutase and catalase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1224168Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested at 1:1 compound to peptide ratio after 17 hrs by thioflavin T fluorescence method2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.
AID1239582Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 assessed as log reduction of colony forming unit at 0.28 mM after 24 hrs2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1265118Inhibition of recombinant human N-terminal His6-tagged AKR1B10 expressed in Escherichia coli BL21 cells using all-trans-retinal as substrate at 20 uM incubated for 15 mins by HPLC method2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
AID468519Antifungal activity against Candida albicans ATCC 10231 after 24 to 72 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID1691283Antiangiogenic activity against VEGF-stimulated HUVEC assessed as reduction in cell viability up to 100 uM measured after 48 hrs by MTT assay2020European journal of medicinal chemistry, May-01, Volume: 193Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy.
AID1594134Inhibition of native soluble pig heart MDH assessed as reduction in MDH enzyme activity using sodium mesoxalate as substrate and NADH by malachite green dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID690148Reducing activity assessed as chlorogenic acid equivalent per mmol standard at 37 degC for 30 mins by Folin-Ciocalteu reagent assay assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1199269Inhibition of His6-tagged human recombinant DNMT1 expressed in insect Sf9 cells assessed as reduction in DNA methyltransferase activity using 5'-biotinylated 45-bp unmethylated or hemimethylated oligonucleotide substrates and [3H]-AdoMet by liquid scintil2015Journal of medicinal chemistry, Mar-26, Volume: 58, Issue:6
Targeting DNA methylation with small molecules: what's next?
AID1780110Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as late necrotic cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period by AnnexinV-FITC/propidium iodide staining based flow cytome2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID1239560Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239537Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID650644Inhibition of Saccharomyces cerevisiae alcohol dehydrogenase measured every 5 mins for 2 hrs by spectrophotometry2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Tea catechins and flavonoids from the leaves of Camellia sinensis inhibit yeast alcohol dehydrogenase.
AID1239557Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID542211Antiviral activity against Human herpesvirus 1 isolate P56 infected in African green monkey vero cells assessed as reduction in viral titer2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID541963Antiviral activity against Human herpesvirus 2 isolate P27 infected in African green monkey CV1 cells assessed as log reduction viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID400259Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 500 molar ratio after 48 hrs relative to TPA2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID1239578Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 at 0.28 mM after 24 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1759522Cytoprotective activity against pig LLC-PK1 cells assessed as reduction in FK506-induced cytotoxicity incubated for 2 hrs followed by FK506 stimulation and measured after 24 hrs by MTT assay2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Identification of gallic acid as a active ingredient of Syzygium aromaticum against tacrolimus-induced damage in renal epithelial LLC-PK1 cells and rat kidney.
AID290594Antiviral activity against Influenza A virus (A/Memphis/1/71(H3N2)) in MDCK cells after 16 hrs by focus forming assay2007Bioorganic & medicinal chemistry letters, Jun-01, Volume: 17, Issue:11
Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity.
AID1371454Plasma concentration in mouse at 100 mg/kg, po at 60 mins by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1890677Bioavailability in CF-1 mouse at 163.8 micromol/kg, IG measured upto 720 mins2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
AID1616229Antileishmanial activity against stationary phase of Leishmania infantum MHOM/MA/67/ITMAP263 promastigotes infected in BALB/c mouse assessed as decrease in parasitic load in liver at 50 mg/kg/day administered orally via gavage as bid for 5 days on 7th day
AID1609119Antiproliferative activity against human NCI-H1650 cells expressing FASN assessed as reduction in cell viability after 72 hrs by MTS assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1264955Cytotoxicity against human MSC assessed as cell viability at 10 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID596473Growth inhibition against human Raji cells assessed as cell viability at 10 uM after 48 hrs by trypan blue based microscopic analysis in presence of superoxide dismutase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID541948Antiviral activity against Human herpesvirus 2 isolate P12 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 12.5 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1239522Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID541965Antiviral activity against Human herpesvirus 2 strain 333 infected in African green monkey CV1 cells assessed as log reduction viral titer at 12.5 ug/ml2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID437513Plasma concentration in po dosed mouse2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
AID1066553Induction of apoptosis in human SKBR3 cells overexpressing ErbB in complete medium assessed as late apoptotic/necrotic cells at 75 uM after 72 hrs by annexin V-FITC/7-AAD staining-based flow cytometric analysis relative to control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1609121Antiproliferative activity against human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as reduction in cell viability after 72 hrs by MTS assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1239541Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239567Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 at 0.28 mM after 4 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239530Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1609170Antiproliferative activity against human A549 cells expressing FASN assessed as reduction in cell viability after 72 hrs by MTS assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1527602Antiinflammatory activity in Sprague-Dawley rat model of acetic acid-induced colitis assessed as reduction in IFNgamma level in serum at 50 mg/kg, po administered for 7 consecutive days and measured on day 8 by ELISA method2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID542179Antiviral activity against Human herpesvirus 2 isolate P11 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1313196Neuroprotective activity against amyloid beta(25 to 35)-induced neurotoxicity in human SH-SY5Y cells assessed as cell viability at 10 uM (Rvb = 62.1 +/- 2.2%)2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Design, synthesis and biological evaluation of novel chiral oxazino-indoles as potential and selective neuroprotective agents against Aβ25-35-induced neuronal damage.
AID1510602Inhibition of Enterobacter cloacae beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID310889Displacement of fluorescent quercetin from Escherichia coli BL21 (DE3) recombinant DNA gyrase B G242007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
AID1239544Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID542177Antiviral activity against Human herpesvirus 2 isolate P47 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID596586Growth inhibition against human HL60 cells assessed as cell viability at 10 uM preincubated with N-acetyl-L-cysteine for 30 mins measured after 48 hrs by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID650647Activation of aldehyde dehydrogenase2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Tea catechins and flavonoids from the leaves of Camellia sinensis inhibit yeast alcohol dehydrogenase.
AID265758Inhibition of FabZ2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID456316ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID647002Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as time dependent reduction in relative fluorescence at 1 uM to 100 uM preincubated for 30 mins prior substrate addition by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1616223Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP263 promastigotes infected in BALB/c mouse peritoneal macrophages assessed as decrease in parasitic infection index incubated for 72 hrs by light microscopy
AID204664Compound was evaluated for its inhibitory activity against recombinant rat SE(squalene epoxidase)2000Bioorganic & medicinal chemistry letters, Nov-20, Volume: 10, Issue:22
Inhibition of vertebrate squalene epoxidase by isoprenyl gallates and phenylalkyl gallates.
AID1609130Inhibition of full length human FASN transfected in HeLa cell lysates at 10 uM using acetyl Co-A/malonyl Co-A as substrate preincubated with enzyme for 2 hrs followed by substrate addition measured after 10 mins in presence of NADPH by microplate reader a2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID774354Toxicity in stationary-phase promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected BALB/c mouse assessed as serum creatinine level at 30 mg/kg, po administered 5 times per week2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID1066544Downregulation of ErbB2 protein expression in human SKBR3 cells in serum free medium at 50 uM after 24 hrs by immunofluorescence staining-based flow cytometric analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID343514Antiviral activity against Influenza A/PR8/34(H1N1)) in dog MDCK cells2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
AID1066541Downregulation of ErbB1 protein expression in human A431 cells at 50 uM after 24 hrs by immunofluorescence staining-based flow cytometric analysis in presence of serum2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1239550Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID751287Inhibition of Plasmodium falciparum FabZ using crotonoyl-CoA as substrate preincubated for 10 mins prior to substrate addition2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.
AID649122Neuroprotective activity against Abeta25-35-induced human PC12 cells assessed as cell viability at 1 uM preincubated for 2 hrs prior Abeta25-35 challenge measured after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Synthesis and biological evaluation of 21-arylidenepregnenolone derivatives as neuroprotective agents.
AID1609161Inhibition of FASN in human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as disruption of AKT/FASN positive feedback loop by measuring FASN expression at 100 uM after 48 hrs in presence of exogenous lipid concentrate by Wester2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID542200Cytotoxicity against African green monkey CV1 cells assessed as viability at 100 uM after 24 hrs2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID704061Competitive inhibition of telomerase in human HeLa cells using dNTP as substrate assessed as ratio of IC50 at saturated substrate concentration to IC50 at Km by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID482769Inhibition of osteoclastogenesis in RANKL-stimulated mouse osteoclast at 10 uM2010Journal of medicinal chemistry, Jun-10, Volume: 53, Issue:11
Emerging targets in osteoporosis disease modification.
AID542196Antiviral activity against Human herpesvirus 1 isolate P32 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID647163Antialzheimer's disease activity in mouse hippocampus assessed as inhibition of beta-secretase mediated amyloid beta1-42 production at 3 mg/kg2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1607715Inhibition of P300 (unknown origin)2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID1239526Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1440626Cytotoxicity against MDCK cells after 48 hrs by MTT assay2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
AID1371412Cytotoxicity against human MML1 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID527267Inhibition of Plasmodium falciparum FabZ by spectrophotometric analysis2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
AID1689111Inhibition of recombinant Influenza A virus (A/USA:Huston/AA/1945 H1N1)) N-terminal His6-tagged PA endonuclease using 6FAM-TGGCAATATCAGCTCCACA-MGBN DNA probe as substrate by TR-FRET assay
AID1708710Inhibition of recombinant His-tagged PGAM1 (unknown origin) expressed in Escherichia coli BL21 using 3-PG as substrate in presence of ADP by Kinase-Glo max luminescent assay2021Bioorganic & medicinal chemistry letters, 03-15, Volume: 36Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
AID596488Induction of apoptosis in human Raji cells assessed as necrotic cells at 10 uM after 24 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 3.4 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID748707Inhibition of tau K19 aggregation (unknown origin)2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
AID1371378Cytotoxicity against human U87 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1224173Inhibition of amyloid beta1-40 (unknown origin) aggregation2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.
AID468507Chemical stability in PBS buffer at pH 7.4 assessed as compound remaining after 16 hrs by HPLC2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID1371375Cytotoxicity against human PANC1 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID542213Antiviral activity against Human herpesvirus 1 F1 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1570154Induction of nitric oxide production in human U266 cells2019European journal of medicinal chemistry, Oct-15, Volume: 180Targeting multiple myeloma with natural polyphenols.
AID1744548Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL peroxidase activity at 10 uM up to 20 mins in presence of cardiolipin by Amplex red staining based fluorescence assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID704071Inhibition of telomerase in human U937 cells2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID1527601Antioxidant activity in Sprague-Dawley rat model of acetic acid-induced colitis assessed as reduction in NO level in tissue at 50 mg/kg, po administered for 7 consecutive days and measured on day 82020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID1578839Inhibition of MexAB/OprM in Pseudomonas aeruginosa PAO1 assessed as potentiation of novobiocin-induced antibacterial activity by measuring novobiocin MIC at 128 ug/ml incubated for 18 hrs (Rvb = 512 ug/ml)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID738071Inhibition of differentiation of mouse 3T3L1 cells assessed as lipid accumulation at 50 uM after 8 days by using Oil Red O staining by spectrophotometry relative to control2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-adipogenic diarylheptanoids from Alnus hirsuta f. sibirica on 3T3-L1 cells.
AID596485Induction of apoptosis in human Raji cells assessed as early apoptotic cells at 10 uM after 12 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 3.7 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID541970Antiviral activity against Human herpesvirus 1 isolate P38 infected in African green monkey vero cells assessed as log reduction in viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1239536Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 7 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID774356Antileishmanial activity against stationary-phase promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in BALB/c mouse assessed as reduction of lesion size at 30 mg/kg, po administered 5 times per week2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID736871Binding affinity to human serum albumin at 10 uM2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID1594143Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reducti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID91436Inhibition against HIV-1 integrase at 200 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID1420023Inhibition of PRAK (unknown origin)2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
AID1264949Cytotoxicity against human MSC assessed as decrease in cell number at 1 to 10 uM after 9 days by methylene blue staining based microscopy relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1520362Inhibition of (1S,3R)-RSL3-induced ferroptosis in HEK293 cells preincubated for 4 hrs followed by erastin stimulation and measured at next day by MTS assay
AID1858784Inhibition of Bcl-B/Bid (unknown origin)2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID704067Inhibition of tetrahymena telomerase using 3'-ACT TCG TAG AGC AGA TTG-5' as substrate at 1 uM incubated for 10 mins prior to extension reaction by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID1371372Cytotoxicity against human A549 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID265759Inhibition of FabI2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID474217Inhibition of FCepsilonRI gamma subunit mRNA expression in human HMC1 cells at 50 uM after 36 hrs by RT-PCR analysis2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
New inhibitors for expression of IgE receptor on human mast cell.
AID1516909Antifungal activity against FLC-resistant Candida tropicalis2019Bioorganic & medicinal chemistry letters, 10-01, Volume: 29, Issue:19
Recent advances in natural antifungal flavonoids and their derivatives.
AID1890681Anti-inflammatory activity in MOG (35 to 55 residues)-induced experimental autoimmune encephalomyelitis mouse model assessed as reversal of clinical scores at 15 mg/kg, po administered twice daily for 25 days2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
AID595315Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at S phase at 25 uM after 48 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID748706Inhibition of full length human tau40 aggregation2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
AID658425Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells.
AID403810Octanol-water partition coefficient, log POW of the compound2005Journal of natural products, Sep, Volume: 68, Issue:9
Efficiency of foam fractionation for the enrichment of nonpolar compounds from aqueous extracts of plant materials.
AID1444843Antiviral activity against HBV infected in human HuS-E/2 cells assessed as inhibition of viral mRNA level at 50 uM treated for 20 hrs measured after 7 days by RT-PCR method relative to control2017Journal of medicinal chemistry, 08-10, Volume: 60, Issue:15
Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
AID300031Inhibition of chymotrypsin like activity of 20S proteasome in leukemia Raji B cells at 25 uM after 4 hrs2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer.
AID453982Inhibition of human neutrophil elastase at 10 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa.
AID1066538Induction of ErbB2 internalization in lysosome/endosome of human SKBR3 cells in serum free medium at 200 uM after 30 mins by immunofluorescence staining-based confocal microscopic analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID658422Induction of AMPKalpha phosphorylation at T172 residue in human MDA-MB-231 cells at 20 uM after 3 hrs by Western blotting analysis relative to control2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells.
AID1066556Antiproliferative activity against human SKBR3 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID542183Antiviral activity against Human herpesvirus 2 isolate P47 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID453981Inhibition of human neutrophil elastase at 3 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa.
AID596391Induction of myeloperoxidase expression in human Raji cells after 24 hrs by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID596478Cell cycle arrest in human Raji cells by assessed as accumulation at subG1 phase at 10 uM using propidium iodide staining by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID468509Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID165920Tested for % viability of Rajii cells, in an in vitro assay for TPA-induced EBV activation at concentration of 100 (mol ratio / 32 pmol TPA)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID541967Antiviral activity against Human herpesvirus 1 isolate P15 infected in African green monkey vero cells assessed as log reduction in viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID690149Reducing activity by cyclic voltammetry2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID277587Inhibition of Plasmodium falciparum ENR in presence of triclosan2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID1239538Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239546Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1541375Neuroprotective activity against amyloid beta (25 to 35)-induced cytotoxicity in human SH-SY5Y cells at 10 uM preincubated for 2 hrs followed by amyloid beta (25 to 35)-stimulation and measured after 24 hrs by MTT assay (Rvb = 71.18 +/- 1.34)2019Journal of natural products, 11-22, Volume: 82, Issue:11
Neuroprotective Dihydro-β-agarofuran-Type Sesquiterpenes from the Seeds of
AID542192Antiviral activity against Human herpesvirus 1 isolate P42 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1371373Cytotoxicity against human NCI-H460 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1239521Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1872389Binding affinity to EED (unknown origin) assessed as dissociation constant SPR assay2022European journal of medicinal chemistry, Mar-05, Volume: 231Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.
AID1813130Reversal of Pgp-mediated paclitaxel resistance in human LCC6MDR cells assessed as paclitaxel IC50 at 1 uM after 5 days by Cell Titer-Glo luminescence assay (Rvb = 152.5 +/- 9.7 uM)2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers.
AID697061Inhibition of chicken liver FASN ketoreductase activity2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID1504260Antioxidant activity assessed as AAPH radical scavenging activity at 12.5 uM by ORAC-FL assay2017Journal of natural products, 11-22, Volume: 80, Issue:11
Bioactive Asarone-Derived Phenylpropanoids from the Rhizome of Acorus tatarinowii Schott.
AID1239587Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 0.28 mM after 24 hrs by time kill assay in presence of 0.2 mM of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID277585Inhibition of Plasmodium falciparum ENR using NADH substrate2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID1605036Inhibition of rabbit skeletal muscle microsomes SERCA1a2020Journal of medicinal chemistry, 03-12, Volume: 63, Issue:5
Sarco/Endoplasmic Reticulum Calcium ATPase Inhibitors: Beyond Anticancer Perspective.
AID1188662Antiproliferative activity against human MCF7 cells2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Progress in the discovery and development of heat shock protein 90 (Hsp90) inhibitors.
AID542204Binding affinity to Envelope glycoprotein B in Human herpesvirus 1 F1 assessed as macromolecular complex formation by SDS-PAGE2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID595316Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at G2/M phase at 25 uM after 48 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID1239583Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 assessed as log reduction of colony forming unit at 0.28 mM after 24 hrs2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1858758Inhibition of Bcl-xL/Bid complex (unknown origin)2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID1780108Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as early apoptotic cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period by AnnexinV-FITC/propidium iodide staining based flow cyto2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID1865603Binding affinity to human NADK (155 to 164 residues) assessed as decrease in deuterium incorporation at 80 uM measured after 30 mins by HDX-MS analysis2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID771680Inhibition of recombinant Plasmodium falciparum FabZ using crotonoyl-CoA as substrate after 10 mins2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
AID1237106Inhibition of rat Dyrk1A using Woodtide as substrate after 40 mins by P81 membrane assay in presence of [33P]-g-ATP2015Bioorganic & medicinal chemistry letters, Aug-01, Volume: 25, Issue:15
Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents.
AID1609166Inhibition of FASN in human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as disruption of AKT/FASN positive feedback loop by measuring ratio of phosphoAKT/AKT expression at 100 uM after 48 hrs in presence of exogenous lipid co2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID548975Inhibition of rat liver microsomal Steroid 5-alpha-reductase after 30 mins by scintillation counting2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and structure-activity relationship of 3-O-acylated (-)-epigallocatechins as 5α-reductase inhibitors.
AID1460721Inhibition of cell proliferation of activated rat HSC-T6 cells incubated for 24 hrs by MTT assay2017Journal of natural products, 04-28, Volume: 80, Issue:4
Catechin-Bound Ceanothane-Type Triterpenoid Derivatives from the Roots of Zizyphus jujuba.
AID1636648Neuroprotective activity against amyloid beta (25 to 35 residues)-induced cell damage in human SH-SY5Y cells assessed as recovery of cell viability at 1 uM preincubated for 2 hrs followed by amyloid beta (25 to 35 residues) addition measured after 24 hrs 2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
AID83434Inhibitory concentration against polymerization in A17 double mutant HIV-1 RT using a template primer of poly rC/dG12-18 and [3H]dGTP; ND is not determined2001Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
Simplified catechin-gallate inhibitors of HIV-1 reverse transcriptase.
AID1594138Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction i2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID300032Inhibition of chymotrypsin like activity of 20S proteasome in leukemia Raji B cells at 25 uM after 24 hrs2007Bioorganic & medicinal chemistry, Aug-01, Volume: 15, Issue:15
A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer.
AID1371455Plasma concentration in mouse at 10 mg/kg, iv at 60 mins by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1609128Induction of apoptosis in human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant at 100 uM after 72 hrs by Annexin-V FITC/PI staining-based flow cytometry2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1152217Binding affinity to rat brain cell membrane2014Bioorganic & medicinal chemistry letters, Jun-15, Volume: 24, Issue:12
Cell membrane mediated (-)-epicatechin effects on upstream endothelial cell signaling: evidence for a surface receptor.
AID1228904Cytotoxicity against mouse L929 cells after 3 days by MTS assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
AID647153Inhibition of recombinant human BACE1 expressed in CHO cells co-transfected with human APP with Swedish mutation assessed as amyloid beta1-40 secretion at 1 uM by alphaLISA technique2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1780102Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as early apoptotic cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period in presence of ZnCl2 by AnnexinV-FITC/propidium iodide sta2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID596482Induction of apoptosis in human Raji cells assessed as necrotic cells at 10 uM after 6 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 3.4 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID566611Inhibition of p38alpha after 1 hr by ELISA2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Catechin derivatives from Parapiptadenia rigida with in vitro wound-healing properties.
AID1578841Inhibition of MexAB/OprM in Pseudomonas aeruginosa PAO1 assessed as potentiation of trimethoprim-induced antibacterial activity by measuring trimethoprim MIC at 128 ug/ml incubated for 18 hrs (Rvb = 128 ug/ml)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID542172Antiviral activity against Human herpesvirus 2 isolate P2 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1224169Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as reduction in amyloid fibril formation at 40 uM after 5 days by Transmission electron microscopy2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.
AID333762Inhibition of hypoxia-induced HIF1 activation in human T47D cells expressing pTK-HRE-luc gene at 100 uM by luciferase reporter assay2004Journal of natural products, Dec, Volume: 67, Issue:12
Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts.
AID542182Antiviral activity against Human herpesvirus 2 isolate P27 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1896157Antiviral activity against HBV infected human DMSO differentiated HuS-E/2 cells assessed as reduction of HBV core protein level incubated for 20 hrs by Western blot analysis2022Journal of medicinal chemistry, 10-13, Volume: 65, Issue:19
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
AID596492Induction of apoptosis in human HL60 cells assessed as intracellular caspase-3 activation after 24 hrs (Rvb = 1.3 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID461142Inhibition of chymotrypsin like activity of 20S proteasome in COMT inhibitor 3,5-dinitrocatechol pretreated human MDA-MB-231 cells lysates with high catechol-O-methyltransferase activity assessed as cleavage of Suc-LLVY-AMC substrate at 10 uM after 2 hrs 2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs.
AID542194Antiviral activity against Human herpesvirus 1 isolate P32 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1609169Selectivity index, ratio of IC50 for human SAE cells lacking FASN expression to IC50 for human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1371411Cytotoxicity against human PANC1 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1616225Selectivity index, ratio of CC50 for mouse peritoneal macrophages to EC50 for Leishmania infantum MHOM/MA/67/ITMAP263 promastigotes infected in BALB/c mouse peritoneal macrophages
AID356133Cytotoxicity against human HCT116 cells after 72 hrs by MTT assay2003Journal of natural products, Jul, Volume: 66, Issue:7
Bioactive novel polyphenols from the fruit of Manilkara zapota (Sapodilla).
AID595313Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at sub-G1 phase at 25 uM after 48 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID492404Binding affinity to human serum albumin in 100 mM phosphate buffer at pH 7.4 assessed as formation of biotin-LC-hydrazide labeled protein carbonyls at 100 uM pretreated 60 mins before biotin-LC-hydrazide challenge measured after 60 mins by SDS-PAGE/Wester2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Structural characteristics of green tea catechins for formation of protein carbonyl in human serum albumin.
AID1271456Antiproliferative activity against human T98G cells after 24 hrs by EZ-Tox assay2016Bioorganic & medicinal chemistry letters, Feb-01, Volume: 26, Issue:3
Gambogic acid induces apoptotic cell death in T98G glioma cells.
AID596491Induction of apoptosis in human Raji cells assessed as necrotic cells at 10 uM by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID468510Antibacterial activity against Micrococcus luteus ATCC 10240 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID400261Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 10 molar ratio after 48 hrs relative to TPA2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID1780109Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as late apoptotic cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period by AnnexinV-FITC/propidium iodide staining based flow cytom2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID1239545Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1858756Binding affinity to Bcl-xL/Bad (unknown origin) assessed as inhibition constant by fluorescence polarisation assay2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID637861Inhibition of GST-tagged human DYRK1A using dephosphorylated MBP as substrate at 10 uM after 10 mins by Kinase-Glo plus luminescent kinase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay.
AID1264959Decrease in ALP activity in human MSC using p-NPP as substrate at 5 uM after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID437509Inhibition of hepatocyte growth factor-induced MET phosphorylation in human HCT116 cells at 5 uM after 30 mins by immunoblot2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
AID548977Anticancer activity against human PC3 cells xenografted in sc dosed SCID mouse assessed as inhibition of tumor growth at 20 mg/kg, ip qd for 14 days2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and structure-activity relationship of 3-O-acylated (-)-epigallocatechins as 5α-reductase inhibitors.
AID598324Cytotoxicity against mouse RAW264.7 cells assessed as cell survival rate at 10 uM by MTT assay2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Discovery of indeno[1,2-c]quinoline derivatives as inhibitors of osteoclastogenesis induced by receptor activator of NF-κB ligand (RANKL).
AID365747Antioxidant activity assessed as DPPH radical scavenging activity2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effects of polymethoxy flavones isolated from Citrus reticulate on degranulation in rat basophilic leukemia RBL-2H3: enhanced inhibition by their combination.
AID1490877Induction of H2O2-inactivated bovine milk lactoperoxidase pseudo-halogenating activity assessed as increase in hypothiocyanate formation by measuring substrate Kcat using thiocyanate as substrate by Lineweaver-Burk plot2017Journal of natural products, 05-26, Volume: 80, Issue:5
Tannins and Tannin-Related Derivatives Enhance the (Pseudo-)Halogenating Activity of Lactoperoxidase.
AID468516Antibacterial activity against Klebsiella pneumoniae ATCC 10031 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID1440625Antiviral activity against influenza B virus (B/Yamagata/16/88) infected in MDCK cells after 2 to 3 days by crystal violet staining based plaque reduction assay2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
AID333761Induction of HIF1 activation in human T47D cells expressing pTK-HRE-luc gene under normoxic condition at 100 uM after 16 hrs by luciferase reporter assay relative to control2004Journal of natural products, Dec, Volume: 67, Issue:12
Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts.
AID468518Antifungal activity against Candida lusitaniae ATCC 42720 after 24 to 72 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID1228906Modulation of P-gp (unknown origin) transfected in human MDA435/LCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 1 uM after 5 days by CellTiter 96 Aqueous assay relative to PTX alone treated cell2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
AID595310Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at G0/G1 phase at 25 uM after 24 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID542188Antiviral activity against Human herpesvirus 1 isolate P15 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1744547Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL complex formation at 10 uM incubated for 15 mins in presence of cardiolipin by Trp-59 fluorescence assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1239547Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1390552Inhibition of pyruvate kinase (unknown origin) at 0.625 uM using 2-PG relative to control2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
AID1239573Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 after 24 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1248031Inhibition of PPARgamma/C/EBPalpha/SREBP1c in mouse 3T3L1 preadipocytes assessed as inhibition of adipocyte differentiation by measuring remaining lipid content at 100 uM measured on day 8 by Oil Red O staining-based spectrophotometric analysis relative t2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Anti-adipogenic activity of a new cyclic diarylheptanoid isolated from Alnus japonica on 3T3-L1 cells via modulation of PPARγ, C/EBPα and SREBP1c signaling.
AID456187Inhibition of reduced carboxymethylated kappa-casein fibril formation measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID461136Inhibition of chymotrypsin like activity of proteasome2010Bioorganic & medicinal chemistry, Feb, Volume: 18, Issue:3
Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs.
AID751803Inhibition of human neutrophil elastase assessed as N-methoxysuccinyl-Ala-Ala-Pro-Val p-nitroanilide conversion to p-nitroaniline at 100 ug/ml after 1 hr by spectrophotometric analysis relative to control2013Bioorganic & medicinal chemistry, Apr-01, Volume: 21, Issue:7
(+)-Usnic acid enamines with remarkable cicatrizing properties.
AID1616226Antileishmanial activity against stationary phase of Leishmania infantum MHOM/MA/67/ITMAP263 promastigotes infected in orally dosed BALB/c mouse assessed as decrease in parasitic load in liver administered via gavage bid for 5 days on 7th day post infecti
AID357310Inhibition of rat squalene epoxidase2001Journal of natural products, Aug, Volume: 64, Issue:8
Ellagitannins and hexahydroxydiphenoyl esters as inhibitors of vertebrate squalene epoxidase.
AID1475198Binding affinity to recombinant human transthyretin expressed in Escherichia coli BL21 at 1:50 protein to ligand molar ratio by STD-NMR spectroscopic method2017Journal of medicinal chemistry, 07-13, Volume: 60, Issue:13
Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal.
AID1465950Inhibition of SPI-1 T3SS in Salmonella typhimurium assessed as reduction in SPI-1 T3SS substrates by measuring SipC protein level at 5 to 100 uM after 4 hrs by Coomassie staining based SDS-PAGE method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID1175718Antimalarial activity against chloroquine-sensitive/mefloquine-resistant Plasmodium falciparum D6 by malaria SYBR green 1-based fluorescence (MSF) assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID400264Cytotoxicity against human Raji cells assessed as cell viability at 100 molar ratio2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID596584Induction of apoptosis in human Raji cells assessed as intracellular caspase-3 activation after 24 hrs (Rvb = 3.4 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID468508Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID1865602Binding affinity to human NADK (410 to 418 residues) assessed as decrease in deuterium incorporation at 80 uM measured after 30 mins by HDX-MS analysis2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID596389Induction of 67 kDa laminin receptor expression in human HL60 cells after 24 hrs by flow cytometry analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID541909Antiviral activity against Human herpesvirus 1 isolate P42 infected in African green monkey vero cells assessed as log reduction in viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1607723Inhibition of HAT (unknown origin) relative to control2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID1239562Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID468515Antibacterial activity against Proteus mirabilis ATCC 27853 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID598319Inhibition of RANKL-induced osteoclastogenesis in mouse RAW264.7 cells assessed as decrease in TRAP-positive multi-nucleated cells after 5 days2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Discovery of indeno[1,2-c]quinoline derivatives as inhibitors of osteoclastogenesis induced by receptor activator of NF-κB ligand (RANKL).
AID437510Inhibition of MET kinase2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
AID1239523Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID400258Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 1000 molar ratio after 48 hrs relative to TPA2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID1282376Inhibition of recombinant GST-tagged CBP (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1239528Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 9 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239540Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID343515Selectivity, ratio of CC50 for dog MDCK cells to EC50 for Influenza (A/PR8/34(H1N1)) in MDCK cells2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
AID1066539Downregulation of ErbB1 protein expression in human A431 cells in serum free medium at 200 uM after 30 mins by immunofluorescence staining-based confocal microscopic analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID596387Cytotoxicity against human UT7 cells assessed as cell growth inhibition at 10 uM after 7 days by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID595306Antiproliferative activity against rat HSC-T6 cells at 100 uM after 48 hrs by MTT assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID1175724Inhibition of human type O erythrocyte ICAM1-mediated Plasmodium falciparum infection with at 50 uM2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID681139TP_TRANSPORTER: increase in dihydrofluorescein intracellular accumulation (dihydrofluorescein: 1 uM) in SK-E2 cells (expressing BSEP)2003Pharmaceutical research, Apr, Volume: 20, Issue:4
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
AID1594145Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID647004Dose-dependent inhibition of recombinant human BACE1 expressed in CHO cells co-transfected with human APP with Swedish mutation assessed as amyloid beta1-40 secretion by alphaLISA technique2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1239532Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID542186Antiviral activity against Human herpesvirus 1 isolate P38 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 40 to 60 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1527600Anti-colitis activity in Sprague-Dawley rat model of acetic acid-induced colitis assessed as histological scores at 50 mg/kg, po administered for 7 consecutive days and measured on day 8 (Rvb = 9.3 +/- 2.8 No_unit)2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID566608Inhibition of TNFalpha-induced NF-kappaB activation in human Jurkat cells at 10 to 55 uM after 24 hrs by electrophoretic mobility shift assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Catechin derivatives from Parapiptadenia rigida with in vitro wound-healing properties.
AID1264946Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 5 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID748705Selectivity ratio of IC50 for full length human tau40 aggregation to IC50 for tau K19 aggregation (unknown origin)2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
AID1175719Antimalarial activity against chloroquine /mefloquine/pyrimethamine-resistant Plasmodium falciparum C235 by malaria SYBR green 1-based fluorescence (MSF) assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID596392Induction of myeloperoxidase expression in human K562 cells after 24 hrs by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1371413Cytotoxicity against human SK-MEL-2 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID542202Antiviral activity against Human herpesvirus 1 F1 assessed as decrease in labeled gD envelope glycoprotein at 100 uM after 2 hrs by electron microscopy2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1264950Cytotoxicity against human MSC assessed as cell viability at 1 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID596490Induction of apoptosis in human Raji cells assessed as late apoptotic or secondary necrotic cells at 10 uM after 24 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 2.2 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1705067Inhibition of endonuclease activity of Influenza A virus (A/California/07/2009(H1N1)) N-terminal GST-tagged polymerase acidic subunit N-terminal domain expressed in Escherichia coli BL21 (DE3) RIL cells using single-stranded circular DNA M13mp18 as substr2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID310891Inhibition of Escherichia coli DNA gyrase B supercoiling activity2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
AID596474Growth inhibition against human HL60 cells assessed as cell viability at 10 uM after 48 hrs by trypan blue based microscopic analysis in presence of catalase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1239543Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 2 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID647161Antialzheimer's disease activity in mouse cortex assessed as inhibition of beta-secretase mediated amyloid beta1-42 production at 3 mg/kg2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID428321Inhibition of human recombinant MMP7 expressed in Escherichia coli by fluorogenic peptide cleavage assay2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.
AID1371370Cytotoxicity against human HT-29 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1889080Inhibition of alpha-Synuclein (unknown origin) aggregation assessed as times difference in midpoint of aggregation at compound to protein molar ratio of 5:1 incubated for 36 hrs under shaking condition and measured every 6 hrs by Thioflavin T based fluore2022Journal of natural products, 02-25, Volume: 85, Issue:2
α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian
AID437512Plasma concentration in po dosed human2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
AID1594137Inhibition of ATPase activity of Escherichia coli GroEL expressed in Escherichia coliDH5alpha incubated for 60 mins using ATP by spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID774360Cytotoxicity against Swiss mouse peritoneal macrophages after 72 hrs by Alamar blue assay2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID1465952Inhibition of SPI-1 T3SS in Salmonella typhimurium assessed as reduction in SPI-1 T3SS substrates by measuring SipB protein level at 5 to 100 uM after 4 hrs by Coomassie staining based SDS-PAGE method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID748713Inhibition of human recombinant brain tau protein (412 amino acid residues) filament assembly expressed in Escherichia coli BL21(DE3) by electron microscopic analysis in presence of heparin2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
AID1858783Inhibition of Bcl-W/Bid (unknown origin)2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1527598Anti-colitis activity in Sprague-Dawley rat model of acetic acid-induced colitis assessed as disease activity index at 50 mg/kg, po administered for 7 consecutive days and measured on day 8 (Rvb = 3.9 +/- 0.4 No_unit)2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID1228875Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation at 100 uM incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Nodulisporiviridins A-H, Bioactive Viridins from Nodulisporium sp.
AID542199Cytotoxicity against African green monkey Vero cells assessed as viability at 100 uM after 24 hrs2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID91435Inhibition against HIV-1 integrase at 1 mM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID1520355Neuroprotective activity against amyloid beta (1 to 42)-induced neurodegeneration in human SH-SY5Y cells assessed as cell viability at 1 uM preincubated for 4 hrs followed by amyloid beta (1 to 42) addition and measured after 48 hrs by MTS assay (Rvb = 55
AID738072Inhibition of differentiation of mouse 3T3L1 cells assessed as lipid accumulation at 10 uM after 8 days by using Oil Red O staining by spectrophotometry relative to control2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-adipogenic diarylheptanoids from Alnus hirsuta f. sibirica on 3T3-L1 cells.
AID1239585Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 0.56 mM after 24 hrs by time kill assay in presence of 0.42 mM of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID343516Antiviral activity against Influenza (A/PR8/34(H1N1))2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
AID1066533Reduction of clustering of GFP-GPI in lipid rafts of human A431 cells at 100 uM after 12 hrs by confocal microscopic analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1371453Tmax in mouse at 10 mg/kg, iv by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1239572Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 after 24 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID638568Antiviral activity against influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh7 infected in MDCK cells assessed as inhibition of viral replication after 4 days by quantitative RT-PCR2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Synthesis and antiviral activity of substituted quercetins.
AID639631Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced MMP9 expression at 50 uM by Western blotting relative to control2011Journal of natural products, May-27, Volume: 74, Issue:5
Phenolic substances from Phagnalon rupestre protect against 2,4,6-trinitrochlorobenzene-induced contact hypersensitivity.
AID356134Cytotoxicity against human SW480 cells after 72 hrs by MTT assay2003Journal of natural products, Jul, Volume: 66, Issue:7
Bioactive novel polyphenols from the fruit of Manilkara zapota (Sapodilla).
AID1371408Cytotoxicity against human A549 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID646998Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 100 uM incubated with substrate for 7 hrs prior compound addition by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1616227Antileishmanial activity against stationary phase of Leishmania infantum MHOM/MA/67/ITMAP263 infected in BALB/c mouse assessed as decrease in parasitic load in liver at 12.5 mg/kg/day administered orally via gavage as bid for 5 days on 7th day post infect
AID1865605Cytotoxicity against human PC-9 cells harboring wild type KRAS assessed as inhibition of cell growth at 60 uM measured on day 42022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID1865601Inhibition of NADK delta 95 kinase domain (unknown origin) at 80 uM measured after 30 mins by HDX-MS analysis2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID729671Cytotoxicity against CHO cells expressing OATP1B3 haplotype 1 after 48 hrs by fluorescence based CellTiter-Glo assay2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID1239563Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1813133Reversal of P-glycoprotein mediated drug resistance in human LCC6MDR cells assessed as reversal of paclitaxel resistance measured after 5 days by Cell Titer-Glo luminescence assay2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers.
AID638570Therapeutic index, ratio of TD50 for MDCK cells to ED50 for influenza A virus (A/swine/OH/511445/2007(H1N1)) Oh72012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Synthesis and antiviral activity of substituted quercetins.
AID1371414Cytotoxicity against human U87 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID697060Inhibition of chicken liver FASN2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID647005Inhibition of recombinant human BACE1 expressed in CHO cells co-transfected with human APP with Swedish mutation assessed as amyloid beta1-40 secretion at 1 nM by alphaLISA technique2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1371452Cmax in mouse at 10 mg/kg, iv by LC-MS/MS method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1889076Inhibition of alpha-Synuclein (unknown origin) aggregation at compound to protein molar ratio of 1:1 incubated for 36 hrs under shaking condition and measured every 6 hrs by Thioflavin T based fluorescence assay relative to control2022Journal of natural products, 02-25, Volume: 85, Issue:2
α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian
AID1609175Inhibition of full length human FASN transfected in HeLa cell lysates at 150 uM using acetyl Co-A/malonyl Co-A as substrate preincubated with enzyme for 2 hrs followed by substrate addition measured after 10 mins in presence of NADPH by microplate reader 2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1705065Inhibition of biotinylated 5-(4-((Z)-3-Carboxy-3-hydroxyacryloyl)-4-(4-chlorobenzyl)piperidine-1-carbonyl)-2-((13,35-dioxo-39-((3aR,4R,6aS)-2-oxohexahydro-1H-thieno[3,4-d]imidazole-4-yl)-3,6,9,16,19,22,25,28,31-nonaoxa-12,34-diazanonatriacontyl)oxy)benzoi2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID1691282Binding affinity to human GRP78 at 1 uM measured after 30 mins by UF-ASMS analysis relative to control2020European journal of medicinal chemistry, May-01, Volume: 193Discovery of small molecules targeting GRP78 for antiangiogenic and anticancer therapy.
AID1633145Inhibition of chymotrypsin-like activity of purified human 20S proteasome assessed as decrease in AMC hydrolysis using Suc-Leu-Leu-Val-Tyr-AMC as substrate incubated for 30 mins by fluorometric analysis2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID453980Inhibition of human neutrophil elastase at 1 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa.
AID1890687Anti-inflammatory activity in MOG (35 to 55 residues)-induced experimental autoimmune encephalomyelitis mouse model assessed as reduction in spinal cord demyelination severity score by Luxol fast blue staining based light microscopic analysis2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Design, synthesis, and biological evaluation of polyphenol derivatives as DYRK1A inhibitors. The discovery of a potentially promising treatment for Multiple Sclerosis.
AID429277Inhibition of PLCgamma1 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID1228905Modulation of P-gp (unknown origin) transfected in human MDA435/LCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 1 uM after 5 days by CellTiter 96 Aqueous assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
AID1609165Inhibition of FASN in human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as disruption of AKT/FASN positive feedback loop by measuring decrease in ratio of phosphoAKT/AKT expression at 100 uM after 48 hrs by Western immunoblot2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID598327Inhibition of RANKL-induced NFAT activation in mouse RAW264.7 cells at 10 uM by firefly luciferase reporter gene assay relative to control2011Journal of medicinal chemistry, Apr-28, Volume: 54, Issue:8
Discovery of indeno[1,2-c]quinoline derivatives as inhibitors of osteoclastogenesis induced by receptor activator of NF-κB ligand (RANKL).
AID1465940Inhibition of SPI-1 T3SS in Salmonella typhimurium infected in human HeLa cells assessed as reduction in bacterial invasion at 100 uM after 30 mins by immunofluorescence analysis2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID1908593Neuroprotective activity against human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35)-induced cytotoxicity at 10 uM incubated for 2 hrs followed by amyloid beta (25 to 35) treatment for 24 hrs by MTT assay2022European journal of medicinal chemistry, Jun-05, Volume: 236Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression.
AID1239529Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1390551Inhibition of LDH (unknown origin) at 0.625 uM using 2-PG relative to control2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
AID596479Cell cycle arrest in human Raji cells by assessed as accumulation at subG1 phase at 10 uM using propidium iodide staining by flow cytometry in presence of superoxide dismutase and catalase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1239542Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID310890Inhibition of Escherichia coli DNA gyrase B ATPase activity2007Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2
Green tea catechins inhibit bacterial DNA gyrase by interaction with its ATP binding site.
AID542205Binding affinity to Envelope glycoprotein D in Human herpesvirus 1 F1 assessed as macromolecular complex formation by SDS-PAGE2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1609172Antiproliferative activity against human PC9 cells harboring FASN expression and EGFR delE746-A750 mutant assessed as cell viability at 100 uM after 72 hrs in presence of exogenous lipid concentrate by MTS assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1288180Antioxidant activity in human HepG2 cells assessed as decrease in fluorescence level by measuring ratio of micromol of quercetin to 100 umol of compound after 2.5 hrs measured every 5 mins for 1 hr by DCFH-DA staining based fluorescence assay2016European journal of medicinal chemistry, May-23, Volume: 114Protective effects of kaempferol against reactive oxygen species-induced hemolysis and its antiproliferative activity on human cancer cells.
AID517164Inhibition of FAS2010Bioorganic & medicinal chemistry letters, Oct-15, Volume: 20, Issue:20
Fatty acid synthase inhibitors of phenolic constituents isolated from Garcinia mangostana.
AID774353Toxicity in stationary-phase promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected BALB/c mouse assessed as serum aspartate aminotransferase level at 30 mg/kg, po administered 5 times per week2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID398697Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced malondialdehyde formation1995Journal of natural products, Sep, Volume: 58, Issue:9
Effect of anthraquinone derivatives on lipid peroxidation in rat heart mitochondria: structure-activity relationship.
AID541946Antiviral activity against Human herpesvirus 2 isolate P2 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 12.5 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1063750Inhibition of influenza A virus RNA-dependent RNA polymerase subunit PA endonuclease activity2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Design of the influenza virus inhibitors targeting the PA endonuclease using 3D-QSAR modeling, side-chain hopping, and docking.
AID774355Antileishmanial activity against stationary-phase promastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in BALB/c mouse assessed as reduction of parasite burden at 30 mg/kg, po administered 5 times per week2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID1239581Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 assessed as log reduction of colony forming unit at 0.28 mM after 4 hrs2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1420022Inhibition of human recombinant GST-tagged DYRK1A expressed in Escherichia coli using KKISGRLSPIMTEQ as substrate after 40 mins in presence of [gamma33P-ATP]2018Journal of medicinal chemistry, 11-21, Volume: 61, Issue:22
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
AID1264951Cytotoxicity against human MSC assessed as cell viability at 5 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID468512Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID774361Antileishmanial activity against intracellular amastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in Swiss mouse peritoneal macrophages assessed as growth inhibition at 12 uM after 72 hrs2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID1858785Inhibition of Bfl-1/Bid (unknown origin)2021European journal of medicinal chemistry, Jan-15, Volume: 210Development of Mcl-1 inhibitors for cancer therapy.
AID468520Antifungal activity against Candida tropicalis IFO 10241 after 24 to 72 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID1689108Antiviral activity against Influenza A virus (A/WSN/1933(H1N1)) infected in dog MDCK cells assessed as reduction in virus-induced cytopathic effect incubated for 48 hrs by MTT assay
AID1264953Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID596390Induction of myeloperoxidase expression in human HL60 cells after 24 hrs by flow cytometry2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID596472Growth inhibition against human HL60 cells assessed as cell viability at 10 uM after 48 hrs by trypan blue based microscopic analysis in presence of superoxide dismutase2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID647156Inhibition of recombinant human BACE1 using substrate conjugated with reporter EDANS and DABCYL at 0.03 mg/mL2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID527268Inhibition of Plasmodium falciparum FabG by spectrophotometric analysis2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.
AID601587Inhibition of Influenza A/Udorn/72/H3N2 full length GST-tagged NS1A/FAM-double strand RNA-interaction at 50 uM after 1 hr by fluorescence polarization assay2011Bioorganic & medicinal chemistry letters, May-15, Volume: 21, Issue:10
Synthesis and evaluation of quinoxaline derivatives as potential influenza NS1A protein inhibitors.
AID1594140Inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured rhodanese refolding by measuring rhodanese enzyme activity 2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1813131Reversal of Pgp-mediated paclitaxel resistance in human LCC6MDR cells assessed as relative fold by measuring paclitaxel IC50 at 1 uM after 5 days by Cell Titer-Glo luminescence assay relative to control2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers.
AID1717775Inhibition of SARS-CoV 3C-like protease (3241 to 3546 residues) expressed in Pichia pastoris GS115 using Dabcyl-KTSAVLQSGFRKME-Edans fluorogenic peptide as substrate measured for 18 mins by fluorescence method2020Journal of medicinal chemistry, 11-25, Volume: 63, Issue:22
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
AID1371377Cytotoxicity against human SK-MEL-2 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID637860Inhibition of GST-tagged human DYRK1A using dephosphorylated MBP as substrate after 10 mins by Kinase-Glo plus luminescent kinase assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay.
AID1889079Inhibition of alpha-Synuclein (unknown origin) aggregation at compound to protein molar ratio of 5:1 incubated for 36 hrs under shaking condition and measured every 6 hrs by Thioflavin T based fluorescence assay relative to control2022Journal of natural products, 02-25, Volume: 85, Issue:2
α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian
AID1625177Displacement of [3H]-CP55940 from CB1 receptor (unknown origin)2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID596481Growth inhibition against human Raji cells assessed as cell viability at 10 uM after 24 hrs by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID20870Partion coefficient of compound was determined between n-octanol and water evaluated by comparison of HPLC peak area1998Bioorganic & medicinal chemistry letters, Jul-21, Volume: 8, Issue:14
Synthesis and antioxidant activity of novel amphipathic derivatives of tea polyphenol.
AID542171Antiviral activity against Human herpesvirus 2 strain 333 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 60 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID566604Antimigratory activity against Swiss albino mouse 3T3 cells assessed as increase of cell numbers at 1 to 20 uM after 12 hrs by by scratch-wound assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Catechin derivatives from Parapiptadenia rigida with in vitro wound-healing properties.
AID1239527Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1371406Cytotoxicity against human HT-29 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID542201Antiviral activity against Human herpesvirus 1 F1 assessed as damage of viral particle at 100 uM after 2 hrs by electron microscopy2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID333763Aqueous stability of the compound2004Journal of natural products, Dec, Volume: 67, Issue:12
Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts.
AID1239539Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239566Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 0.56 mM after 4 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID639630Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced MMP9 expression at 25 uM by Western blotting relative to control2011Journal of natural products, May-27, Volume: 74, Issue:5
Phenolic substances from Phagnalon rupestre protect against 2,4,6-trinitrochlorobenzene-induced contact hypersensitivity.
AID1724083Stabilization of wild type human transthyretin expressed in Escherichia coli BL21(DE3) assessed as decrease in TTR-amyloid beta fibril formation at 10 uM preincubated for 6 hrs with transthyretin followed by measuring after 96 hrs maintaining pH of 4.4 by2020Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18
Monoaryl derivatives as transthyretin fibril formation inhibitors: Design, synthesis, biological evaluation and structural analysis.
AID1066540Downregulation of ErbB2 protein expression in human SKBR3 cells in serum free medium at 200 uM after 30 mins by immunofluorescence staining-based confocal microscopic analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1066555Antiproliferative activity against human SKBR3 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID774362Antileishmanial activity against intracellular amastigotes of Leishmania amazonensis MHOM/BR/75/LTB0016 infected in Swiss mouse peritoneal macrophages assessed as inhibition of infection index after 72 hrs by light microscopic analysis2013Journal of natural products, Oct-25, Volume: 76, Issue:10
In vitro and in vivo effects of (-)-epigallocatechin 3-O-gallate on Leishmania amazonensis.
AID403352Inhibition of COX2 at 25 uM2005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID542184Antiviral activity against Human herpesvirus 1 isolate P15 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 40 to 60 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID405143Antiviral activity against HIV1 assessed as six-helix bundle formation assay2007Antimicrobial agents and chemotherapy, Jul, Volume: 51, Issue:7
A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.
AID1264960Decrease in ALP activity in human MSC using p-NPP as substrate at 10 uM after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1371407Cytotoxicity against human COLO201 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID265762Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K12006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID1558317Inhibition of Zika virus NS2B (1421 to 1469 residues) - NS3 (1503 to 1688 residues) expressed in Escherichia coli BL21(DE3) cells using Dabcyl-KTSAVLQSGFRKME-Edans as substrate after 11 mins by FRET assay2020Journal of medicinal chemistry, 01-23, Volume: 63, Issue:2
Drugs for the Treatment of Zika Virus Infection.
AID1625178Displacement of [3H]-CP55940 from CB2 receptor (unknown origin)2019Journal of natural products, 03-22, Volume: 82, Issue:3
Plant-Based Modulators of Endocannabinoid Signaling.
AID355163Inhibition of Streptococcus sobrinus glucosyltransferase assessed as blockade of adherent water insoluble glucan synthesis at 1 ug/mL1996Journal of natural products, Sep, Volume: 59, Issue:9
Macrocarpals H, I, and J from the Leaves of Eucalyptus globulus.
AID1066543Downregulation of ErbB1 protein expression in human A431 cells in serum free medium at 50 uM after 24 hrs by immunofluorescence staining-based flow cytometric analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1616228Antileishmanial activity against stationary phase of Leishmania infantum MHOM/MA/67/ITMAP263 infected in BALB/c mouse assessed as decrease in parasitic load in liver at 25 mg/kg/day administered orally via gavage as bid for 5 days on 7th day post infectio
AID1371404Cytotoxicity against human MDA-MB-231 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID542187Antiviral activity against Human herpesvirus 1 isolate P42 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 40 to 60 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1578836Inhibition of MexAB/OprM in Pseudomonas aeruginosa PAO1 assessed as potentiation of carbenicillin-induced antibacterial activity by measuring carbenicillin MIC at 128 ug/ml incubated for 18 hrs (Rvb = 64 ug/ml)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID1371463Displacement of [3H]resveratrol from Sprague-Dawley rat brain plasma membranes after 1 hr by beta counting method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID429185Antioxidant activity assessed as radical DPPH scavenging activity2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID1239549Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID542173Antiviral activity against Human herpesvirus 2 isolate P11 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID456190Inhibition of beta amyloid (1 to 42) fibril formation at 50 ug/mL by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1228903Cytotoxicity against human MDA435/LCC6MDR cells after 3 days by MTS assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
AID750063Antiadipogenic activity in mouse 3T3L1 cells assessed as differentiation of preadipocytes to adipocytes after 8 days by spectrophotometry2013Bioorganic & medicinal chemistry letters, Jun-01, Volume: 23, Issue:11
Anti-adipogenic activity of compounds isolated from Idesia polycarpa on 3T3-L1 cells.
AID541952Antiviral activity against Human herpesvirus 2 strain 333 strain 333 infected in African green monkey CV-1 cells2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID390532Cytotoxicity against mouse L1210 cells after 24 hrs by WST8 assay2008Bioorganic & medicinal chemistry, Nov-15, Volume: 16, Issue:22
Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells.
AID468517Antifungal activity against Candida krusei IFO 1664 after 24 to 72 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID1609116Selectivity index, ratio of IC50 for human SAE cells lacking FASN expression to IC50 for human NCI-H1703 cells expressing FASN2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1371405Cytotoxicity against human T47D cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID761658Growth inhibition of MEF expressing Pin12013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.
AID165903In vitro assay for EBV activation in Raji cells induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) at the concentration of 500 (mol ratio / 32 pmol TPA); (%Viability=>80)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID1440624Antiviral activity against influenza A virus (A/Sydney/5/97) infected in MDCK cells after 2 to 3 days by crystal violet staining based plaque reduction assay2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
Inhibitors of Influenza Virus Polymerase Acidic (PA) Endonuclease: Contemporary Developments and Perspectives.
AID320801Inhibition of beta amyloid 25-35 fibril formation at 10 uM2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
New polyphenols active on beta-amyloid aggregation.
AID704068Inhibition of tetrahymena telomerase using 3'-ACT TCG TAG AGC AGA TTG-5' as substrate incubated for 10 mins prior to extension reaction by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID751288Inhibition of Plasmodium falciparum FabG using acetoacetyl-CoA as substrate2013Journal of natural products, Jun-28, Volume: 76, Issue:6
Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.
AID647151Inhibition of recombinant human BACE1 expressed in CHO cells co-transfected with human APP with Swedish mutation assessed as amyloid beta1-40 secretion at 0.01 uM by alphaLISA technique2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1570153Induction of apoptosis in human RPMI8226 cells at 10 to 20 uM by TUNEL assay relative to control2019European journal of medicinal chemistry, Oct-15, Volume: 180Targeting multiple myeloma with natural polyphenols.
AID1239535Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 6 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1239553Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID704059Competitive inhibition of tetrahymena telomerase using 3'-ACT TCG TAG AGC AGA TTG-5' as substrate assessed as ratio of IC50 at saturated substrate concentration to IC50 at Km by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID1239534Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID542212Antiviral activity against Human herpesvirus 1 F1 infected in African green monkey vero cells assessed as reduction in viral titer2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1070215Inhibition of Trichomonas vaginalis uridine nucleoside ribohydrolase using 5-fluorouridine as substrate at 0.04 to 200 uM after 40 mins by NMR spectrometric analysis2014Bioorganic & medicinal chemistry letters, Feb-15, Volume: 24, Issue:4
Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.
AID1813147Reversal of Pgp-mediated paclitaxel resistance in human LCC6MDR cells assessed as paclitaxel IC50 at 10 uM after 5 days by Cell Titer-Glo luminescence assay (Rvb = 152.5 +/- 9.7 uM)2021European journal of medicinal chemistry, Dec-15, Volume: 226Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers.
AID1066542Downregulation of ErbB2 protein expression in human SKBR3 cells at 50 uM after 24 hrs by immunofluorescence staining-based flow cytometric analysis in presence of serum2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1607716Inhibition of PCAF (unknown origin)2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID428322Inhibition of human recombinant MMP2 expressed in Escherichia coli by fluorogenic peptide cleavage assay2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.
AID596487Induction of apoptosis in human Raji cells assessed as late apoptotic or secondary necrotic cells at 10 uM after 12 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 2.2 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1465944Effect on SopE2-CPG2-HA fusion protein expression expressed in Salmonella typhimurium at 0.39 to 100 uM after 4 hrs by Western blot method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID1365686Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation at 20 uM incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay relative to control2017Bioorganic & medicinal chemistry letters, 11-01, Volume: 27, Issue:21
Flavonoids and their derivatives with β-amyloid aggregation inhibitory activity from the leaves and twigs of Pithecellobium clypearia Benth.
AID542191Antiviral activity against Human herpesvirus 1 isolate P38 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1175717Antimalarial activity against chloroquine-resistant/mefloquine-sensitive Plasmodium falciparum W2 by malaria SYBR green 1-based fluorescence (MSF) assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs.
AID729675Cytotoxicity against wild type CHO cells after 48 hrs by fluorescence based CellTiter-Glo assay2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID1228876Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay2015Journal of natural products, Jun-26, Volume: 78, Issue:6
Nodulisporiviridins A-H, Bioactive Viridins from Nodulisporium sp.
AID541964Antiviral activity against Human herpesvirus 2 isolate P47 infected in African green monkey CV1 cells assessed as log reduction viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1371457Tmax in mouse at 100 mg/kg, po by HPLC method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1594135Inhibition of native rhodanese (unknown origin) assessed as reduction in rhodanese enzyme activity after 45 mins by Fe(SCN)3 dye based spectrometric analysis2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1520354Neuroprotective activity against amyloid beta (1 to 42)-induced neurodegeneration in human SH-SY5Y cells assessed as cell viability at 10 uM preincubated for 4 hrs followed by amyloid beta (1 to 42) addition and measured after 48 hrs by MTS assay (Rvb = 6
AID647162Antialzheimer's disease activity in mouse hippocampus assessed as inhibition of beta-secretase mediated amyloid beta1-42 production at 1.5 mg/kg2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID542189Antiviral activity against Human herpesvirus 1 isolate P25 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1371371Cytotoxicity against human COLO201 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID596587Growth inhibition against human Raji cells assessed as cell viability at 10 uM preincubated with N-acetyl-L-cysteine for 30 mins measured after 48 hrs by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1895851Inhibition of Bacillus anthracis lethal factor2021European journal of medicinal chemistry, Dec-15, Volume: 226Zinc enzymes in medicinal chemistry.
AID658431Inhibition of mammosphere formation in human MDA-MB-231 cells at 20 uM after 7 days by inverted phase-contrast microscopy2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells.
AID429186Inhibition of Syk phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID596385Cytotoxicity against human Raji cells assessed as cell growth inhibition after 7 days by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1193983Reduction in amyloid beta plaques in Tg2576 mouse2015Bioorganic & medicinal chemistry, Apr-15, Volume: 23, Issue:8
β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
AID689851Antioxidant activity assessed as superoxide dismutase-like activity by SOD-WST assay2012Journal of natural products, Oct-26, Volume: 75, Issue:10
Diarylheptanoid sulfates and related compounds from Myrica rubra bark.
AID596583Induction of apoptosis in human HL60 cells assessed as intracellular caspase-3 activation after 48 hrs (Rvb = 1.3 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID318324Antioxidant activity assessed as ABTS radical scavenging activity2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
AID1888156Inhibition of Influenza A virus N-terminal domain of PA endonuclease using 6FAM-TGGCAATATCAGCTCCACA-MGBNFQ as fluorescent substrate by FRET analysis2022European journal of medicinal chemistry, Jan-05, Volume: 227Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PA
AID1616224Antileishmanial activity against Leishmania infantum MHOM/MA/67/ITMAP263 promastigotes infected in BALB/c mouse peritoneal macrophages assessed as decrease in parasitic infection index at 48 uM incubated for 72 hrs by light microscopy relative to control
AID647001Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as dose dependent reduction in relative fluorescence compound preincubated for 30 mins prior substrate addition measured after 6 to 7 hrs by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1239551Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID541953Antiviral activity against Human herpesvirus 2 isolate P2 infected in African green monkey CV1 cells2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1534335Inhibition of bovine GDH2019European journal of medicinal chemistry, Feb-01, Volume: 163Discovery and development of small molecule modulators targeting glutamine metabolism.
AID1243512Neuroprotective activity in human SH-SY5Y cells assessed as production against amyloid beta (25 to 35)-induced cell death by measuring cell viability at 10 uM after 24 hrs by MTT assay2015Journal of natural products, Sep-25, Volume: 78, Issue:9
Natural β-Dihydroagarofuran-Type Sesquiterpenoids as Cognition-Enhancing and Neuroprotective Agents from Medicinal Plants of the Genus Celastrus.
AID1865609Cytotoxicity against human H23 cells harboring KRAS G12C mutant assessed as inhibition of cell growth at 30 uM2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID646973Inhibition of recombinant human BACE1 expressed in CHO cells co-transfected with human APP with Swedish mutation assessed as amyloid beta1-40 secretion at 10 uM by alphaLISA technique2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1264952Cytotoxicity against human MSC assessed as cell viability at 10 uM measured on day 1 by alamar blue assay (Rvb = 97 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID646977Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 1 uM incubated with substrate for 6 hrs prior compound addition by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1193982Reduction in amyloid beta levels in Tg2576 mouse2015Bioorganic & medicinal chemistry, Apr-15, Volume: 23, Issue:8
β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
AID456318DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID542170Antiviral activity against Human herpesvirus 1 F1 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1465941Inhibition of SPI-1 T3SS in Salmonella typhimurium infected in human HeLa cells assessed as reduction in bacterial invasion at 100 uM after 30 mins by flow cytometry2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID541947Antiviral activity against Human herpesvirus 2 isolate P11 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 12.5 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1371464Displacement of [3H]-CP5594 from human recombinant CB1 receptor expressed in Chem1 cells after 90 mins by scintillation counting method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1371409Cytotoxicity against human NCI-H460 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID468511Antibacterial activity against Staphylococcus epidermidis ATCC 0155 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID761659Inhibition of full length Pin1 (unknown origin) using WFY(pS)PR-pNA as substrate by spectrophotometric analysis2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.
AID542209Antiviral activity against Human herpesvirus 1 isolate P38 infected in African green monkey vero cells assessed as reduction in viral titer2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID541962Antiviral activity against Human herpesvirus 2 isolate P22 infected in African green monkey CV1 cells assessed as log reduction viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1264956Cytotoxicity against human MSC assessed as cell viability at 1 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1066545Cell cycle arrest in human A431 cells at 50 to 75 uM after 36 hrs by propidium iodide staining-based flow cytometric analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1633146Inhibition of chymotrypsin-like activity of human 26S proteasome extracted from human Jurkat cells assessed as decrease in AMC hydrolysis using Z-Gly-Gly-Arg-AMC as substrate after 90 mins by fluorometric analysis2019European journal of medicinal chemistry, Apr-01, Volume: 167Another look at phenolic compounds in cancer therapy the effect of polyphenols on ubiquitin-proteasome system.
AID542190Antiviral activity against Human herpesvirus 1 isolate P32 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 30 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID646976Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 10 uM incubated with substrate for 7 hrs prior compound addition by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID1780098Cardioprotective activity against hypoxia/reoxygenation-induced injury in rat H9c2 cells assessed as cell viability at 10 uM treated after 8 hrs of hypoxia and before 16 hrs of reoxygenation period by MTT assay2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID646987Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 1 uM preincubated for 30 mins prior substrate addition measured after 6 hrs by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID400260Inhibition of TPA-induced EBV-early antigen activation in human Raji cells assessed as EA activation at 100 molar ratio after 48 hrs relative to TPA2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID1371415Cytotoxicity against human LN229 cells assessed as cell viability at 6 uM after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID1889077Binding affinity to alpha-Synuclein (unknown origin) at compound to protein molar ratio of 5:1 incubated for 3 hrs by mass spectroscopy analysis2022Journal of natural products, 02-25, Volume: 85, Issue:2
α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian
AID456183Inhibition of reduced carboxymethylated kappa-casein fibril formation at 50 ug/mL measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID428320Inhibition of human recombinant MT1-MMP expressed in Escherichia coli by fluorogenic peptide cleavage assay2009Bioorganic & medicinal chemistry letters, Aug-01, Volume: 19, Issue:15
Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group.
AID566607Antimigratory activity against Swiss albino mouse 3T3 cells assessed as increase of cell numbers at 2 ng/ml after 12 hrs by by scratch-wound assay2010Journal of natural products, Dec-27, Volume: 73, Issue:12
Catechin derivatives from Parapiptadenia rigida with in vitro wound-healing properties.
AID1488475Inhibition of recombinant human ACE at 100 uM using Mca-R-P-PG-F-S-A-F-K(Dnp)-OH as substrate measured every 2 mins for 8 mins by fluorescence assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Discovery of a potent angiotensin converting enzyme inhibitor via virtual screening.
AID658430Inhibition of mammosphere formation in human MDA-MB-231 cells at 10 uM after 7 days by inverted phase-contrast microscopy2012Bioorganic & medicinal chemistry, May-01, Volume: 20, Issue:9
Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells.
AID1781851Inhibition of COL1A1 promotor activity in human LX2 cells at 20 uM incubated for 24 hrs by luciferase reporter gene assay2021Bioorganic & medicinal chemistry, 11-01, Volume: 49Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways.
AID1704260Inhibition of SARS-CoV 3C-like protease (3241 to 3546 residues) expressed in Pichia pastoris GS115 using Dabcyl-KTSAVLQSGFRKME-Edans fluorogenic peptide as substrate measured for 18 mins by fluorescence method2020European journal of medicinal chemistry, Nov-15, Volume: 206The development of Coronavirus 3C-Like protease (3CL
AID343513Cytotoxicity against MDCK cells by MTT assay2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
AID429276Inhibition of PLCgamma2 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Inhibitory effects of flavonoids isolated from Fragaria ananassa Duch on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3.
AID542176Antiviral activity against Human herpesvirus 2 isolate P27 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID682901Inhibition of HER2 phosphorylation in human SK-BR-3 cells after 6 hrs by Western blot analysis2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
New synthetic inhibitors of fatty acid synthase with anticancer activity.
AID396448Anti-aging activity in human dermal fibroblasts assessed as inhibition rate of MMP1 expression at 10 uM relative to control2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID541968Antiviral activity against Human herpesvirus 1 isolate P25 infected in African green monkey vero cells assessed as log reduction in viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1594142Selectivity index, ratio of IC50 for inhibition of native rhodanese (unknown origin) to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coli DH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduct2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID265761Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF542006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID1865604Binding affinity to human NADK (345 to 365 residues) assessed as decrease in deuterium incorporation at 80 uM measured after 30 mins by HDX-MS analysis2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID1780103Zinc ionophore activity assessed as uptake of zinc ions into liposomes by measuring increase in liposome-encapsulated FluoZin3-fluorescence at 10 uM measured after 1 hr in presence of ZnCl2 by fluorescence analysis relative to control2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID1465951Inhibition of SPI-1 T3SS in Salmonella typhimurium assessed as reduction in SPI-1 T3SS substrates by measuring SopB protein level at 5 to 100 uM after 4 hrs by Coomassie staining based SDS-PAGE method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID1364925Antiviral activity against Chikungunya virus infected in HEK293T cells assessed as reduction in infectious virus particle production by luciferase reporter gene assay2017Bioorganic & medicinal chemistry, 08-15, Volume: 25, Issue:16
The medicinal chemistry of Chikungunya virus.
AID1153323Inhibition of BACE1 in mouse N2A cells transfected with human APP Swedish mutant assessed as amyloid beta (1-42) production at 10 uM2014Bioorganic & medicinal chemistry letters, Jul-01, Volume: 24, Issue:13
β-Secretase (BACE1)-inhibiting C-methylrotenoids from Abronia nana suspension cultures.
AID1228929Modulation of P-gp (unknown origin) transfected in human MDA435/LCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 10 uM after 5 days by CellTiter 96 Aqueous assay relative to PTX alone treated cell2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
AID1616104Inhibition of ATP synthase isolates from rat brain cells using succinate as substrate preincubated for 5 mins followed by substrate addition2019European journal of medicinal chemistry, Nov-15, Volume: 182Recent advancements in mechanistic studies and structure activity relationship of F
AID1239579Antibacterial activity against vancomycin-intermediate resistant Staphylococcus aureus Mu50 at 0.56 mM after 24 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID595314Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at G0/G1 phase at 25 uM after 48 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID1066557Ratio of EC50 for human A431 cells overexpressing ErbB in complete medium to EC50 for human A431 cells overexpressing ErbB in serum-free medium2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1282378Inhibition of recombinant TIP60 (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1264945Induction of osteogenic differentiation in human MSC assessed as increase in ALP activity at 1 uM using p-NPP as substrate after 9 days by colorimetric method relative to control2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID400262Cytotoxicity against human Raji cells assessed as cell viability at 1000 molar ratio2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID1609120Selectivity index, ratio of IC50 for human SAE cells lacking FASN expression to IC50 for human NCI-H1650 cells expressing FASN2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1578838Inhibition of MexAB/OprM in Pseudomonas aeruginosa PAO1 assessed as potentiation of ciprofloxacin-induced antibacterial activity by measuring ciprofloxacin MIC at 128 ug/ml incubated for 18 hrs (Rvb = 1 ug/ml)2019Journal of medicinal chemistry, 10-10, Volume: 62, Issue:19
Antibiotic Adjuvants: Make Antibiotics Great Again!
AID761657Growth inhibition of Pin1-deficient MEF2013Bioorganic & medicinal chemistry letters, Aug-01, Volume: 23, Issue:15
Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.
AID1744553Permeability constant, logPe of compound incubated for 2 to 30 hrs by PAMPA assay2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID1371456Cmax in mouse at 100 mg/kg, po by HPLC method2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID639632Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced MMP9 expression at 100 uM by Western blotting relative to control2011Journal of natural products, May-27, Volume: 74, Issue:5
Phenolic substances from Phagnalon rupestre protect against 2,4,6-trinitrochlorobenzene-induced contact hypersensitivity.
AID1781853Cytotoxicity against human LX2 cells assessed as cell death incubated for 24 hrs by MTT assay2021Bioorganic & medicinal chemistry, 11-01, Volume: 49Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways.
AID1744549Inhibition of cytochrome c (unknown origin) assessed as reduction reduction of cyt c from its ferric state to ferrous state at 10 uM incubated for 20 mins in presence of cardiolipin by UV-vis Spectrophotometric assay relative to control2021Bioorganic & medicinal chemistry, 03-01, Volume: 33A role of flavonoids in cytochrome c-cardiolipin interactions.
AID319370Inhibition of 6PGD2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID542178Antiviral activity against Human herpesvirus 2 isolate P2 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1465946Inhibition of SPI-1 T3SS in Salmonella typhimurium assessed as reduction in SPI-1 T3SS substrates by measuring FliD protein level at 5 to 100 uM after 4 hrs by Coomassie staining based SDS-PAGE method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID1239577Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at 0.56 mM after 24 hrs by time kill assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1527599Anti-colitis activity in Sprague-Dawley rat model of acetic acid-induced colitis assessed as colon mucosa damage index at 50 mg/kg, po administered for 7 consecutive days and measured on day 8 (Rvb = 3.3 +/- 0.6 No_unit)2020European journal of medicinal chemistry, Jan-01, Volume: 185Discovery of small-molecule candidates against inflammatory bowel disease.
AID1140778Inhibition of HSP90 (unknown origin) by luciferase refolding assay2014Bioorganic & medicinal chemistry letters, May-15, Volume: 24, Issue:10
Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors.
AID1239554Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1066552Induction of apoptosis in human A431 cells overexpressing ErbB in complete medium assessed as late apoptotic/necrotic cells at 75 uM after 72 hrs by annexin V-FITC/7-AAD staining-based flow cytometric analysis relative to control2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID453983Inhibition of human neutrophil elastase at 30 uM2010Bioorganic & medicinal chemistry letters, Jan-15, Volume: 20, Issue:2
Evaluation of human neutrophil elastase inhibitory effect of iridoid glycosides from Hedyotis diffusa.
AID1636645Neuroprotective activity against amyloid beta (25 to 35 residues)-induced cell damage in human SH-SY5Y cells assessed as cell viability at 10 uM preincubated for 2 hrs followed by amyloid beta (25 to 35 residues) addition measured after 24 hrs by MTT assa2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
AID319374Plasma concentration in human at 50 mg/kg, po2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID542203Antiviral activity against Human herpesvirus 1 F1 assessed as decrease in labeled gB envelope glycoprotein at 100 uM after 2 hrs by electron microscopy2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1889078Inhibition of alpha-Synuclein (unknown origin) aggregation assessed as time difference in midpoint of aggregation at compound to protein molar ratio of 1:1 incubated for 36 hrs under shaking condition and measured every 6 hrs by Thioflavin T based fluores2022Journal of natural products, 02-25, Volume: 85, Issue:2
α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated β-Carboline Sulfamate from the Ascidian
AID771681Inhibition of recombinant Plasmodium falciparum 3D7 FabG using acetoacetyl-CoA as substrate after 10 mins in presence of NADPH2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
AID1176223Neuroprotective activity in human SH-SY5Y cells assessed as inhibition Abeta25-35-induced reduction of cell viability at 1 uM compound pretreated for 2 hrs before induction cell viability measured after 24 hrs (Rvb = 69.77%)2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Synthesis and biological evaluation of novel marine-derived indole-based 1,2,4-oxadiazoles derivatives as multifunctional neuroprotective agents.
AID396443Anti-aging activity in human dermal fibroblasts assessed as expression rate of procollagen type 1 formation at 10 uM relative to control2009Bioorganic & medicinal chemistry letters, Jan-15, Volume: 19, Issue:2
Synthesis and in vitro biological activity of retinyl polyhydroxybenzoates, novel hybrid retinoid derivatives.
AID596480Growth inhibition against human HL60 cells assessed as cell viability at 10 uM after 24 hrs by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID650646Inhibition of aldehyde dehydrogenase2012Bioorganic & medicinal chemistry, Apr-01, Volume: 20, Issue:7
Tea catechins and flavonoids from the leaves of Camellia sinensis inhibit yeast alcohol dehydrogenase.
AID1062363Inhibition of human GST-fused DYRK1A expressed in Escherichia coli using KISGRLSPIMTEQ as substrate2013Journal of medicinal chemistry, Dec-12, Volume: 56, Issue:23
Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.
AID318326Inhibition of human recombinant DHFR at 100 uM2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
AID1371374Cytotoxicity against human BxPC3 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID542185Antiviral activity against Human herpesvirus 1 isolate P25 infected in African green monkey vero cells assessed as log reduction in viral titer at 100 uM after 40 to 60 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID542181Antiviral activity against Human herpesvirus 2 isolate P22 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 20 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID542169Antiviral activity against Human herpesvirus 1 isolate P56 infected in African green monkey vero cells assessed as reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1228930Modulation of P-gp (unknown origin) transfected in human MDA435/LCC6MDR cells assessed as reversible of paclitaxel resistance measured as IC50 for paclitaxel at 10 uM after 5 days by CellTiter 96 Aqueous assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
AID265760Inhibition of FabG2006Journal of medicinal chemistry, Jun-01, Volume: 49, Issue:11
Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids.
AID548978Anticancer activity against human PC3 cells xenografted in sc dosed SCID mouse assessed as inhibition of tumor growth at 80 mg/kg, ip qd for 14 days2010European journal of medicinal chemistry, Dec, Volume: 45, Issue:12
Synthesis and structure-activity relationship of 3-O-acylated (-)-epigallocatechins as 5α-reductase inhibitors.
AID595309Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at sub-G1 phase at 25 uM after 24 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID475504Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1264954Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 3 days measured on day 4 by alamar blue assay (Rvb = 97 to 100%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID475505Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins2009Bioorganic & medicinal chemistry letters, Sep-01, Volume: 19, Issue:17
A chemical screening approach reveals that indole fluorescence is quenched by pre-fibrillar but not fibrillar amyloid-beta.
AID1609118Selectivity index, ratio of IC50 for human SAE cells lacking FASN expression to IC50 for human NCI-H1299 cells expressing FASN expression2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID681155TP_TRANSPORTER: increase in bodipy intracellular accumulation (Bodipy: 0.2 uM) in SK-E2 cells (expressing BSEP)2003Pharmaceutical research, Apr, Volume: 20, Issue:4
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
AID541957Antiviral activity against Human herpesvirus 2 isolate P27 infected in African green monkey CV1 cells2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID729672Cytotoxicity against CHO cells expressing OATP1B1*1b after 48 hrs by fluorescence based CellTiter-Glo assay2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID376602Neuroprotective effect against 6-OHDA-induced neurotoxicity in human SH-SY5Y cells at 0.1 uM treated 1 hr before 6-OHDA injury after 24 hrs by MTT assay relative to control2006Journal of natural products, Apr, Volume: 69, Issue:4
Neuroprotective bibenzyl glycosides of Stemona tuberosa roots.
AID1066546Cell cycle arrest in human SKBR3 cells at 50 to 75 uM after 36 hrs by propidium iodide staining-based flow cytometric analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1689112Binding affinity to recombinant Influenza A virus (A/USA:Huston/AA/1945 H1N1)) N-terminal His6-tagged PA endonuclease assessed as dissociation constant by SPR analysis
AID1636647Neuroprotective activity against amyloid beta (25 to 35 residues)-induced cell damage in human SH-SY5Y cells assessed as cell viability at 1 uM preincubated for 2 hrs followed by amyloid beta (25 to 35 residues) addition measured after 24 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
AID83435Inhibition of polymerization in wild type HIV-1 RT with poly rC/dG12-18 template primer and [3H]dGTP2001Bioorganic & medicinal chemistry letters, Oct-22, Volume: 11, Issue:20
Simplified catechin-gallate inhibitors of HIV-1 reverse transcriptase.
AID1705068Inhibition of Influenza A virus (A/California/07/2009(H1N1)) neuraminidase at 400 uM by DNA-linked inhibitor antibody assay2020European journal of medicinal chemistry, Dec-15, Volume: 208Unraveling the anti-influenza effect of flavonoids: Experimental validation of luteolin and its congeners as potent influenza endonuclease inhibitors.
AID1390565Antiproliferative activity in human NCI-H1299 cells after 72 hrs2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
AID541961Antiviral activity against Human herpesvirus 2 isolate P12 infected in African green monkey CV1 cells assessed as log reduction viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID596585Induction of apoptosis in human Raji cells assessed as intracellular caspase-3 activation after 48 hrs (Rvb = 3.4 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1510615Inhibition of Bacillus cereus 569/H9 beta-lactamase incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis2019ACS medicinal chemistry letters, Jun-13, Volume: 10, Issue:6
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
AID1607749Inhibition of CBP (unknown origin)2019European journal of medicinal chemistry, Sep-15, Volume: 178Histone acetyltransferase inhibitors: An overview in synthesis, structure-activity relationship and molecular mechanism.
AID1862312Inhibition of Hen egg white lysozyme fibril formation by Thioflavin T spectroscopic assay relative to control2022European journal of medicinal chemistry, Oct-05, Volume: 240Regioselective pyrrolizidine bis-spirooxindoles as efficient anti-amyloidogenic agents.
AID1513555Antiproliferative activity against human SKBR3 cells2019Journal of medicinal chemistry, 01-10, Volume: 62, Issue:1
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design.
AID541914Antiviral activity against Human herpesvirus 1 isolate P38 infected in African green monkey vero cells assessed as reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1865607Cytotoxicity against human A549 cells harboring KRAS G12C mutant assessed as inhibition of cell growth at 50 uM2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID736866Cell cycle arrest in CHO cells expressing OATP1B3 haplotype 1 assessed as accumulation at G0/G1 phase at 1 uM after 48 hrs using propidium iodide and FITC Annexin V staining by flow cytometry2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID1224170Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.
AID437511Inhibition of MET kinase by Dixon plot analysis2009Journal of medicinal chemistry, Nov-12, Volume: 52, Issue:21
Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: kinetic and molecular docking studies.
AID1371379Cytotoxicity against human LN229 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID646957Induction of H2O2 production in human HT-29 cells at 100 ug/ml after 72 hrs by ferrous oxidation xylenol orange assay2012Journal of natural products, Jan-27, Volume: 75, Issue:1
Hamamelitannin from witch hazel (Hamamelis virginiana) displays specific cytotoxic activity against colon cancer cells.
AID1465945Inhibition of SPI-1 T3SS in Salmonella typhimurium expressing SopE2-CPG2-HA fusion protein assessed as reduction in type 3 protein secretion using Glu-CyFur as substrate after 4 hrs by fluorescence assay2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID1865599Binding affinity to N-terminal full length NADK (unknown origin) expressed in Escherichia coli BL21(DE3) cells assessed as dissociation constant by surface plasmon resonance assay2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID1239556Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 3 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID474219Inhibition of FCepsilonRI beta subunit mRNA expression in human HMC1 cells at 50 uM after 36 hrs by RT-PCR analysis2010Bioorganic & medicinal chemistry letters, Apr-01, Volume: 20, Issue:7
New inhibitors for expression of IgE receptor on human mast cell.
AID1066534Reduction of clustering of GFP-GPI in lipid rafts of human SKBR3 cells at 100 uM after 12 hrs by confocal microscopic analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID468513Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID541912Antiviral activity against Human herpesvirus 1 isolate P25 infected in African green monkey vero cells assessed as reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1609122Cytotoxicity against human SAE cells lacking FASN expression assessed as reduction in cell viability after 72 hrs by MTS assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1865608Cytotoxicity against human H358 cells harboring KRAS G12C mutant assessed as inhibition of cell growth at 30 uM2022ACS medicinal chemistry letters, Nov-10, Volume: 13, Issue:11
(-)-Epigallocatechin Gallate is a Noncompetitive Inhibitor of NAD Kinase.
AID1465942Effect on growth of Salmonella typhimurium at 100 uM2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID165901In vitro assay for EBV activation in Raji cells induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) at the concentration of 100 (mol ratio / 32 pmol TPA)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID1465953Inhibition of SPI-1 T3SS in Salmonella typhimurium assessed as reduction in SPI-1 T3SS substrates by measuring SipA protein level at 5 to 100 uM after 4 hrs by Coomassie staining based SDS-PAGE method2017Bioorganic & medicinal chemistry, 06-01, Volume: 25, Issue:11
Epigallocatechin-3-gallate inhibits bacterial virulence and invasion of host cells.
AID1780101Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as viable cells at 10 uM treated after 8 hrs of hypoxia and before 2 hrs of reoxygenation period in presence of ZnCl2 by AnnexinV-FITC/propidium iodide staining bas2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID492403Chemical stability in 100 mM phosphate buffer at pH 7.4 at 100 uM after 60 mins by HPLC analysis2010Bioorganic & medicinal chemistry, Jul-15, Volume: 18, Issue:14
Structural characteristics of green tea catechins for formation of protein carbonyl in human serum albumin.
AID1239558Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1371368Cytotoxicity against human MDA-MB-231 cells assessed as decrease in cell viability after 48 hrs by MTT assay2017Journal of medicinal chemistry, 12-14, Volume: 60, Issue:23
Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
AID319372Inhibition of G6PD-mediated NADPH production in mouse 3T3-L1 cells2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID1475194Binding affinity to recombinant human transthyretin expressed in Escherichia coli BL21 by STD-NMR spectroscopic method2017Journal of medicinal chemistry, 07-13, Volume: 60, Issue:13
Insights on the Interaction between Transthyretin and Aβ in Solution. A Saturation Transfer Difference (STD) NMR Analysis of the Role of Iododiflunisal.
AID1264957Cytotoxicity against human MSC assessed as cell viability at 5 uM treated for 6 days measured on day 7 by alamar blue assay (Rvb = 96 to 101%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
AID1228902Cytotoxicity against human LCC-6 cells after 3 days by MTS assay2015Journal of medicinal chemistry, Jun-11, Volume: 58, Issue:11
Potent and Nontoxic Chemosensitizer of P-Glycoprotein-Mediated Multidrug Resistance in Cancer: Synthesis and Evaluation of Methylated Epigallocatechin, Gallocatechin, and Dihydromyricetin Derivatives.
AID542174Antiviral activity against Human herpesvirus 2 isolate P12 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM within 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID646985Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 10 uM preincubated for 30 mins prior substrate addition measured after 6 hrs by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID704055Inhibition of Thermus aquaticus DNA polymerase using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate after 15 mins by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID1594144Inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in GroEL/GroES-mediated denatured soluble pig heart MDH refolding by measuring MDH enzyme acti2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID68587Inhibitory activity against lipid peroxidation of egg-phosphatidylcholine (PC) liposome caused by water-soluble radical initiator [2,2'-azobis(2-amidinopropane) dihydrochloride] (AAPH)1998Bioorganic & medicinal chemistry letters, Jul-21, Volume: 8, Issue:14
Synthesis and antioxidant activity of novel amphipathic derivatives of tea polyphenol.
AID277583Inhibition of Plasmodium falciparum ENR2007Journal of medicinal chemistry, Feb-22, Volume: 50, Issue:4
Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR).
AID1674837Modulation of NF-kappaB in Sprague-Dawley rat BMM assessed as inhibition of M-CSF/RANKL-induced osteoclast differentiation by measuring decrease in TRAP-positive multinucleated cells at 100 uM measured after 5 days by TRAP-staining based assay relative to2020Bioorganic & medicinal chemistry letters, 09-15, Volume: 30, Issue:18
Inhibitory effect of oolonghomobisflavan B on osteoclastogenesis by suppressing p38 MAPK activation.
AID704056Mixed type inhibition of tetrahymena telomerase using dNTP as substrate assessed as ratio of IC50 at saturated substrate concentration to IC50 at Km by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID646988Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 1 uM preincubated for 30 mins prior substrate addition measured after 7 hrs by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID638569Cytotoxicity against MDCK cells after 4 days2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Synthesis and antiviral activity of substituted quercetins.
AID1239561Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 8 after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID1636646Neuroprotective activity against amyloid beta (25 to 35 residues)-induced cell damage in human SH-SY5Y cells assessed as recovery of cell viability at 10 uM preincubated for 2 hrs followed by amyloid beta (25 to 35 residues) addition measured after 24 hrs2016Bioorganic & medicinal chemistry letters, 08-15, Volume: 26, Issue:16
Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity.
AID595311Cell cycle arrest in rat HSC-T6 cells assessed as inhibition of DNA synthesis at S phase at 25 uM after 24 hrs2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Antiproliferative triterpenes from the leaves and twigs of Juglans sinensis on HSC-T6 cells.
AID1176224Neuroprotective activity in human SH-SY5Y cells assessed as inhibition Abeta25-35-induced reduction of cell viability at 10 uM compound pretreated for 2 hrs before induction cell viability measured after 24 hrs (Rvb = 69.77%)2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Synthesis and biological evaluation of novel marine-derived indole-based 1,2,4-oxadiazoles derivatives as multifunctional neuroprotective agents.
AID1239524Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 5 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID541959Antiviral activity against Human herpesvirus 2 isolate P2 infected in African green monkey CV1 cells assessed as log reduction viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1066537Induction of ErbB2 internalization in lysosome/endosome of human A431 cells in serum free medium at 200 uM after 30 mins by by immunofluorescence staining-based confocal microscopic analysis2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1781852Inhibition of COL1A1 promotor activity in human LX2 cells at 50 uM incubated for 24 hrs by luciferase reporter gene assay2021Bioorganic & medicinal chemistry, 11-01, Volume: 49Discovery of 1,8-naphthalidine derivatives as potent anti-hepatic fibrosis agents via repressing PI3K/AKT/Smad and JAK2/STAT3 pathways.
AID738070Inhibition of differentiation of mouse 3T3L1 cells assessed as lipid accumulation at 100 uM after 8 days by using Oil Red O staining by spectrophotometry relative to control2013Bioorganic & medicinal chemistry letters, Apr-01, Volume: 23, Issue:7
Anti-adipogenic diarylheptanoids from Alnus hirsuta f. sibirica on 3T3-L1 cells.
AID1239520Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 1 by disk diffusion assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID468514Antibacterial activity against Escherichia coli ATCC 10536 after 24 hrs by NCCLS method2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
AID542207Antiviral activity against Human herpesvirus 1 isolate P25 infected in African green monkey vero cells assessed as reduction in viral titer2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1066554Ratio of EC50 for human SKBR3 cells overexpressing ErbB in complete medium to EC50 for human SKBR3 cells overexpressing ErbB in serum-free medium2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID432200ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity index at pH 7 by spectrophotometry2009Journal of natural products, Jun, Volume: 72, Issue:6
The role of phenolic hydroxy groups in the free radical scavenging activity of betalains.
AID646996Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 100 uM preincubated for 30 mins prior substrate addition measured after 7 hrs by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID675178Inhibition of DNMT1 in human HeLa cell nuclear extract assessed as methylated substrate level at 10 uM by ELISA2012European journal of medicinal chemistry, Sep, Volume: 55New cytosine derivatives as inhibitors of DNA methylation.
AID1282375Inhibition of recombinant GST-tagged p300 (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID1557213Antibacterial activity against Streptococcus mutans2019MedChemComm, Jul-01, Volume: 10, Issue:7
Targeting
AID637863Inhibition of DYRK1A in human 293T cells assessed as reduction of GLI1 transcription activity at 50 uM after 12 hrs by dual-luciferase reporter gene assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Discovery of potent small molecule inhibitors of DYRK1A by structure-based virtual screening and bioassay.
AID542168Antiviral activity against Human herpesvirus 1 isolate P42 infected in African green monkey vero cells assessed as reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1239533Antibacterial activity against methicillin-resistant Staphylococcus aureus isolate 4 after 24 hrs by checkerboard assay2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID541960Antiviral activity against Human herpesvirus 2 isolate P11 infected in African green monkey CV1 cells assessed as log reduction viral titer at 50 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID1780100Inhibition of apoptosis in hypoxia/reoxygenation induced injury in rat H9c2 cells assessed as caspase-3 activity at 10 uM treated after 8 hrs of hypoxia and before 16 hrs of reoxygenation period in presence of ZnCl2 (Rvb = 187%)2021Bioorganic & medicinal chemistry, 09-15, Volume: 46Zinc ionophores isolated from Terminalia bellirica fruit rind extract protect against cardiomyocyte hypoxia/reoxygenation injury.
AID1520356Neuroprotective activity against amyloid beta (1 to 42)-induced neurodegeneration in human SH-SY5Y cells assessed as cell viability at 0.5 uM preincubated for 4 hrs followed by amyloid beta (1 to 42) addition and measured after 48 hrs by MTS assay (Rvb =
AID1066558Antiproliferative activity against human A431 cells overexpressing ErbB in complete medium assessed as cell viability after 48 hrs by WST-1 assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID646978Inhibition of recombinant human BACE1 using Eu-CEVNLDAEFK-Qsy7 as substrate assessed as reduction in relative fluorescence at 1 uM incubated with substrate for 7 hrs prior compound addition by HTRF assay2012Bioorganic & medicinal chemistry letters, Feb-01, Volume: 22, Issue:3
The green tea polyphenol (2)-epigallocatechin-3-gallate (EGCG) is not a β-secretase inhibitor.
AID400263Cytotoxicity against human Raji cells assessed as cell viability at 500 molar ratio2004Journal of natural products, Mar, Volume: 67, Issue:3
Dimeric flavonol glycoside and galloylated C-glucosylchromones from Kunzea ambigua.
AID729673Cytotoxicity against CHO cells expressing OATP1B3 haplotype 1 after 48 hrs by fluorescence based CellTiter-Glo assay relative to wild type CHO cells2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID1239552Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as reduction of epigallocatechin gallate MIC after 24 hrs by checkerboard assay in presence of quercetin2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID697062Cytotoxicity against human SKBR3 cells2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
The lipogenesis pathway as a cancer target.
AID690145Cytotoxicity against human HepG2 cells incubated for 24 hrs by MTT assay2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
AID1759523Antioxidant activity assessed as reduction in FK506-induced ROS production by DPPH assay2021Bioorganic & medicinal chemistry letters, 06-01, Volume: 41Identification of gallic acid as a active ingredient of Syzygium aromaticum against tacrolimus-induced damage in renal epithelial LLC-PK1 cells and rat kidney.
AID336155Antioxidant activity assessed as DPPH free radical scavenging activity after 30 mins2002Journal of natural products, Sep, Volume: 65, Issue:9
New diarylheptanoids from the stems of Carpinus cordata.
AID541945Antiviral activity against Human herpesvirus 2 strain 333 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 100 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID704064Mixed type inhibition of telomerase in human HeLa cells using 5'-AAT CCG TCG AGC AGA GTT-3' as substrate assessed as ratio of IC50 at saturated substrate concentration to IC50 at Km by telomeric repeat amplification protocol2012Journal of medicinal chemistry, Apr-26, Volume: 55, Issue:8
A new strategy for detection and development of tractable telomerase inhibitors.
AID1594136Selectivity index, ratio of IC50 for inhibition of native soluble pig heart MDH to IC50 for inhibition of Escherichia coli GroEL expressed in Escherichia coliDH5alpha/Escherichia coli GroES expressed in Escherichia coli BL21 (DE3) assessed as reduction in2019Bioorganic & medicinal chemistry letters, 05-01, Volume: 29, Issue:9
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
AID1187047Antiviral activity against HCV genotype 1a assessed as inhibition of viral entry into Huh7 cells treated at 50 uM for 2 hr followed by 28 hrs incubation period in compound-free medium by immunofluorescence assay2014Bioorganic & medicinal chemistry letters, Sep-01, Volume: 24, Issue:17
Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
AID639775Inhibition of KDM4E2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Lysine demethylases inhibitors.
AID1520353Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation at 25 uM after 7 days by ThT-based fluorometric method relative to control
AID1066559Antiproliferative activity against human A431 cells overexpressing ErbB in serum-free medium assessed as cell viability after 48 hrs by WST-1 assay2014Journal of natural products, Feb-28, Volume: 77, Issue:2
Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
AID1683648Neuroprotective activity in human SH-SY5Y cells assessed as reduction in amyloid beta (25 to 35)-induced cytotoxicity by measuring cell viability at 10 uM after 24 hrs by MTT assay relative to control2020Journal of natural products, 12-24, Volume: 83, Issue:12
Neuroprotective and Anti-inflammatory Ditetrahydrofuran-Containing Diarylheptanoids from
AID398696Inhibition of lipid peroxidation in Sprague-Dawley rat heart mitochondria assessed as inhibition of FeSO4-induced oxygen consumption1995Journal of natural products, Sep, Volume: 58, Issue:9
Effect of anthraquinone derivatives on lipid peroxidation in rat heart mitochondria: structure-activity relationship.
AID541951Antiviral activity against Human herpesvirus 2 isolate P47 infected in African green monkey CV1 cells assessed as log reduction in viral titer at 12.5 uM2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus.
AID736870Binding affinity to human serum albumin at 1 uM2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.
AID596386Cytotoxicity against human K562 cells assessed as cell growth inhibition at 10 uM after 7 days by trypan blue based microscopic analysis2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID330776Binding affinity to BCL22007Proceedings of the National Academy of Sciences of the United States of America, Dec-04, Volume: 104, Issue:49
Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis.
AID319375Ratio of IC50 for yeast G6PD to IC50 for G6PD-mediated NADPH production in mouse 3T3-L1 cells2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
Catechin gallates are NADP+-competitive inhibitors of glucose-6-phosphate dehydrogenase and other enzymes that employ NADP+ as a coenzyme.
AID1724081Inhibition of N-terminal His6-tagged human tau K18deltaK280 mutant assessed as inhibition of protein aggregation
AID1282377Inhibition of recombinant PCAF (unknown origin) using histone H4 peptide substrate assessed as reduction in NADH formation by spectrophotometric analysis2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
KATching-Up on Small Molecule Modulators of Lysine Acetyltransferases.
AID596484Induction of apoptosis in human Raji cells assessed as late apoptotic or secondary necrotic cells at 10 uM after 6 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 2.2 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID1557226Inhibition of Streptococcus mutans F-ATPase activity relative to control2019MedChemComm, Jul-01, Volume: 10, Issue:7
Targeting
AID1705466Binding affinity to wild type TTR (unknown origin) expressed in bacterial expression system by isothermal titration calorimetry2020Journal of medicinal chemistry, 12-10, Volume: 63, Issue:23
Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments.
AID1609115Antiproliferative activity against human NCI-H1703 cells expressing FASN assessed as reduction in cell viability after 72 hrs by MTS assay2019European journal of medicinal chemistry, Nov-15, Volume: 182Galloyl esters of trans-stilbenes are inhibitors of FASN with anticancer activity on non-small cell lung cancer cells.
AID1248402Inhibition of human salivary alpha-amylase using rice starch as substrate after 12 mins by microplate reader analysis2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
AID1239580Antibacterial activity against methicillin-resistant Staphylococcus aureus NCTC 12493 assessed as log reduction of colony forming unit at 0.28 mM after 2 hrs2015Journal of natural products, Aug-28, Volume: 78, Issue:8
In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus.
AID456193Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 42) fibril formation2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
AID1316797Inhibition of wild type His-tagged translin/trax E126A mutant (unknown origin) coexpressed in Escherichia coli BL21 cells using RNase Alert as substrate at 30 uM incubated for 10 mins prior to substrate addition monitored over 60 mins by fluorescence assa2016Bioorganic & medicinal chemistry letters, 10-15, Volume: 26, Issue:20
A druggable target for rescuing microRNA defects.
AID318317Stability in human HT29 cells assessed as half life2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Synthesis and biological activity of a 3,4,5-trimethoxybenzoyl ester analogue of epicatechin-3-gallate.
AID596486Induction of apoptosis in human Raji cells assessed as necrotic cells at 10 uM after 12 hrs by measuring phosphatidylserine translocation using annexin V-FITC/propidium iodide staining by FACS (Rvb = 3.4 %)2011Journal of natural products, Apr-25, Volume: 74, Issue:4
(-)-Epigallocatechin-3-O-gallate induces nonapoptotic cell death in leukemia cells independent of the 67 kDa laminin receptor.
AID165922Tested for % viability of Rajii cells, in an in vitro assay for TPA-induced EBV activation at concentration of 500 (mol ratio / 32 pmol TPA)2000Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1799773SPA Assay from Article 10.1016/j.abb.2004.02.039: \\Inhibition of fucosyltransferase VII by gallic acid and its derivatives.\\2004Archives of biochemistry and biophysics, May-01, Volume: 425, Issue:1
Inhibition of fucosyltransferase VII by gallic acid and its derivatives.
AID1799774TACE Inhibition Assay from Article 10.1016/j.abb.2004.02.039: \\Inhibition of fucosyltransferase VII by gallic acid and its derivatives.\\2004Archives of biochemistry and biophysics, May-01, Volume: 425, Issue:1
Inhibition of fucosyltransferase VII by gallic acid and its derivatives.
AID1799783Enzymatic Assay from Article 10.1074/jbc.M109.067967: \\Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1.\\2010The Journal of biological chemistry, Mar-12, Volume: 285, Issue:11
Characterization of a novel class of polyphenolic inhibitors of plasminogen activator inhibitor-1.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2009The Journal of biological chemistry, Aug-21, Volume: 284, Issue:34
Solution structure of human cardiac troponin C in complex with the green tea polyphenol, (-)-epigallocatechin 3-gallate.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2011Cancer prevention research (Philadelphia, Pa.), Sep, Volume: 4, Issue:9
Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1.
AID1346093Human lysine acetyltransferase 2B (2.3.1.48 Histone acetyltransferases (HATs))2009Cancer research, Jan-15, Volume: 69, Issue:2
Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
AID1346108Human E1A binding protein p300 (Non-enzymatic BRD containing proteins)2009Cancer research, Jan-15, Volume: 69, Issue:2
Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2012PLoS pathogens, , Volume: 8, Issue:8
Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5,297)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (0.08)18.7374
1990's156 (2.95)18.2507
2000's1469 (27.73)29.6817
2010's2766 (52.22)24.3611
2020's902 (17.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.57 (24.57)
Research Supply Index8.64 (2.92)
Research Growth Index6.91 (4.65)
Search Engine Demand Index141.11 (26.88)
Search Engine Supply Index3.99 (0.95)

This Compound (44.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials173 (3.17%)5.53%
Reviews454 (8.32%)6.00%
Case Studies7 (0.13%)4.05%
Observational1 (0.02%)0.25%
Other4,821 (88.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (55)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase I Single-arm, Multicenter Pilot Study Aimed at Validating γ-OHPdG as a Biomarker and Testing the Effects of Polyphenon E on Its Levels in Patients With Cirrhosis [NCT03278925]Phase 114 participants (Actual)Interventional2018-08-09Active, not recruiting
Catechins and Omega-3 Fatty Acids Impact on Fatty Acid Synthase Activity in the Prostate: A Randomized Controlled Trial [NCT00253643]89 participants (Actual)Interventional2005-07-31Completed
Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis [NCT03740295]Phase 260 participants (Actual)Interventional2018-10-05Completed
Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy [NCT01183767]Phase 2/Phase 333 participants (Actual)Interventional2010-12-30Completed
Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans [NCT03194620]12 participants (Actual)Interventional2016-08-31Completed
Phase II, Randomized, Double Blind, Placebo Controlled Pilot Study of Polyphenon E in Men With Localized Prostate Cancer Scheduled to Undergo Radical Prostatectomy [NCT01340599]Phase 25 participants (Actual)Interventional2006-10-31Terminated(stopped due to Slow accrual)
Effects of EGCG (Epigallocatechin Gallate) in Huntington's Disease The ETON-Study - A Randomized, Double-blind, Stratified, Placebo-controlled Prospective Investigator Initiated Multicenter Trial - [NCT01357681]Phase 254 participants (Actual)Interventional2011-09-30Completed
Phase ⅠStudy of Oral Green Tea Extract as Maintenance Therapy for Extensive-stage Small Cell Lung Cancer [NCT01317953]0 participants Expanded AccessAvailable
The Polyphenol Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism During Graded Exercise in Man. [NCT03199430]Phase 48 participants (Actual)Interventional2015-09-30Completed
Phase II Randomized Controlled Trial of Epigallocatechin Gallate for Hepatocellular Carcinoma Chemoprevention [NCT06015022]Phase 260 participants (Anticipated)Interventional2023-12-01Not yet recruiting
The Clinical and Biologic Evaluation of Polyphenon E, an Extract of Green Tea Containing EGCG, in Plasma Cell Dyscrasias - Pilot Study [NCT00942422]Phase 28 participants (Actual)Interventional2009-11-30Terminated(stopped due to Low accrual and early termination)
Fibroids and Unexplained Infertility Treatment With Epigallocatechin Gallate; A Natural CompounD in Green Tea (FRIEND) [NCT05364008]Phase 3200 participants (Anticipated)Interventional2023-01-05Recruiting
The Effect of Extract of Green Tea on Obese Women Obese Related Hormone Peptides [NCT02147041]Phase 2/Phase 392 participants (Anticipated)Interventional2012-05-31Enrolling by invitation
Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease [NCT00951834]Phase 2/Phase 321 participants (Actual)Interventional2009-10-31Completed
Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids: a Randomized Controlled Trial [NCT05409872]108 participants (Anticipated)Interventional2022-09-15Recruiting
Epigallocatechin Gallate (EGCG) as Therapeutic Tool to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children [NCT02558933]36 participants (Actual)Interventional2016-03-31Completed
Pharmacokinetics and Hepatic Safety of EGCG [NCT04177693]Phase 139 participants (Actual)Interventional2020-11-24Completed
A Randomized Controlled Study on the Effects of Tea Catechin Consumption on the Prevention of Influenza Infection in Healthy Adults [NCT01008020]200 participants (Anticipated)Interventional2009-11-30Completed
Prevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal Intervention [NCT03978052]200 participants (Anticipated)Interventional2019-10-30Recruiting
Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. [NCT03928847]Early Phase 135 participants (Actual)Interventional2017-12-01Completed
A Pilot Study to Evaluate the Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients With Curative Resections. [NCT02891538]Early Phase 150 participants (Anticipated)Interventional2017-01-31Recruiting
A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG [NCT00666562]Phase 231 participants (Actual)Interventional2008-07-02Completed
[NCT02577393]Phase 283 participants (Anticipated)Interventional2015-04-30Enrolling by invitation
Phase II Trial of Polyphenon E in Current and Former Smokers With Bronchial Dysplasia [NCT00611650]Phase 223 participants (Actual)Interventional2006-10-31Terminated(stopped due to Slow recruitment)
Egcg, a dyrk1a Inhibitor as Therapeutic Tool for Reversing Cognitive Deficits in Down Syndrome Individuals. [NCT01394796]Phase 231 participants (Actual)Interventional2010-05-31Completed
Monocentric, Prospective, Doubleblind, Randomised/Stratified, Placebocontrolled Two-arm Study to Evaluate the Effect of Sunphenon EGCg (Main Component Epigallocatechin-Gallat) on the Increase of Brain Atrophy in the Cerebral Magnetic Resonance Tomography [NCT00799890]Phase 2/Phase 361 participants (Actual)Interventional2009-05-31Completed
Salivary Interactions With Chemosensations [NCT03883880]32 participants (Actual)Interventional2019-01-05Terminated(stopped due to COVID (completed first intervention type only))
A Randomised Trial for the Treatment of Cardiac AMyloid Light-chain Amyloidosis With the Green Tea Compound Epigallocatechin-3-gallate (TAME-AL) [NCT02015312]Phase 238 participants (Actual)Interventional2013-04-30Completed
Phase II Trial of Polyphenon E in Former Smokers With Abnormal Sputa [NCT00573885]Phase 253 participants (Actual)Interventional2008-01-31Completed
Dose Ranging Study of Oral Epigallocatechin-3-gallate (EGCG) Given Daily for 12 Weeks to Patients With Idiopathic Pulmonary Fibrosis (IPF) Evaluating Safety, PK Interactions With Standard of Care Drugs, and Biomarkers of Drug Effect [NCT05195918]Phase 150 participants (Anticipated)Interventional2023-08-24Recruiting
Reducing Frailty for Older Cancer Survivors Using Supplements (ReFOCUS): A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer [NCT04553666]Phase 214 participants (Actual)Interventional2021-03-15Completed
The Effects of Tea Catechin Extracts Containing Mask on the Prevention of Influenza Infection [NCT00812448]180 participants (Actual)Interventional2008-12-31Completed
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions [NCT05625308]40 participants (Actual)Interventional2022-07-01Completed
The Role of Tea Catechins and Caffeine in Relation to Energy Metabolism in Man [NCT00611416]15 participants (Actual)Interventional2005-11-30Completed
Estrogen Receptors Beta (ER-B) as Therapeutic Targets for the Improvement of Cognitive Performance in Fragile-X (TESXF) [NCT01855971]Phase 244 participants (Actual)Interventional2013-06-11Completed
Sunphenon EGCg (Epigallocatechin-gallate) in Relapsing-remitting Multiple Sclerosis (SuniMS Study) [NCT00525668]Phase 1/Phase 2120 participants (Actual)Interventional2007-09-30Completed
The Influence of Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy Using Two Different Calcium Silicate-based Materials on Postoperative Pain and Success Rate in Mature Permanent Molars With Irreversible Pulpitis: A Randomized Clin [NCT05811403]64 participants (Anticipated)Interventional2023-07-01Recruiting
Phase Ib Study of Polyphenon E in a Pre-prostatectomy Prostate Cancer Cohort [NCT00459407]Phase 150 participants (Actual)Interventional2007-03-31Completed
Functional Effects of Epigallocatechingallate on Retinal Function in Glaucoma [NCT00476138]Phase 1/Phase 240 participants (Anticipated)Interventional2006-11-30Recruiting
Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women With a History of Hormone Receptor-Negative Breast Cancer [NCT00516243]Phase 140 participants (Actual)Interventional2007-07-31Completed
Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients With Barrett's Esophagus [NCT00233935]Phase 155 participants (Actual)Interventional2005-11-30Completed
Phase I Drug Interaction Clinical Study of Polyphenon E [NCT00091325]Phase 10 participants Interventional2004-10-31Completed
Placebo-Controlled, Dose-Blinded, Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Polyphenon E (EGCG) 14 Day Monotherapy in Antiretroviral Naïve and Experienced, HIV-1-Infected Subjects [NCT01433289]Phase 123 participants (Actual)Interventional2010-12-31Completed
A Phase II Trial of Polyphenon E for Cervical Cancer Prevention [NCT00303823]Phase 298 participants (Actual)Interventional2005-09-30Completed
A Phase 2 Randomized Controlled Trial of Epigallocatechin-3-Gallate (EGCG) on Frailty and Inflammation in Older Survivors of Cancer [NCT06068543]Phase 2118 participants (Anticipated)Interventional2024-01-01Not yet recruiting
Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool [NCT01699711]Phase 287 participants (Actual)Interventional2012-02-29Completed
Study of Epstein-Barr Virus Reactivation and the Effect of Dietary Supplement Epigallocatechin Gallate (EGCG) on Virus Reactivation in Remission Patients With Nasopharyngeal Carcinoma - A Randomized Trial [NCT01744587]353 participants (Actual)Interventional2013-04-30Active, not recruiting
Impact of Slowly Digestible Carbohydrates on the Gut-brain Axis [NCT05349903]20 participants (Actual)Interventional2021-11-10Completed
Randomized Phase II Trial of Polyphenon E vs.Placebo in Patients at High Risk of Recurrent Colonic Neoplasia [NCT01606124]Phase 239 participants (Actual)Interventional2012-06-30Terminated(stopped due to pending expiration of the supply of study agent.)
A Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Green Tea on Albuminuria in Patients With Diabetic Nephropathy and Use of Maximum Dose of ACE-I and / or Angiotensin II Receptor Blocker. [NCT01923597]Phase 250 participants (Actual)Interventional2013-11-30Completed
The Use of Vitamin D in Combination With Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in the Treatment of Women With Uterine Fibroid [NCT05448365]Phase 360 participants (Anticipated)Interventional2022-07-01Recruiting
Effect of Epigallocatechin-3-Gallate Solution Versus Sodium Hypochlorite as a Root Canal Irrigant on Post-Operative Pain Intensity and Bacterial Load Reduction in Asymptomatic Necrotic Mandibular Premolars: A Randomized Clinical Trial [NCT05988788]42 participants (Anticipated)Interventional2023-10-31Not yet recruiting
Phase 2 Randomized Placebo Controlled Trial of Polyphenon E in MS [NCT01451723]Phase 211 participants (Actual)Interventional2011-07-31Terminated(stopped due to Unusual high frequency of elevated liver function tests.)
A Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Trial to Protect Health Workers Against COVID-19 by Using Previfenon® as Chemoprophylaxis During a SARS-CoV-2 Outbreak. The HERD Study [NCT04446065]Phase 2/Phase 3524 participants (Anticipated)Interventional2020-09-30Not yet recruiting
Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis [NCT05116098]Phase 1100 participants (Anticipated)Interventional2021-11-30Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

TrialOutcome
NCT00253643 (2) [back to overview]Cell Proliferation by Ki67-immunohistochemistry at Pre- and Post-intervention
NCT00253643 (2) [back to overview]Fatty Acid Synthase Expression by Immunohistochemistry at Pre- and Post-intervention (FAS Summary Score)
NCT00303823 (4) [back to overview]Progression - Persistent Oncogenic HPV Positivity, With Evidence of Progression to Worsening Cervical Intraepithelial Neoplasia or Invasive Cancer
NCT00303823 (4) [back to overview]Partial Response - Clearance of Oncogenic HPV With Evidence of Low Grade Cervical Intraepithelial Neoplasia
NCT00303823 (4) [back to overview]No Response - Persistent Oncogenic HPV Positivity, With or Without Evidence of Low Grade Cervical Intraepithelial Neoplasia
NCT00303823 (4) [back to overview]Complete Response - Clearance of Oncogenic Human Papillomavirus (HPV) and Complete Colposcopic, Histologic and Cytologic Clearance of Disease
NCT00666562 (13) [back to overview]Absolute Change for Baseline From EGCG in Serum Samples
NCT00666562 (13) [back to overview]Absolute Change for Baseline of EGCG in Urine Samples
NCT00666562 (13) [back to overview]Levels of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Tumor Tissue Samples
NCT00666562 (13) [back to overview]Serum Insulin Growth Factor-1 (IGF-1) Levels Assessed by ELISA
NCT00666562 (13) [back to overview]Serum IGFBP-3 Levels Assessed by ELISA
NCT00666562 (13) [back to overview]Metabolism of EGCG in Serum and Urine in Relation to Pharmacogenetic Polymorphisms in Uridinediphosphate- Glucuronosyltransferase (UGT)
NCT00666562 (13) [back to overview]Metabolism of EGCG in Serum and Urine in Relation to Pharmacogenetic Polymorphisms in Catechol-O-Methyltransferase (COMT)
NCT00666562 (13) [back to overview]Levels of Surrogate Intermediate Endpoint Biomarkers in Malignant and Nonmalignant Bladder Tissue Assessed by Immunohistochemistry
NCT00666562 (13) [back to overview]Levels of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Normal Tissue Samples
NCT00666562 (13) [back to overview]Absolute Change From Baseline of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Plasma Samples
NCT00666562 (13) [back to overview]Epigallocatechin Gallate (EGCG) Levels in Nonmalignant Bladder Tissue (e.g., Normal-appearing Urothelium, Inflammatory Lesions in the Bladder, Sessile Noninvasive Bladder Tumors, and Papillary Noninvasive Bladder Tumors)
NCT00666562 (13) [back to overview]Absolute Change From Baseline of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E in Urine Samples
NCT00666562 (13) [back to overview]Levels of EGCG in Malignant Bladder Tissue
NCT00942422 (1) [back to overview]Sustained M-protein Reduction of ≥ 25% From Baseline
NCT01433289 (5) [back to overview]Composite of Pharmacokinetics Time Frame: Predose, 0,0.5,1,1.5,2,3,4,6,8,12 Hours Post-dose
NCT01433289 (5) [back to overview]Number of Participants With Adverse Events
NCT01433289 (5) [back to overview]Median Change of log10 HIV-1 RNA Copies/ml
NCT01433289 (5) [back to overview]Number of Participants Achieving > 0.75 or 1.0 log10 Reduction in HIV-1 RNA or <400 Copies/ml
NCT01433289 (5) [back to overview]The Mean Change in CD4+ T Lymphocyte Counts
NCT01606124 (2) [back to overview]Percent Change in Rectal ACF, Pre- and Post Intervention at 6 Months
NCT01606124 (2) [back to overview]Tolerability as Estimated Using the Percent Dose of Treatment Received at 6 Months
NCT03928847 (6) [back to overview]Change of Serum Biomarker COMP Before and After EGCG Treatment in ILD Patients
NCT03928847 (6) [back to overview]Difference of Biomarker Collagen I Between EGCG-treated and Non-treated Patient Groups
NCT03928847 (6) [back to overview]EGCG PK Level in Healthy Volunteers
NCT03928847 (6) [back to overview]Change of Serum Biomarker Periostin Before and After EGCG Treatment in ILD Patients
NCT03928847 (6) [back to overview]Difference of Biomarker Snail1 Between EGCG-treated and Non-treated Patient Groups
NCT03928847 (6) [back to overview]Difference of Biomarker p-Smad3 Between EGCG-treated and Non-treated Patient Groups
NCT04177693 (11) [back to overview]Change in Serum Folate Level Between DHFR-Wild Type (WT) Group and DHFR-Hetero or Homo Group.
NCT04177693 (11) [back to overview]Change in Serum Folate Level Between MTHFR1298-Wild Type (WT) Group and MTHFR1298-Hetero Group
NCT04177693 (11) [back to overview]Changes in Total Bilirubin
NCT04177693 (11) [back to overview]Changes in Estrogen (E2)
NCT04177693 (11) [back to overview]Changes in Epigallocatechin Gallate (EGCG)
NCT04177693 (11) [back to overview]Changes in Epigallocatechin (EGC)
NCT04177693 (11) [back to overview]Changes in Epicatechin Gallate(ECG)
NCT04177693 (11) [back to overview]Change in Serum Folate Level Between MTHFR677-Wild Type (WT) Group and MTHFR677-Hetero Group
NCT04177693 (11) [back to overview]Changes in Endometrial Thickness
NCT04177693 (11) [back to overview]Changes in ALT/SGPT
NCT04177693 (11) [back to overview]Changes in Alkaline Phosphatase

Cell Proliferation by Ki67-immunohistochemistry at Pre- and Post-intervention

Cell Proliferation by Ki67 is calculated as the percent stained by immunohistochemistry. Ki-67 values were log-transformed because the original distribution was skewed. Analysis was done on log-base2 transformed values. (NCT00253643)
Timeframe: End of study

Intervention%age of cells & nuclei stained (Median)
Arm I18.5
Arm II8
Arm III10
Arm IV12

[back to top]

Fatty Acid Synthase Expression by Immunohistochemistry at Pre- and Post-intervention (FAS Summary Score)

Sections of paraffin-embedded prostate biopsy tissue were stained for fatty acid synthase (FAS) expression. The FAS Summary Score was calculated as the product of percent stained (1=0-25%, 2=25-50%, 3=51-75%, 4=76-100%) and stain intensity (0-3) by immunohistochemistry. The range of the product is 0-300. (NCT00253643)
Timeframe: Baseline (pre-intervention) and end of study (time to surgery for those with malignant findings or up to 8 weeks for those with benign biopsies, post-intervention)

,,,
Interventionunits on a scale (Mean)
PRE dataPOST data
Arm I147140.7
Arm II158.8159.3
Arm III138.3145.2
Arm IV102.3152.2

[back to top]

Progression - Persistent Oncogenic HPV Positivity, With Evidence of Progression to Worsening Cervical Intraepithelial Neoplasia or Invasive Cancer

(NCT00303823)
Timeframe: 4 months

Interventionparticipants (Number)
Polyphenon E6
Placebo3

[back to top]

Partial Response - Clearance of Oncogenic HPV With Evidence of Low Grade Cervical Intraepithelial Neoplasia

(NCT00303823)
Timeframe: 4 months

Interventionparticipants (Number)
Polyphenon E1
Placebo6

[back to top]

No Response - Persistent Oncogenic HPV Positivity, With or Without Evidence of Low Grade Cervical Intraepithelial Neoplasia

(NCT00303823)
Timeframe: 4 months

Interventionparticipants (Number)
Polyphenon E27
Placebo26

[back to top]

Complete Response - Clearance of Oncogenic Human Papillomavirus (HPV) and Complete Colposcopic, Histologic and Cytologic Clearance of Disease

(NCT00303823)
Timeframe: 4 months

Interventionparticipants (Number)
Polyphenon E7
Placebo6

[back to top]

Absolute Change for Baseline From EGCG in Serum Samples

The difference between the amount at the end of study (up to 28 days) from baseline. (NCT00666562)
Timeframe: Baseline and up to 28 days

Interventionng/mL (Mean)
Arm I (Placebo)0.28
Arm II (800mg Polyphenon E, Placebo)82.33
Arm III (1200mg Polyphenon E)85.37

[back to top]

Absolute Change for Baseline of EGCG in Urine Samples

The difference between the amount at the end of study (up to 28 days) from baseline. (NCT00666562)
Timeframe: Baseline and up to 28 days

Interventionng/mL (Mean)
Arm I (Placebo)0.00
Arm II (800mg Polyphenon E, Placebo)1.93
Arm III (1200mg Polyphenon E)3.38

[back to top]

Levels of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Tumor Tissue Samples

(NCT00666562)
Timeframe: up to 28 days

,,
Interventionng/mL (Mean)
epicatechin gallate (ECG)epicatechin (EC)epigallocatechin (EGC)
Arm I (Placebo)0.000.000.00
Arm II (800mg Polyphenon E, Placebo)0.000.000.00
Arm III (1200mg Polyphenon E)0.000.000.60

[back to top]

Serum Insulin Growth Factor-1 (IGF-1) Levels Assessed by ELISA

(NCT00666562)
Timeframe: Baseline and up to day 28

,,
Interventionng/mL (Mean)
BaselineEnd of Study
Arm I (Placebo)135.06131.86
Arm II (800mg Polyphenon E, Placebo)122.22124.22
Arm III (1200mg Polyphenon E)132.12132.27

[back to top]

Serum IGFBP-3 Levels Assessed by ELISA

(NCT00666562)
Timeframe: Baseline and up to 28 days

,,
Interventionng/mL (Mean)
BaselineEnd of Study
Arm I (Placebo)1918.312020.31
Arm II (800mg Polyphenon E, Placebo)1679.611800.08
Arm III (1200mg Polyphenon E)1824.861624.03

[back to top]

Metabolism of EGCG in Serum and Urine in Relation to Pharmacogenetic Polymorphisms in Uridinediphosphate- Glucuronosyltransferase (UGT)

(NCT00666562)
Timeframe: At Baseline

,,,
Interventionng/mL (Mean)
PlasmaUrine
5/6 Genotype2.971.72
6/6 Genotype2.090.86
6/7 Genotype2.020.10
7/7 Genotype0.000.00

[back to top]

Metabolism of EGCG in Serum and Urine in Relation to Pharmacogenetic Polymorphisms in Catechol-O-Methyltransferase (COMT)

(NCT00666562)
Timeframe: At Baseline

,,
Interventionng/mL (Mean)
PlasmaSerum
Alanine/Alanine2.480.43
Alanine/Glycine0.570.69
Glycine/Glycine4.120.00

[back to top]

Levels of Surrogate Intermediate Endpoint Biomarkers in Malignant and Nonmalignant Bladder Tissue Assessed by Immunohistochemistry

(NCT00666562)
Timeframe: up to 28 days

,,
Interventionoptical density (Mean)
PCNAMMP2ClusterinVEGFp27
Arm I (Placebo)0.410.160.0740.0110.36
Arm II (800mg Polyphenon E, Placebo)0.380.180.0610.0210.35
Arm III (1200mg Polyphenon E)0.350.160.0460.0130.31

[back to top]

Levels of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Normal Tissue Samples

(NCT00666562)
Timeframe: up to 28 days

,,
Interventionng/mL (Mean)
epicatechin gallate (ECG)epicatechin (EC)epigallocatechin (EGC)
Arm I (Placebo)0.000.000.00
Arm II (800mg Polyphenon E, Placebo)0.000.000.20
Arm III (1200mg Polyphenon E)0.000.200.00

[back to top]

Absolute Change From Baseline of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E Plasma Samples

The difference between the amount at the end of study (up to 28 days) from baseline. (NCT00666562)
Timeframe: Baseline and up to 28 days

,,
Interventionng/mL (Mean)
epicatechin gallate (ECG)epicatechin (EC)epigallocatechin (EGC)
Arm I (Placebo)0.170.000.00
Arm II (800mg Polyphenon E, Placebo)8.380.976.93
Arm III (1200mg Polyphenon E)8.620.313.46

[back to top]

Epigallocatechin Gallate (EGCG) Levels in Nonmalignant Bladder Tissue (e.g., Normal-appearing Urothelium, Inflammatory Lesions in the Bladder, Sessile Noninvasive Bladder Tumors, and Papillary Noninvasive Bladder Tumors)

Comparison of nonmalignant bladder tissue levels of EGCG between the placebo group and the EGCG groups combined using student t-test. (NCT00666562)
Timeframe: up to 28 days

Interventionng/mL (Mean)
Arm I (Placebo)0.00
Arm II (800mg Polyphenon E, Placebo)0.50
Arm III (1200mg Polyphenon E)1.72

[back to top]

Absolute Change From Baseline of Other Catechins (Epicatechin Gallate, Epicatechin, and Epigallocatechin) Found in Polyphenon E in Urine Samples

The difference between the amount at the end of study (up to 28 days) from baseline. (NCT00666562)
Timeframe: Baseline and up to 28 days

,,
Interventionng/mL (Mean)
epicatechin gallate (ECG)epicatechin (EC)Epigallocatechin (EGC)
Arm I (Placebo)0.000.520.20
Arm II (800mg Polyphenon E, Placebo)1.132.413.60
Arm III (1200mg Polyphenon E)1.495.3312.16

[back to top]

Levels of EGCG in Malignant Bladder Tissue

(NCT00666562)
Timeframe: up to 28 days

Interventionng/mL (Mean)
Arm I (Placebo)0.00
Arm II (800mg Polyphenon E, Placebo)0.00
Arm III (1200mg Polyphenon E)2.54

[back to top]

Sustained M-protein Reduction of ≥ 25% From Baseline

"This is a monthly blood test, done at the beginning of each cycle of therapy. The M-protein is a surrogate marker routinely used to estimate the degree of plasma cell cyto-reduction brought about by therapy. In active multiple myeloma, a 25% reduction in the M-protein level would correspond to a minor response, an improvement recognized as having some clinical benefit." (NCT00942422)
Timeframe: Day one of each 28-day cycle for a total of up to 6 cycles

Interventionpercentage of patients (Number)
Defined Green Tea Catechin Extract / Correlative Analysis0

[back to top]

Composite of Pharmacokinetics Time Frame: Predose, 0,0.5,1,1.5,2,3,4,6,8,12 Hours Post-dose

Plasma PK parameters of EGCG after single dose and at steady state (after 14 day EGCG treatment). (NCT01433289)
Timeframe: Predose, 0,0.5,1,1.5,2,3,4,6,8,12 Hours Post-dose on Days 1 and 14

,,
InterventionRatio (Geometric Mean)
t 1/2CmaxAUC 0-12CL/F
Polyphenon E 1600 mg/Day1.081.211.40.75
Polyphenon E 2400 mg/Day1.141.331.280.81
Polyphenon E 3200 mg/Day0.90.650.881.21

[back to top]

Number of Participants With Adverse Events

Safety of Polyphenon E (800mg, 1200mg, 1600mg EGCG twice daily for 14 days) in HIV-1-infected subjects. (NCT01433289)
Timeframe: 14 days

,,,
InterventionParticipants (Count of Participants)
Grade 1 AE Grade 1 AE- Mild; asymptomatic or mild symptoms, intervention not indicatedGrade 2 AE- Moderate; minimal, local or noninvasive intervention indicatedGrade 3 AE- Severe; but not immediately life-threatening; hospitalization indicated; disablingGrade 4 AE- Life-threatening consequences; urgent intervention indicated.Grade 5 AE- Death related to AE
Placebo00000
Polyphenon E 1600 mg/Day10000
Polyphenon E 2400 mg/Day20000
Polyphenon E 3200 mg/Day30000

[back to top]

Median Change of log10 HIV-1 RNA Copies/ml

Median change of log10 HIV-1 RNA copies/ml from baseline in subjects who have completed 14 days of treatment (800mg, 1200mg, 1600mg EGCG bid) or placebo. (NCT01433289)
Timeframe: Baseline and 14 days

Interventionlog10 HIV RNA copies/ml (Median)
Polyphenon E 1600 mg/Day0.01
Polyphenon E 2400 mg/Day-0.07
Polyphenon E 3200 mg/Day0.17
Placebo Placebo0.01

[back to top]

Number of Participants Achieving > 0.75 or 1.0 log10 Reduction in HIV-1 RNA or <400 Copies/ml

The number of participants achieving >0.75 or 1.0 log10 reduction in HIV-1 RNA or <400 copies/ml with 14 days of Polyphenon E (800mg, 1200mg, or 1600mg EGCG bid) or placebo. (NCT01433289)
Timeframe: Baseline to 14 days

Interventionparticipants (Number)
Polyphenon E 1600 mg/Day0
Polyphenon E 2400 mg/Day0
Polyphenon E 3200 mg/Day0
Placebo0

[back to top]

The Mean Change in CD4+ T Lymphocyte Counts

The mean change in CD4+ T lymphocyte counts when participants have had Polyphenon E (800mg, 1200mg, 1600mg EGCG bid for 14 days). (NCT01433289)
Timeframe: Baseline to 14 days

Intervention10^6 cells/L (Mean)
Polyphenon E 1600 mg/Day11.833333
Polyphenon E 2400 mg/Day16.166667
Polyphenon E 3200 mg/Day11.800000
Placebo Placebo8.166667

[back to top]

Percent Change in Rectal ACF, Pre- and Post Intervention at 6 Months

The primary endpoint is based on a modified intent-to-treat procedure which includes all patients with baseline and 6-month ACF data. The percent change in rectal ACF (≤ 15 cm from the anal verge) for each patient is calculated as their Pre-Registration number of rectal ACF minus the number of rectal ACF present at the 6-month post-intervention exam, divided by the number of rectal ACF present at Pre-Registration times 100. (NCT01606124)
Timeframe: 6 months

Interventionpercentage change (Mean)
Arm I (Polyphenon E)3.7
Arm II (Placebo)0.0

[back to top]

Tolerability as Estimated Using the Percent Dose of Treatment Received at 6 Months

Tolerability as estimated using the percent dose of treatment received for each patient by dividing the total dose received by the targeted (i.e., protocol specified) total dose. (NCT01606124)
Timeframe: 6 months

Interventionpercentage of targeted dose (Mean)
Arm I (Polyphenon E)83.2
Arm II (Placebo)91.7

[back to top]

Change of Serum Biomarker COMP Before and After EGCG Treatment in ILD Patients

Change from baseline to day 14 in serum biomarkers associated with IPF, Cartilage Oligomeric Matrix Protein (COMP) measured by ELISA. (NCT03928847)
Timeframe: Day 1 to day 14

Interventionng/ml (Mean)
Before EGCG treatmentAfter EGCG treatment
EGCG Treatment in ILD Patients137.297.9

[back to top]

Difference of Biomarker Collagen I Between EGCG-treated and Non-treated Patient Groups

Levels of biomarker Collagen I in lung biopsy tissues 14 days after EGCG were measured by western blot and differences were compared between EGCG-treated and non-treated groups. (NCT03928847)
Timeframe: 14 days

Interventionpercentage of reference sample (Mean)
No Treatment Control in ILD Patients0.894
EGCG Treatment in ILD Patients0.136

[back to top]

EGCG PK Level in Healthy Volunteers

EGCG plasma levels in healthy volunteers were measured at 0, 0.5, 2, and 4 hours after a single dose at 450 mg, 600 mg, or 750 mg dosage by liquid chromatography-mass spectrometry (LC-MS). (NCT03928847)
Timeframe: 0, 0.5, 2, 4 hours after EGCG

,,
InterventionnM (Mean)
0 hour after EGCG0.5 hour after EGCG2 hours after EGCG4 hours after EGCG
ECGC PK in Healthy Volunteers 600 mgNA6122266741
EGCG PK in Healthy Volunteers 450 mgNA8611136659
EGCG PK in Healthy Volunteers 750 mgNA31261582702

[back to top]

Change of Serum Biomarker Periostin Before and After EGCG Treatment in ILD Patients

Change from baseline to day 14 in serum biomarkers associated with IPF, Periostin measured by ELISA. (NCT03928847)
Timeframe: Day 1 to day 14

Interventionng/ml (Mean)
Before EGCG treatmentAfter EGCG treatment
EGCG Treatment in ILD Patients41.935.2

[back to top]

Difference of Biomarker Snail1 Between EGCG-treated and Non-treated Patient Groups

Levels of biomarker Snail1 in lung biopsy tissues 14 days after EGCG were measured by western blot and differences were compared between EGCG-treated and non-treated groups. (NCT03928847)
Timeframe: 14 days

Interventionpercentage of reference sample (Mean)
No Treatment Control in ILD Patients0.825
EGCG Treatment in ILD Patients0.132

[back to top]

Difference of Biomarker p-Smad3 Between EGCG-treated and Non-treated Patient Groups

Levels of biomarker p-Smad3 in lung biopsy tissues 14 days after EGCG were measured by western blot and differences were compared between EGCG-treated and non-treated groups. (NCT03928847)
Timeframe: 14 days

Interventionpercentage of reference sample (Mean)
No Treatment Control in ILD Patients0.913
EGCG Treatment in ILD Patients0.284

[back to top]

Change in Serum Folate Level Between DHFR-Wild Type (WT) Group and DHFR-Hetero or Homo Group.

Change in serum folate levels between DHFR-Wild Type (WT) group and DHFR-Hetero or homo group. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

Interventionng/mL (Mean)
DHFR-Wild Type (WT) Group-3.9
DHFR-Hetero or Homo Group.-2.1

[back to top]

Change in Serum Folate Level Between MTHFR1298-Wild Type (WT) Group and MTHFR1298-Hetero Group

Change in serum folate levels between MTHFR1298-Wild Type (WT) group and MTHFR1298-Hetero group (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

Interventionng/mL (Mean)
MTHFR1298-Wild Type (WT) Group-1.5
MTHFR1298-Hetero Group-3.8

[back to top]

Changes in Total Bilirubin

Changes in total bilirubin between the 3 groups. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

Interventionmg/dL (Mean)
EGCG Daily Alone.0.1
EGCG With Clomiphene Citrate0
EGCG With Letrozole0

[back to top]

Changes in Estrogen (E2)

Changes in Estrogen (E2) between the 3 groups. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

Interventionpg/mL (Mean)
EGCG Daily Alone.-50.9
EGCG With Clomiphene Citrate-49.4
EGCG With Letrozole-50.2

[back to top]

Changes in Epigallocatechin Gallate (EGCG)

Changes in epigallocatechin gallate (EGCG) from Visit 1 to Visit 4 (end of study). EGCG levels measured at 1 hour after taking study medication were used for both visits. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

InterventionnM (Median)
EGCG Daily Alone.5.8
EGCG With Clomiphene Citrate256.3
EGCG With Letrozole86.4

[back to top]

Changes in Epigallocatechin (EGC)

Changes in epigallocatechin (EGC) from Visit 1 to Visit 4 (end of study). EGC levels measured at 1 hour after taking study medication were used for both visits. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

InterventionnM (Median)
EGCG Daily Alone.-58.9
EGCG With Clomiphene Citrate8.9
EGCG With Letrozole35.4

[back to top]

Changes in Epicatechin Gallate(ECG)

Changes in epicatechin gallate(ECG) from Visit 1 to Visit 4 (end of study). ECG levels measured at 1 hour after taking study medication were used for both visits. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

InterventionnM (Median)
EGCG Daily Alone.7.6
EGCG With Clomiphene Citrate64.1
EGCG With Letrozole60.3

[back to top]

Change in Serum Folate Level Between MTHFR677-Wild Type (WT) Group and MTHFR677-Hetero Group

Change in serum folate levels between MTHFR677-Wild Type (WT) group and MTHFR677-Hetero group (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

Interventionng/mL (Mean)
MTHFR677-Wild Type (WT) Group-3.2
MTHFR677-Hetero Group-2.0

[back to top]

Changes in Endometrial Thickness

Changes in endometrial thickness between the 3 groups. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

Interventionmm (Mean)
EGCG Daily Alone.-1.9
EGCG With Clomiphene Citrate1.4
EGCG With Letrozole0.6

[back to top]

Changes in ALT/SGPT

Changes in alanine aminotransferase /SGPT between the 3 groups. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

InterventionU/L (Mean)
EGCG Daily Alone.1.1
EGCG With Clomiphene Citrate4.4
EGCG With Letrozole-1.0

[back to top]

Changes in Alkaline Phosphatase

Changes in Alkaline Phosphatase between the 3 groups. (NCT04177693)
Timeframe: Baseline, and Visit 4 (end of study, up to 40 days)

InterventionU/L (Mean)
EGCG Daily Alone.-1.5
EGCG With Clomiphene Citrate-5.6
EGCG With Letrozole-6.0

[back to top]